MORGAN STANLEY (Form: 10-Q, Received: 11/03/2020 16:09:46)

$ in millions

At
September 30,
2020

At
June 30,
2020

Derivatives

Funding liabilities²

false--12-31Q32020truefalse0000895421MORGAN STANLEY0.370.160.200.230.070.077809000000101850000000.01240.01110.01170.01010.00250.01100.00680.01100.01300.01050.01141283860000001229330000001.001.00160.17241.0070.0870.75110.15110.99170.21291.0070.1080.50110.15110.980.010.0135000000003500000000203889397920388939791593973680157644798864461000000691440000000.070.440.940.260.100.000.070.050.380.750.260.020.210.780.250.000.060.700.980.130.060.000.060.060.370.720.280.020.230.810.280.001.080.961.000.800.00390.090.110.000.690.150.00090.010.840.470.930.280.00190.020.531.030.620.801.030.051.080.510.100.510.000.700.011.020.940.470.960.031.04209900000036790000000.180.940.100.460.630.130.440.720.631.830.991821.040.620.01170.04690.900.980.600.440.000.950.110.561.560.150.630.901.560.160.950.100.460.590.140.410.720.590.070.4330.000.290.00470.00090.090.050.790.110.020.850.100.320.240.040.240.470.240.180.93280.450.360.00840.00810.360.700.370.010.060.200.060.080.370.620.130.440.870.620.950.991160.950.560.01380.04350.920.960.600.440.000.050.090.591.620.320.640.971.620.180.060.080.370.750.080.420.920.750.080.4310.000.290.00710.00200.160.050.600.070.020.070.080.130.000.040.250.590.000.190.92280.520.350.01160.00790.420.700.170.010.950.060.95400000015000000320400000034420000000.04460.03180.00690.02870.02250.02970.06680.05800.00520.01910.03800.03797330000001166000000444920299462445991 0000895421 2020-01-01 2020-09-30 0000895421 ms:MorganStanleyCushingMLPHighIncomeIndexETNsdueMarch212031Member 2020-01-01 2020-09-30 0000895421 us-gaap:SeriesFPreferredStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:SeriesEPreferredStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:SeriesAPreferredStockMember 2020-01-01 2020-09-30 0000895421 ms:SeriesLPreferredStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0000895421 ms:GlobalMediumTermNotesSeriesAFixedRateStepUpSeniorNotesDue2026ofMorganStanleyFinanceLLCMember 2020-01-01 2020-09-30 0000895421 ms:SeriesKPreferredStockMember 2020-01-01 2020-09-30 0000895421 ms:SeriesIPreferredStockMember 2020-01-01 2020-09-30 0000895421 2020-10-30 0000895421 2020-07-01 2020-09-30 0000895421 2019-07-01 2019-09-30 0000895421 2019-01-01 2019-09-30 0000895421 2020-09-30 0000895421 2019-12-31 0000895421 us-gaap:PreferredStockMember 2019-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2020-06-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000895421 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2019-12-31 0000895421 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0000895421 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2020-09-30 0000895421 2019-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2019-01-01 2019-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0000895421 us-gaap:TreasuryStockMember 2019-09-30 0000895421 us-gaap:TreasuryStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2019-09-30 0000895421 us-gaap:RetainedEarningsMember 2020-06-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000895421 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0000895421 us-gaap:PreferredStockMember 2020-09-30 0000895421 us-gaap:RetainedEarningsMember 2019-09-30 0000895421 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0000895421 us-gaap:TreasuryStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2019-12-31 0000895421 us-gaap:TreasuryStockMember 2020-07-01 2020-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2019-09-30 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2018-12-31 0000895421 us-gaap:TreasuryStockMember 2018-12-31 0000895421 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2019-06-30 0000895421 us-gaap:NoncontrollingInterestMember 2020-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2019-12-31 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-06-30 0000895421 us-gaap:NoncontrollingInterestMember 2018-12-31 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:RetainedEarningsMember 2019-06-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000895421 us-gaap:RetainedEarningsMember 2018-12-31 0000895421 us-gaap:CommonStockMember 2019-09-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2020-01-01 2020-09-30 0000895421 us-gaap:NoncontrollingInterestMember 2020-06-30 0000895421 us-gaap:TreasuryStockMember 2019-12-31 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2019-06-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2019-09-30 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2020-06-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2018-12-31 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2018-12-31 0000895421 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2020-09-30 0000895421 us-gaap:TreasuryStockMember 2020-09-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2020-07-01 2020-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000895421 us-gaap:TreasuryStockMember 2019-06-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2020-07-01 2020-09-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2019-06-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2019-07-01 2019-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000895421 us-gaap:CommonStockMember 2020-09-30 0000895421 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2019-07-01 2019-09-30 0000895421 ms:CommonStockIssuedToEmployeeTrustMember 2020-06-30 0000895421 us-gaap:TreasuryStockMember 2020-06-30 0000895421 us-gaap:TrustForBenefitOfEmployeesMember 2019-01-01 2019-09-30 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0000895421 us-gaap:RetainedEarningsMember 2019-12-31 0000895421 us-gaap:RetainedEarningsMember 2020-09-30 0000895421 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000895421 2018-12-31 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member ms:AllowanceforCreditLossesonEmployeeLoansMember 2019-12-31 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member ms:AllowanceforCreditLossesMember 2019-12-31 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member us-gaap:RetainedEarningsMember 2019-12-31 0000895421 ms:ETRADEFinancialCorporationMember us-gaap:SubsequentEventMember 2020-10-02 0000895421 ms:EatonVanceCorp.Member us-gaap:SubsequentEventMember 2020-10-08 0000895421 ms:EatonVanceCorp.Member us-gaap:SubsequentEventMember 2020-10-08 2020-10-08 0000895421 ms:ETRADEFinancialCorporationMember us-gaap:SubsequentEventMember 2020-10-02 2020-10-02 0000895421 ms:ETRADEFinancialCorporationMember ms:SeriesMPreferredStockandSeriesNPreferredStockMember us-gaap:SubsequentEventMember 2020-10-02 2020-10-02 0000895421 ms:ETRADEFinancialCorporationMember us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2020-10-02 2020-10-02 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:SecuredLendingFacilitiesMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:SecuritiesBasedLendingandOtherLoansMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:CommercialPortfolioSegmentMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:SecuredLendingFacilitiesMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:SecuritiesBasedLendingandOtherLoansMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:CommercialPortfolioSegmentMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:ResidentialPortfolioSegmentMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:ResidentialPortfolioSegmentMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember 2020-09-30 0000895421 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2020-01-01 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-07-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-07-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-07-01 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2019-06-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2020-06-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-01-01 2019-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2019-01-01 2019-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-06-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-07-01 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2018-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2019-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2018-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-06-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-01-01 2019-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:OtherSecuredFinancingsMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:BorrowingsMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:DepositsMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2018-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:NonderivativeTradingLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2018-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-06-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member ms:CorporateandOtherDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000895421 us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember 2019-12-31 0000895421 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000895421 2020-04-01 2020-06-30 0000895421 2020-01-01 2020-03-31 0000895421 ms:AccountsReceivableAndOtherReceivablesNetMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FutureMember 2019-12-31 0000895421 ms:AccountsReceivableAndOtherReceivablesNetMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FutureMember 2020-09-30 0000895421 us-gaap:PrivateEquityFundsMember 2020-09-30 0000895421 us-gaap:RealEstateFundsMember 2020-09-30 0000895421 us-gaap:RealEstateFundsMember 2019-12-31 0000895421 us-gaap:HedgeFundsMember 2020-09-30 0000895421 us-gaap:HedgeFundsMember 2019-12-31 0000895421 us-gaap:PrivateEquityFundsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:PropertyPlantAndEquipmentAndCapitalizedSoftwareCostsMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherInvestmentsMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:PropertyPlantAndEquipmentAndCapitalizedSoftwareCostsMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:LiabilityMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLiabilitiesMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:PropertyPlantAndEquipmentAndCapitalizedSoftwareCostsMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:LendingCommitmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:LiabilityMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:AssetsMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherInvestmentsMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:IntangibleAssetsMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLiabilitiesMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:LiabilityMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:AssetsMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLiabilitiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLiabilitiesMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:PropertyPlantAndEquipmentAndCapitalizedSoftwareCostsMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:IntangibleAssetsMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:LendingCommitmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherInvestmentsMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:AssetsMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherInvestmentsMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:LendingCommitmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:AssetsMember 2019-01-01 2019-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:LendingCommitmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:IntangibleAssetsMember 2020-07-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:LiabilityMember 2020-01-01 2020-09-30 0000895421 us-gaap:FairValueMeasurementsNonrecurringMember ms:IntangibleAssetsMember 2019-07-01 2019-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel12And3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateEquitiesMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueCorporateLoanModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputWeightedAverageCostOfCapitalMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueWarehouseModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCreditCorrelationMember ms:ValuationTechniqueCorrelationModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueCorporateLoanModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputWeightedAverageCostOfCapitalMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputExitMultipleMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputExitMultipleMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCreditCorrelationMember ms:ValuationTechniqueCorrelationModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputFundingSpreadMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCommodityVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputMarginLoanMember ms:ValuationTechniqueMarginLoanMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputForeignExchangeVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCreditCorrelationMember ms:ValuationTechniqueCorrelationModelMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputContingencyProbabilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputForwardPowerPriceMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCommodityVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputForwardPowerPriceMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCrossCommodityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputVolatilitySkewMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueCorporateLoanModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputContingencyProbabilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCrossCommodityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCreditCorrelationMember ms:ValuationTechniqueCorrelationModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueCorporateLoanModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputExitMultipleMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputMarginLoanMember ms:ValuationTechniqueMarginLoanMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputContingencyProbabilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueWarehouseModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCommodityVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputContingencyProbabilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputFundingSpreadMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputForwardPowerPriceMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueWarehouseModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputForeignExchangeVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputWeightedAverageCostOfCapitalMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputExitMultipleMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCommodityVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueWarehouseModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputFundingSpreadMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputFundingSpreadMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueWarehouseModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCommodityVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputContingencyProbabilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputForeignExchangeVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputForwardPowerPriceMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member ms:CorporateEquitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCrossCommodityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInflationVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputFundingSpreadMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCreditCorrelationMember ms:ValuationTechniqueCorrelationModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputForeignExchangeVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCrossCommodityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueWarehouseModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputWeightedAverageCostOfCapitalMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCommodityVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputVolatilitySkewMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputForwardPowerPriceMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueCorporateLoanModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputForwardPowerPriceMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:MeasurementInputDiscountRateMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCrossCommodityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputVolatilitySkewMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:MeasurementInputDiscountRateMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputContingencyProbabilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateCurveCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputWeightedAverageCostOfCapitalMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputBondVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:MeasurementInputDiscountRateMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputExitMultipleMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueMarginLoanMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MeasurementInputCreditSpreadMember ms:ValuationTechniqueCorporateLoanModelMember 2020-09-30 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CorporateandOtherDebtSecuritiesMember ms:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputAtTheMoneyVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCashSyntheticBasisMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputInterestRateCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputMarginLoanMember ms:ValuationTechniqueMarginLoanMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCreditCorrelationMember ms:ValuationTechniqueCorrelationModelMember 2020-09-30 0000895421 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputCashSyntheticBasisMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateCurveMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MortgageAndAssetBackedSecuritiesMember ms:MeasurementInputBondPriceMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputEquityForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:SeniorDebtObligationsMember ms:MeasurementInputLoanPriceMember ms:ValuationTechniqueComparablePricingMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputFundingSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000895421 srt:ArithmeticAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CreditRiskContractMember ms:MeasurementInputFundingSpreadMember ms:ValuationTechniqueComparablePricingMember 2019-12-31 0000895421 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputEquityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2019-12-31 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2020-09-30 0000895421 srt:MedianMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputWeightedAverageCostOfCapitalMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember ms:MeasurementInputInterestRateForeignExchangeCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:CommodityAndOtherContractsMember ms:MeasurementInputCrossCommodityCorrelationMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember ms:MeasurementInputVolatilitySkewMember us-gaap:ValuationTechniqueOptionPricingModelMember 2020-09-30 0000895421 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember ms:MeasurementInputExitMultipleMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:TradingRevenueMember 2020-01-01 2020-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:OtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:DepositsMember us-gaap:OtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:TradingRevenueMember 2020-01-01 2020-09-30 0000895421 us-gaap:DebtMember us-gaap:TradingRevenueMember 2020-01-01 2020-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:OtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:TradingRevenueMember 2019-01-01 2019-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:OtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:DepositsMember us-gaap:OtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:DebtMember us-gaap:OtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:TradingRevenueMember 2019-01-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:TradingRevenueMember 2020-01-01 2020-09-30 0000895421 us-gaap:DebtMember us-gaap:TradingRevenueMember 2019-01-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:TradingRevenueMember 2019-01-01 2019-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:OtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:OtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:TradingRevenueMember 2020-07-01 2020-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:OtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:OtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:OtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:OtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:OtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000895421 us-gaap:DepositsMember us-gaap:TradingRevenueMember 2019-07-01 2019-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:OtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:TradingRevenueMember 2019-07-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:TradingRevenueMember 2020-07-01 2020-09-30 0000895421 us-gaap:DepositsMember us-gaap:OtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:TradingRevenueMember 2019-07-01 2019-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:OtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000895421 us-gaap:DebtMember us-gaap:TradingRevenueMember 2020-07-01 2020-09-30 0000895421 us-gaap:WrittenLoanCommitmentFairValueOptionMember us-gaap:TradingRevenueMember 2020-07-01 2020-09-30 0000895421 ms:LoansAndOtherDebtMember us-gaap:TradingRevenueMember 2019-07-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:InterestExpenseMember 2020-01-01 2020-09-30 0000895421 us-gaap:DebtMember 2019-01-01 2019-09-30 0000895421 us-gaap:DebtMember 2020-01-01 2020-09-30 0000895421 us-gaap:DebtMember 2020-07-01 2020-09-30 0000895421 us-gaap:DebtMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000895421 us-gaap:DebtMember 2019-07-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000895421 us-gaap:DebtMember us-gaap:InterestExpenseMember 2020-07-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000895421 us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:NondesignatedMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember 2019-12-31 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 us-gaap:ExchangeTradedMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeClearedMember 2019-12-31 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember 2019-12-31 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-09-30 0000895421 us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:NondesignatedMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember us-gaap:NondesignatedMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ExchangeClearedMember 2020-09-30 0000895421 us-gaap:NondesignatedMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ExchangeTradedMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember 2019-12-31 0000895421 ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2019-12-31 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember ms:SingleNameCreditDefaultSwapMember 2019-12-31 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember ms:IndexAndBasketCreditDefaultSwapMember 2019-12-31 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember ms:TranchedIndexAndBasketCreditDefaultSwapMember 2020-09-30 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember us-gaap:CreditDefaultSwapMember 2019-12-31 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember ms:IndexAndBasketCreditDefaultSwapMember 2020-09-30 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember us-gaap:CreditDefaultSwapMember 2020-09-30 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember ms:SingleNameCreditDefaultSwapMember 2020-09-30 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember ms:TranchedIndexAndBasketCreditDefaultSwapMember 2019-12-31 0000895421 us-gaap:BorrowingsMember 2019-12-31 0000895421 us-gaap:DepositsMember 2020-09-30 0000895421 us-gaap:BorrowingsMember 2020-09-30 0000895421 us-gaap:AvailableforsaleSecuritiesMember 2019-12-31 0000895421 us-gaap:AvailableforsaleSecuritiesMember 2020-09-30 0000895421 us-gaap:DepositsMember 2019-12-31 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember 2020-09-30 0000895421 us-gaap:CreditDefaultSwapBuyingProtectionMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2020-01-01 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2020-07-01 2020-09-30 0000895421 us-gaap:BorrowingsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-07-01 2019-09-30 0000895421 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2020-07-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2019-07-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2020-01-01 2020-09-30 0000895421 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:DepositsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2019-01-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2020-07-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2020-07-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000895421 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2019-01-01 2019-09-30 0000895421 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2019-07-01 2019-09-30 0000895421 us-gaap:BorrowingsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2020-01-01 2020-09-30 0000895421 us-gaap:BorrowingsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000895421 us-gaap:DepositsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2020-01-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2020-01-01 2020-09-30 0000895421 us-gaap:BorrowingsMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2020-07-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestIncomeMember 2020-07-01 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2019-12-31 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalNoninvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:CreditDefaultSwapMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember us-gaap:OtherCreditDerivativesMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember us-gaap:InternalInvestmentGradeMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:SingleNameCreditDefaultSwapMember 2019-12-31 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember 2019-12-31 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:CreditDerivativesSellingProtectionMember ms:TotalIndexAndBasketCreditDefaultSwapsMember 2019-12-31 0000895421 ms:DerivativeCreditRiskRelatedContingentFeaturestriggeringCircumstancesTwoNotchCreditRatingDowngradeMember 2020-09-30 0000895421 ms:DerivativeCreditRiskRelatedContingentFeaturesTriggeringCircumstancesOneNotchCreditRatingDowngradeMember 2020-09-30 0000895421 us-gaap:CollaborativeArrangementMember 2020-09-30 0000895421 ms:AssetBackedSecuritiesFederalFamilyEducationLoanProgramMember 2020-09-30 0000895421 us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000895421 ms:AssetBackedSecuritiesFederalFamilyEducationLoanProgramMember 2019-12-31 0000895421 us-gaap:USTreasurySecuritiesMember 2019-12-31 0000895421 us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-09-30 0000895421 us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0000895421 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2020-09-30 0000895421 ms:CorporateandOtherDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-12-31 0000895421 us-gaap:CorporateBondSecuritiesMember 2019-12-31 0000895421 us-gaap:CorporateBondSecuritiesMember 2020-09-30 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-09-30 0000895421 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0000895421 us-gaap:USTreasurySecuritiesMember 2020-09-30 0000895421 ms:CorporateandOtherDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2019-12-31 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2020-09-30 0000895421 us-gaap:USTreasurySecuritiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-01-01 2020-09-30 0000895421 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2020-01-01 2020-09-30 0000895421 ms:CorporateandOtherDebtSecuritiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-01-01 2020-09-30 0000895421 us-gaap:CorporateBondSecuritiesMember 2020-01-01 2020-09-30 0000895421 ms:AssetBackedSecuritiesFederalFamilyEducationLoanProgramMember 2020-01-01 2020-09-30 0000895421 us-gaap:USTreasuryAndGovernmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:MaturityOvernightMember 2019-12-31 0000895421 us-gaap:MaturityUpTo30DaysMember 2019-12-31 0000895421 us-gaap:Maturity30To90DaysMember 2019-12-31 0000895421 us-gaap:MaturityOver90DaysMember 2019-12-31 0000895421 us-gaap:MaturityOver90DaysMember 2020-09-30 0000895421 us-gaap:MaturityUpTo30DaysMember 2020-09-30 0000895421 us-gaap:MaturityOvernightMember 2020-09-30 0000895421 us-gaap:Maturity30To90DaysMember 2020-09-30 0000895421 us-gaap:CollateralizedSecuritiesOtherMember 2019-12-31 0000895421 ms:CorporateEquitiesMember 2020-09-30 0000895421 us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-09-30 0000895421 ms:CorporateandOtherDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:AssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0000895421 ms:CorporateEquitiesMember 2019-12-31 0000895421 us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-09-30 0000895421 us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000895421 us-gaap:AssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0000895421 us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000895421 us-gaap:CollateralizedSecuritiesOtherMember 2020-09-30 0000895421 ms:CorporateandOtherDebtSecuritiesMember 2019-12-31 0000895421 ms:SecuredLendingFacilitiesMember 2020-09-30 0000895421 ms:NoninvestmentGradeMember ms:SecuredLendingFacilitiesMember 2020-09-30 0000895421 ms:InvestmentGradeMember ms:SecuredLendingFacilitiesMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember 2019-12-31 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2020-01-01 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:CommercialPortfolioSegmentMember 2020-01-01 2020-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2019-12-31 0000895421 ms:SecuredLendingFacilitiesMember 2020-01-01 2020-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000895421 us-gaap:CommercialPortfolioSegmentMember 2020-09-30 0000895421 ms:SecuredLendingFacilitiesMember 2019-12-31 0000895421 us-gaap:CommercialPortfolioSegmentMember 2019-12-31 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember 2020-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-09-30 0000895421 us-gaap:CommercialPortfolioSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember 2019-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember 2018-12-31 0000895421 us-gaap:ResidentialPortfolioSegmentMember 2019-01-01 2019-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2019-01-01 2019-09-30 0000895421 us-gaap:CommercialPortfolioSegmentMember 2018-12-31 0000895421 ms:SecuredLendingFacilitiesMember 2019-01-01 2019-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember 2018-12-31 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2019-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2018-12-31 0000895421 us-gaap:CommercialPortfolioSegmentMember 2019-09-30 0000895421 ms:SecuredLendingFacilitiesMember 2018-12-31 0000895421 ms:SecuredLendingFacilitiesMember 2019-09-30 0000895421 ms:SecuritiesBasedLendingMember 2020-09-30 0000895421 ms:NoninvestmentGradeMember ms:OtherLoansMember 2020-09-30 0000895421 ms:InvestmentGradeMember ms:OtherLoansMember 2020-09-30 0000895421 ms:InvestmentGradeMember us-gaap:CommercialPortfolioSegmentMember 2020-09-30 0000895421 ms:NoninvestmentGradeMember us-gaap:CommercialPortfolioSegmentMember 2020-09-30 0000895421 ms:NoninvestmentGradeMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-09-30 0000895421 ms:InvestmentGradeMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember ms:DebttoValueRatioGreaterthan80PercentMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember ms:DebttoValueRatioLessthanorEqualto80PercentMember 2020-09-30 0000895421 ms:FICOScoreBetween680and739Member us-gaap:ResidentialPortfolioSegmentMember 2020-09-30 0000895421 ms:FICOScoreGreaterthanorEqualto740Member us-gaap:ResidentialPortfolioSegmentMember 2020-09-30 0000895421 ms:FICOScoreLessthan680Member us-gaap:ResidentialPortfolioSegmentMember 2020-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember us-gaap:FinancingReceivables1To29DaysPastDueMember 2020-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember ms:FinancialAssetPastDueMinusCurrentMember 2020-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember ms:FinancialAssetPastDueMember 2020-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember ms:FinancialAssetPastDueMinusCurrentMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember ms:FinancialAssetPastDueMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember us-gaap:FinancingReceivables1To29DaysPastDueMember 2020-09-30 0000895421 us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivables1To29DaysPastDueMember 2020-09-30 0000895421 ms:SecuredLendingFacilitiesMember ms:FinancialAssetPastDueMinusCurrentMember 2020-09-30 0000895421 us-gaap:ResidentialPortfolioSegmentMember ms:FinancialAssetPastDueMinusCurrentMember 2020-09-30 0000895421 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancingReceivables1To29DaysPastDueMember 2020-09-30 0000895421 ms:FinancialAssetPastDueMinusCurrentMember 2020-09-30 0000895421 ms:SecuredLendingFacilitiesMember us-gaap:FinancingReceivables1To29DaysPastDueMember 2020-09-30 0000895421 us-gaap:CommercialPortfolioSegmentMember ms:FinancialAssetPastDueMember 2020-09-30 0000895421 ms:FinancialAssetPastDueMember 2020-09-30 0000895421 us-gaap:CommercialPortfolioSegmentMember ms:FinancialAssetPastDueMinusCurrentMember 2020-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember ms:FinancialAssetPastDueMember 2020-09-30 0000895421 us-gaap:FinancingReceivables1To29DaysPastDueMember 2020-09-30 0000895421 ms:SecuredLendingFacilitiesMember ms:FinancialAssetPastDueMember 2020-09-30 0000895421 2019-01-01 2019-12-31 0000895421 ms:NoLongerEmployedbytheFirmMember 2020-09-30 0000895421 ms:CurrentlyEmployedbytheFirmMember 2020-09-30 0000895421 ms:InvestmentManagementSegmentMember 2019-01-01 2019-09-30 0000895421 ms:InvestmentManagementSegmentMember 2019-07-01 2019-09-30 0000895421 ms:InvestmentManagementSegmentMember 2020-01-01 2020-09-30 0000895421 ms:InvestmentManagementSegmentMember 2020-07-01 2020-09-30 0000895421 ms:InvestmentManagementSegmentMember 2019-12-31 0000895421 ms:InvestmentManagementSegmentMember 2020-09-30 0000895421 ms:MitsubishiUfjMorganStanleySecuritiesCoLtdMember 2020-01-01 2020-09-30 0000895421 ms:MitsubishiUfjMorganStanleySecuritiesCoLtdMember 2020-07-01 2020-09-30 0000895421 ms:MitsubishiUfjMorganStanleySecuritiesCoLtdMember 2019-07-01 2019-09-30 0000895421 ms:MitsubishiUfjMorganStanleySecuritiesCoLtdMember 2019-01-01 2019-09-30 0000895421 ms:DeutscheBankNationalTrustCompany2007Nc4VMorganStanleyMortgageCapitalHoldingsLlcMember us-gaap:PendingLitigationMember 2020-09-30 0000895421 ms:CaseNumber153637AndCaseNumber154353Member us-gaap:PendingLitigationMember 2020-09-30 0000895421 ms:ChinaDevelopmentIndustrialBankVersusMorganStanleyCoIncorporatedEtAliiMember us-gaap:PendingLitigationMember 2020-09-30 0000895421 ms:DeutscheBankNationalTrustCompany2007Nc4VMorganStanleyMortgageCapitalHoldingsLlcMember srt:MaximumMember us-gaap:PendingLitigationMember 2020-09-30 0000895421 us-gaap:StandbyLettersOfCreditMember 2020-09-30 0000895421 ms:FinancialGuarantyInsuranceCompanyVMorganStanleyAbsCapitalIIncEtAlTrust2007Nc4Member us-gaap:PendingLitigationMember 2020-09-30 0000895421 ms:CaseNumber153637AndCaseNumber154353Member srt:MaximumMember us-gaap:PendingLitigationMember 2020-09-30 0000895421 ms:ChinaDevelopmentIndustrialBankVersusMorganStanleyCoIncorporatedEtAliiMember us-gaap:PendingLitigationMember 2020-01-01 2020-09-30 0000895421 ms:ChinaDevelopmentIndustrialBankVersusMorganStanleyCoIncorporatedEtAliiMember srt:MaximumMember us-gaap:PendingLitigationMember 2020-09-30 0000895421 us-gaap:CommercialLoanMember 2020-09-30 0000895421 ms:CentralCounterpartyCommitmentMember 2020-09-30 0000895421 ms:CommitmentsForwardStartingReverseRepurchaseAgreementsMember 2020-09-30 0000895421 ms:CommitmentsLettersOfCreditAndOtherFinancialGuaranteesObtainedToSatisfyCollateralRequirementsMember 2020-09-30 0000895421 ms:SecuritiesBasedLendingandOtherLoansMember 2020-09-30 0000895421 ms:CommitmentsInvestmentActivitiesMember 2020-09-30 0000895421 us-gaap:RealEstateMember 2020-09-30 0000895421 ms:FirmCommitmentContractMember 2020-09-30 0000895421 ms:SecuredLendingFacilitiesMember 2020-09-30 0000895421 ms:WholeLoanSalesRepresentationsAndWarrantiesMember 2020-09-30 0000895421 us-gaap:CreditRiskContractMember 2020-09-30 0000895421 us-gaap:MarketValueGuaranteeMember 2020-09-30 0000895421 us-gaap:DerivativeMember 2020-09-30 0000895421 ms:GeneralPartnerGuaranteeMember 2020-09-30 0000895421 ms:SecuritizationsRepresentationsAndGuaranteesMember 2020-09-30 0000895421 us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:LiquidityFacilitiesGuaranteeMember 2020-09-30 0000895421 ms:ClearingMemberGuaranteeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember us-gaap:DerivativeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember us-gaap:CreditRiskContractMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember us-gaap:MarketValueGuaranteeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember us-gaap:CreditRiskContractMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:ClearingMemberGuaranteeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:SecuritizationsRepresentationsAndGuaranteesMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:GeneralPartnerGuaranteeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember us-gaap:MarketValueGuaranteeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember us-gaap:DerivativeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember us-gaap:StandbyLettersOfCreditMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:SecuritizationsRepresentationsAndGuaranteesMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember us-gaap:MarketValueGuaranteeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:GeneralPartnerGuaranteeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:LiquidityFacilitiesGuaranteeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:LiquidityFacilitiesGuaranteeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:WholeLoanSalesRepresentationsAndWarrantiesMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:ClearingMemberGuaranteeMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:WholeLoanSalesRepresentationsAndWarrantiesMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember us-gaap:StandbyLettersOfCreditMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember ms:SecuritizationsRepresentationsAndGuaranteesMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember us-gaap:StandbyLettersOfCreditMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember us-gaap:DerivativeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:LiquidityFacilitiesGuaranteeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember us-gaap:OtherCreditDerivativesMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember us-gaap:StandbyLettersOfCreditMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:ClearingMemberGuaranteeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember us-gaap:MarketValueGuaranteeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:GeneralPartnerGuaranteeMember 2020-09-30 0000895421 ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember us-gaap:CreditRiskContractMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:ClearingMemberGuaranteeMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember ms:SecuritizationsRepresentationsAndGuaranteesMember 2020-09-30 0000895421 ms:MoreThanFiveYearsFromBalanceSheetDateMember ms:WholeLoanSalesRepresentationsAndWarrantiesMember 2020-09-30 0000895421 ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember us-gaap:DerivativeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:GeneralPartnerGuaranteeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:LiquidityFacilitiesGuaranteeMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember us-gaap:CreditRiskContractMember 2020-09-30 0000895421 ms:LessThanTwelveMonthsFromBalanceSheetDateMember ms:WholeLoanSalesRepresentationsAndWarrantiesMember 2020-09-30 0000895421 ms:OtherConsumerAndCommercialLoansMember 2019-12-31 0000895421 ms:OtherConsumerAndCommercialLoansMember 2020-09-30 0000895421 us-gaap:SecuritiesAssetsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:SecuritiesAssetsMember us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:SecuritiesAssetsMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-12-31 0000895421 us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:CommercialMortgageBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:SecuritiesAssetsMember 2019-12-31 0000895421 us-gaap:SecuritiesAssetsMember us-gaap:CommercialMortgageBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:SecuritiesAssetsMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-09-30 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-12-31 0000895421 us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:SecuritiesAssetsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:SecuritiesAssetsMember ms:OtherConsumerAndCommercialLoansMember 2020-09-30 0000895421 us-gaap:SecuritiesAssetsMember ms:OtherConsumerAndCommercialLoansMember 2019-12-31 0000895421 us-gaap:SecuritiesAssetsMember 2020-09-30 0000895421 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-09-30 0000895421 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0000895421 ms:MunicipalTenderOptionBondsMember 2019-12-31 0000895421 ms:DebtandEquityInterestsMember us-gaap:CollateralizedDebtObligationsMember 2019-12-31 0000895421 ms:CommitmentsGuaranteesAndOtherMember ms:MunicipalTenderOptionBondsMember 2019-12-31 0000895421 ms:OtherVariableInterestsMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember ms:MunicipalTenderOptionBondsMember 2019-12-31 0000895421 us-gaap:StructuredFinanceMember 2019-12-31 0000895421 ms:DebtandEquityInterestsMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:AssetsMember us-gaap:StructuredFinanceMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:StructuredFinanceMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 ms:CommitmentsGuaranteesAndOtherMember us-gaap:StructuredFinanceMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember ms:MunicipalTenderOptionBondsMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember ms:OtherVariableInterestsMember 2019-12-31 0000895421 ms:CommitmentsGuaranteesAndOtherMember us-gaap:CollateralizedDebtObligationsMember 2019-12-31 0000895421 us-gaap:CollateralizedDebtObligationsMember 2019-12-31 0000895421 us-gaap:AssetsMember ms:OtherVariableInterestsMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:StructuredFinanceMember 2019-12-31 0000895421 ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 ms:CommitmentsGuaranteesAndOtherMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 ms:DebtandEquityInterestsMember us-gaap:StructuredFinanceMember 2019-12-31 0000895421 us-gaap:AssetsMember us-gaap:CollateralizedDebtObligationsMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember ms:OtherVariableInterestsMember 2019-12-31 0000895421 ms:DebtandEquityInterestsMember ms:MunicipalTenderOptionBondsMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:CollateralizedDebtObligationsMember 2019-12-31 0000895421 ms:DebtandEquityInterestsMember ms:OtherVariableInterestsMember 2019-12-31 0000895421 us-gaap:AssetsMember ms:MunicipalTenderOptionBondsMember 2019-12-31 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:CollateralizedDebtObligationsMember 2019-12-31 0000895421 ms:CommitmentsGuaranteesAndOtherMember ms:OtherVariableInterestsMember 2019-12-31 0000895421 us-gaap:AssetsMember ms:MortgageAndAssetBackedSecuritiesMember 2019-12-31 0000895421 us-gaap:EquityContractMember us-gaap:OverTheCounterMember 2020-09-30 0000895421 us-gaap:EquityContractMember us-gaap:OverTheCounterMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:ResidentialMortgageMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:CreditLinkedNotesAndOtherMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:ResidentialMortgageMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:CommercialMortgageBackedSecuritiesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember ms:CreditLinkedNotesAndOtherMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:ResidentialMortgageMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:CommercialMortgageBackedSecuritiesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:CommercialMortgageBackedSecuritiesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember ms:CreditLinkedNotesAndOtherMember 2020-09-30 0000895421 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0000895421 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-09-30 0000895421 us-gaap:AssetsMember us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember ms:OtherVariableInterestsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:LiabilityMember ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 ms:DebtandEquityInterestsMember ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 ms:DebtandEquityInterestsMember ms:OtherVariableInterestsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 ms:CommitmentsGuaranteesAndOtherMember ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember ms:OtherVariableInterestsMember 2020-09-30 0000895421 us-gaap:StructuredFinanceMember 2020-09-30 0000895421 ms:OtherVariableInterestsMember 2020-09-30 0000895421 ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 us-gaap:AssetsMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 ms:DebtandEquityInterestsMember us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:StructuredFinanceMember 2020-09-30 0000895421 us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 us-gaap:LiabilityMember us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 us-gaap:AssetsMember ms:MunicipalTenderOptionBondsMember 2020-09-30 0000895421 ms:DebtandEquityInterestsMember us-gaap:StructuredFinanceMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:StructuredFinanceMember 2020-09-30 0000895421 ms:CommitmentsGuaranteesAndOtherMember us-gaap:StructuredFinanceMember 2020-09-30 0000895421 us-gaap:LiabilityMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 ms:DebtandEquityInterestsMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 us-gaap:LiabilityMember us-gaap:StructuredFinanceMember 2020-09-30 0000895421 us-gaap:LiabilityMember ms:OtherVariableInterestsMember 2020-09-30 0000895421 ms:CommitmentsGuaranteesAndOtherMember ms:MortgageAndAssetBackedSecuritiesMember 2020-09-30 0000895421 ms:CommitmentsGuaranteesAndOtherMember ms:OtherVariableInterestsMember 2020-09-30 0000895421 ms:CommitmentsGuaranteesAndOtherMember us-gaap:CollateralizedDebtObligationsMember 2020-09-30 0000895421 us-gaap:AssetsMember ms:OtherVariableInterestsMember 2020-09-30 0000895421 us-gaap:AssetsMember us-gaap:StructuredFinanceMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:FairValueInputsLevel3Member 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:FairValueInputsLevel2Member 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:FairValueInputsLevel2Member 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:FairValueInputsLevel3Member 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:FairValueInputsLevel2Member 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:FairValueInputsLevel3Member 2020-09-30 0000895421 ms:CollateralizedLoanObligationsEntitiesSponsoredByNonAffiliatesMember us-gaap:CommercialLoanMember 2020-07-01 2020-09-30 0000895421 ms:CollateralizedLoanObligationsEntitiesSponsoredByNonAffiliatesMember us-gaap:CommercialLoanMember 2019-01-01 2019-09-30 0000895421 ms:CollateralizedLoanObligationsEntitiesSponsoredByNonAffiliatesMember us-gaap:CommercialLoanMember 2020-01-01 2020-09-30 0000895421 ms:CollateralizedLoanObligationsEntitiesSponsoredByNonAffiliatesMember us-gaap:CommercialLoanMember 2019-07-01 2019-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember ms:CreditLinkedNotesAndOtherMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:ResidentialMortgageMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:ResidentialMortgageMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:CreditLinkedNotesAndOtherMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember ms:CreditLinkedNotesAndOtherMember 2019-12-31 0000895421 ms:MSAndCoMember 2020-01-01 2020-09-30 0000895421 ms:MorganStanleyPrivateBankNationalAssociationMember 2020-01-01 2020-09-30 0000895421 ms:MorganStanleySmithBarneyLlcMember 2020-01-01 2020-09-30 0000895421 ms:MorganStanleyBankNationalAssociationMember 2020-01-01 2020-09-30 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:ResidentialMortgageMember 2019-12-31 0000895421 ms:MortgageAndAssetBackedSecuritiesMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-09-30 0000895421 us-gaap:StructuredFinanceMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-09-30 0000895421 ms:MortgageAndAssetBackedSecuritiesMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0000895421 ms:OtherVariableInterestsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0000895421 ms:OtherVariableInterestsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-09-30 0000895421 us-gaap:StructuredFinanceMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:NoninvestmentGradeMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember 2019-12-31 0000895421 ms:SpecialPurposeEntitiesMember ms:InvestmentGradeMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000895421 ms:MSAndCoMember 2020-09-30 0000895421 ms:MSAndCoMember 2019-12-31 0000895421 ms:MorganStanleyPrivateBankNationalAssociationMember 2019-12-31 0000895421 ms:MorganStanleyBankNationalAssociationMember 2020-09-30 0000895421 ms:MorganStanleyPrivateBankNationalAssociationMember 2020-09-30 0000895421 ms:MorganStanleyBankNationalAssociationMember 2019-12-31 0000895421 ms:MorganStanleySmithBarneyLlcMember 2020-09-30 0000895421 ms:MorganStanleySmithBarneyLlcMember 2019-12-31 0000895421 ms:AOCIDebtValuationAdjustmentNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 ms:AOCIDebtValuationAdjustmentIncludingNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossAttributableToNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2019-07-01 2019-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentIncludingNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossAttributableToNoncontrollingInterestMember 2020-01-01 2020-09-30 0000895421 ms:SeriesLPreferredStockMember 2020-09-30 0000895421 us-gaap:SeriesAPreferredStockMember 2020-09-30 0000895421 us-gaap:SeriesCPreferredStockMember 2020-09-30 0000895421 us-gaap:SeriesHPreferredStockMember 2019-12-31 0000895421 ms:SeriesIPreferredStockMember 2019-12-31 0000895421 ms:SeriesJPreferredStockMember 2020-09-30 0000895421 ms:SeriesJPreferredStockMember 2019-12-31 0000895421 ms:SeriesKPreferredStockMember 2020-09-30 0000895421 ms:SeriesIPreferredStockMember 2020-09-30 0000895421 ms:SeriesKPreferredStockMember 2019-12-31 0000895421 us-gaap:SeriesEPreferredStockMember 2020-09-30 0000895421 ms:SeriesLPreferredStockMember 2019-12-31 0000895421 us-gaap:SeriesHPreferredStockMember 2020-09-30 0000895421 us-gaap:SeriesAPreferredStockMember 2019-12-31 0000895421 us-gaap:SeriesFPreferredStockMember 2020-09-30 0000895421 us-gaap:SeriesEPreferredStockMember 2019-12-31 0000895421 us-gaap:SeriesFPreferredStockMember 2019-12-31 0000895421 us-gaap:SeriesCPreferredStockMember 2019-12-31 0000895421 ms:SeriesLPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesAPreferredStockMember 2019-01-01 2019-09-30 0000895421 ms:SeriesIPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesCPreferredStockMember 2019-01-01 2019-09-30 0000895421 ms:SeriesJPreferredStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:SeriesFPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesGPreferredStockMember 2019-01-01 2019-09-30 0000895421 ms:SeriesKPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesCPreferredStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:SeriesEPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesHPreferredStockMember 2020-01-01 2020-09-30 0000895421 ms:SeriesJPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesHPreferredStockMember 2019-01-01 2019-09-30 0000895421 us-gaap:SeriesGPreferredStockMember 2020-01-01 2020-09-30 0000895421 us-gaap:SeriesCPreferredStockMember 2020-07-01 2020-09-30 0000895421 us-gaap:SeriesFPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesIPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesHPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesEPreferredStockMember 2019-07-01 2019-09-30 0000895421 ms:SeriesLPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesAPreferredStockMember 2020-07-01 2020-09-30 0000895421 us-gaap:SeriesHPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesJPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesGPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesAPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesFPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesEPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesKPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesJPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesLPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesIPreferredStockMember 2020-07-01 2020-09-30 0000895421 us-gaap:SeriesGPreferredStockMember 2020-07-01 2020-09-30 0000895421 ms:SeriesKPreferredStockMember 2019-07-01 2019-09-30 0000895421 us-gaap:SeriesCPreferredStockMember 2019-07-01 2019-09-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2019-09-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-06-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-06-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2020-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2020-07-01 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2019-12-31 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedTranslationAdjustmentMember 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2020-06-30 0000895421 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-06-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2019-06-30 0000895421 ms:AOCIDebtValuationAdjustmentParentMember 2018-12-31 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 ms:AOCIDebtValuationAdjustmentIncludingNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossAttributableToNoncontrollingInterestMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 ms:AOCIDebtValuationAdjustmentIncludingNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 ms:AOCIDebtValuationAdjustmentNoncontrollingInterestMember 2019-01-01 2019-09-30 0000895421 ms:MitsubishiUfjFinancialGroupIncMember 2020-01-01 2020-09-30 0000895421 ms:CumulativeEffectPeriodofAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201602Member us-gaap:RetainedEarningsMember 2018-12-31 0000895421 us-gaap:OperatingSegmentsMember ms:InstitutionalSecuritiesSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:WealthManagementSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InvestmentManagementSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember 2019-07-01 2019-09-30 0000895421 us-gaap:CreditRiskContractMember 2019-01-01 2019-09-30 0000895421 ms:EquityAndIndexContractMember 2019-07-01 2019-09-30 0000895421 us-gaap:InterestRateContractMember 2020-01-01 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember 2019-01-01 2019-09-30 0000895421 ms:CommodityAndOtherContractsMember 2020-01-01 2020-09-30 0000895421 us-gaap:InterestRateContractMember 2020-07-01 2020-09-30 0000895421 ms:EquityAndIndexContractMember 2020-01-01 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember 2019-01-01 2019-09-30 0000895421 us-gaap:CreditRiskContractMember 2020-07-01 2020-09-30 0000895421 us-gaap:ForeignExchangeContractMember 2020-01-01 2020-09-30 0000895421 us-gaap:CreditRiskContractMember 2019-07-01 2019-09-30 0000895421 ms:CommodityAndOtherContractsMember 2020-07-01 2020-09-30 0000895421 ms:CommodityAndOtherContractsMember 2019-07-01 2019-09-30 0000895421 us-gaap:InterestRateContractMember 2019-01-01 2019-09-30 0000895421 us-gaap:InterestRateContractMember 2019-07-01 2019-09-30 0000895421 ms:EquityAndIndexContractMember 2020-07-01 2020-09-30 0000895421 ms:EquityAndIndexContractMember 2019-01-01 2019-09-30 0000895421 us-gaap:ForeignExchangeContractMember 2020-07-01 2020-09-30 0000895421 us-gaap:CreditRiskContractMember 2020-01-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InstitutionalSecuritiesSegmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:IntersegmentEliminationMember 2020-07-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:WealthManagementSegmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InvestmentManagementSegmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:IntersegmentEliminationMember 2019-07-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:WealthManagementSegmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InstitutionalSecuritiesSegmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InvestmentManagementSegmentMember 2019-07-01 2019-09-30 0000895421 srt:AsiaMember 2020-07-01 2020-09-30 0000895421 srt:AsiaMember 2019-07-01 2019-09-30 0000895421 us-gaap:EMEAMember 2019-07-01 2019-09-30 0000895421 us-gaap:EMEAMember 2020-07-01 2020-09-30 0000895421 srt:AmericasMember 2019-01-01 2019-09-30 0000895421 us-gaap:EMEAMember 2019-01-01 2019-09-30 0000895421 srt:AmericasMember 2019-07-01 2019-09-30 0000895421 srt:AmericasMember 2020-07-01 2020-09-30 0000895421 srt:AsiaMember 2019-01-01 2019-09-30 0000895421 srt:AmericasMember 2020-01-01 2020-09-30 0000895421 srt:AsiaMember 2020-01-01 2020-09-30 0000895421 us-gaap:EMEAMember 2020-01-01 2020-09-30 0000895421 ms:WealthManagementSegmentMember 2019-12-31 0000895421 ms:InstitutionalSecuritiesSegmentMember 2020-09-30 0000895421 ms:InstitutionalSecuritiesSegmentMember 2019-12-31 0000895421 ms:WealthManagementSegmentMember 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember us-gaap:InvestmentAdviceMember ms:InstitutionalSecuritiesSegmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:AccountingStandardsUpdate201409Member 2019-01-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:UnderwritingMember ms:InstitutionalSecuritiesSegmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:UnderwritingMember ms:InstitutionalSecuritiesSegmentMember 2020-07-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember us-gaap:InvestmentAdviceMember ms:InstitutionalSecuritiesSegmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember us-gaap:InvestmentAdviceMember ms:InstitutionalSecuritiesSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccountingStandardsUpdate201409Member 2019-07-01 2019-09-30 0000895421 us-gaap:AccountingStandardsUpdate201409Member 2020-01-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:UnderwritingMember ms:InstitutionalSecuritiesSegmentMember 2019-01-01 2019-09-30 0000895421 us-gaap:AccountingStandardsUpdate201409Member 2020-07-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember us-gaap:InvestmentAdviceMember ms:InstitutionalSecuritiesSegmentMember 2019-07-01 2019-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:UnderwritingMember ms:InstitutionalSecuritiesSegmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InstitutionalSecuritiesSegmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:WealthManagementSegmentMember 2020-01-01 2020-09-30 0000895421 us-gaap:IntersegmentEliminationMember 2020-01-01 2020-09-30 0000895421 us-gaap:OperatingSegmentsMember ms:InvestmentManagementSegmentMember 2020-01-01 2020-09-30 xbrli:pure xbrli:shares iso4217:USD xbrli:shares iso4217:USD ms:security iso4217:EUR



Table of Contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020

Commission File Number 1-11758

(Exact name of Registrant as specified in its charter)




Delaware	1585 Broadway			36-3145972	(212)	761-4000
(State or other jurisdiction of incorporation or organization)	New York,	NY	10036	(I.R.S. Employer Identification No.)	(Registrant’s telephone number, including area code)
	(Address of principal executive offices, including zip code)			(I.R.S. Employer Identification No.)	(Registrant’s telephone number, including area code)



Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol(s)	Name of exchange on which registered
Common Stock, $0.01 par value	MS	New York Stock Exchange
Depositary Shares, each representing 1/1,000th interest in a share of Floating Rate	MS/PA	New York Stock Exchange
Non-Cumulative Preferred Stock, Series A, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate	MS/PE	New York Stock Exchange
Non-Cumulative Preferred Stock, Series E, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate	MS/PF	New York Stock Exchange
Non-Cumulative Preferred Stock, Series F, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate	MS/PI	New York Stock Exchange
Non-Cumulative Preferred Stock, Series I, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate	MS/PK	New York Stock Exchange
Non-Cumulative Preferred Stock, Series K, $0.01 par value
Depository Shares, each representing 1/1000th interest in a share of 4.875%	MS/PL	New York Stock Exchange
Non-Cumulative Preferred Stock, Series L, $0.01 par value
Global Medium-Term Notes, Series A, Fixed Rate Step-Up Senior Notes Due 2026	MS/26C	New York Stock Exchange
of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto)
Morgan Stanley Cushing® MLP High Income Index ETNs due March 21, 2031	MLPY	NYSE Arca, Inc.

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):



Large accelerated filer	☒	Accelerated filer	☐	Non-accelerated filer	☐	Smaller reporting company	☐	Emerging growth company	☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of October 30, 2020, there were 1,809,198,248 shares of the Registrant’s Common Stock, par value $0.01 per share, outstanding.



Table of Contents

QUARTERLY REPORT ON FORM 10-Q

For the quarter ended September 30, 2020



Table of Contents		Part	Item	Page
Risk Factors		II	1A	1
Financial Information		I		2
Management’s Discussion and Analysis of Financial Condition and Results of Operations		I	2	2
Introduction				2
Executive Summary				3
Business Segments				9
Supplemental Financial Information				20
Accounting Development Updates				20
Critical Accounting Policies				21
Liquidity and Capital Resources				21
Balance Sheet				21
Regulatory Requirements				26
Quantitative and Qualitative Disclosures about Risk		I	3	34
Market Risk				34
Credit Risk				36
Country and Other Risks				42
Report of Independent Registered Public Accounting Firm				45
Consolidated Financial Statements and Notes		I	1	46
Consolidated Income Statements (Unaudited)				46
Consolidated Comprehensive Income Statements (Unaudited)				47
Consolidated Balance Sheets (Unaudited at September 30, 2020)				48
Consolidated Statements of Changes in Total Equity (Unaudited)				49
Consolidated Cash Flow Statements (Unaudited)				50
Notes to Consolidated Financial Statements (Unaudited)				51
1.	Introduction and Basis of Presentation			51
2.	Significant Accounting Policies			52
3.	Acquisitions			54
4.	Cash and Cash Equivalents			55
5.	Fair Values			55
6.	Fair Value Option			61
7.	Derivative Instruments and Hedging Activities			63
8.	Investment Securities			66
9.	Collateralized Transactions			69
10.	Loans, Lending Commitments and Related Allowance for Credit Losses			70
11.	Other Assets—Equity Method Investments			73
12.	Deposits			73
13.	Borrowings and Other Secured Financings			74
14.	Commitments, Guarantees and Contingencies			74
15.	Variable Interest Entities and Securitization Activities			77
16.	Regulatory Requirements			79
17.	Total Equity			82
18.	Interest Income and Interest Expense			84
19.	Income Taxes			84
20.	Segment, Geographic and Revenue Information			85
Financial Data Supplement (Unaudited)				88
Glossary of Common Terms and Acronyms				89
Other Information		II		91
Legal Proceedings		II	1	91
Unregistered Sales of Equity Securities and Use of Proceeds		II	2	91
Controls and Procedures		I	4	92
Exhibits		II	6	92
Signatures				S-1



Table of Contents

Available Information

We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains a website, www.sec.gov, that contains annual, quarterly and current reports, proxy and information statements and other information that issuers file electronically with the SEC. Our electronic SEC filings are available to the public at the SEC’s website.

Our website is www.morganstanley.com. You can access our Investor Relations webpage at www.morganstanley.com/about-us-ir. We make available free of charge, on or through our Investor Relations webpage, our proxy statements, annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as amended (“Exchange Act”), as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. We also make available, through our Investor Relations webpage, via a link to the SEC’s website, statements of beneficial ownership of our equity securities filed by our directors, officers, 10% or greater shareholders and others under Section 16 of the Exchange Act.

You can access information about our corporate governance at www.morganstanley.com/about-us-governance and our sustainability initiatives at www.morganstanley.com/about-us/sustainability-at-morgan-stanley. Our webpages include:


•	Amended and Restated Certificate of Incorporation;


•	Amended and Restated Bylaws;


•	Charters for our Audit Committee, Compensation, Management Development and Succession Committee, Nominating and Governance Committee, Operations and Technology Committee, and Risk Committee;


•	Corporate Governance Policies;


•	Policy Regarding Corporate Political Activities;


•	Policy Regarding Shareholder Rights Plan;


•	Equity Ownership Commitment;


•	Code of Ethics and Business Conduct;


•	Code of Conduct;


•	Integrity Hotline Information;


•	Environmental and Social Policies; and


•	Sustainability Report.

Our Code of Ethics and Business Conduct applies to all directors, officers and employees, including our Chief Executive Officer, Chief Financial Officer and Deputy Chief Financial Officer. We will post any amendments to the Code of Ethics and Business Conduct and any waivers that are required to be disclosed by the rules of either the SEC or the New York Stock Exchange LLC (“NYSE”) on our website. You can request a copy of these documents, excluding exhibits, at no cost, by contacting Investor Relations, 1585 Broadway, New York, NY 10036 (212-761-4000). The information on our website is not incorporated by reference into this report.



Table of Contents

Risk Factors

In addition to “Risk Factors” in Part I, Item 1A of the 2019 Form 10-K, please refer to the risk factors under Item 8.01 “Other Matters” in each of the the Current Reports on Form 8-K filed with the SEC on April 16, 2020 and October 2, 2020, respectively.



	1	September 2020 Form 10-Q



Table of Contents

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Introduction

Morgan Stanley is a global financial services firm that maintains significant market positions in each of its business segments—Institutional Securities, Wealth Management and Investment Management. Morgan Stanley, through its subsidiaries and affiliates, provides a wide variety of products and services to a large and diversified group of clients and customers, including corporations, governments, financial institutions and individuals. Unless the context otherwise requires, the terms “Morgan Stanley,” “Firm,” “us,” “we” or “our” mean Morgan Stanley (the “Parent Company”) together with its consolidated subsidiaries. See the “Glossary of Common Terms and Acronyms” for the definition of certain terms and acronyms used throughout this Form 10-Q.

A description of the clients and principal products and services of each of our business segments is as follows:

Institutional Securities provides investment banking, sales and trading, lending and other services to corporations, governments, financial institutions and high to ultra-high net worth clients. Investment banking services consist of capital raising and financial advisory services, including services relating to the underwriting of debt, equity and other securities, as well as advice on mergers and acquisitions, restructurings, real estate and project finance. Sales and trading services include sales, financing, prime brokerage and market-making activities in the equity and fixed income businesses. Lending activities include originating corporate loans and commercial real estate loans, providing secured lending facilities, and extending financing to sales and trading customers. Other activities include Asia wealth management services, investments and research.

Wealth Management provides a comprehensive array of financial services and solutions to individual investors and small to medium-sized businesses and institutions covering: brokerage and investment advisory services; financial and wealth planning services; stock plan administration services; annuity and insurance products; securities-based lending, residential real estate loans and other lending products; banking; and retirement plan services.

Investment Management provides a broad range of investment strategies and products that span geographies, asset classes, and public and private markets to a diverse group of clients across institutional and intermediary channels. Strategies and products, which are offered through a variety of investment vehicles, include equity, fixed income, liquidity and alternative/other products. Institutional clients include defined benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors and corporations. Individual clients are generally served through intermediaries, including affiliated and non-affiliated distributors.

Management’s Discussion and Analysis includes certain metrics which we believe to be useful to us, investors, analysts and other stakeholders by providing further transparency about, or an additional means of assessing, our financial condition and operating results. Such metrics, when used, are defined and may be different from or inconsistent with metrics used by other companies.

The results of operations in the past have been, and in the future may continue to be, materially affected by: competition; risk factors; legislative, legal and regulatory developments; and other factors. These factors also may have an adverse impact on our ability to achieve our strategic objectives. Additionally, the discussion of our results of operations herein may contain forward-looking statements. These statements, which reflect management’s beliefs and expectations, are subject to risks and uncertainties that may cause actual results to differ materially. For a discussion of the risks and uncertainties that may affect our future results, see “Forward-Looking Statements,” “Business—Competition,” “Business—Supervision and Regulation,” and “Risk Factors” herein and in the 2019 Form 10-K, and “Liquidity and Capital Resources—Regulatory Requirements” herein. In addition, see “Executive Summary” herein and “Risk Factors” for information on the current and possible future effects of the COVID-19 pandemic on our results.



September 2020 Form 10-Q	2



Table of Contents
Management’s Discussion and Analysis

Executive Summary

Overview of Financial Results

Consolidated Results—Three Months Ended September 30, 2020


•	Firm Net revenues were up 16% and Net income applicable to Morgan Stanley was up 25%, reflecting strength across all business segments, and resulting in an annualized ROTCE of 15.0% (see “Non-GAAP Financial Measures” herein).


•	Institutional Securities Net revenues of $6,062 million increased as a result of higher sales and trading and strength in equity underwriting.


•	Wealth Management delivered pre-tax income of $1.1 billion with a pre-tax profit margin of 24%, reflecting strong fee-based flows and increased loan and deposit balances.


•	Investment Management reported long-term net flows of $10.4 billion and AUM of $715 billion driving revenue growth of 38%.


•	Our provision for credit losses on loans and lending commitments was $111 million.


•	At September 30, 2020, our standardized Common Equity Tier 1 capital ratio was 17.4%.

Strategic Transactions


•	On October 2, 2020, we completed the acquisition of ETRADE Financial Corporation (“ETRADE”). For further information, see “Business Segments—Wealth Management.”


•	On October 8, 2020, we entered into a definitive agreement under which we will acquire Eaton Vance Corp. (“Eaton Vance”), subject to customary closing conditions. For further information, see “Business Segments—Investment Management.”

Net Revenues

($ in millions)

Net Income Applicable to Morgan Stanley

($ in millions)

Earnings per Diluted Common Share

We reported net revenues of $11,657 million in the quarter ended September 30, 2020 (“current quarter,” or “3Q 2020”), compared with $10,032 million in the quarter ended September 30, 2019 (“prior year quarter,” or “3Q 2019”). For the current quarter, net income applicable to Morgan Stanley was $2,717 million, or $1.66 per diluted common share, compared with $2,173 million or $1.27 per diluted common share, in the prior year quarter.

We reported net revenues of $34,558 million in the nine months ended September 30, 2020 (“current year period,” or “YTD 2020”), compared with $30,562 million in the period ended September 30, 2019 (“prior year period,” or “YTD 2019”). For the current year period, net income applicable to Morgan Stanley was $7,611 million, or $4.62 per diluted common share, compared with $6,803 million or $3.89 per diluted common share, in the prior year period.



	3	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

Non-interest Expenses¹

($ in millions)


1.	The percentages on the bars in the chart represent the contribution of compensation and benefits expenses and non-compensation expenses to the total.

Current Quarter


•	Compensation and benefits expenses of $5,086 million in the current quarter increased 15% from the prior year quarter, primarily as a result of increases in discretionary incentive compensation and the formulaic payout to Wealth Management representatives, driven by higher revenues, and higher expenses related to certain deferred compensation plans linked to investment performance.


•	Non-compensation expenses of $3,084 million in the current quarter increased 7% from the prior year quarter, primarily as a result of higher volume-related expenses and increased information processing and communication expenses, partially offset by a decrease in marketing and business development expenses.

Current Year Period

•

Compensation and benefits expenses of $15,404 million in the current year period increased 13% from the prior year period, primarily as a result of increases in discretionary incentive compensation and the formulaic payout to Wealth Management representatives, driven by higher revenues, partially offset by lower compensation associated with carried interest and certain deferred compensation plans linked to investment performance.

•

Non-compensation expenses of $9,166 million in the current year period increased 9% from the prior year period, primarily as a result of higher volume-related expenses, an increase in the provision for credit losses for lending commitments and off-balance sheet instruments, and increased information processing and communication expenses. These increases were partially offset by a decrease in marketing and business development expenses.

Income Taxes

The current quarter included intermittent net discrete tax benefits of $113 million, principally associated with the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of tax examinations in certain jurisdictions. The prior year quarter included intermittent net discrete tax benefits of $89 million primarily associated with the filing of the 2018 federal tax return and the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations.

The current year period included intermittent net discrete tax benefits of $10 million. The prior year period included intermittent net discrete tax benefits of $190 million, primarily associated with the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations and other matters. For further information, see “Supplemental Financial Information—Income Tax Matters”

herein.



September 2020 Form 10-Q	4



Table of Contents
Management’s Discussion and Analysis

Business Segment Results

Net Revenues by Segment¹

($ in millions)

Net Income Applicable to Morgan Stanley by Segment¹

($ in millions)


1.	The percentages on the bars in the charts represent the contribution of each business segment to the total of the applicable financial category and may not sum to 100% due to intersegment eliminations. See Note 20 to the financial statements for details of intersegment eliminations.

Current Quarter


•	Institutional Securities net revenues of $6,062 million in the current quarter increased 21% from the prior year quarter primarily due to higher sales and trading and equity underwriting revenues.


•	Wealth Management net revenues of $4,657 million in the current quarter increased 7% principally due to gains from investments associated with certain employee deferred compensation plans. Excluding these investment gains, revenues increased modestly, reflecting higher Asset management revenues on positive net flows, partially offset by lower Net interest.


•	Investment Management net revenues of $1,056 million in the current quarter increased 38% from the prior year quarter, primarily due to higher Investments revenues, driven by accrued carried interest and investment gains in an Asia private equity fund, and higher Asset management revenues as a result of higher average AUM.



	5	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

Current Year Period


•	Institutional Securities net revenues of $18,944 million in the current year period increased 24% from the prior year period. The increase is primarily due to higher sales and trading and underwriting revenues, partially offset by losses on loans and lending commitments held for sale, an increase in the provision for credit losses on loans held for investment, and a decrease in advisory revenues.


•	Wealth Management net revenues of $13,374 million in the current year period increased 2% from the prior year period, primarily due to higher Asset management revenues, largely as a result of market appreciation, and higher Commissions and fees, partially offset by lower Net interest.


•	Investment Management net revenues of $2,634 million in the current year period increased 9% from the prior year period primarily due to higher Asset management revenues as a result of higher average AUM.

Net Revenues by Region^{1, 2}

($ in millions)


1.	The percentages on the bars in the charts represent the contribution of each region to the total.


2.	For a discussion of how the geographic breakdown of net revenues is determined, see Note 20 to the financial statements in the 2019 Form 10-K.

Current quarter revenues in Asia increased 58%, primarily driven by Equity sales and trading within the Institutional Securities business segment. Americas revenues increased 12%,

primarily driven by Institutional Securities business segment sales and trading, as well as the Wealth Management business segment. EMEA revenues were relatively unchanged in the current quarter.

Current year period revenues in Asia increased 44% and the Americas increased 11%, primarily driven by the Institutional Securities business segment. EMEA revenues were relatively unchanged in the current year period.

Coronavirus Disease (“COVID-19”) Pandemic

The COVID-19 pandemic and related voluntary and government-imposed social and business restrictions have had, and will likely continue to have, a severe impact on global economic conditions and the environment in which we operate our businesses. We have implemented a return-to-workplace program, which is phased based on role, location and employee willingness and ability to return, and focused on the health and safety of all staff. The Firm continues to be fully operational, with more than 85% of global employees and more than 90% of employees in the Americas working from home as of September 30, 2020.

Though we are unable to estimate the extent of the impact, the ongoing COVID-19 pandemic and related global economic crisis may have adverse impacts on our future operating results. To date, given our unique business model, economic conditions have affected our businesses in different ways. We have increased our allowance for credit losses on loans and lending commitments, and the persistence of low interest rates has continued to negatively affect our net interest margin in the Wealth Management business segment. Overall for the Firm, increased client trading and capital markets activity, particularly in the first half of the year, has benefited Institutional Securities business segment results in Sales and trading and Investment banking underwriting revenues. However, the high levels of client trading and capital markets activity experienced in the current year period may not be repeated and Investment banking advisory activity may continue to be subdued. Refer to “Risk Factors” herein and Forward Looking Statements in the 2019 Form 10-K.

We continue to use the elements of our Enterprise Risk Management framework to manage the significant uncertainty in the present economic and market conditions. See “Quantitative and Qualitative Disclosures about Risk” in the 2019 Form 10-K for further information.



September 2020 Form 10-Q	6



Table of Contents
Management’s Discussion and Analysis

Selected Financial Information and Other Statistical Data



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions	2020			2019			2020			2019
Net income applicable to Morgan Stanley	$	2,717		$	2,173		$	7,611		$	6,803
Preferred stock dividends	120			113			377			376
Earnings applicable to Morgan Stanley common shareholders	$	2,597		$	2,060		$	7,234		$	6,427

Expense efficiency ratio¹	70.1		%	73.0		%	71.1		%	72.0		%
ROE²	13.2		%	11.2		%	12.6		%	11.8		%
Adjusted ROE³	12.6		%	10.7		%	12.5		%	11.5		%
ROTCE^2,3	15.0		%	12.9		%	14.3		%	13.5		%
Adjusted ROTCE³	14.3		%	12.3		%	14.2		%	13.1		%
Pre-tax profit margin⁴	29.9		%	27.0		%	28.9		%	28.0		%
Pre-tax profit margin by segment⁴
Institutional Securities	34		%	26		%	32		%	28		%
Wealth Management	24		%	28		%	25		%	28		%
Investment Management	30		%	22		%	26		%	22		%



in millions, except per share and employee data	At September 30, 2020			At December 31, 2019
Liquidity resources⁵	$	267,292		$	215,868
Loans⁶	$	146,237		$	130,637
Total assets	$	955,940		$	895,429
Deposits	$	239,253		$	190,356
Borrowings	$	203,444		$	192,627
Common shares outstanding	1,576			1,594
Common shareholders' equity	$	79,874		$	73,029
Tangible common shareholders’ equity³	$	70,646		$	63,780
Book value per common share⁷	$	50.67		$	45.82
Tangible book value per common share^3,7	$	44.81		$	40.01
Worldwide employees	63,051			60,431
Capital ratios⁸
Common Equity Tier 1 capital—Advanced	16.9		%	16.9		%
Common Equity Tier 1 capital—Standardized	17.4		%	16.4		%
Tier 1 capital—Advanced	19.0		%	19.2		%
Tier 1 capital—Standardized	19.5		%	18.6		%
Tier 1 leverage	8.3		%	8.3		%
SLR⁹	7.4		%	6.4		%


1.	The expense efficiency ratio represents total non-interest expenses as a percentage of net revenues.


2.	ROE and ROTCE represent annualized earnings applicable to Morgan Stanley common shareholders as a percentage of average common equity and average tangible common equity, respectively.


3.	Represents a non-GAAP financial measure. See “Selected Non-GAAP Financial Information” herein.


4.	Pre-tax profit margin represents income before income taxes as a percentage of net revenues.


5.	For a discussion of Liquidity resources, see “Liquidity and Capital Resources—Liquidity Risk Management Framework—Liquidity Resources” herein.


6.	Amounts include loans held for investment (net of allowance) and loans held for sale but exclude loans at fair value, which are included in Trading assets in the balance sheets (see Note 10 to the financial statements).


7.	Book value per common share and tangible book value per common share equal common shareholders’ equity and tangible common shareholders’ equity, respectively, divided by common shares outstanding.


8.	At September 30, 2020 and December 31, 2019, our risk-based capital ratios are based on the Advanced Approach and the Standardized Approach rules, respectively. For a discussion of our capital ratios, see “Liquidity and Capital Resources—Regulatory Requirements” herein.


9.	At September 30, 2020, our SLR reflects the impact of a Federal Reserve interim final rule in effect until March 31, 2021. For further information, see “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments” herein.

Selected Non-GAAP Financial Information

We prepare our financial statements using U.S. GAAP. From time to time, we may disclose certain “non-GAAP financial measures” in this document or in the course of our earnings releases, earnings and other conference calls, financial presentations, definitive proxy statement and otherwise. A “non-GAAP financial measure” excludes, or includes, amounts from the most directly comparable measure calculated and presented in accordance with U.S. GAAP. We consider the non-GAAP financial measures we disclose to be useful to us, investors, analysts and other stakeholders by providing further transparency about, or an alternate means of assessing, our financial condition, operating results, prospective regulatory capital requirements or capital adequacy.

These measures are not in accordance with, or a substitute for, U.S. GAAP and may be different from or inconsistent with non-GAAP financial measures used by other companies. Whenever we refer to a non-GAAP financial measure, we will also generally define it or present the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP, along with a reconciliation of the differences between the U.S. GAAP financial measure and the non-GAAP financial measure.

The principal non-GAAP financial measures presented in this document are set forth in the following tables.



	7	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

Reconciliations from U.S. GAAP to Non-GAAP Consolidated Financial Measures



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions, except per share data	2020			2019			2020			2019
Earnings applicable to Morgan Stanley common shareholders	$	2,597		$	2,060		$	7,234		$	6,427
Impact of adjustments	(113		)	(89		)	(10		)	(190		)
Adjusted earnings applicable to Morgan Stanley common shareholders—non-GAAP¹	$	2,484		$	1,971		$	7,224		$	6,237
Earnings per diluted common share	$	1.66		$	1.27		$	4.62		$	3.89
Impact of adjustments	(0.07		)	(0.06		)	—			(0.12		)
Adjusted earnings per diluted common share—non-GAAP¹	$	1.59		$	1.21		$	4.62		$	3.77
Effective income tax rate	21.1		%	18.2		%	22.2		%	19.1		%
Impact of adjustments	3.2		%	3.2		%	0.1		%	2.2		%
Adjusted effective income tax rate—non-GAAP¹	24.3		%	21.4		%	22.3		%	21.3		%



	Average Monthly Balance
	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions	2020			2019			2020			2019
Tangible equity
Morgan Stanley shareholders' equity	$	87,210		$	81,912		$	85,378		$	81,028
Less: Goodwill and net intangible assets	(9,260		)	(9,389		)	(9,248		)	(9,097		)
Tangible Morgan Stanley shareholders' equity—Non-GAAP	$	77,950		$	72,523		$	76,130		$	71,931
Common shareholders' equity	$	78,690		$	73,392		$	76,858		$	72,508
Less: Goodwill and net intangible assets	(9,260		)	(9,389		)	(9,248		)	(9,097		)
Tangible common shareholders' equity—Non-GAAP	$	69,430		$	64,003		$	67,610		$	63,411



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in billions	2020			2019			2020			2019
Average common equity
Unadjusted—GAAP	$	78.7		$	73.4		$	76.9		$	72.5
Adjusted¹—Non-GAAP	78.7			73.4			76.9			72.4
ROE²
Unadjusted—GAAP	13.2		%	11.2		%	12.6		%	11.8		%
Adjusted—Non-GAAP^{1, 3}	12.6		%	10.7		%	12.5		%	11.5		%
Average tangible common equity—Non-GAAP
Unadjusted	$	69.4		$	64.0		$	67.6		$	63.4
Adjusted¹	69.4			64.0			67.6			63.3
ROTCE²—Non-GAAP
Unadjusted	15.0		%	12.9		%	14.3		%	13.5		%
Adjusted^{1, 3}	14.3		%	12.3		%	14.2		%	13.1		%

Non-GAAP Financial Measures by Business Segment



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in billions	2020			2019			2020			2019
Average common equity^{4, 5}
Institutional Securities	$	42.8		$	40.4		$	42.8		$	40.4
Wealth Management	18.2			18.2			18.2			18.2
Investment Management	2.6			2.5			2.6			2.5
Average tangible common equity^{4, 5}
Institutional Securities	$	42.3		$	39.9		$	42.3		$	39.9
Wealth Management	10.4			10.2			10.4			10.2
Investment Management	1.7			1.5			1.7			1.5
ROE⁶
Institutional Securities	14.5		%	9.8		%	13.4		%	10.8		%
Wealth Management	17.9		%	20.6		%	18.2		%	20.2		%
Investment Management	34.0		%	22.1		%	23.0		%	21.5		%
ROTCE⁶
Institutional Securities	14.7		%	9.9		%	13.5		%	10.9		%
Wealth Management	31.4		%	36.9		%	31.7		%	36.2		%
Investment Management	52.6		%	35.6		%	35.6		%	34.7		%

Adjusted amounts exclude net discrete tax provisions (benefits) that are intermittent and include those that are recurring. Provisions (benefits) related to conversion of employee share-based awards are expected to occur every year and, as such, are considered recurring discrete tax items. For further information on net discrete tax provisions (benefits), see “Supplemental Financial Information—Income Tax Matters” herein.


2.	ROE and ROTCE represent annualized earnings applicable to Morgan Stanley common shareholders as a percentage of average common equity and average tangible common equity, respectively. When excluding intermittent net discrete tax provisions (benefits), both the numerator and average denominator are adjusted.


3.	The calculations used in determining our “ROE and ROTCE Targets” referred to in the following section are the Adjusted ROE and Adjusted ROTCE amounts shown in this table.


4.	Average common equity and average tangible common equity for each business segment is determined using our Required Capital framework (see "Liquidity and Capital Resources—Regulatory Requirements—Attribution of Average Common Equity According to the Required Capital Framework” herein).


5.	The sums of the segments' Average common equity and Average tangible common equity do not equal the Consolidated measures due to Parent equity.


6.	The calculation of ROE and ROTCE by segment uses annualized net income applicable to Morgan Stanley by segment less preferred dividends allocated to each segment as a percentage of average common equity and average tangible common equity, respectively, allocated to each segment.



September 2020 Form 10-Q	8



Table of Contents
Management’s Discussion and Analysis

Return on Tangible Common Equity Target

In January 2020, we established an ROTCE Target of 13% to 15% to be achieved over the next two years.

Our ROTCE Target is a forward-looking statement that was based on a normal market environment and may be materially affected by many factors, including, among other things: mergers and acquisitions; macroeconomic and market conditions; legislative and regulatory developments; industry trading and investment banking volumes; equity market levels; interest rate environment; outsized legal expenses or penalties; the ability to maintain a reduced level of expenses; and capital levels.

With the COVID–19 pandemic, and the current global economic crisis, it is uncertain that the ROTCE Target will be met within the originally stated time frame. See “Coronavirus Disease (COVID–19) Pandemic” herein and “Risk Factors” for further information on market and economic conditions and their effects on our financial results.

For further information on non-GAAP measures (ROTCE excluding intermittent net discrete tax items), see “Selected Non-GAAP Financial Information” herein. For information on the impact of intermittent net discrete tax items, see “Supplemental Financial Information—Income Tax Matters” herein.

Business Segments

Substantially all of our operating revenues and operating expenses are directly attributable to our business segments. Certain revenues and expenses have been allocated to each business segment, generally in proportion to its respective net revenues, non-interest expenses or other relevant measures.

For an overview of the components of our business segments, net revenues, compensation expense and income taxes, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments” in the 2019 Form 10-K.



	9	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

Institutional Securities

Income Statement Information



	Three Months Ended September 30,
$ in millions	2020		2019			% Change
Revenues
Investment banking	$	1,707	$	1,535		11	%
Trading	2,807		2,533			11	%
Investments	87		(18		)	N/M
Commissions and fees	639		643			(1	)%
Asset management	114		100			14	%
Other	114		51			124	%
Total non-interest revenues	5,468		4,844			13	%
Interest income	1,086		3,112			(65	)%
Interest expense	492		2,933			(83	)%
Net interest	594		179			N/M
Net revenues	6,062		5,023			21	%
Compensation and benefits	2,001		1,768			13	%
Non-compensation expenses	2,013		1,948			3	%
Total non-interest expenses	4,014		3,716			8	%
Income before provision for income taxes	2,048		1,307			57	%
Provision for income taxes	385		189			104	%
Net income	1,663		1,118			49	%
Net income applicable to noncontrolling interests	16		45			(64	)%
Net income applicable to Morgan Stanley	$	1,647	$	1,073		53	%



	Nine Months Ended September 30,
$ in millions	2020			2019		% Change
Revenues
Investment banking	$	4,902		$	4,158	18	%
Trading	10,375			8,221		26	%
Investments	98			257		(62	)%
Commissions and fees	2,230			1,889		18	%
Asset management	342			310		10	%
Other	(628		)	416		N/M
Total non-interest revenues	17,319			15,251		14	%
Interest income	4,809			9,457		(49	)%
Interest expense	3,184			9,376		(66	)%
Net interest	1,625			81		N/M
Net revenues	18,944			15,332		24	%
Compensation and benefits	6,767			5,376		26	%
Non-compensation expenses	6,186			5,591		11	%
Total non-interest expenses	12,953			10,967		18	%
Income before provision for income taxes	5,991			4,365		37	%
Provision for income taxes	1,326			703		89	%
Net income	4,665			3,662		27	%
Net income applicable to noncontrolling interests	75			97		(23	)%
Net income applicable to Morgan Stanley	$	4,590		$	3,565	29	%

Investment Banking

Investment Banking Revenues



	Three Months Ended September 30,
$ in millions	2020		2019		% Change
Advisory	$	357	$	550	(35	)%
Underwriting:
Equity	874		401		118	%
Fixed income	476		584		(18	)%
Total Underwriting	1,350		985		37	%
Total Investment banking	$	1,707	$	1,535	11	%



	Nine Months Ended September 30,
$ in millions	2020		2019		% Change
Advisory	$	1,181	$	1,462	(19	)%
Underwriting:
Equity	2,092		1,286		63	%
Fixed income	1,629		1,410		16	%
Total Underwriting	3,721		2,696		38	%
Total Investment banking	$	4,902	$	4,158	18	%



September 2020 Form 10-Q	10



Table of Contents
Management’s Discussion and Analysis

Investment Banking Volumes



	Three Months Ended September 30,				Nine Months Ended September 30,
$ in billions	2020		2019		2020		2019
Completed mergers and acquisitions¹	$	88	$	215	$	633	$	582
Equity and equity-related offerings^{2, 3}	25		17		74		47
Fixed income offerings^{2, 4}	91		90		304		211

Source: Refinitiv data as of October 1, 2020. Transaction volumes may not be indicative of net revenues in a given period. In addition, transaction volumes for prior periods may vary from amounts previously reported due to the subsequent withdrawal, change in value or change in timing of certain transactions.


1.	Includes transactions of $100 million or more. Based on full credit to each of the advisors in a transaction.


2.	Based on full credit for single book managers and equal credit for joint book managers.


3.	Includes Rule 144A issuances and registered public offerings of common stock, convertible securities and rights offerings.


4.	Includes Rule 144A and publicly registered issuances, non-convertible preferred stock, mortgage-backed and asset-backed securities, and taxable municipal debt. Excludes leveraged loans and self-led issuances.

Investment Banking Revenues in the Current Quarter

Investment banking revenues of $1,707 million in the current quarter increased 11% from the prior year quarter, reflecting an increase in revenues in our Equity underwriting business, partially offset by a decrease in revenues in our Advisory and Fixed income underwriting businesses.


•	Advisory revenues decreased in the current quarter primarily as a result of lower volumes of completed M&A activity.


•	Equity underwriting revenues increased, primarily in initial public offerings, follow-on offerings and secondary block share trades, on overall higher volumes in the current quarter.


•	Fixed income underwriting revenues decreased in the current quarter primarily in non-investment grade and investment grade loan issuances, reflecting lower event-driven activity.

Investment Banking Revenues in the Current Year Period

Investment banking revenues of $4,902 million in the current year period increased 18% from the prior year period, reflecting an increase in revenues in our underwriting businesses, partially offset by a decrease in revenues in our Advisory business.


•	Advisory revenues decreased in the current year period as there were fewer completed transactions.


•	Equity underwriting revenues increased, primarily in follow-on offerings, secondary block share trades, initial public offerings and convertible issuances, on overall higher volumes in the current year period.


•	Fixed income underwriting revenues increased, primarily in investment grade and non-investment grade bond issuances, partially offset by investment grade loan issuances, on overall higher volumes.

See “Investment Banking Volumes” herein.

Sales and Trading Net Revenues

By Income Statement Line Item



	Three Months Ended September 30,
$ in millions	2020		2019		% Change
Trading	$	2,807	$	2,533	11	%
Commissions and fees	639		643		(1	)%
Asset management	114		100		14	%
Net interest	594		179		N/M
Total	$	4,154	$	3,455	20	%



	Nine Months Ended September 30,
$ in millions	2020		2019		% Change
Trading	$	10,375	$	8,221	26	%
Commissions and fees	2,230		1,889		18	%
Asset management	342		310		10	%
Net interest	1,625		81		N/M
Total	$	14,572	$	10,501	39	%

By Business



	Three Months Ended September 30,
	Three Months Ended September 30,
$ in millions	2020			2019		% Change
Equity	$	2,262		$	1,991	14	%
Fixed Income	1,924			1,430		35	%
Other	(32		)	34		(194	)%
Total	$	4,154		$	3,455	20	%



	Nine Months Ended September 30,
	Nine Months Ended September 30,
$ in millions	2020		2019		% Change
Equity	$	7,303	$	6,136	19	%
Fixed Income	7,160		4,273		68	%
Other	109		92		18	%
Total	$	14,572	$	10,501	39	%



	11	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

Sales and Trading Revenues—Equity and Fixed Income



	Three Months Ended September 30, 2020
					Net
$ in millions	Trading		Fees¹		Interest²			Total
Financing	$	929	$	108	$	116		$	1,153
Execution services	606		580		(77		)	1,109
Total Equity	$	1,535	$	688	$	39		$	2,262
Total Fixed Income	$	1,420	$	65	$	439		$	1,924



	Three Months Ended September 30, 2019
					Net
$ in millions	Trading		Fees¹		Interest²			Total
Financing	$	1,049	$	88	$	(90	)	$	1,047
Execution services	446		564		(66		)	944
Total Equity	$	1,495	$	652	$	(156	)	$	1,991
Total Fixed Income	$	1,329	$	90	$	11		$	1,430



	Nine Months Ended September 30, 2020
					Net
$ in millions	Trading		Fees¹		Interest²			Total
Financing	$	2,847	$	325	$	172		$	3,344
Execution services	2,134		2,014		(189		)	3,959
Total Equity	$	4,981	$	2,339	$	(17	)	$	7,303
Total Fixed Income	$	5,661	$	234	$	1,265		$	7,160



	Nine Months Ended September 30, 2019
					Net
$ in millions	Trading		Fees¹		Interest²			Total
Financing	$	3,249	$	280	$	(500	)	$	3,029
Execution services	1,597		1,671		(161		)	3,107
Total Equity	$	4,846	$	1,951	$	(661	)	$	6,136
Total Fixed Income	$	4,200	$	249	$	(176	)	$	4,273


1.	Includes Commissions and fees and Asset management revenues.


2.	Includes funding costs, which are allocated to the businesses based on funding usage.

Sales and Trading Net Revenues in the Current Quarter

Equity

Equity sales and trading net revenues of $2,262 million in the current quarter increased 14% from the prior year quarter, reflecting increases in both our execution services and financing businesses.


•	Financing revenues increased from the prior year quarter, primarily driven by client activity. The effect of lower interest rates was an increase in Net interest driven by lower funding costs, partially offset by reduced Trading revenues.


•	Execution services revenues increased from the prior year quarter primarily due to higher Trading revenues reflecting

favorable inventory management results and higher client activity in derivatives products.

Fixed Income

Fixed Income sales and trading net revenues of $1,924 million in the current quarter were 35% higher than the prior year quarter, reflecting strong performance across all products.


•	Global macro products revenues increased primarily due to improved inventory management in rates and foreign exchange products, partially offset by lower levels of client activity across all products.


•	Credit products revenues increased primarily driven by improved inventory management and higher client activity, which benefited from an active primary market in the current quarter. Net interest revenues increased reflecting lower funding costs.


•	Commodities products and Other revenues increased primarily due to favorable inventory management in Commodities, mainly in precious metals products.

Other


•	Other sales and trading losses of $32 million in the current quarter primarily reflect losses on economic hedges related to certain Borrowings and corporate lending activity, partially offset by gains from investments associated with certain employee deferred compensation plans.

Sales and Trading Net Revenues in the Current Year Period

Equity

Equity sales and trading net revenues of $7,303 million in the current year period increased 19% from the prior year period, reflecting increases in both our execution services and financing businesses.


•	Financing revenues increased from the prior year period, primarily driven by client activity. The effect of lower interest rates was an increase in Net interest driven by lower funding costs, partially offset by reduced Trading revenues.


•	Execution services revenues increased from the prior year period, reflecting higher client activity and favorable inventory management results in cash equities and derivatives, partially offset by the impact of counterparty exposure losses.



September 2020 Form 10-Q	12



Table of Contents
Management’s Discussion and Analysis

Fixed Income

Fixed Income sales and trading net revenues of $7,160 million in the current year period were 68% higher than the prior year period, reflecting strong performance across all products.


•	Global macro products revenues increased primarily due to higher client activity in both rates and foreign exchange products and improved inventory management results.


•	Credit products revenues increased primarily due to higher client activity in corporate credit and securitized products from higher volumes and wider bid-offer spreads, partially offset by the effect of widening credit spreads on inventory. Net interest revenues increased reflecting lower funding costs and higher average balances in secured lending facilities.


•	Commodities products and Other revenues increased primarily reflecting favorable inventory management and higher client activity in commodities, partially offset by lower client structuring activity within derivatives counterparty credit risk management.

Other


•	Other sales and trading revenues of $109 million in the current year period increased from the prior year period reflecting gains on hedges associated with corporate lending activity, partially offset by lower yields on liquidity investments, lower gains from investments associated with certain employee deferred compensation plans and losses on economic hedges related to certain Borrowings.

Investments, Other Revenues, Non-interest Expenses, and Income Tax Items

Investments


•	Net investments gains of $87 million in the current quarter include gains on certain business-related investments compared with losses in the prior year quarter.


•	Net investments gains of $98 million in the current year period include gains on certain business-related investments. The prior year period included gains associated with an investment’s initial public offering.

Other Revenues


•	Other revenues of $114 million in the current quarter increased compared to the prior year quarter primarily as a result of mark-to-market gains on loans and lending commitments held for sale as credit spreads tightened, partially offset by an increase in the provision for credit losses on loans held for investment.


•	Other net losses of $628 million in the current year period were primarily as a result of mark-to-market losses on loans

and lending commitments held for sale as credit spreads widened and an increase in the provision for credit losses on loans held for investment.

Non-interest Expenses

Non-interest expenses of $4,014 million in the current quarter increased from the prior year quarter, primarily reflecting a 13% increase in Compensation and benefits expenses.


•	Compensation and benefits expenses increased in the current quarter primarily due to increases in discretionary incentive compensation, driven by higher revenues, and higher expenses related to certain deferred compensation plans linked to investment performance.


•	Non-compensation expenses increased in the current quarter primarily due to higher volume-related expenses and information processing and communications expenses, partially offset by lower litigation costs.

Non-interest expenses of $12,953 million in the current year period increased from the prior year period, reflecting a 26% increase in Compensation and benefits expenses and an 11% increase in Non-compensation expenses.


•	Compensation and benefits expenses increased in the current year period primarily due to increases in discretionary incentive compensation, driven by higher revenues, partially offset by lower expenses related to certain deferred compensation plans linked to investment performance.


•	Non-compensation expenses increased in the current year period primarily due to higher volume-related expenses, an increase in the provision for credit losses for lending commitments held for investment and off-balance sheet instruments, and higher information processing and communications expenses. Partially offsetting these increases were lower marketing and business development expenses.

Income Tax Items


•	The current quarter and prior year quarter included intermittent net discrete tax benefits of $115 million and $67 million, respectively.


•	The current year period and prior year period included intermittent net discrete tax benefits of $17 million and $168 million, respectively.

For further information, see “Supplemental Financial Information—Income Tax Matters” herein.



	13	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

Wealth Management

Income Statement Information



	Three Months Ended September 30,
$ in millions	2020		2019		% Change
Revenues
Investment banking	$	135	$	118	14	%
Trading	268		61		N/M
Investments	1		—		N/M
Commissions and fees	477		416		15	%
Asset management	2,793		2,639		6	%
Other	94		81		16	%
Total non-interest revenues	3,768		3,315		14	%
Interest income	1,065		1,378		(23	)%
Interest expense	176		335		(47	)%
Net interest	889		1,043		(15	)%
Net revenues	4,657		4,358		7	%
Compensation and benefits	2,684		2,340		15	%
Non-compensation expenses	853		780		9	%
Total non-interest expenses	3,537		3,120		13	%
Income before provision for income taxes	$	1,120	$	1,238	(10	)%
Provision for income taxes	278		276		1	%
Net income applicable to Morgan Stanley	$	842	$	962	(12	)%



	Nine Months Ended September 30,
$ in millions	2020		2019		% Change
Revenues
Investment banking	$	403	$	365	10	%
Trading	413		525		(21	)%
Investments	9		1		N/M
Commissions and fees	1,538		1,250		23	%
Asset management	7,980		7,544		6	%
Other	216		281		(23	)%
Total non-interest revenues	10,559		9,966		6	%
Interest income	3,468		4,139		(16	)%
Interest expense	653		950		(31	)%
Net interest	2,815		3,189		(12	)%
Net revenues	13,374		13,155		2	%
Compensation and benefits	7,625		7,184		6	%
Non-compensation expenses	2,432		2,302		6	%
Total non-interest expenses	10,057		9,486		6	%
Income before provision for income taxes	$	3,317	$	3,669	(10	)%
Provision for income taxes	758		830		(9	)%
Net income applicable to Morgan Stanley	$	2,559	$	2,839	(10	)%

Financial Information and Statistical Data



	At September 30, 2020			At December 31, 2019
$ in billions, except employee data	At September 30, 2020			At December 31, 2019
Client assets	$	2,852		$	2,700
Fee-based client assets¹	$	1,333		$	1,267
Fee-based client assets as a percentage of total client assets	47		%	47		%
Client liabilities²	$	100		$	90
Investment securities	$	88.6		$	67.2
Loans and lending commitments	$	105.9		$	93.2
Wealth Management representatives	15,469			15,468



	Three Months Ended September 30,
	2020		2019
Per representative:
Annualized revenues ($ in thousands)³	$	1,207	$	1,118
Client assets ($ in millions)⁴	$	184	$	165
Fee-based asset flows ($ in billions)⁵	$	23.8	$	15.5



	Nine Months Ended September 30,
	2020		2019
Per representative:
Annualized revenues ($ in thousands)³	$	1,155	$	1,121
Client assets ($ in millions)⁴	$	184	$	165
Fee-based asset flows ($ in billions)⁵	$	53.3	$	40.1


1.	Fee-based client assets represent the amount of assets in client accounts where the fee for services is calculated based on those assets.


2.	Client liabilities include securities-based and other loans (including tailored lending), residential real estate loans and margin lending.


3.	Revenues per representative equals Wealth Management’s annualized net revenues divided by the average number of representatives.


4.	Client assets per representative equals total period-end client assets divided by period-end number of representatives.


5.	Excludes institutional cash management-related activity. For a description of the Inflows and Outflows included within Fee-based asset flows, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments—Wealth Management” in the 2019 Form 10-K.



September 2020 Form 10-Q	14



Table of Contents
Management’s Discussion and Analysis

Transactional Revenues



	Three Months Ended September 30,
$ in millions	2020			2019			% Change
Investment banking	$	135		$	118		14	%
Trading	268			61			N/M
Commissions and fees	477			416			15	%
Total	$	880		$	595		48	%
Transactional revenues as a % of Net revenues	19		%	14		%



	Nine Months Ended September 30,
$ in millions	2020			2019			% Change
Investment banking	$	403		$	365		10	%
Trading	413			525			(21	)%
Commissions and fees	1,538			1,250			23	%
Total	$	2,354		$	2,140		10	%
Transactional revenues as a % of Net revenues	18		%	16		%

Net Revenues

Transactional Revenues

Transactional revenues of $880 million in the current quarter increased 48% from the prior year quarter primarily as a result of higher Trading revenues and higher Commissions and fees.


•	Trading revenues increased in the current quarter primarily due to gains from investments associated with certain employee deferred compensation plans, partially offset by lower fixed income revenues.


•	Commissions and fees increased in the current quarter primarily due to increased client activity in equities.

Transactional revenues of $2,354 million in the current year period increased 10% from the prior year period primarily as a result of higher Commissions and fees, partially offset by lower Trading revenues.


•	Trading revenues decreased in the current year period primarily due to lower fixed income revenues.


•	Commissions and fees increased in the current year period primarily due to increased client activity in equities.

Asset Management

Asset management revenues of $2,793 million in the current quarter increased 6% compared with the prior year quarter due to higher fee-based asset levels during the current quarter as a result of positive net flows and market appreciation, partially offset by lower average fee rates.

Asset management revenues of $7,980 million in the current year period increased 6% from the prior year period primarily

due to higher fee-based asset levels during the current year period as a result of market appreciation and positive net flows, partially offset by lower average fee rates.

See “Fee-Based Client Assets—Rollforwards” herein.

Other

Other revenues of $216 million in the current year period decreased 23% from the prior year period primarily due to lower realized gains from the AFS securities portfolio and an increase in the provision for credit losses.

Net Interest

Net interest of $889 million and $2,815 million decreased 15% and 12%, from the prior year periods primarily due to the net effect of lower interest rates, partially offset by growth in Loans and increases in investment portfolio balances driven by higher brokerage sweep deposits.

Non-interest Expenses

Non-interest expenses of $3,537 million in the current quarter increased 13% from the prior year quarter, primarily as a result of higher Compensation and benefits expenses.


•	Compensation and benefits expenses increased in the current quarter, primarily due to higher expenses related to certain deferred compensation plans linked to investment performance and an increase in the formulaic payout to Wealth Management representatives, driven by higher compensable revenues.


•	Non-compensation expenses increased in the current quarter, reflecting a regulatory charge, as well as expenses associated with the E*TRADE acquisition, partially offset by lower marketing and business development expenses.

Non-interest expenses of $10,057 million in the current year period increased 6% from the prior year period, primarily as a result of higher Compensation and benefits expenses.


•	Compensation and benefits expenses increased in the current year period primarily due to an increase in the formulaic payout to Wealth Management representatives, driven by higher compensable revenues, as well as higher salaries.


•	Non-compensation expenses increased in the current year period, reflecting a regulatory charge, as well as expenses associated with the E*TRADE acquisition and incremental expenses related to Solium Capital, Inc., partially offset by lower marketing and business development expenses.



	15	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

Fee-Based Client Assets

Rollforwards



$ in billions	At June 30, 2020		Inflows		Outflows			Market Impact		At September 30, 2020
Separately managed¹	$	313	$	19	$	(4	)	$	14	$	342
Unified managed	305		16		(12		)	18		327
Advisor	149		8		(8		)	9		158
Portfolio manager	431		21		(16		)	23		459
Subtotal	$	1,198	$	64	$	(40	)	$	64	$	1,286
Cash management	38		12		(3		)	—		47
Total fee-based client assets	$	1,236	$	76	$	(43	)	$	64	$	1,333



$ in billions	At June 30, 2019		Inflows		Outflows			Market Impact		At September 30, 2019
Separately managed¹	$	296	$	15	$	(5	)	$	6	$	312
Unified managed	292		12		(10		)	1		295
Advisor	149		7		(8		)	—		148
Portfolio manager	400		19		(14		)	2		407
Subtotal	$	1,137	$	53	$	(37	)	$	9	$	1,162
Cash management	22		4		(3		)	1		24
Total fee-based client assets	$	1,159	$	57	$	(40	)	$	10	$	1,186



$ in billions	At December 31, 2019		Inflows		Outflows			Market Impact			At September 30, 2020
Separately managed¹	$	322	$	37	$	(14	)	$	(3	)	$	342
Unified managed	313		43		(33		)	4			327
Advisor	155		22		(21		)	2			158
Portfolio manager	435		62		(43		)	5			459
Subtotal	$	1,225	$	164	$	(111	)	$	8		$	1,286
Cash management	42		21		(16		)	—			47
Total fee-based client assets	$	1,267	$	185	$	(127	)	$	8		$	1,333



$ in billions	At December 31, 2018		Inflows		Outflows			Market Impact		At September 30, 2019
Separately managed¹	$	279	$	38	$	(15	)	$	10	$	312
Unified managed	257		35		(30		)	33		295
Advisor	137		20		(24		)	15		148
Portfolio manager	353		54		(38		)	38		407
Subtotal	$	1,026	$	147	$	(107	)	$	96	$	1,162
Cash management	20		12		(12		)	4		24
Total fee-based client assets	$	1,046	$	159	$	(119	)	$	100	$	1,186


1.	Includes non-custody account values reflecting prior quarter-end balances due to a lag in the reporting of asset values by third-party custodians.

Average Fee Rates



	Three Months Ended September 30,		Nine Months Ended September 30,
Fee rate in bps	2020	2019	2020	2019
Separately managed	15	15	14	15
Unified managed	99	99	99	100
Advisor	85	86	85	87
Portfolio manager	94	96	94	95
Subtotal	73	74	72	74
Cash management	5	6	5	6
Total fee-based client assets	71	73	70	73

For a description of fee-based client assets and rollforward items in the previous tables, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments—Wealth Management—Fee-Based Client Assets” in the 2019 Form 10-K.

Acquisition of E*TRADE

On October 2, 2020, we completed the acquisition of E*TRADE principally via the issuance of approximately $11 billion of common shares. In addition, we issued $0.7 billion of preferred shares in exchange for E*TRADE’s existing preferred stock. We believe the combination will increase the scale and breadth of Morgan Stanley’s Wealth Management franchise, and position us to be an industry leader in Wealth Management across all channels and wealth segments.

The business activities of E*TRADE will be reported within the Wealth Management business segment beginning in the fourth quarter of 2020, and the following table illustrates how E*TRADE’s primary revenues will be presented.



E*TRADE Revenues	Morgan Stanley Revenues
Net interest income	Net interest
Fees and service charges	Commissions and fees¹ Asset management
Commissions	Commissions and fees


1.	The primary element of this mapping is revenues from order flow payments.

Non-interest expenses are also expected to be impacted by integration costs. For additional information on the acquisition of E*TRADE, see Note 3 to the financial statements.



September 2020 Form 10-Q	16



Table of Contents
Management’s Discussion and Analysis

Investment Management

Income Statement Information



	Three Months Ended September 30,
$ in millions	2020			2019			% Change
Revenues
Trading	$	2		$	2		—	%
Investments	258			105			146	%
Commissions and fees	1			1			—	%
Asset management	795			664			20	%
Other	1			—			N/M
Total non-interest revenues	1,057			772			37	%
Interest income	7			4			75	%
Interest expense	8			12			(33	)%
Net interest	(1		)	(8		)	88	%
Net revenues	1,056			764			38	%
Compensation and benefits	401			319			26	%
Non-compensation expenses	340			280			21	%
Total non-interest expenses	741			599			24	%
Income before provision for income taxes	315			165			91	%
Provision for income taxes	72			27			167	%
Net income	243			138			76	%
Net income applicable to noncontrolling interests	18			—			N/M
Net income applicable to Morgan Stanley	$	225		$	138		63	%



	Nine Months Ended September 30,
$ in millions	2020			2019			% Change
Revenues
Investment banking	$	—		$	(1	)	100	%
Trading	(13		)	(2		)	N/M
Investments	552			543			2	%
Commissions and fees	1			1			—	%
Asset management	2,144			1,893			13	%
Other	(39		)	(6		)	N/M
Total non-interest revenues	2,645			2,428			9	%
Interest income	22			14			57	%
Interest expense	33			35			(6	)%
Net interest	(11		)	(21		)	48	%
Net revenues	2,634			2,407			9	%
Compensation and benefits	1,012			1,049			(4	)%
Non-compensation expenses	948			820			16	%
Total non-interest expenses	1,960			1,869			5	%
Income before provision for income taxes	674			538			25	%
Provision for income taxes	136			104			31	%
Net income	538			434			24	%
Net income applicable to noncontrolling interests	81			32			153	%
Net income applicable to Morgan Stanley	$	457		$	402		14	%

Net Revenues

Investments

Investments revenues of $258 million in the current quarter increased 146% from the prior year quarter, primarily due to higher accrued carried interest and investment gains in an Asia private equity fund, principally driven by gains from an underlying investment.

Investments revenues of $552 million in the current year period were relatively unchanged from the prior year period as higher accrued carried interest and investment gains in an Asia private equity fund, principally driven by gains from an underlying investment, were mostly offset by the reversal of accrued carried interest and investment losses in real estate, infrastructure and certain private equity funds.

Asset Management

Asset management revenues of $795 million in the current quarter and $2,144 million in the current year period increased 20% and 13% from the prior year quarter and prior year period, respectively, primarily as a result of higher average AUM, driven by strong investment performance and positive long-term net flows.

See “Assets Under Management or Supervision” herein.



	17	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

Other

Other losses of $39 million in the current year period primarily reflect an impairment of an investment in a third-party asset manager in the second quarter of 2020.

Non-interest Expenses

Non-interest expenses of $741 million in the current quarter increased 24% from the prior year quarter as a result of higher Compensation and benefits expenses and higher Non-compensation expenses.


•	Compensation and benefits expenses increased in the current quarter primarily as a result of higher expenses related to certain deferred compensation plans linked to investment performance, increases in discretionary incentive compensation driven by higher Asset management revenues, and higher compensation associated with carried interest.


•	Non-compensation expenses in the current quarter increased from the prior year quarter primarily as a result of higher fee sharing paid to intermediaries on higher average AUM.

Non-interest expenses of $1,960 million in the current year period increased 5% from the prior year period primarily as a result of higher Non-compensation expenses.


•	Compensation and benefits expenses decreased in the current year period primarily as a result of lower compensation associated with carried interest partially offset by higher expenses related to certain deferred compensation plans linked to investment performance, and increases in discretionary incentive compensation driven by higher Asset management revenues.


•	Non-compensation expenses in the current year period increased from the prior year period primarily as a result of higher fee sharing paid to intermediaries on higher average AUM.

Assets Under Management or Supervision

Rollforwards



$ in billions	At June 30, 2020		Inflows		Outflows			Market Impact		Other		At September 30, 2020
Equity	$	168	$	24	$	(14	)	$	23	$	1	$	202
Fixed income	84		8		(5		)	1		4		92
Alternative/Other	145		6		(7		)	4		2		150
Long-term AUM subtotal	397		38		(26		)	28		7		444
Liquidity	268		319		(317		)	—		1		271
Total AUM	$	665	$	357	$	(343	)	$	28	$	8	$	715



$ in billions	At June 30, 2019		Inflows		Outflows			Market Impact			Other			At September 30, 2019
Equity	$	128	$	10	$	(8	)	$	(4	)	$	—		$	126
Fixed income	71		6		(4		)	2			(1		)	74
Alternative/Other	135		5		(4		)	2			(3		)	135
Long-term AUM subtotal	334		21		(16		)	—			(4		)	335
Liquidity	163		311		(301		)	(1		)	—			172
Total AUM	$	497	$	332	$	(317	)	$	(1	)	$	(4	)	$	507



$ in billions	At December 31, 2019		Inflows		Outflows			Market Impact			Other		At September 30, 2020
Equity	$	138	$	56	$	(35	)	$	42		$	1	$	202
Fixed income	79		29		(20		)	1			3		92
Alternative/Other	139		21		(15		)	(1		)	6		150
Long-term AUM subtotal	356		106		(70		)	42			10		444
Liquidity	196		1,174		(1,100		)	1			—		271
Total AUM	$	552	$	1,280	$	(1,170	)	$	43		$	10	$	715



$ in billions	At December 31, 2018		Inflows		Outflows			Market Impact		Other			At September 30, 2019
Equity	$	103	$	28	$	(23	)	$	18	$	—		$	126
Fixed income	68		17		(15		)	5		(1		)	74
Alternative/Other	128		17		(14		)	8		(4		)	135
Long-term AUM subtotal	299		62		(52		)	31		(5		)	335
Liquidity	164		965		(956		)	1		(2		)	172
Total AUM	$	463	$	1,027	$	(1,008	)	$	32	$	(7	)	$	507

Average AUM



	Three Months Ended September 30,				Nine Months Ended September 30,
$ in billions	2020		2019		2020		2019
Equity	$	190	$	127	$	159	$	120
Fixed income	90		73		84		70
Alternative/Other	148		135		143		133
Long-term AUM subtotal	428		335		386		323
Liquidity	267		169		244		166
Total AUM	$	695	504		$	630	$	489

Average Fee Rates



	Three Months Ended September 30,		Nine Months Ended September 30,
Fee rate in bps	2020	2019	2020	2019
Equity	76	76	75	76
Fixed income	29	32	29	32
Alternative/Other	58	62	59	65
Long-term AUM	60	61	59	62
Liquidity	15	17	16	17
Total AUM	43	46	42	47

For a description of the asset classes and rollforward items in the previous tables, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments—Investment Management—Assets Under Management or Supervision” in the 2019 Form 10-K.



September 2020 Form 10-Q	18



Table of Contents
Management’s Discussion and Analysis

Planned Acquisition of Eaton Vance

On October 8, 2020, we entered into a definitive agreement under which we will acquire Eaton Vance Corp. (“Eaton Vance”), a leading provider of advanced investment management strategies and wealth management solutions, in a cash and stock transaction valued, as of the announcement, at approximately $7 billion, based on the closing price of our common stock and the number of Eaton Vance’s fully diluted shares outstanding on October 7, 2020. Under the terms of the agreement, Eaton Vance common stockholders will receive $28.25 in cash and 0.5833 shares of our common shares for each Eaton Vance common share. In addition, Eaton Vance common shareholders will receive a one-time special cash dividend of $4.25 per share to be paid pre-closing by Eaton Vance. The acquisition is subject to customary closing conditions, and is expected to close in the second quarter of 2021.



	19	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

Supplemental Financial Information

Income Tax Matters

Effective Tax Rate



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions	2020			2019			2020			2019
U.S. GAAP	21.1		%	18.2		%	22.2		%	19.1		%
Adjusted effective income tax rate—non-GAAP¹	24.3		%	21.4		%	22.3		%	21.3		%
Net discrete tax provisions (benefits)
Recurring²	$	—		$	—		$	(94	)	$	(127	)
Intermittent³	(113		)	(89		)	(10		)	(190		)


1.	The adjusted effective income tax rate is a non-GAAP measure that excludes net discrete tax provisions (benefits) that are intermittent and includes those that are recurring. For further information on non-GAAP measures, see “Selected Non-GAAP Financial Information” herein.


2.	Provisions (benefits) related to conversion of employee share-based awards are expected to occur every year and, as such, are considered recurring discrete tax items.


3.	Includes all tax provisions (benefits) that have been determined to be discrete, other than Recurring items as defined above.

The current quarter included intermittent net discrete tax benefits principally associated with the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of tax examinations in certain jurisdictions.

The prior year quarter included intermittent net discrete tax benefits primarily associated with the filing of the 2018 federal tax return and the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations.

The prior year period included intermittent net discrete tax benefits primarily associated with the remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations and other matters. See Note 19 to the financial statements for further information.

U.S. Bank Subsidiaries

Our U.S. bank subsidiaries as of September 30, 2020, Morgan Stanley Bank N.A. (“MSBNA”) and Morgan Stanley Private Bank, National Association (“MSPBNA”) (collectively, “U.S. Bank Subsidiaries”) accept deposits; provide loans to corporations, governments, financial institutions and high to ultra-high net worth clients; and invest in securities. Lending activity recorded in the U.S. Bank Subsidiaries from the Institutional Securities business segment primarily includes loans and lending commitments to corporate clients. Lending activity recorded in the U.S. Bank Subsidiaries from the Wealth Management business segment primarily includes securities-based lending, which allows clients to borrow money against

the value of qualifying securities, and residential real estate loans.

For a further discussion of our credit risks, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk.” For a further discussion about loans and lending commitments, see Notes 10 and 14 to the financial statements.

U.S. Bank Subsidiaries’ Supplemental Financial Information¹



$ in billions	At September 30, 2020		At December 31, 2019
Assets	$	266.2	$	219.6
Investment securities portfolio:
Investment securities—AFS	62.9		42.4
Investment securities—HTM	28.2		26.1
Total investment securities	$	91.1	$	68.5
Deposits²	$	238.0	$	189.3
Wealth Management Loans³
Residential real estate	$	33.6	$	30.2
Securities-based lending and Other⁴	57.7		49.9
Total	$	91.3	$	80.1
Institutional Securities Loans³
Corporate	$	7.8	$	5.6
Secured lending facilities	28.2		26.8
Commercial and Residential real estate	8.6		12.0
Securities-based lending and Other	4.7		5.4
Total	$	49.3	$	49.8


1.	Amounts exclude transactions between the bank subsidiaries, as well as deposits from the Parent Company and affiliates.


2.	For further information on deposits, see “Liquidity and Capital Resources—Funding Management—Unsecured Financing” herein.


3.	For a further discussion of loans in the Wealth Management and Institutional Securities business segments, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk” herein.


4.	Other loans primarily include tailored lending.

Accounting Development Updates

The Financial Accounting Standards Board has issued certain accounting updates, which we have either determined are not applicable or are not expected to have a significant impact on our financial statements.



September 2020 Form 10-Q	20



Table of Contents
Management’s Discussion and Analysis

Critical Accounting Policies

Our financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions (see Note 1 to the financial statements). We believe that of our significant accounting policies (see Note 2 to the financial statements in the 2019 Form 10-K and Note 2 to the financial statements), the fair value, goodwill and intangible assets, legal and regulatory contingencies and income taxes policies involve a higher degree of judgment and complexity. For a further discussion about our critical accounting policies, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” in the 2019 Form 10-K.

Liquidity and Capital Resources

Senior management, with oversight by the Asset/Liability Management Committee and the Board of Directors (“Board”), establishes and maintains our liquidity and capital policies. Through various risk and control committees, senior management reviews business performance relative to these policies, monitors the availability of alternative sources of financing, and oversees the liquidity, interest rate and currency sensitivity of our asset and liability position. Our Treasury department, Firm Risk Committee, Asset/Liability Management Committee, and other committees and control groups assist in evaluating, monitoring and controlling the impact that our business activities have on our balance sheet, liquidity and capital structure. Liquidity and capital matters are reported regularly to the Board and the Risk Committee of the Board.

Balance Sheet

We monitor and evaluate the composition and size of our balance sheet on a regular basis. Our balance sheet management process includes quarterly planning, business-specific thresholds, monitoring of business-specific usage versus key performance metrics and new business impact assessments.

We establish balance sheet thresholds at the consolidated and business segment levels. We monitor balance sheet utilization and review variances resulting from business activity and market fluctuations. On a regular basis, we review current performance versus established thresholds and assess the need to re-allocate our balance sheet based on business unit needs. We also monitor key metrics, including asset and liability size and capital usage.

Total Assets by Business Segment



	At September 30, 2020
$ in millions	IS		WM		IM		Total
Assets
Cash and cash equivalents	$	72,592	$	22,018	$	162	$	94,772
Trading assets at fair value	289,528		298		4,142		293,968
Investment securities	42,149		88,556		—		130,705
Securities purchased under agreements to resell	73,637		14,646		—		88,283
Securities borrowed	100,175		628		—		100,803
Customer and other receivables	57,593		14,067		877		72,537
Loans¹	54,918		91,302		17		146,237
Other assets²	13,731		12,910		1,994		28,635
Total assets	$	704,323	$	244,425	$	7,192	$	955,940



	At December 31, 2019
$ in millions	IS		WM		IM		Total
Assets
Cash and cash equivalents	$	67,657	$	14,247	$	267	$	82,171
Trading assets at fair value	293,477		47		3,586		297,110
Investment securities	38,524		67,201		—		105,725
Securities purchased under agreements to resell	80,744		7,480		—		88,224
Securities borrowed	106,199		350		—		106,549
Customer and other receivables	39,743		15,190		713		55,646
Loans¹	50,557		80,075		5		130,637
Other assets²	14,300		13,092		1,975		29,367
Total assets	$	691,201	$	197,682	$	6,546	$	895,429

IS—Institutional Securities

WM—Wealth Management

IM—Investment Management


1.	Amounts include loans held for investment, net of allowance, and loans held for sale but exclude loans at fair value, which are included in Trading assets in the balance sheets (see Note 10 to the financial statements).


2.	Other assets primarily includes Goodwill and Intangible assets, premises, equipment and software, ROU assets related to leases, other investments, and deferred tax assets.

A substantial portion of total assets consists of liquid marketable securities and short-term receivables arising principally from sales and trading activities in the Institutional Securities business segment. Total assets increased to $956 billion at September 30, 2020 from $895 billion at December 31, 2019.

Wealth Management assets increased driven by continued growth in Loans as well as in the investment portfolio, comprising Investment securities, Cash and cash equivalents, and Securities purchased under agreements to resell, as a result of significantly higher deposits in this segment.

Institutional Securities’ assets were also higher, reflecting increases within Customer and other receivables, primarily in Equity financing.

Liquidity Risk Management Framework

The core components of our Liquidity Risk Management Framework are the Required Liquidity Framework, Liquidity Stress Tests and Liquidity Resources, which support our target



	21	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

liquidity profile. For a further discussion about the Firm’s Required Liquidity Framework and Liquidity Stress Tests, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Liquidity Risk Management Framework” in the 2019 Form 10-K.

At September 30, 2020 and December 31, 2019, we maintained sufficient liquidity to meet current and contingent funding obligations as modeled in our Liquidity Stress Tests.

Liquidity Resources

We maintain sufficient liquidity resources, which consist of HQLA and cash deposits with banks (“Liquidity Resources”) to cover daily funding needs and to meet strategic liquidity targets sized by the Required Liquidity Framework and Liquidity Stress Tests. The total amount of Liquidity Resources is actively managed by us considering the following components: unsecured debt maturity profile; balance sheet size and composition; funding needs in a stressed environment, inclusive of contingent cash outflows; legal entity, regional and segment liquidity requirements; regulatory requirements; and collateral requirements.

The amount of Liquidity Resources we hold is based on our risk tolerance and is subject to change depending on market and Firm-specific events. The Liquidity Resources are primarily held within the Parent Company and its major operating subsidiaries. The Total HQLA values in the tables immediately following are different from Eligible HQLA which, in accordance with the LCR rule, also takes into account certain regulatory weightings and other operational considerations.

Liquidity Resources by Type of Investment¹



$ in millions	At September 30, 2020		At December 31, 2019
Cash deposits with central banks	$	41,639	$	35,025
Unencumbered HQLA Securities²:
U.S. government obligations	113,058		88,754
U.S. agency and agency mortgage-backed securities	63,961		50,732
Non-U.S. sovereign obligations³	37,470		29,909
Other investment grade securities	1,398		1,591
Total HQLA²	$	257,526	$	206,011
Cash deposits with banks (non-HQLA)	9,766		9,857
Total Liquidity Resources	$	267,292	$	215,868


1.	In the first quarter of 2020, we changed our internal measure of liquidity from the Global Liquidity Reserve to Liquidity Resources, which is more closely aligned with the regulatory definition of HQLA. Prior periods have been recast to conform to the current presentation.


2.	HQLA is presented prior to applying weightings and includes all HQLA held in subsidiaries.


3.	Primarily composed of unencumbered Japanese, UK, French, German and Dutch government obligations.


4.

Liquidity Resources by Bank and Non-Bank Legal Entities¹



$ in millions	At September 30, 2020		At December 31, 2019		Average Daily Balance Three Months Ended September 30, 2020
Bank legal entities
Domestic	$	115,821	$	75,894	$	113,991
Foreign	5,384		4,049		5,624
Total Bank legal entities	121,205		79,943		119,615
Non-Bank legal entities
Domestic:
Parent Company	62,561		53,128		74,587
Non-Parent Company	30,215		28,905		34,341
Total Domestic	92,776		82,033		108,928
Foreign	53,311		53,892		55,933
Total Non-Bank legal entities	146,087		135,925		164,861
Total Liquidity Resources	$	267,292	$	215,868	$	284,476


1.	In the first quarter of 2020, we changed our internal measure of liquidity from the Global Liquidity Reserve to Liquidity Resources, which is more closely aligned with the regulatory definition of HQLA. Prior periods have been recast to conform to the current presentation.

Liquidity Resources may fluctuate from period to period based on the overall size and composition of our balance sheet, the maturity profile of our unsecured debt and estimates of funding needs in a stressed environment, among other factors. Liquidity Resources increased in the current year period primarily due to an increase in deposits.

Regulatory Liquidity Framework

Liquidity Coverage Ratio

We and our U.S. Bank Subsidiaries are subject to LCR requirements, including a requirement to calculate each entity’s LCR on each business day. The requirements are designed to ensure that banking organizations have sufficient Eligible HQLA to cover net cash outflows arising from significant stress over 30 calendar days, thus promoting the short-term resilience of the liquidity risk profile of banking organizations. In determining Eligible HQLA for LCR purposes, weightings (or asset haircuts) are applied to HQLA and certain HQLA held in subsidiaries are excluded.

As of September 30, 2020, we and our U.S. Bank Subsidiaries are compliant with the minimum required LCR of 100%.



September 2020 Form 10-Q	22



Table of Contents
Management’s Discussion and Analysis

Liquidity Coverage Ratio



	Average Daily Balance Three Months Ended
$ in millions	September 30, 2020			June 30, 2020
Eligible HQLA¹
Cash deposits with central banks	$	36,481		$	52,369
Securities²	170,817			155,251
Total Eligible HQLA¹	$	207,298		$	207,620
LCR	136		%	147		%


1.	Under the LCR rule, Eligible HQLA is calculated using weightings and excluding certain HQLA held in subsidiaries.


2.	Primarily includes U.S. Treasuries, U.S. agency mortgage-backed securities, sovereign bonds and investment grade corporate bonds.

The decrease in the LCR in the current quarter is due to higher average outflows, primarily related to secured funding with remaining maturities of less than 30 days.

Net Stable Funding Ratio

The U.S. banking agencies have finalized a rule to implement the NSFR, which requires large banking organizations to maintain sufficiently stable sources of funding over a one-year time horizon, and will apply to us and our U.S. Bank Subsidiaries. These requirements become effective on July 1, 2021 and we will be in compliance with the final rule by the effective date.

Funding Management

We manage our funding in a manner that reduces the risk of disruption to our operations. We pursue a strategy of diversification of secured and unsecured funding sources (by product, investor and region) and attempt to ensure that the tenor of our liabilities equals or exceeds the expected holding period of the assets being financed.

We fund our balance sheet on a global basis through diverse sources. These sources include our equity capital, borrowings, securities sold under agreements to repurchase, securities lending, deposits, letters of credit and lines of credit. We have active financing programs for both standard and structured products targeting global investors and currencies.

Secured Financing

For a discussion of our secured financing activities, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Funding Management—Secured Financing” in the 2019 Form 10-K.

Collateralized Financing Transactions



$ in millions	At September 30, 2020		At December 31, 2019
Securities purchased under agreements to resell and Securities borrowed	$	189,086	$	194,773
Securities sold under agreements to repurchase and Securities loaned	$	49,300	$	62,706
Securities received as collateral¹	$	8,799	$	13,022



	Average Daily Balance Three Months Ended
$ in millions	September 30, 2020		December 31, 2019
Securities purchased under agreements to resell and Securities borrowed	$	182,181	$	210,257
Securities sold under agreements to repurchase and Securities loaned	$	58,474	$	64,870


1.	Included within Trading assets in the balance sheets.

Securities sold under agreements to repurchase and Securities loaned decreased to $49 billion at September 30, 2020 from $63 billion at December 31, 2019 primarily as a result of changes to our funding profile as a result of changes in the composition of our assets and liabilities.

See Note 2 to the financial statements in the 2019 Form 10-K and Note 9 to the financial statements for more details on collateralized financing transactions.

In addition to the collateralized financing transactions shown in the previous table, we engage in financing transactions collateralized by customer-owned securities, which are segregated in accordance with regulatory requirements. Receivables under these financing transactions, primarily margin loans, are included in Customer and other receivables in the balance sheets, and payables under these financing transactions, primarily to prime brokerage customers, are included in Customer and other payables in the balance sheets. Our risk exposure on these transactions is mitigated by collateral maintenance policies. We also hold related liquidity reserves.

Unsecured Financing

For a discussion of our unsecured financing activities, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Funding Management—Unsecured Financing” in the 2019 Form 10-K.



	23	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

Deposits



$ in millions	At September 30, 2020		At December 31, 2019
Savings and demand deposits:
Brokerage sweep deposits¹	$	164,146	$	121,077
Savings and other	38,431		28,388
Total Savings and demand deposits	202,577		149,465
Time deposits	36,676		40,891
Total	$	239,253	$	190,356


1.	Amounts represent balances swept from client brokerage accounts.

Deposits are primarily sourced from our Wealth Management clients and are considered to have stable, low-cost funding characteristics. Total deposits at September 30, 2020 increased compared with December 31, 2019, primarily driven by continued increases in brokerage sweep and savings deposits.

Borrowings by Remaining Maturity at September 30, 2020¹



$ in millions	Parent Company		Subsidiaries		Total
Original maturities of one year or less	$	—	$	4,553	$	4,553
Original maturities greater than one year
2020	$	641	$	828	$	1,469
2021	19,964		6,186		26,150
2022	16,418		4,011		20,429
2023	15,316		4,657		19,973
2024	15,938		5,436		21,374
Thereafter	83,172		26,324		109,496
Total	$	151,449	$	47,442	$	198,891
Total Borrowings	$	151,449	$	51,995	$	203,444
Maturities over next 12 months²					$	20,247


1.	Original maturity in the table is generally based on contractual final maturity. For borrowings with put options, remaining maturity represents the earliest put date.


2.	Includes only borrowings with original maturities greater than one year.

Borrowings of $203 billion as of September 30, 2020 increased modestly when compared with $193 billion at December 31, 2019.

We believe that accessing debt investors through multiple distribution channels helps provide consistent access to the unsecured markets. In addition, the issuance of borrowings with original maturities greater than one year allows us to reduce reliance on short-term credit sensitive instruments. Borrowings with original maturities greater than one year are generally managed to achieve staggered maturities, thereby mitigating refinancing risk, and to maximize investor diversification through sales to global institutional and retail clients across regions, currencies and product types.

The availability and cost of financing to us can vary depending on market conditions, the volume of certain trading and lending activities, our credit ratings and the overall availability of credit. We also engage in, and may continue to engage in, repurchases of our borrowings in the ordinary course of business.

For further information on Borrowings, see Note 13 to the financial statements.

Credit Ratings

We rely on external sources to finance a significant portion of our daily operations. The cost and availability of financing generally are impacted by our credit ratings, among other things. In addition, our credit ratings can have an impact on certain trading revenues, particularly in those businesses where longer-term counterparty performance is a key consideration, such as certain OTC derivative transactions. When determining credit ratings, rating agencies consider both company-specific and industry-wide factors. These include regulatory or legislative changes, the macroeconomic environment and perceived levels of support, among other things. See also “Risk Factors— Liquidity Risk” in the 2019 Form 10-K.

Parent Company and U.S. Bank Subsidiaries' Issuer Ratings at October 30, 2020



	Parent Company
	Short-Term Debt	Long-Term Debt	Rating Outlook
DBRS, Inc.	R-1 (middle)	A (high)	Stable
Fitch Ratings, Inc.	F1	A	Negative
Moody’s Investors Service, Inc.	P-1	A2	Rating Under Review
Rating and Investment Information, Inc.	a-1	A	Stable
S&P Global Ratings	A-2	BBB+	Stable



	MSBNA
	Short-Term Debt	Long-Term Debt	Rating Outlook
Fitch Ratings, Inc.	F1	A+	Negative
Moody’s Investors Service, Inc.	P-1	Aa3	Stable
S&P Global Ratings	A-1	A+	Stable



	MSPBNA
	Short-Term Debt	Long-Term Debt	Rating Outlook
Moody’s Investors Service, Inc.	P-1	Aa3	Stable
S&P Global Ratings	A-1	A+	Stable

On April 22, 2020, Fitch Ratings, Inc. placed the Parent Company and MSBNA ratings on Negative outlook, a change from Stable, related to their expectation of significant operating environment headwinds due to the disruption to economic activity and financial markets from the COVID-19 pandemic.

On October 2, 2020, Moody’s Investors Service, Inc. (“Moody’s”) upgraded the issuer ratings of the Parent Company from A3 to A2 and U.S. Bank Subsidiaries from A1 to Aa3 and changed the outlooks to Stable. On October 29, Moody’s placed issuer ratings of the Parent Company under review for possible upgrade, changing their outlook from Stable to Rating Under Review.



September 2020 Form 10-Q	24



Table of Contents
Management’s Discussion and Analysis

Incremental Collateral or Terminating Payments

In connection with certain OTC derivatives and certain other agreements where we are a liquidity provider to certain financing vehicles associated with the Institutional Securities business segment, we may be required to provide additional collateral, immediately settle any outstanding liability balances with certain counterparties or pledge additional collateral to certain clearing organizations in the event of a future credit rating downgrade irrespective of whether we are in a net asset or net liability position. See Note 7 to the financial statements for additional information on OTC derivatives that contain such contingent features.

While certain aspects of a credit rating downgrade are quantifiable pursuant to contractual provisions, the impact it would have on our business and results of operations in future periods is inherently uncertain and would depend on a number of interrelated factors, including, among other things, the magnitude of the downgrade, the rating relative to peers, the rating assigned by the relevant agency pre-downgrade, individual client behavior and future mitigating actions we might take. The liquidity impact of additional collateral requirements is included in our Liquidity Stress Tests.

Capital Management

We view capital as an important source of financial strength and actively manage our consolidated capital position based upon, among other things, business opportunities, risks, capital availability and rates of return together with internal capital policies, regulatory requirements and rating agency guidelines. In the future, we may expand or contract our capital base to address the changing needs of our businesses.

Common Stock Repurchases



	Three Months Ended September 30,				Nine Months Ended September 30,
in millions, except for per share data	2020		2019		2020		2019
Number of shares	—		36		29		90
Average price per share	$	—	$	41.92	$	46.01	$	42.77
Total	$	—	$	1,500	$	1,347	$	3,860

On March 15, 2020, the Financial Services Forum announced that its eight U.S. Bank members, including us, had voluntarily suspended their share repurchase programs. On June 25, 2020, the Federal Reserve published summary results of CCAR and announced that large BHCs generally would be restricted in making share repurchases during the current quarter, and on September 30, 2020, the restrictions were extended through the fourth quarter of 2020. For more information on our capital plan, see “Liquidity and Capital Resources—Regulatory Requirements—Capital Plans and Stress Tests” herein.

For further information on our common stock repurchases, see Note 17 to the financial statements.

For a description of our capital plan, see “Liquidity and Capital Resources—Regulatory Requirements—Capital Plans and Stress Tests” herein.

Common Stock Dividend Announcement



Announcement date	October 15, 2020
Amount per share		$0.35
Date to be paid	November 13, 2020
Shareholders of record as of	October 30, 2020

On June 25, 2020, the Federal Reserve announced that it would limit common stock dividend payments in the current quarter for all large BHCs, and on September 30, 2020, the restrictions were extended through the fourth quarter of 2020. For additional information, see “Liquidity and Capital Resources—Regulatory Requirements—Capital Plans and Stress Tests” herein.

Preferred Stock Dividend Announcement



Announcement date	September 15, 2020
Date paid	October 15, 2020
Shareholders of record as of	September 30, 2020

For additional information on common and preferred stock, see Note 17 to the financial statements.

Off-Balance Sheet Arrangements and Contractual Obligations

Off-Balance Sheet Arrangements

We enter into various off-balance sheet arrangements, including through unconsolidated SPEs and lending-related financial instruments (e.g., guarantees and commitments), primarily in connection with the Institutional Securities and Investment Management business segments.

We utilize SPEs primarily in connection with securitization activities. For information on our securitization activities, see Note 14 to the financial statements in the 2019 Form 10-K.

For information on our commitments, obligations under certain guarantee arrangements and indemnities, see Note 14 to the financial statements. For a further discussion of our lending commitments, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk—Loans and Lending Commitments.”

Contractual Obligations

For a discussion about our contractual obligations, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Contractual Obligations” in the 2019 Form 10-K.



	25	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

Regulatory Requirements

Regulatory Capital Framework

We are an FHC under the Bank Holding Company Act of 1956, as amended (“BHC Act”), and are subject to the regulation and oversight of the Federal Reserve. The Federal Reserve establishes capital requirements for us, including “well-capitalized” standards, and evaluates our compliance with such capital requirements. Regulatory capital requirements established by the Federal Reserve are largely based on the Basel III capital standards established by the Basel Committee and also implement certain provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank Act”). The OCC establishes similar capital requirements and standards for our U.S. Bank Subsidiaries. For us to remain an FHC, we must remain well-capitalized in accordance with standards established by the Federal Reserve and our U.S. Bank Subsidiaries must remain well-capitalized in accordance with standards established by the OCC. For additional information on regulatory capital requirements for our U.S. Bank Subsidiaries, see Note 16 to the financial statements.

Regulatory Capital Requirements

We are required to maintain minimum risk-based and leverage-based capital and TLAC ratios. For more information, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Capital Requirements” in the 2019 Form 10-K. For additional information on TLAC, see “Total Loss-Absorbing Capacity, Long-Term Debt and Clean Holding Company Requirements” herein.

Risk-Based Regulatory Capital. Minimum risk-based capital ratio requirements apply to Common Equity Tier 1 capital, Tier 1 capital and Total capital (which includes Tier 2 capital). Capital standards require certain adjustments to, and deductions from, capital for purposes of determining these ratios.

Risk-Based Regulatory Capital Ratio Requirements



	At September 30, 2020				Beginning October 1, 2020
	Standardized and Advanced				Standardized		Advanced
Capital buffers
Capital conservation buffer			2.5	%	—		2.5	%
Stress capital buffer (“SCB”)¹			N/A		5.7	%	N/A
G-SIB capital surcharge²			3	%	3	%	3	%
CCyB³			0	%	0	%	0	%
Capital buffer requirement⁴			5.5	%	8.7	%	5.5	%
			At September 30, 2020		Beginning October 1, 2020
	Regulatory Minimum		Standardized and Advanced		Standardized		Advanced
Required ratios⁵
Common Equity Tier 1 capital ratio	4.5	%	10.0	%	13.2	%	10.0	%
Tier 1 capital ratio	6.0	%	11.5	%	14.7	%	11.5	%
Total capital ratio	8.0	%	13.5	%	16.7	%	13.5	%


1.	For additional information on the SCB, see “Capital Plans and Stress Tests” and “Regulatory Developments—Stress Capital Buffer Final Rule” herein.


2.	For a further discussion of the G-SIB capital surcharge, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Requirements—G-SIB Capital Surcharge” in the 2019 Form 10-K.


3.	The CCyB can be set up to 2.5%, but is currently set by the U.S. banking agencies at zero.

The capital buffer requirement represents the amount of Common Equity Tier 1 capital we must maintain above the minimum risk-based capital requirements in order to avoid restrictions on our ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers. Beginning October 1, 2020, our Standardized Approach capital buffer requirement is equal to the sum of our SCB, G-SIB capital surcharge and CCyB, and our Advanced Approach capital buffer requirement is equal to our 2.5% capital conservation buffer, G-SIB capital surcharge and CCyB.


5.	Required ratios represent the regulatory minimum plus the capital buffer requirement.

Our risk-based capital ratios for purposes of determining regulatory compliance are the lower of the capital ratios computed under (i) the standardized approaches for calculating credit risk and market risk RWA (“Standardized Approach”) or (ii) the applicable advanced approaches for calculating credit risk, market risk and operational risk RWA (“Advanced Approach”). The credit risk RWA calculations between the two approaches differ in that the Standardized Approach requires calculation of RWA using prescribed risk weights, whereas the Advanced Approach utilizes models to calculate exposure amounts and risk weights. At September 30, 2020 and December 31, 2019, our ratios for determining regulatory compliance are based on the Advanced Approach and the Standardized Approach rules, respectively.

Leverage-Based Regulatory Capital. Minimum leverage-based capital requirements include a Tier 1 leverage ratio and an SLR. We are required to maintain an SLR of 5%, inclusive of an enhanced SLR capital buffer of at least 2%.

As of September 30, 2020, our risk-based and leverage-based capital amounts and ratios, as well as RWA, adjusted average assets and supplementary leverage exposure are calculated



September 2020 Form 10-Q	26



Table of Contents
Management’s Discussion and Analysis

excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period. For further information, see “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments” herein.

Regulatory Capital Ratios



	At September 30, 2020
$ in millions	Required Ratio¹		Standardized			Advanced
Risk-based capital
Common Equity Tier 1 capital			$	71,157		$	71,157
Tier 1 capital			79,905			79,905
Total capital			90,018			89,763
Total RWA			408,850			420,081
Common Equity Tier 1 capital ratio	10.0	%	17.4		%	16.9		%
Tier 1 capital ratio	11.5	%	19.5		%	19.0		%
Total capital ratio	13.5	%	22.0		%	21.4		%

$ in millions			Required Ratio¹			At September 30, 2020
Leverage-based capital
Adjusted average assets²						$	962,435
Tier 1 leverage ratio			4.0		%	8.3		%
Supplementary leverage exposure^3,4						$	1,084,348
SLR⁴			5.0		%	7.4		%



	At December 31, 2019
$ in millions	Required Ratio¹		Standardized			Advanced
Risk-based capital
Common Equity Tier 1 capital			$	64,751		$	64,751
Tier 1 capital			73,443			73,443
Total capital			82,708			82,423
Total RWA			394,177			382,496
Common Equity Tier 1 capital ratio	10.0	%	16.4		%	16.9		%
Tier 1 capital ratio	11.5	%	18.6		%	19.2		%
Total capital ratio	13.5	%	21.0		%	21.5		%

$ in millions			Required Ratio¹			At December 31, 2019
Leverage-based capital
Adjusted average assets²						$	889,195
Tier 1 leverage ratio			4.0		%	8.3		%
Supplementary leverage exposure³						$	1,155,177
SLR			5.0		%	6.4		%


1.	Required ratios are inclusive of any buffers applicable as of the date presented. Failure to maintain the buffers would result in restrictions on our ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers.

Adjusted average assets represents the denominator of the Tier 1 leverage ratio and is composed of the average daily balance of consolidated on-balance sheet assets for the quarters ending on the respective balance sheet dates, reduced by disallowed goodwill, intangible assets, investments in covered funds, defined benefit pension plan assets, after-tax gain on sale from assets sold into securitizations, investments in our own capital instruments, certain deferred tax assets and other capital deductions.

Supplementary leverage exposure is the sum of Adjusted average assets used in the Tier 1 leverage ratio and other adjustments, primarily: (i) for derivatives, potential future exposure and the effective notional principal amount of sold credit protection offset by qualifying purchased credit protection; (ii) the counterparty credit risk for repo-style transactions; and (iii) the credit equivalent amount for off-balance sheet exposures.

Based on a Federal Reserve interim final rule in effect until March 31, 2021, our SLR and Supplementary leverage exposure as of September 30, 2020 reflect the exclusion of U.S. Treasury securities and deposits at Federal Reserve Banks. As of September 30, 2020, the impact of the interim final rule on our SLR was an improvement of 87 bps. For further information, see “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments” herein.



	27	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

Regulatory Capital



$ in millions	At September 30, 2020			At December 31, 2019			Change
Common Equity Tier 1 capital
Common stock and surplus	$	4,350		$	5,228		$	(878	)
Retained earnings	76,353			70,589			5,764
AOCI	(537		)	(2,788		)	2,251
Regulatory adjustments and deductions:
Net goodwill	(7,242		)	(7,081		)	(161		)
Net intangible assets	(1,776		)	(2,012		)	236
Other adjustments and deductions¹	9			815			(806		)
Total Common Equity Tier 1 capital	$	71,157		$	64,751		$	6,406
Additional Tier 1 capital
Preferred stock	$	8,520		$	8,520		$	—
Noncontrolling interests	625			607			18
Additional Tier 1 capital	$	9,145		$	9,127		$	18
Deduction for investments in covered funds	(397		)	(435		)	38
Total Tier 1 capital	$	79,905		$	73,443		$	6,462
Standardized Tier 2 capital
Subordinated debt	$	8,681		$	8,538		$	143
Noncontrolling interests	147			143			4
Eligible ACL	1,287			590			697
Other adjustments and deductions	(2		)	(6		)	4
Total Standardized Tier 2 capital	$	10,113		$	9,265		$	848
Total Standardized capital	$	90,018		$	82,708		$	7,310
Advanced Tier 2 capital
Subordinated debt	$	8,681		$	8,538		$	143
Noncontrolling interests	147			143			4
Eligible credit reserves	1,032			305			727
Other adjustments and deductions	(2		)	(6		)	4
Total Advanced Tier 2 capital	$	9,858		$	8,980		$	878
Total Advanced capital	$	89,763		$	82,423		$	7,340


1.	Other adjustments and deductions used in the calculation of Common Equity Tier 1 capital primarily includes net after-tax DVA, the credit spread premium over risk-free rate for derivative liabilities, defined benefit pension plan assets, after-tax gain on sale from assets sold into securitizations, investments in our own capital instruments and certain deferred tax assets.

RWA Rollforward



	Nine Months Ended September 30, 2020
$ in millions	Standardized			Advanced
Credit risk RWA
Balance at December 31, 2019	$	342,684		$	228,927
Change related to the following items:
Derivatives	4,622			24,322
Securities financing transactions	(9,314		)	514
Securitizations	(1,595		)	(3,016		)
Investment securities	2,468			3,904
Commitments, guarantees and loans	5,017			1,776
Cash	718			1,838
Equity investments	3,027			3,207
Other credit risk¹	(601		)	(762		)
Total change in credit risk RWA	$	4,342		$	31,783
Balance at September 30, 2020	$	347,026		$	260,710
Market risk RWA
Balance at December 31, 2019	$	51,493		$	51,597
Change related to the following items:
Regulatory VaR	9,673			9,673
Regulatory stressed VaR	1,987			1,987
Incremental risk charge	180			180
Comprehensive risk measure	210			106
Specific risk:
Non-securitization	(99		)	(99		)
Securitization	(1,620		)	(1,620		)
Total change in market risk RWA	$	10,331		$	10,227
Balance at September 30, 2020	$	61,824		$	61,824
Operational risk RWA
Balance at December 31, 2019	N/A			$	101,972
Change in operational risk RWA	N/A			(4,425		)
Balance at September 30, 2020	N/A			$	97,547
Total RWA	$	408,850		$	420,081

Regulatory VaR—VaR for regulatory capital requirements


1.	Amounts reflect assets not in a defined category, non-material portfolios of exposures and unsettled transactions, as applicable.

Credit risk RWA increased in the current year period under both the Standardized and Advanced Approaches primarily from an increase in Derivatives exposure driven by market volatility, an increase in Investment securities mainly due to increased exposures to U.S. government and agency securities, and an increase in Equity investments due to increased exposure and market value gains. Under the Standardized Approach, increased exposures in lending activities within the Wealth Management and Institutional Securities business segments were partially offset by a decrease in Securities financing transactions. Under the Advanced Approach, the increased exposure in Derivatives and higher credit spread volatilities also led to an increase in RWA related to CVA.

Market risk RWA increased in the current year period under both the Standardized and Advanced Approaches primarily due to an increase in Regulatory VaR mainly as a result of higher market volatility.



September 2020 Form 10-Q	28



Table of Contents
Management’s Discussion and Analysis

Total Loss-Absorbing Capacity, Long-Term Debt and Clean Holding Company Requirements

The Federal Reserve has established external TLAC, long-term debt (“LTD”) and clean holding company requirements for top-tier BHCs of U.S. G-SIBs (“covered BHCs”), including the Parent Company. These requirements are designed to ensure that covered BHCs will have enough loss-absorbing resources at the point of failure to be recapitalized through the conversion of eligible LTD to equity or otherwise by imposing losses on eligible LTD or other forms of TLAC where an SPOE resolution strategy is used.

Required and Actual TLAC and Eligible LTD Ratios



					Actual Amount/Ratio
$ in millions	Regulatory Minimum		Required Ratio¹		At September 30, 2020			At December 31, 2019
External TLAC²					$	202,472		$	196,888
External TLAC as a % of RWA	18.0	%	21.5	%	48.2		%	49.9		%
External TLAC as a % of leverage exposure	7.5	%	9.5	%	18.7		%	17.0		%
Eligible LTD³					$	114,952		$	113,624
Eligible LTD as a % of RWA	9.0	%	9.0	%	27.4		%	28.8		%
Eligible LTD as a % of leverage exposure	4.5	%	4.5	%	10.6		%	9.8		%

Required ratios are inclusive of applicable buffers.The final rule imposes TLAC buffer requirements on top of both the risk-based and leverage exposure-based external TLAC minimum requirements. The risk-based TLAC buffer is equal to the sum of 2.5%, our Method 1 G-SIB surcharge and the CCyB, if any, as a percentage of total RWA. The leverage exposure-based TLAC buffer is equal to 2% of our total leverage exposure. Failure to maintain the buffers would result in restrictions on our ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers.


2.	External TLAC consists of Common Equity Tier 1 capital and Additional Tier 1 capital (each excluding any noncontrolling minority interests), as well as eligible LTD.


3.	Consists of TLAC-eligible LTD reduced by 50% for amounts of unpaid principal due to be paid in more than one year but less than two years from each respective balance sheet date.

We are in compliance with all TLAC requirements as of September 30, 2020 and December 31, 2019. For a further discussion of TLAC and related requirements, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Requirements—Regulatory Capital Requirements—Total Loss-Absorbing Capacity, Long-Term Debt and Clean Holding Company Requirements” in the 2019 Form 10-K.

Capital Plans and Stress Tests

Pursuant to the Dodd-Frank Act, the Federal Reserve has adopted capital planning and stress test requirements for large BHCs, which form part of the Federal Reserve’s annual CCAR framework.

We submitted our 2020 Capital Plan (“Capital Plan”) and company-run stress test results to the Federal Reserve on April 6, 2020. On June 25, 2020, the Federal Reserve published

summary results of its supervisory stress tests of each large BHC. On June 29, 2020, we disclosed a summary of the results of our company-run stress tests on our Investor Relations website. On September 4, 2020, we announced we will be subject to an SCB of 5.7% beginning October 1, 2020, which reflects the Federal Reserve’s corrected 2020 supervisory stress test results. We had previously announced that we would be subject to an SCB of 5.9%, which reflected the Federal Reserve’s original 2020 supervisory stress test results released in June 2020. Together with other features of the regulatory capital framework, this revised SCB results in an aggregate Standardized Approach Common Equity Tier 1 required ratio of 13.2%. Generally, our SCB will be updated annually based on the results of the supervisory stress test. See “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments—Stress Capital Buffer Final Rule” herein for additional information on the SCB.

The Federal Reserve required each large BHC to update and resubmit its capital plan. On November 2, 2020, we resubmitted our 2020 Capital Plan and company-run stress test results based on revised scenarios released by the Federal Reserve on September 17, 2020. We expect that the Federal Reserve will publish summary results of the second round of supervisory stress tests for each large BHC, including us, by the end of this year.

Based on the Federal Reserve announcement on June 25, 2020, all large BHCs were subject to capital action restrictions in the current quarter. Except as noted below, these restrictions generally prohibit large BHCs from making any capital distribution (excluding any capital distribution arising from the issuance of a capital instrument eligible for inclusion in the numerator of a regulatory capital ratio), unless otherwise approved by the Federal Reserve. Large BHCs are, however, authorized to make share repurchases relating to issuances of common stock related to employee stock ownership plans; provided that a BHC does not increase the amount of its common stock dividends, to pay common stock dividends that do not exceed an amount equal to the average of the BHC’s net income for the four preceding calendar quarters, unless otherwise specified by the Federal Reserve; and to make scheduled payments on additional Tier 1 and Tier 2 capital instruments. On September 30, 2020, the Federal Reserve announced that such capital action restrictions would be extended through the fourth quarter of 2020. For a further discussion of our capital plans, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Balance Sheet—Capital Management” herein and in the 2019 Form 10-K.

Attribution of Average Common Equity According to the Required Capital Framework

Our required capital (“Required Capital”) estimation is based on the Required Capital framework, an internal capital adequacy measure. Common equity attribution to the business segments



	29	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

is based on capital usage calculated under the Required Capital framework, as well as each business segment’s relative contribution to our total Required Capital.

The Required Capital framework is a risk-based and leverage-based capital measure, which is compared with our regulatory capital to ensure that we maintain an amount of going concern capital after absorbing potential losses from stress events, where applicable, at a point in time. The amount of capital allocated to the business segments is generally set at the beginning of each year and remains fixed throughout the year until the next annual reset unless a significant business change occurs (e.g., acquisition or disposition). We define the difference between our total average common equity and the sum of the average common equity amounts allocated to our business segments as Parent common equity. We generally hold Parent common equity for prospective regulatory requirements, organic growth, acquisitions and other capital needs.

We are currently evaluating potential updates to our Required Capital framework to take into account changes to our risk-based capital requirements resulting from the SCB and we will continue to evaluate the framework with respect to the impact of other future regulatory requirements, as appropriate.

Average Common Equity Attribution¹



	Three Months Ended September 30,				Nine Months Ended September 30,
$ in billions	2020		2019		2020		2019
Institutional Securities	$	42.8	$	40.4	$	42.8	$	40.4
Wealth Management	18.2		18.2		18.2		18.2
Investment Management	2.6		2.5		2.6		2.5
Parent	15.1		12.3		13.3		11.4
Total	$	78.7	$	73.4	$	76.9	$	72.5


1.	The attribution of average common equity to the business segments is a non-GAAP financial measure. See “Selected Non-GAAP Financial Information” herein.

Resolution and Recovery Planning

Pursuant to the Dodd-Frank Act, we are required to periodically submit to the Federal Reserve and the FDIC a resolution plan that describes our strategy for a rapid and orderly resolution under the U.S. Bankruptcy Code in the event of our material financial distress or failure. Our next resolution plan submission will be a targeted resolution plan in July 2021.

As described in our most recent resolution plan, which was submitted on June 28, 2019, our preferred resolution strategy is an SPOE strategy. In line with our SPOE strategy, the Parent Company has transferred, and has agreed to transfer on an ongoing basis, certain assets to its wholly owned, direct subsidiary Morgan Stanley Holdings LLC (the “Funding IHC”). In addition, the Parent Company has entered into an amended and restated support agreement with its material entities (including the Funding IHC) and certain other subsidiaries. In the event of a resolution scenario, the Parent Company would be obligated to contribute all of its Contributable Assets to our

material entities and/or the Funding IHC. The Funding IHC would be obligated to provide capital and liquidity, as applicable, to our material entities. The combined implication of the SPOE resolution strategy and the requirement to maintain certain levels of TLAC is that losses in resolution would be imposed on the holders of eligible long-term debt and other forms of eligible TLAC issued by the Parent Company before any losses are imposed on the holders of the debt securities of our operating subsidiaries or before putting U.S. taxpayers at risk.

For more information about resolution and recovery planning requirements and our activities in these areas, including the implications of such activities in a resolution scenario, see “Business—Supervision and Regulation—Financial Holding Company—Resolution and Recovery Planning,” “Risk Factors—Legal, Regulatory and Compliance Risk” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Requirements—Resolution and Recovery Planning” in the 2019 Form 10-K.

Regulatory Developments

Final Rule on the Regulatory Capital Treatment for Investments in Certain Unsecured Debt Instruments Issued by G-SIBs

The U.S. banking agencies have issued a final rule that, among other things, modifies the regulatory capital framework for large U.S. banking organizations, including us and our U.S. Bank Subsidiaries. Under the final rule, such organizations are required to make certain deductions from regulatory capital for their investments in certain unsecured debt instruments (including eligible LTD in the TLAC framework) issued by the Parent Company and other G-SIBs. These requirements become effective on April 1, 2021 and we expect to be in compliance with the final rule by the effective date.

CFTC Final Rule on Capital Requirements for Swap Dealers

The CFTC has finalized rules establishing capital requirements for CFTC-registered swap dealers not subject to regulation by a prudential regulator. Compliance with these rules, which will apply to a number of our subsidiaries that are CFTC-registered swap dealers, is required by October 6, 2021.

Final Rule to Amend the Covered Fund Provisions of the Volcker Rule

The Federal financial regulatory agencies responsible for the Volcker Rule’s implementing regulations have finalized a rule that revises the prohibition on certain investments by banking entities with defined covered funds. The final rule adds certain new exclusions from the definition of covered fund, while streamlining others. It also simplifies certain restrictions on



September 2020 Form 10-Q	30



Table of Contents
Management’s Discussion and Analysis

inter-affiliate relationships with covered funds. The final rule was effective October 1, 2020.

Stress Capital Buffer Final Rule

The Federal Reserve has adopted a final rule to integrate its annual capital planning and stress testing requirements with existing applicable regulatory capital requirements. The final rule, which applies to certain BHCs, introduces an SCB and related changes to the capital planning and stress testing processes.

The SCB applies only with respect to Standardized Approach risk-based capital requirements and replaces the existing Common Equity Tier 1 capital conservation buffer of 2.5%. The SCB is the greater of (i) the maximum decline in our Common Equity Tier 1 capital ratio under the severely adverse scenario over the supervisory stress test measurement period plus the sum of the four quarters of planned common stock dividends divided by the projected RWAs from the quarter in which the Firm’s projected Common Equity Tier 1 capital ratio reaches its minimum in the supervisory stress test and (ii) 2.5%. Beginning October 1, 2020, risk-based regulatory capital requirements under the Standardized Approach include the SCB, as summarized above, as well as our Common Equity Tier 1 GSIB capital surcharge and any applicable Common Equity Tier 1 CCyB.

The final rule makes related changes to capital planning and stress testing processes for BHCs subject to the SCB. In particular, the supervisory stress test will assume that BHCs generally maintain a constant level of assets and RWAs throughout the projection period. In addition, the supervisory stress test will no longer assume that BHCs make all planned capital distributions, although the SCB will incorporate the dollar amount of four quarters of planned common stock dividends, as summarized above.

The final rule does not change regulatory capital requirements under the Advanced Approach, the Tier 1 leverage ratio or the SLR.

Regulatory Developments in Response to COVID-19

In the United States, the Federal Reserve, the other U.S. state and federal financial regulatory agencies and Congress have taken actions to mitigate disruptions to economic activity and financial stability resulting from COVID-19.

Federal Reserve and other U.S. Banking Agency Actions

The Federal Reserve has established, or has taken steps to establish, a range of facilities and programs to support the U.S. economy and U.S. marketplace participants in response to economic disruptions associated with COVID-19. Through these facilities and programs, the Federal Reserve has taken steps to directly or indirectly purchase assets or debt instruments

from, or make loans to, U.S. companies, financial institutions, municipalities and other market participants. In the current year period, we have participated as principal, as well as on behalf of clients, in certain of these facilities and programs and we may participate in other of these facilities and programs in the future.

In addition, the Federal Reserve has taken a range of other actions to support the flow of credit to households and businesses. For example, the Federal Reserve has set the target range for the federal funds rate at 0 to 0.25% and has increased its holdings of U.S. Treasury securities and agency mortgage-backed securities, purchased agency commercial mortgage-backed securities, and established a facility to purchase corporate debt securities and shares of exchange-traded funds holding such securities. The Federal Reserve has also encouraged depository institutions to borrow from the discount window and has lowered the primary credit rate for such borrowings by 150 basis points to 0.25% while extending the term of such loans up to 90 days. In addition, reserve requirements have been reduced to zero.

Acting in concert with the other U.S. banking agencies, the Federal Reserve has also issued statements encouraging banking organizations to use their capital and liquidity buffers as they lend to households and businesses affected by COVID-19.

Further, the Federal Reserve along with the other U.S. banking agencies, issued guidance stating that granting certain concessions to borrowers that are current on existing loans, either individually or as part of a program for creditworthy borrowers who are experiencing short-term financial or operational problems as a result of the COVID-19 pandemic, generally would not be considered TDRs under applicable U.S. GAAP. This guidance also clarifies that efforts to work with borrowers of one-to-four family residential mortgages impacted by the COVID-19 pandemic and meeting certain criteria will not result in such loans being deemed restructured or modified for purposes of regulatory capital requirements.

The Federal Reserve and other U.S. banking agencies have also issued a series of rulemakings in response to the COVID-19 pandemic, including to facilitate banking organizations’ use of their capital buffers:


•	Supplementary Leverage Ratio Interim Final Rules. The Federal Reserve has adopted an interim final rule that excludes, on a temporary basis, U.S. Treasury securities and deposits at Federal Reserve Banks from our supplementary leverage exposure from April 1, 2020 to March 31, 2021.

A similar interim final rule issued by the OCC along with the other U.S. banking agencies provides national banks, including MSBNA and MSPBNA, an optional election, which is considered on a case-by-case basis by the OCC if received after June 30, 2020, to apply similar relief. If elected and approved, a national bank must receive prior approval from the OCC before making any capital distributions while the



	31	September 2020 Form 10-Q



Table of Contents
Management’s Discussion and Analysis

exclusion is in effect. As of September 30, 2020, neither MSBNA nor MSPBNA made this optional election.

•

Revisions to Definition of Eligible Retained Income. The U.S. banking agencies have adopted as final an interim final rule, which was effective March 20, 2020, amending the definition of eligible retained income in their respective capital rules. As amended, eligible retained income is defined by the U.S. banking agencies as the greater of (i) net income for the four preceding calendar quarters, net of any distributions and associated tax effects not already reflected in net income, and (ii) the average of net income over the preceding four quarters. This definition applies with respect to any payout restrictions applicable in the event of a breach of any regulatory capital buffers, including any applicable CCyB, G-SIB capital surcharge, capital conservation buffer, the enhanced SLR and, once effective, SCB, which replaces the capital conservation buffer under the Standardized Approach.

Separately, the Federal Reserve has adopted as final an interim final rule, which was effective March 26, 2020, amending the definition of eligible retained income under its TLAC rule to be consistent with the revised definition of eligible retained income in the regulatory capital framework, as summarized above.

•

Regulatory Capital and Stress Testing Developments Related to Implementation of CECL. The U.S. banking agencies have adopted a final rule, consistent with an interim final rule which was effective March 31, 2020, altering, for purposes of the regulatory capital and TLAC requirements, the required adoption time period for CECL. We have elected to apply a transition method provided by the rule, under which the effects of CECL on our regulatory capital and TLAC requirements are deferred for two years, followed by a three-year phase-in of the aggregate capital effects of the two-year deferral.

Non-U.S. Central Bank Actions

In addition to actions taken by the Federal Reserve, many non-U.S. central banks have announced similar facilities and programs in response to the economic and market disruptions associated with COVID-19. Firm subsidiaries operating in non-U.S. markets may participate, or perform customer facilitation roles, in such non-U.S. facilities or programs.

The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”)

The CARES Act was signed into law on March 27, 2020. Pursuant to the CARES Act, the U.S. Treasury has the authority to provide loans, guarantees and other investments in support of eligible businesses, states and municipalities affected by the economic effects of COVID-19. Some of these funds may also be used to support the several Federal Reserve programs and facilities described in “Federal Reserve Actions” previously or additional programs or facilities that are established by the

Federal Reserve under its Section 13(3) authority and meet certain criteria. Among other provisions, the CARES Act also includes funding for the Small Business Administration to expand lending, relief from certain U.S. GAAP requirements to allow COVID-19-related loan modifications to not be categorized as TDRs and a range of incentives to encourage deferment, forbearance or modification of consumer credit and mortgage contracts.

The CARES Act also includes several measures that temporarily adjust existing laws or regulations. These include providing the FDIC with additional authority to guarantee the deposits of solvent insured depository institutions held in non-interest-bearing business transaction accounts to a maximum amount specified by the FDIC, reinstating the FDIC’s Temporary Liquidity Guarantee Authority to guarantee debt obligations of solvent insured depository institutions or depository institution holding companies, temporarily allowing the U.S. Treasury to fully guarantee money market mutual funds and granting additional authority to the OCC to provide certain exemptions to the lending limits imposed on national banks.

Other Matters

U.K. Withdrawal from the E.U.

On January 31, 2020, the U.K. withdrew from the E.U. under the terms of a withdrawal agreement between the U.K. and the E.U. The withdrawal agreement provides for a transition period to the end of December 2020, during which time the U.K. will continue to apply E.U. law as if it were a member state, and U.K. firms’ rights to provide financial services in E.U. member states will continue. Access to the E.U. market after the transition period remains subject to negotiation.

We have prepared the structure of our European operations for a range of potential outcomes, including for the possibility that U.K. financial firms’ access to E.U. markets after the transition period is limited, and we expect to be able to continue to serve our clients and customers under each of these potential outcomes.

For more information on the U.K.’s withdrawal from the E.U., our related preparations and the potential impact on our operations, see “Risk Factors— International Risk” in the 2019 Form 10-K. For further information regarding our exposure to the U.K., see also “Quantitative and Qualitative Disclosures about Risk—Country and Other Risks."

Planned Replacement of London Interbank Offered Rate and Replacement or Reform of Other Interest Rates

Central banks around the world, including the Federal Reserve, have commissioned committees and working groups of market participants and official sector representatives to replace LIBOR and replace or reform other interest rate benchmarks (collectively, the “IBORs”). Accordingly, we have established



September 2020 Form 10-Q	32



Table of Contents
Management’s Discussion and Analysis

and are undertaking a Firmwide IBOR transition plan to promote the transition to alternative reference rates, which takes into account the considerable uncertainty regarding the availability of LIBOR beyond 2021.

For a further discussion of the expected replacement of the IBORs and/or reform of interest rate benchmarks, and the related risks and our transition plan, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Requirements—Other Matters” and “Risk Factors—Risk Management,” respectively, in the 2019 Form 10-K.



	33	September 2020 Form 10-Q



Table of Contents

Quantitative and Qualitative Disclosures about Risk

Management believes effective risk management is vital to the success of our business activities. For a discussion of our Enterprise Risk Management framework and risk management functions, see “Quantitative and Qualitative Disclosures about Risk—Risk Management” in the 2019 Form 10-K.

Market Risk

Market risk refers to the risk that a change in the level of one or more market prices, rates, spreads, indices, volatilities, correlations or other market factors, such as market liquidity, will result in losses for a position or portfolio. Generally, we incur market risk as a result of trading, investing and client facilitation activities, principally within the Institutional Securities business segment where the substantial majority of our VaR for market risk exposures is generated. In addition, we incur non-trading market risk, principally within the Wealth Management and Investment Management business segments. The Wealth Management business segment primarily incurs non-trading market risk from lending and deposit-taking activities. The Investment Management business segment primarily incurs non-trading market risk from capital investments in alternative and other funds. For a further discussion of market risk, see “Quantitative and Qualitative Disclosures about Risk—Market Risk” in the 2019 Form 10-K.

Trading Risks

We are exposed to a wide range of risks related to interest rates and credit spreads, equity prices, foreign exchange rates and commodity prices, and the associated implied volatilities and spreads, related to the global markets in which we conduct our trading activities.

The statistical technique known as VaR is one of the tools we use to measure, monitor and review the market risk exposures of our trading portfolios.

For information regarding our primary risk exposures and market risk management, VaR methodology, assumptions and limitations, see “Quantitative and Qualitative Disclosures about Risk—Market Risk—Trading Risks” in the 2019 Form 10-K.

95%/One-Day Management VaR for the Trading Portfolio



	Three Months Ended
	September 30, 2020
$ in millions	Period End			Average			High²		Low²
Interest rate and credit spread	$	32		$	38		$	49	$	29
Equity price	27			30			39		19
Foreign exchange rate	11			9			12		7
Commodity price	17			22			29		16
Less: Diversification benefit¹	(38		)	(53		)	N/A		N/A
Primary Risk Categories	$	49		$	46		$	57	$	37
Credit Portfolio	21			25			31		20
Less: Diversification benefit¹	(8		)	(13		)	N/A		N/A
Total Management VaR	$	62		$	58		$	78	$	45



	Three Months Ended
	June 30, 2020
$ in millions	Period End			Average			High²		Low²
Interest rate and credit spread	$	42		$	47		$	59	$	36
Equity price	38			25			38		20
Foreign exchange rate	10			11			15		8
Commodity price	25			16			25		11
Less: Diversification benefit¹	(68		)	(49		)	N/A		N/A
Primary Risk Categories	$	47		$	50		$	62	$	44
Credit Portfolio	26			25			30		23
Less: Diversification benefit¹	(1		)	(15		)	N/A		N/A
Total Management VaR	$	72		$	60		$	78	$	47


1.	Diversification benefit equals the difference between the total Management VaR and the sum of the component VaRs. This benefit arises because the simulated one-day losses for each of the components occur on different days; similar diversification benefits also are taken into account within each component.


2.	The high and low VaR values for the total Management VaR and each of the component VaRs might have occurred on different days during the quarter, and therefore, the diversification benefit is not an applicable measure.

Average total Management VaR and Management VaR for the Primary Risk Categories decreased from the three months ended June 30, 2020 primarily as a result of reduced credit spread risk partially offset by increased equity risk.



September 2020 Form 10-Q	34



Table of Contents
Risk Disclosures

Distribution of VaR Statistics and Net Revenues

We evaluate the reasonableness of our VaR model by comparing the potential declines in portfolio values generated by the model with corresponding actual trading results for the Firm, as well as individual business units. For days where losses exceed the VaR statistic, we examine the drivers of trading losses to evaluate the VaR model’s accuracy relative to realized trading results. There were no loss days in the current quarter.

Daily 95%/One-Day Total Management VaR for the Current Quarter

($ in millions)

Daily Net Trading Revenues for the Current Quarter

($ in millions)

The previous histogram shows the distribution of daily net trading revenues for the current quarter. Daily net trading revenues include profits and losses from Interest rate and credit spread, Equity price, Foreign exchange rate, Commodity price, and Credit Portfolio positions and intraday trading activities for our trading businesses. Certain items such as fees, commissions and net interest income are excluded from daily net trading revenues and the VaR model. Revenues required for Regulatory VaR backtesting further exclude intraday trading.

Non-Trading Risks

We believe that sensitivity analysis is an appropriate representation of our non-trading risks. The following sensitivity analyses cover substantially all of the non-trading risk in our portfolio.

Credit Spread Risk Sensitivity¹


1.	Amounts represent the potential gain for each 1 bps widening of our credit spread.


2.	Relates to Borrowings carried at fair value.

U.S. Bank Subsidiaries’ Net Interest Income Sensitivity Analysis



$ in millions	At September 30, 2020			At June 30, 2020
Basis point change
+100	$	1,014		$	599
-100	(338		)	(351		)

The previous table presents an analysis of selected instantaneous upward and downward parallel interest rate shocks (subject to a floor of zero percent in the downward scenario) on net interest income over the next 12 months for our U.S. Bank Subsidiaries. These shocks are applied to our 12-month forecast for our U.S. Bank Subsidiaries, which incorporates market expectations of interest rates and our forecasted business activity.

We do not manage to any single rate scenario but rather manage net interest income in our U.S. Bank Subsidiaries to optimize across a range of possible outcomes, including non-parallel rate change scenarios. The sensitivity analysis assumes that we take no action in response to these scenarios, assumes there are no changes in other macroeconomic variables normally correlated with changes in interest rates, and includes subjective assumptions regarding customer and market re-pricing behavior and other factors. The change in sensitivity to interest rates in the positive 100 basis point scenario between September 30, 2020 and June 30, 2020 was primarily driven by the impact of changes to assumptions as a result of an analysis of deposit pricing through a full interest rate cycle.



	35	September 2020 Form 10-Q



Table of Contents
Risk Disclosures

Investments Sensitivity, Including Related Carried Interest



	Loss from 10% Decline
$ in millions	At September 30, 2020		At June 30, 2020
Investments related to Investment Management activities	$	349	$	329
Other investments:
MUMSS	176		170
Other Firm investments	203		188

MUMSS—Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.

We have exposure to public and private companies through direct investments, as well as through funds that invest in these assets. These investments are predominantly equity positions with long investment horizons, a portion of which is for business facilitation purposes. The market risk related to these investments is measured by estimating the potential reduction in net income associated with a 10% decline in investment values and related impact on performance-based fees, as applicable.

Asset Management Revenue Sensitivity

Certain asset management revenues in the Wealth Management and Investment Management business segments are derived from management fees, which are based on fee-based client assets in Wealth Management or AUM in Investment Management (together, “client holdings”). The assets underlying client holdings are primarily composed of equity, fixed income and alternative investments, and are sensitive to changes in related markets. The overall level of these revenues depends on multiple factors that include, but are not limited to, the level and duration of a market increase or decline, price volatility, the geographic and industry mix of client assets, and client behavior such as the rate and magnitude of client investments and redemptions. Therefore, overall revenues do not correlate completely with changes in the related markets.

Credit Risk

Credit risk refers to the risk of loss arising when a borrower, counterparty or issuer does not meet its financial obligations to us. We are primarily exposed to credit risk from institutions and individuals through our Institutional Securities and Wealth Management business segments. For a further discussion of our credit risks, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk” in the 2019 Form 10-K.

Loans and Lending Commitments



	At September 30, 2020
$ in millions	HFI			HFS		FVO		Total
Institutional Securities:
Corporate	$	7,628		$	8,552	$	14	$	16,194
Secured lending facilities	26,496			3,521		445		30,462
Commercial and Residential real estate	7,265			928		1,593		9,786
Securities-based lending and Other	1,277			57		5,729		7,063
Total Institutional Securities	42,666			13,058		7,781		63,505
Wealth Management:
Residential real estate	33,674			12		—		33,686
Securities-based lending and Other	57,723			—		—		57,723
Total Wealth Management	91,397			12		—		91,409
Total Investment Management¹	6			11		552		569
Total loans	134,069			13,081		8,333		155,483
ACL	(913		)					(913		)
Total loans, net of ACL	$	133,156		$	13,081	$	8,333	$	154,570
Lending commitments²								$	120,098
Total exposure								$	274,668



	At December 31, 2019
$ in millions	HFI			HFS		FVO		Total
Institutional Securities:
Corporate	$	5,426		$	6,192	$	20	$	11,638
Secured lending facilities	24,502			4,200		951		29,653
Commercial and Residential real estate	7,859			2,049		3,290		13,198
Securities-based lending and Other	503			123		6,814		7,440
Total Institutional Securities	38,290			12,564		11,075		61,929
Wealth Management:
Residential real estate	30,184			13		—		30,197
Securities-based lending and Other	49,930			—		—		49,930
Total Wealth Management	80,114			13		—		80,127
Total Investment Management¹	5			—		251		256
Total loans	118,409			12,577		11,326		142,312
ACL	(349		)					(349		)
Total loans, net of ACL	$	118,060		$	12,577	$	11,326	$	141,963
Lending commitments²								$	120,068
Total exposure								$	262,031

HFI—Held for investment; HFS—Held for sale; FVO—Fair value option

Total exposure—consists of Total loans, net of ACL, and Lending commitments


1.	Investment Management business segment loans are related to certain of our activities as an investment advisor and manager. At September 30, 2020 and December 31, 2019, loans held at fair value are predominantly the result of the consolidation of CLO vehicles, managed by Investment Management, composed primarily of senior secured loans to corporations.


2.	Lending commitments represent the notional amount of legally binding obligations to provide funding to clients for lending transactions. Since commitments associated with these business activities may expire unused or may not be utilized to full capacity, they do not necessarily reflect the actual future cash funding requirements.

We provide loans and lending commitments to a variety of customers including large corporate and institutional clients as well as high to ultra-high net worth individuals. In addition, we purchase loans in the secondary market. Loans and lending



September 2020 Form 10-Q	36



Table of Contents
Risk Disclosures

commitments are either held for investment, held for sale or carried at fair value. For more information on these loan classifications, see Note 2 to the financial statements in the 2019 Form 10-K.

Total loans and lending commitments increased by approximately $13 billion since December 31, 2019, primarily due to growth within the Wealth Management business segment driven by securities-based loans and residential real estate loans. Within the Institutional Securities business segment, growth in loans and lending commitments was primarily driven by Secured lending facilities and Corporate, partially offset by a decrease in Commercial real estate.

See Notes 5, 10 and 14 to the financial statements for further information.

Beginning late in the first quarter of 2020 and following in part from the U.S. government’s enactment of the CARES Act, we have received requests from certain clients for modifications of their credit agreements with us, which in some cases include deferral of their loan payments. Requests for loan payment deferrals related to Residential real estate loans are immediately granted, while Commercial real estate loan deferrals require careful consideration prior to approval. As of September 30, 2020, the unpaid principal balance of loans with approved deferrals of principal and interest payments currently in place amounted to less than $2 billion, with approximately one-third in each of our Wealth Management business segment commercial real estate-related tailored lending portfolio, which is included within Securities-based lending and Other, our Wealth Management business segment Residential real estate loans and our Institutional Securities business segment, primarily within Commercial real estate.

In addition to these principal and interest deferrals, we are also working with clients regarding modifications of certain other terms under their original loan agreements that do not impact contractual loan payments. We have granted such relief to certain borrowers, primarily within Secured lending facilities and Corporate loans. Such modifications include agreements to modify margin calls for Secured lending facilities, typically in return for additional payments which improve loan-to-value ratios. In some cases we have agreed to temporarily not enforce certain covenants, for example debt or interest coverage ratios, typically in return for other structural enhancements.

Granting loan deferral or modification requests does not necessarily mean that we will incur credit losses and we do not believe modifications have had a material impact on the risk profile of our loan portfolio. Modifications are considered in our evaluation of overall credit risk. Generally, loans with payment deferrals remain on accrual status and loans with other modifications remain on current status.

Requests for deferrals and other modifications could continue in future periods given the ongoing uncertain global economic

and market conditions. See “Executive Summary—Coronavirus Disease (COVID-19) Pandemic,” and “Risk Factors” herein for further information. See also “Forward Looking Statements” in the 2019 Form 10-K. For additional information on regulatory guidance which permits certain loan modifications for borrowers impacted by COVID-19 to not be accounted for and reported as TDRs and the Firm’s accounting policies for such modifications, see “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments” herein and Note 2 to the financial statements, respectively. For information on HFI loans on nonaccrual status, see “Status of Loans Held for Investment” herein and Notes 2 and 10 to the financial statements. For HFI loans modified and reported as TDRs, see Notes 2 and 10 to the financial statements.

Allowance for Credit Losses—Loans and Lending Commitments



$ in millions
December 31, 2019¹	$	590
Effect of CECL adoption	(41		)
Gross charge-offs	(59		)
Recoveries	5
Net (charge-offs) recoveries	(54		)
Provision²	757
Other	8
September 30, 2020	$	1,260
ACL—Loans	$	913
ACL—Lending commitments	347


1.	At December 31, 2019, the ACL for Loans and Lending commitments was $349 million and $241 million, respectively.


2.	In the current quarter, the provision for loan losses was $63 million and the provision for losses on lending commitments was $48 million. In the current year period, the provision for loan losses was $601 million and the provision for losses on lending commitments was $156 million.

Credit exposure arising from our loans and lending commitments is measured in accordance with our internal risk management standards. Risk factors considered in determining the aggregate allowance for loan and commitment losses include the borrower’s financial strength, industry, facility structure, loan-to-value ratio, debt service ratio, collateral and covenants. Qualitative and environmental factors such as economic and business conditions, nature and volume of the portfolio and lending terms, and volume and severity of past due loans may also be considered.

The aggregate allowance for loans and lending commitments increased in the current year period, principally reflecting the provision for credit losses within the Institutional Securities business segment primarily resulting from the continued economic impact of COVID-19. This provision was the result of risks related to vulnerable sectors and higher downgrade sensitivity, changes in asset quality trends, as well as revisions to our forecasts reflecting expected future market and macroeconomic conditions. The base scenario used in our ACL models as of September 30, 2020 was generated using a combination of industry consensus economic forecasts, forward rates, and internally developed and validated models. Given the



	37	September 2020 Form 10-Q



Table of Contents
Risk Disclosures

nature of our lending portfolio, the most sensitive model input is U.S. GDP. The base scenario, among other things, assumes a continued recovery in the last quarter of 2020 through 2021, supported by fiscal stimulus and monetary policy measures. See Note 2 to the financial statements for a discussion of the Firm’s ACL methodology under CECL.

Status of Loans Held for Investment



	At September 30, 2020				At December 31, 2019
	IS		WM		IS		WM
Accrual	99.1	%	99.8	%	99.0	%	99.9	%
Nonaccrual¹	0.9	%	0.2	%	1.0	%	0.1	%


1.	These loans are on nonaccrual status because the loans were past due for a period of 90 days or more or payment of principal or interest was in doubt.

Institutional Securities Loans and Lending Commitments¹



	At September 30, 2020
	Contractual Years to Maturity
$ in millions	Less than 1		1-3		3-5		Over 5		Total
Loans
AA	$	274	$	—	$	—	$	—	$	274
A	874		1,062		39		229		2,204
BBB	3,958		5,726		3,314		295		13,293
BB	12,683		7,920		6,273		491		27,367
Other NIG	5,403		6,519		3,791		2,423		18,136
Unrated²	63		151		155		1,056		1,425
Total loans, net of ACL	23,255		21,378		13,572		4,494		62,699
Lending commitments
AAA	—		50		—		—		50
AA	4,157		1,267		1,878		—		7,302
A	6,310		8,290		7,901		564		23,065
BBB	5,422		15,408		15,761		310		36,901
BB	4,150		7,154		7,291		1,311		19,906
Other NIG	979		8,491		5,533		3,193		18,196
Unrated²	4		1		21		20		46
Total lending commitments	21,022		40,661		38,385		5,398		105,466
Total exposure	$	44,277	$	62,039	$	51,957	$	9,892	$	168,165



	At December 31, 2019
	Contractual Years to Maturity
$ in millions	Less than 1		1-3		3-5		Over 5		Total
Loans
AA	$	7	$	50	$	—	$	5	$	62
A	955		923		516		277		2,671
BBB	2,297		5,589		3,592		949		12,427
BB	9,031		11,189		9,452		1,449		31,121
Other NIG	4,020		5,635		2,595		1,143		13,393
Unrated²	117		82		131		1,628		1,958
Total loans, net of ACL	16,427		23,468		16,286		5,451		61,632
Lending commitments
AAA	—		50		—		—		50
AA	2,838		908		2,509		—		6,255
A	6,461		7,287		9,371		298		23,417
BBB	7,548		13,780		20,560		753		42,641
BB	2,464		5,610		8,333		1,526		17,933
Other NIG	2,193		4,741		7,062		2,471		16,467
Unrated²	—		9		107		7		123
Total lending commitments	21,504		32,385		47,942		5,055		106,886
Total exposure	$	37,931	$	55,853	$	64,228	$	10,506	$	168,518

NIG–Non-investment grade


1.	Counterparty credit ratings are internally determined by the Credit Risk Management Department (“CRM”).


2.	Unrated loans and lending commitments are primarily trading positions that are measured at fair value and risk-managed as a component of market risk. For a further discussion of our market risk, see “Market Risk” herein.

Institutional Securities Loans and Lending Commitments by Industry



$ in millions	At September 30, 2020		At December 31, 2019
Industry
Financials	$	41,916	$	40,992
Real estate	24,827		28,348
Industrials	15,650		13,136
Communications services	12,529		12,165
Consumer discretionary	11,253		9,589
Healthcare	10,788		14,113
Energy	10,088		9,461
Utilities	9,994		9,905
Information technology	9,808		9,201
Consumer staples	8,476		9,724
Materials	5,626		5,577
Insurance	3,975		3,755
Other	3,235		2,552
Total exposure	$	168,165	$	168,518

Sectors Currently in Focus due to COVID-19

The continuing effect on economic activity of COVID-19 and related governmental actions have impacted borrowers in many sectors and industries. While we are carefully monitoring all of our Institutional Securities business segment exposures, certain sectors are more sensitive to the current economic environment and are continuing to receive heightened focus. The sectors



September 2020 Form 10-Q	38



Table of Contents
Risk Disclosures

currently in focus are: air travel, retail, upstream energy, lodging and leisure, and healthcare services and systems. As of September 30, 2020, exposures to these sectors are included across the Industrials, Financials, Real estate, Consumer discretionary, Energy and Healthcare industries in the previous table, and in aggregate represent approximately 10% of total Institutional Securities business segment lending exposure. The substantial majority of these exposures are either investment grade and/or secured by collateral. The future developments of COVID-19 and related government actions and their effect on the economic environment remain uncertain; therefore, the sectors impacted and the extent of the impacts may change over time. Refer to “Risk Factors” herein.

Institutional Securities Lending Activities

The Institutional Securities business segment lending activities include Corporate, Secured lending facilities, Commercial real estate and Securities-based lending and Other. Over 90% of our total lending exposure, which consists of loans and lending commitments, is investment grade and/or secured by collateral.

Corporate comprises relationship and event-driven loans and lending commitments, which typically consist of revolving lines of credit, term loans and bridge loans; may have varying terms; may be senior or subordinated; may be secured or unsecured; are generally contingent upon representations, warranties and contractual conditions applicable to the borrower; and may be syndicated, traded or hedged. For additional information on event-driven loans, see “Institutional Securities Event-Driven Loans and Lending Commitments” herein.

Secured lending facilities include loans provided to clients, which are collateralized by various assets including residential and commercial real estate mortgage loans, corporate loans, and other assets. These facilities generally provide for overcollateralization. Credit risk with respect to these loans and lending commitments arises from the failure of a borrower to perform according to the terms of the loan agreement and/or a decline in the underlying collateral value. The Firm monitors collateral levels against the requirements of lending agreements.

Commercial real estate loans are primarily senior, secured by underlying real estate and typically in term loan form. In addition, as part of certain of its trading and securitization activities, Institutional Securities may also hold residential real estate loans.

Securities-based lending and Other includes financing extended to sales and trading customers and corporate loans purchased in the secondary market.

Institutional Securities Event-Driven Loans and Lending Commitments



	At September 30, 2020
	Contractual Years to Maturity
$ in millions	Less than 1		1-3		3-5		Over 5		Total
Loans, net of ACL	$	1,891	$	1,185	$	710	$	1,216	$	5,002
Lending commitments	2,346		5,088		2,257		3,697		13,388
Total exposure	$	4,237	$	6,273	$	2,967	$	4,913	$	18,390



	At December 31, 2019
	Contractual Years to Maturity
$ in millions	Less than 1		1-3		3-5		Over 5		Total
Loans, net of ACL	$	1,194	$	1,024	$	839	$	390	$	3,447
Lending commitments	7,921		5,012		2,285		3,090		18,308
Total exposure	$	9,115	$	6,036	$	3,124	$	3,480	$	21,755

Event-driven loans and lending commitments are associated with a particular event or transaction, such as to support client merger, acquisition, recapitalization or project finance activities. Balances may fluctuate as such lending is related to transactions that vary in timing and size from period to period.

Institutional Securities Loans and Lending Commitments Held for Investment



	At September 30, 2020
$ in millions	Loans			Lending Commitments			Total
Corporate	$	7,628		$	65,358		$	72,986
Secured lending facilities	26,496			8,122			34,618
Commercial real estate	7,265			286			7,551
Other	1,277			1,178			2,455
Total, before ACL	$	42,666		$	74,944		$	117,610
ACL	$	(806	)	$	(342	)	$	(1,148	)



	At December 31, 2019
$ in millions	Loans			Lending Commitments			Total
Corporate	$	5,426		$	61,716		$	67,142
Secured lending facilities	24,502			6,105			30,607
Commercial real estate	7,859			425			8,284
Other	503			832			1,335
Total, before ACL	$	38,290		$	69,078		$	107,368
ACL	$	(297	)	$	(236	)	$	(533	)



	39	September 2020 Form 10-Q



Table of Contents
Risk Disclosures

Institutional Securities Allowance for Credit Losses—Loans and Lending Commitments



$ in millions	Corporate			Secured lending facilities			Commercial real estate			Other			Total
At December 31, 2019
ACL—Loans	$	115		$	101		$	75		$	6		$	297
ACL—Lending commitments	$	201		$	27		$	7		$	1		$	236
Total	$	316		$	128		$	82		$	7		$	533
Effect of CECL adoption	(43		)	(53		)	35			3			(58		)
Gross charge-offs	(33		)	—			(26		)	—			(59		)
Recoveries	3			—			—			2			5
Net (charge-offs) recoveries	(30		)	—			(26		)	2			(54		)
Provision (release)¹	400			155			180			(16		)	719
Other	3			1			(38		)	42			8
Total at September 30, 2020	$	646		$	231		$	233		$	38		$	1,148
ACL—Loans	$	367		$	191		$	222		$	26		$	806
ACL—Lending commitments	279			40			11			12			342


1.	In the current quarter, the provision for loan losses was $66 million and the provision for losses on lending commitments was $47 million. In the current year period, the provision for loan losses was $562 million and the provision for losses on lending commitments was $157 million.

Institutional Securities HFI Loans—Ratios of Allowance for Credit Losses to Balance Before Allowance



	At September 30, 2020		At December 31, 2019
Corporate	4.8	%	2.1	%
Secured lending facilities	0.7	%	0.4	%
Commercial real estate	3.1	%	1.0	%
Other	2.0	%	1.2	%
Total Institutional Securities loans	1.9	%	0.8	%

Wealth Management Loans and Lending Commitments



	At September 30, 2020
	Contractual Years to Maturity
$ in millions	Less than 1		1-3		3-5		Over 5		Total
Securities-based lending and Other	$	49,714	$	4,411	$	1,869	$	1,680	$	57,674
Residential real estate	11		4		1		33,612		33,628
Total loans, net of ACL	$	49,725	$	4,415	$	1,870	$	35,292	$	91,302
Lending commitments	11,797		2,240		326		269		14,632
Total exposure	$	61,522	$	6,655	$	2,196	$	35,561	$	105,934



	At December 31, 2019
	Contractual Years to Maturity
$ in millions	Less than 1		1-3		3-5		Over 5		Total
Securities-based lending and Other	$	41,863	$	3,972	$	2,783	$	1,284	$	49,902
Residential real estate	13		11		—		30,149		30,173
Total loans, net of ACL	$	41,876	$	3,983	$	2,783	$	31,433	$	80,075
Lending commitments	10,219		2,564		71		307		13,161
Total exposure	$	52,095	$	6,547	$	2,854	$	31,740	$	93,236

The principal Wealth Management business segment lending activities include securities-based lending and residential real estate loans.

Securities-based lending allows clients to borrow money against the value of qualifying securities, generally for any purpose other than purchasing, trading or carrying securities, or refinancing margin debt. For more information about our securities-based lending and residential real estate loans, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk” in the 2019 Form 10-K.

For the current year period, Loans and Lending commitments associated with the Wealth Management business segment increased, driven by securities-based loans and residential real estate loans.

Wealth Management Allowance for Credit Losses—Loans and Lending Commitments



$ in millions
December 31, 2019¹	$	57
Effect of CECL adoption	17
Provision²	38
September 30, 2020	$	112
ACL—Loans	$	107
ACL—Lending commitments	5


1.	At December 31, 2019, the total ACL for Loans and Lending commitments was $52 million and $5 million, respectively.


2.	In the current quarter, the release for loan losses was $3 million and the provision for losses on lending commitments was $1 million. In the current year period the provision for loan losses was $39 million and the release for losses on lending commitments was $1 million.

At September 30, 2020, more than 75% of Wealth Management residential real estate loans were to borrowers with “Exceptional” or “Very Good” FICO scores (i.e., exceeding 740). Additionally, Wealth Management’s securities-based lending portfolio remains well-collateralized and subject to daily client margining, which includes requiring customers to deposit additional collateral, or reduce debt positions, when necessary.

Customer and Other Receivables

Margin Loans



	At September 30, 2020
$ in millions	IS		WM		Total
Customer receivables representing margin loans	$	35,604	$	9,054	$	44,658



	At December 31, 2019
$ in millions	IS		WM		Total
Customer receivables representing margin loans	$	22,216	$	9,700	$	31,916

The Institutional Securities and Wealth Management business segments provide margin lending arrangements, which allow customers to borrow against the value of qualifying securities, primarily for the purpose of purchasing additional securities, as



September 2020 Form 10-Q	40



Table of Contents
Risk Disclosures

well as to collateralize short positions. Margin lending activities generally have lower credit risk due to the value of collateral held and their short-term nature. Amounts may fluctuate from period to period as overall client balances change as a result of market levels, client positioning and leverage.

Employee Loans



$ in millions	At September 30, 2020			At December 31, 2019
Currently employed by the Firm	$	2,940		N/A
No longer employed by the Firm	142			N/A
Employee loans	$	3,082		$	2,980
ACL¹	(165		)	(61		)
Employee loans, net of ACL	$	2,917		$	2,919
Remaining repayment term, weighted average in years	5.1			4.8


1.	The change in ACL includes a $124 million increase due to the adoption of CECL on January 1, 2020.

Employee loans are granted in conjunction with a program established primarily to recruit certain Wealth Management representatives and are full recourse and generally require periodic repayments. The ACL as of September 30, 2020 was calculated under CECL, while the ACL at December 31, 2019 was calculated under the prior incurred loss model. The related provision is recorded in Compensation and benefits expense in the income statements. See Note 2 to the financial statements for a description of the CECL allowance methodology, including credit quality indicators, for employee loans. For additional information on employee loans, see Note 10 to the financial statements.

Derivatives

Fair Value of OTC Derivative Assets



	Counterparty Credit Rating¹
$ in millions	AAA			AA			A			BBB			NIG			Total
At September 30, 2020
Less than 1 year	$	667		$	10,653		$	36,327		$	23,017		$	10,481		$	81,145
1-3 years	641			5,332			17,817			13,616			7,196			44,602
3-5 years	389			5,091			11,562			8,447			3,648			29,137
Over 5 years	4,496			34,274			87,181			64,958			16,119			207,028
Total, gross	$	6,193		$	55,350		$	152,887		$	110,038		$	37,444		$	361,912
Counterparty netting	(3,107		)	(42,447		)	(122,838		)	(83,836		)	(22,686		)	(274,914		)
Cash and securities collateral	(2,897		)	(10,830		)	(25,423		)	(20,621		)	(8,865		)	(68,636		)
Total, net	$	189		$	2,073		$	4,626		$	5,581		$	5,893		$	18,362



	Counterparty Credit Rating¹
$ in millions	AAA			AA			A			BBB			NIG			Total
At December 31, 2019
Less than 1 year	$	371		$	9,195		$	31,789		$	22,757		$	6,328		$	70,440
1-3 years	378			5,150			17,707			11,495			9,016			43,746
3-5 years	502			4,448			9,903			6,881			3,421			25,155
Over 5 years	3,689			24,675			70,765			40,542			14,587			154,258
Total, gross	$	4,940		$	43,468		$	130,164		$	81,675		$	33,352		$	293,599
Counterparty netting	(2,172		)	(33,521		)	(103,452		)	(62,345		)	(19,514		)	(221,004		)
Cash and securities collateral	(2,641		)	(8,134		)	(22,319		)	(14,570		)	(10,475		)	(58,139		)
Total, net	$	127		$	1,813		$	4,393		$	4,760		$	3,363		$	14,456



$ in millions	At September 30, 2020		At December 31, 2019
Industry
Utilities	$	4,407	$	4,275
Financials	4,394		3,448
Industrials	1,796		914
Healthcare	1,442		991
Regional governments	966		791
Information technology	901		659
Not-for-profit organizations	796		657
Energy	775		524
Materials	590		325
Sovereign governments	549		403
Consumer staples	385		129
Consumer discretionary	371		370
Communications services	325		381
Insurance	302		214
Real estate	287		315
Other	76		60
Total	$	18,362	$	14,456


1.	Counterparty credit ratings are determined internally by CRM.

We are exposed to credit risk as a dealer in OTC derivatives. Credit risk with respect to derivative instruments arises from the possibility that a counterparty may fail to perform according to the terms of the contract. In the current year period, our exposure to credit risk arising from OTC derivatives has increased, primarily as a function of the effect of market factors and



	41	September 2020 Form 10-Q



Table of Contents
Risk Disclosures

volatility on the valuation of our positions, although exposure has declined since peaking in March 2020. For more information on derivatives, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk—Derivatives” in the 2019 Form 10-K and Note 7 to the financial statements.

Country Risk

Country risk exposure is the risk that events in, or that affect, a foreign country (any country other than the U.S.) might adversely affect us. We actively manage country risk exposure through a comprehensive risk management framework that combines credit and market fundamentals and allows us to effectively identify, monitor and limit country risk. For a further discussion of our country risk exposure see, “Quantitative and Qualitative Disclosures about Risk—Country and Other Risks” in the 2019 Form 10-K.

Our sovereign exposures consist of financial contracts and obligations entered into with sovereign and local governments. Our non-sovereign exposures consist of financial contracts and obligations entered into primarily with corporations and financial institutions. Index credit derivatives are included in the following country risk exposure table. Each reference entity within an index is allocated to that reference entity’s country of risk. Index exposures are allocated to the underlying reference entities in proportion to the notional weighting of each reference entity in the index, adjusted for any fair value receivable or payable for that reference entity. Where credit risk crosses multiple jurisdictions, for example, a CDS purchased from an issuer in a specific country that references bonds issued by an entity in a different country, the fair value of the CDS is reflected in the Net Counterparty Exposure row based on the country of the CDS issuer. Further, the notional amount of the CDS adjusted for the fair value of the receivable or payable is reflected in the Net Inventory row based on the country of the underlying reference entity.

Top 10 Non-U.S. Country Exposures at September 30, 2020



United Kingdom
$ in millions	Sovereigns			Non-sovereigns			Total
Net inventory¹	$	1,145		$	928		$	2,073
Net counterparty exposure²	69			11,183			11,252
Loans	—			2,831			2,831
Lending commitments	—			6,607			6,607
Exposure before hedges	1,214			21,549			22,763
Hedges³	(311		)	(1,470		)	(1,781		)
Net exposure	$	903		$	20,079		$	20,982



Germany
$ in millions	Sovereigns			Non-sovereigns			Total
Net inventory¹	$	(1,168	)	$	(14	)	$	(1,182	)
Net counterparty exposure²	214			3,280			3,494
Loans	—			2,092			2,092
Lending commitments	(1		)	4,428			4,427
Exposure before hedges	(955		)	9,786			8,831
Hedges³	(286		)	(867		)	(1,153		)
Net exposure	$	(1,241	)	$	8,919		$	7,678



Japan
$ in millions	Sovereigns			Non-sovereigns			Total
Net inventory¹	$	2,182		$	512		$	2,694
Net counterparty exposure²	57			4,505			4,562
Loans	—			562			562
Exposure before hedges	2,239			5,579			7,818
Hedges³	(96		)	(228		)	(324		)
Net exposure	$	2,143		$	5,351		$	7,494



France
$ in millions	Sovereigns			Non-sovereigns			Total
Net inventory¹	$	1,214		$	(334	)	$	880
Net counterparty exposure²	18			3,444			3,462
Loans	—			525			525
Lending commitments	—			3,047			3,047
Exposure before hedges	1,232			6,682			7,914
Hedges³	(6		)	(815		)	(821		)
Net exposure	$	1,226		$	5,867		$	7,093



Spain
$ in millions	Sovereigns			Non-sovereigns			Total
Net inventory¹	$	(809	)	$	28		$	(781	)
Net counterparty exposure²	7			284			291
Loans	—			4,061			4,061
Lending commitments	—			620			620
Exposure before hedges	(802		)	4,993			4,191
Hedges³	—			(123		)	(123		)
Net exposure	$	(802	)	$	4,870		$	4,068



Australia
$ in millions	Sovereigns		Non-sovereigns			Total
Net inventory¹	$	1,893	$	261		$	2,154
Net counterparty exposure²	6		637			643
Loans	—		392			392
Lending commitments	—		798			798
Exposure before hedges	1,899		2,088			3,987
Hedges³	—		(174		)	(174		)
Net exposure	$	1,899	$	1,914		$	3,813



India
$ in millions	Sovereigns		Non-sovereigns		Total
Net inventory¹	$	1,795	$	595	$	2,390
Net counterparty exposure²	—		821		821
Loans	—		205		205
Exposure before hedges	1,795		1,621		3,416
Net exposure	$	1,795	$	1,621	$	3,416



September 2020 Form 10-Q	42



Table of Contents
Risk Disclosures



China
$ in millions	Sovereigns			Non-sovereigns			Total
Net inventory¹	$	(184	)	$	1,506		$	1,322
Net counterparty exposure²	103			481			584
Loans	—			772			772
Lending commitments	—			765			765
Exposure before hedges	(81		)	3,524			3,443
Hedges³	(82		)	(122		)	(204		)
Net exposure	$	(163	)	$	3,402		$	3,239



Canada
$ in millions	Sovereigns			Non-sovereigns			Total
Net inventory¹	$	(66	)	$	330		$	264
Net counterparty exposure²	60			1,477			1,537
Loans	—			155			155
Lending commitments	—			1,380			1,380
Exposure before hedges	(6		)	3,342			3,336
Hedges³	—			(108		)	(108		)
Net exposure	$	(6	)	$	3,234		$	3,228



Netherlands
$ in millions	Sovereigns			Non-sovereigns			Total
Net inventory¹	$	(5	)	$	280		$	275
Net counterparty exposure²	—			760			760
Loans	—			420			420
Lending commitments	—			1,768			1,768
Exposure before hedges	(5		)	3,228			3,223
Hedges³	(32		)	(210		)	(242		)
Net exposure	$	(37	)	$	3,018		$	2,981


1.	Net inventory represents exposure to both long and short single-name and index positions (i.e., bonds and equities at fair value and CDS based on a notional amount assuming zero recovery adjusted for the fair value of any receivable or payable).


2.	Net counterparty exposure (e.g., repurchase transactions, securities lending and OTC derivatives) is net of the benefit of collateral received and also is net by counterparty when legally enforceable master netting agreements are in place. For more information, see “Additional Information—Top 10 Non-U.S. Country Exposures” herein.

Amounts represent net CDS hedges (purchased and sold) on net counterparty exposure and lending executed by trading desks responsible for hedging counterparty and lending credit risk exposures. Amounts are based on the CDS notional amount assuming zero recovery adjusted for any fair value receivable or payable. For further description of the contractual terms for purchased credit protection and whether they may limit the effectiveness of our hedges, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk—Derivatives” in the 2019 Form 10-K.

Additional Information—Top 10 Non-U.S. Country Exposures

Collateral Held against Net Counterparty Exposure¹



$ in millions		At September 30, 2020
Country of Risk	Collateral²
Germany	Japan and France	$	13,464
United Kingdom	U.K., U.S. and Spain	12,093
Other	Japan, U.S. and Canada	23,884


1.	The benefit of collateral received is reflected in the Top 10 Non-U.S. Country Exposures at September 30, 2020.


2.	Primarily consists of cash as well as government obligations of the countries listed.

Country Risk Exposures Related to the U.K.

At September 30, 2020, our country risk exposures in the U.K. included net exposures of $20,982 million (as shown in the Top 10 Non-U.S. Country Exposures table) and overnight deposits of $6,168 million. The $20,079 million of exposures to non-sovereigns were diversified across both names and sectors and include $6,753 million to U.K.-focused counterparties that generate more than one-third of their revenues in the U.K., $5,163 million to geographically diversified counterparties, and $7,273 million to exchanges and clearinghouses.

Operational Risk

Operational risk refers to the risk of loss, or of damage to our reputation, resulting from inadequate or failed processes or systems, from human factors or from external events (e.g., fraud, theft, legal and compliance risks, cyber attacks or damage to physical assets). We may incur operational risk across the full scope of our business activities, including revenue-generating activities (e.g., sales and trading) and support and control groups (e.g., information technology and trade processing). For a further discussion about our operational risk, see “Quantitative and Qualitative Disclosures about Risk—Operational Risk” in the 2019 Form 10-K. In addition, for further information on market and economic conditions and their effects on risk in general, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—Coronavirus Disease (COVID-19) Pandemic” and “Risk Factors” herein.

Model Risk

Model risk refers to the potential for adverse consequences from decisions based on incorrect or misused model outputs. Model risk can lead to financial loss, poor business and strategic decision making or damage to our reputation. The risk inherent in a model is a function of the materiality, complexity and uncertainty around inputs and assumptions. Model risk is generated from the use of models impacting financial statements, regulatory filings, capital adequacy assessments and the formulation of strategy. For a further discussion about our model risk, see “Quantitative and Qualitative Disclosures about Risk—Model Risk” in the 2019 Form 10-K.

Liquidity Risk

Liquidity risk refers to the risk that we will be unable to finance our operations due to a loss of access to the capital markets or difficulty in liquidating our assets. Liquidity risk also encompasses our ability (or perceived ability) to meet our financial obligations without experiencing significant business disruption or reputational damage that may threaten our viability as a going concern. For a further discussion about our liquidity risk, see “Quantitative and Qualitative Disclosures about Risk—Liquidity Risk” in the 2019 Form 10-K and “Management’s Discussion and Analysis of Financial Condition and Results of



	43	September 2020 Form 10-Q



Table of Contents
Risk Disclosures

Operations—Liquidity and Capital Resources” herein. In addition, for further information on market and economic conditions and their effects on risk in general, see “Risk Factors” herein.

Legal and Compliance Risk

Legal and compliance risk includes the risk of legal or regulatory sanctions, material financial loss, including fines, penalties, judgments, damages and/or settlements, or loss to reputation that we may suffer as a result of failure to comply with laws, regulations, rules, related self-regulatory organization standards and codes of conduct applicable to our business activities. This risk also includes contractual and commercial risk, such as the risk that a counterparty’s performance obligations will be unenforceable. It also includes compliance with AML, terrorist financing, and anti-corruption rules and regulations. For a further discussion about our legal and compliance risk, see “Quantitative and Qualitative Disclosures about Risk—Legal and Compliance Risk” in the 2019 Form 10-K.



September 2020 Form 10-Q	44



Table of Contents

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders of Morgan Stanley:

Results of Review of Interim Financial Information

We have reviewed the accompanying condensed consolidated balance sheet of Morgan Stanley and subsidiaries (the “Firm”) as of September 30, 2020, and the related condensed consolidated income statements, comprehensive income statements, and statements of changes in total equity for the three-month and nine-month periods ended September 30, 2020 and 2019, and the cash flow statements for the nine-month periods ended September 30, 2020 and 2019, and the related notes (collectively referred to as the “interim financial information”). Based on our reviews, we are not aware of any material modifications that should be made to the accompanying interim financial information for it to be in conformity with accounting principles generally accepted in the United States of America.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Firm as of December 31, 2019, and the related consolidated income statement, comprehensive income statement, cash flow statement and statement of changes in total equity for the year then ended (not presented herein) included in the Firm’s Annual Report on Form 10-K; and in our report dated February 27, 2020, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2019 is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

Basis for Review Results

This interim financial information is the responsibility of the Firm’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Firm in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our reviews in accordance with the standards of the PCAOB. A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

/s/ Deloitte & Touche LLP

New York, New York

November 3, 2020



	45	September 2020 Form 10-Q



Table of Contents
Consolidated Income Statements (Unaudited)



	Three Months Ended September 30,				Nine Months Ended September 30,
in millions, except per share data	2020		2019		2020			2019
Revenues
Investment banking	$	1,826	$	1,635	$	5,239		$	4,467
Trading	3,092		2,608		10,831			8,781
Investments	346		87		659			801
Commissions and fees	1,037		990		3,499			2,935
Asset management	3,664		3,363		10,346			9,632
Other	206		131		(458		)	685
Total non-interest revenues	10,171		8,814		30,116			27,301
Interest income	2,056		4,350		7,917			13,146
Interest expense	570		3,132		3,475			9,885
Net interest	1,486		1,218		4,442			3,261
Net revenues	11,657		10,032		34,558			30,562
Non-interest expenses
Compensation and benefits	5,086		4,427		15,404			13,609
Brokerage, clearing and exchange fees	697		637		2,153			1,860
Information processing and communications	616		557		1,768			1,627
Professional services	542		531		1,526			1,582
Occupancy and equipment	373		353		1,103			1,053
Marketing and business development	78		157		273			460
Other	778		660		2,343			1,803
Total non-interest expenses	8,170		7,322		24,570			21,994
Income before provision for income taxes	3,487		2,710		9,988			8,568
Provision for income taxes	736		492		2,221			1,636
Net income	$	2,751	$	2,218	$	7,767		$	6,932
Net income applicable to noncontrolling interests	34		45		156			129
Net income applicable to Morgan Stanley	$	2,717	$	2,173	$	7,611		$	6,803
Preferred stock dividends	120		113		377			376
Earnings applicable to Morgan Stanley common shareholders	$	2,597	$	2,060	$	7,234		$	6,427
Earnings per common share
Basic	$	1.68	$	1.28	$	4.68		$	3.94
Diluted	$	1.66	$	1.27	$	4.62		$	3.89
Average common shares outstanding
Basic	1,542		1,604		1,546			1,632
Diluted	1,566		1,627		1,565			1,653



September 2020 Form 10-Q	46	See Notes to Consolidated Financial Statements



Table of Contents
Consolidated Comprehensive Income Statements (Unaudited)



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions	2020			2019			2020			2019
Net income	$	2,751		$	2,218		$	7,767		$	6,932
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	110			(99		)	(1		)	(56		)
Change in net unrealized gains (losses) on available-for-sale securities	(62		)	214			1,558			1,252
Pension, postretirement and other	5			3			29			7
Change in net debt valuation adjustment	(563		)	337			744			(529		)
Total other comprehensive income (loss)	$	(510	)	$	455		$	2,330		$	674
Comprehensive income	$	2,241		$	2,673		$	10,097		$	7,606
Net income applicable to noncontrolling interests	34			45			156			129
Other comprehensive income (loss) applicable to noncontrolling interests	28			2			79			(20		)
Comprehensive income applicable to Morgan Stanley	$	2,179		$	2,626		$	9,862		$	7,497



See Notes to Consolidated Financial Statements	47	September 2020 Form 10-Q



Table of Contents
Consolidated Balance Sheets



$ in millions, except share data	(Unaudited) At September 30, 2020			At December 31, 2019
Assets
Cash and cash equivalents	$	94,772		$	82,171
Trading assets at fair value ($122,933 and $128,386 were pledged to various parties)	293,968			297,110
Investment securities (includes $84,536 and $62,223 at fair value)	130,705			105,725
Securities purchased under agreements to resell (includes $15 and $4 at fair value)	88,283			88,224
Securities borrowed	100,803			106,549
Customer and other receivables	72,537			55,646
Loans:
Held for investment (net of allowance of $913 and $349)	133,156			118,060
Held for sale	13,081			12,577
Goodwill	7,348			7,143
Intangible assets (net of accumulated amortization of $3,442 and $3,204)	1,880			2,107
Other assets	19,407			20,117
Total assets	$	955,940		$	895,429
Liabilities
Deposits (includes $3,679 and $2,099 at fair value)	$	239,253		$	190,356
Trading liabilities at fair value	145,016			133,356
Securities sold under agreements to repurchase (includes $1,166 and $733 at fair value)	41,376			54,200
Securities loaned	7,924			8,506
Other secured financings (includes $10,185 and $7,809 at fair value)	13,857			14,698
Customer and other payables	192,300			197,834
Other liabilities and accrued expenses	22,952			21,155
Borrowings (includes $69,144 and $64,461 at fair value)	203,444			192,627
Total liabilities	866,122			812,732
Commitments and contingent liabilities (see Note 14)
Equity
Morgan Stanley shareholders’ equity:
Preferred stock	8,520			8,520
Common stock, $0.01 par value:
Shares authorized: 3,500,000,000; Shares issued: 2,038,893,979; Shares outstanding: 1,576,447,988 and 1,593,973,680	20			20
Additional paid-in capital	24,015			23,935
Retained earnings	76,061			70,589
Employee stock trusts	2,992			2,918
Accumulated other comprehensive income (loss)	(537		)	(2,788		)
Common stock held in treasury at cost, $0.01 par value (462,445,991 and 444,920,299 shares)	(19,685		)	(18,727		)
Common stock issued to employee stock trusts	(2,992		)	(2,918		)
Total Morgan Stanley shareholders’ equity	88,394			81,549
Noncontrolling interests	1,424			1,148
Total equity	89,818			82,697
Total liabilities and equity	$	955,940		$	895,429



September 2020 Form 10-Q	48	See Notes to Consolidated Financial Statements



Table of Contents
Consolidated Statements of Changes in Total Equity (Unaudited)



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions	2020			2019			2020			2019
Preferred Stock
Beginning and ending balance	$	8,520		$	8,520		$	8,520		$	8,520
Common Stock
Beginning and ending balance	20			20			20			20
Additional Paid-in Capital
Beginning balance	23,782			23,446			23,935			23,794
Share-based award activity	232			196			79			(154		)
Other net increases	1			7			1			9
Ending balance	24,015			23,649			24,015			23,649
Retained Earnings
Beginning balance	74,015			67,588			70,589			64,175
Cumulative adjustments for accounting changes¹	—			—			(100		)	63
Net income applicable to Morgan Stanley	2,717			2,173			7,611			6,803
Preferred stock dividends²	(120		)	(113		)	(377		)	(376		)
Common stock dividends²	(551		)	(577		)	(1,662		)	(1,594		)
Ending balance	76,061			69,071			76,061			69,071
Employee Stock Trusts
Beginning balance	3,018			2,889			2,918			2,836
Share-based award activity	(26		)	(24		)	74			29
Ending balance	2,992			2,865			2,992			2,865
Accumulated Other Comprehensive Income (Loss)
Beginning balance	1			(2,051		)	(2,788		)	(2,292		)
Net change in Accumulated other comprehensive income (loss)	(538		)	453			2,251			694
Ending balance	(537		)	(1,598		)	(537		)	(1,598		)
Common Stock Held In Treasury at Cost
Beginning balance	(19,693		)	(15,799		)	(18,727		)	(13,971		)
Share-based award activity	38			57			882			1,138
Repurchases of common stock and employee tax withholdings	(30		)	(1,538		)	(1,840		)	(4,447		)
Ending balance	(19,685		)	(17,280		)	(19,685		)	(17,280		)
Common Stock Issued to Employee Stock Trusts
Beginning balance	(3,018		)	(2,889		)	(2,918		)	(2,836		)
Share-based award activity	26			24			(74		)	(29		)
Ending balance	(2,992		)	(2,865		)	(2,992		)	(2,865		)
Non-Controlling Interests
Beginning balance	1,364			1,121			1,148			1,160
Net income applicable to non-controlling interests	34			45			156			129
Net change in Accumulated other comprehensive income (loss) applicable to non-controlling interests	28			2			79			(20		)
Other net increases (decreases)	(2		)	—			41			(101		)
Ending balance	1,424			1,168			1,424			1,168
Total Equity	$	89,818		$	83,550		$	89,818		$	83,550


1.	See Notes 2 and 17 for further information regarding cumulative adjustments for accounting changes.


2.	See Note 17 for information regarding dividends per share for each class of stock.



See Notes to Consolidated Financial Statements	49	September 2020 Form 10-Q



Table of Contents
Consolidated Cash Flow Statements (Unaudited)



	Nine Months Ended September 30,
$ in millions	2020			2019
Cash flows from operating activities
Net income	$	7,767		$	6,932
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Stock-based compensation expense	802			825
Depreciation and amortization	2,363			1,987
Provision for (Release of) credit losses on lending activities	757			104
Other operating adjustments	663			(114		)
Changes in assets and liabilities:
Trading assets, net of Trading liabilities	18,442			17,036
Securities borrowed	5,746			(16,088		)
Securities loaned	(582		)	(2,217		)
Customer and other receivables and other assets	(17,098		)	(5,135		)
Customer and other payables and other liabilities	(5,818		)	22,721
Securities purchased under agreements to resell	(59		)	5,155
Securities sold under agreements to repurchase	(12,824		)	9,703
Net cash provided by (used for) operating activities	159			40,909
Cash flows from investing activities
Proceeds from (payments for):
Other assets—Premises, equipment and software, net	(905		)	(1,460		)
Changes in loans, net	(13,592		)	(10,079		)
Investment securities:
Purchases	(41,147		)	(35,078		)
Proceeds from sales	7,220			13,561
Proceeds from paydowns and maturities	11,240			8,183
Other investing activities	(254		)	(848		)
Net cash provided by (used for) investing activities	(37,438		)	(25,721		)
Cash flows from financing activities
Net proceeds from (payments for):
Other secured financings	229			(587		)
Deposits	48,734			(7,084		)
Proceeds from issuance of Borrowings	42,169			23,697
Payments for:
Borrowings	(38,151		)	(30,391		)
Repurchases of common stock and employee tax withholdings	(1,840		)	(4,447		)
Cash dividends	(2,008		)	(2,082		)
Other financing activities	(208		)	(286		)
Net cash provided by (used for) financing activities	48,925			(21,180		)
Effect of exchange rate changes on cash and cash equivalents	955			(1,548		)
Net increase (decrease) in cash and cash equivalents	12,601			(7,540		)
Cash and cash equivalents, at beginning of period	82,171			87,196
Cash and cash equivalents, at end of period	$	94,772		$	79,656
Supplemental Disclosure of Cash Flow Information
Cash payments for:
Interest	$	3,747		$	9,760
Income taxes, net of refunds	1,675			1,603



September 2020 Form 10-Q	50	See Notes to Consolidated Financial Statements



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

1. Introduction and Basis of Presentation

The Firm

Morgan Stanley is a global financial services firm that maintains significant market positions in each of its business segments—Institutional Securities, Wealth Management and Investment Management. Morgan Stanley, through its subsidiaries and affiliates, provides a wide variety of products and services to a large and diversified group of clients and customers, including corporations, governments, financial institutions and individuals. Unless the context otherwise requires, the terms “Morgan Stanley” or the “Firm” mean Morgan Stanley (the “Parent Company”) together with its consolidated subsidiaries. See the “Glossary of Common Terms and Acronyms” for the definition of certain terms and acronyms used throughout this Form 10-Q.

A description of the clients and principal products and services of each of the Firm’s business segments is as follows:

corporations. Individual clients are generally served through intermediaries, including affiliated and non-affiliated distributors.

Basis of Financial Information

The financial statements are prepared in accordance with U.S. GAAP, which requires the Firm to make estimates and assumptions regarding the valuations of certain financial instruments, the valuations of goodwill and intangible assets, the outcome of legal and tax matters, deferred tax assets, ACL, and other matters that affect its financial statements and related disclosures. The Firm believes that the estimates utilized in the preparation of its financial statements are prudent and reasonable. Actual results could differ materially from these estimates.

Certain reclassifications have been made to prior periods to conform to the current presentation. The Notes are an integral part of the Firm's financial statements. The Firm has evaluated subsequent events for adjustment to or disclosure in these financial statements through the date of this report and has not identified any recordable or disclosable events not otherwise reported in these financial statements or the notes thereto.

The accompanying financial statements should be read in conjunction with the Firm’s financial statements and notes thereto included in the 2019 Form 10-K. Certain footnote disclosures included in the 2019 Form 10-K have been condensed or omitted from these financial statements as they are not required for interim reporting under U.S. GAAP. The financial statements reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for the fair presentation of the results for the interim period. The results of operations for interim periods are not necessarily indicative of results for the entire year.

Consolidation

The financial statements include the accounts of the Firm, its wholly owned subsidiaries and other entities in which the Firm has a controlling financial interest, including certain VIEs (see Note 15). Intercompany balances and transactions have been eliminated. For consolidated subsidiaries that are not wholly owned, the third-party holdings of equity interests are referred to as noncontrolling interests. The net income attributable to noncontrolling interests for such subsidiaries is presented as Net income applicable to noncontrolling interests in the income statements. The portion of shareholders’ equity that is attributable to noncontrolling interests for such subsidiaries is presented as noncontrolling interests, a component of Total equity, in the balance sheets.

For a discussion of the Firm’s significant regulated U.S. and international subsidiaries and its involvement with VIEs, see Note 1 to the financial statements in the 2019 Form 10-K.



	51	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

2. Significant Accounting Policies

For a detailed discussion about the Firm’s significant accounting policies and for further information on accounting updates adopted in the prior year, see Note 2 to the financial statements in the 2019 Form 10-K.

During the nine months ended September 30, 2020 (“current year period”), there were no significant revisions to the Firm’s significant accounting policies, other than for the accounting updates adopted.

Accounting Updates Adopted in 2020

Reference Rate Reform

The Firm adopted the Reference Rate Reform accounting update in the current year period. There was no impact to the Firm’s financial statements upon initial adoption.

This accounting update provides optional accounting relief to entities with contracts, hedge accounting relationships or other transactions that reference LIBOR or other interest rate benchmarks for which the referenced rate is expected to be discontinued or replaced. The Firm is applying the accounting relief as relevant contract and hedge accounting relationship modifications are made during the course of the reference rate reform transition period. The optional relief generally allows for contract modifications solely related to the replacement of the reference rate to be accounted for as a continuation of the existing contract instead of as an extinguishment of the contract, and would therefore not trigger certain accounting impacts that would otherwise be required. It also allows entities to change certain critical terms of existing hedge accounting relationships that are affected by reference rate reform, and these changes would not require de-designating the hedge accounting relationship. The optional relief ends December 31, 2022.

Financial Instruments—Credit Losses

The Firm adopted the Financial Instruments—Credit Losses accounting update on January 1, 2020.

This accounting update impacted the impairment model for certain financial assets measured at amortized cost by requiring a CECL methodology to estimate expected credit losses over the entire life of the financial asset, recorded at inception or purchase. CECL replaced the loss model previously applicable to loans held for investment, HTM securities and other receivables carried at amortized cost, such as employee loans.

The update also eliminated the concept of other-than-temporary impairment for AFS securities and instead requires impairments on AFS securities to be recognized in earnings through an allowance when the fair value is less than amortized cost and a credit loss exists, and through a permanent reduction of the

amortized cost basis when the securities are expected to be sold before recovery of amortized cost.

For certain portfolios, we determined that there are de minimus or zero expected credit losses, for example, for lending and financing transactions, such as Securities borrowed, Securities purchased under agreements to resell and certain other portfolios where collateral arrangements are being followed. Also, we have zero expected credit losses for certain financial assets based on the credit quality of the borrower or issuer, such as U.S. government and agency securities.

At transition on January 1, 2020, the adoption of this accounting standard resulted in an increase in the allowance for credit losses of $131 million with a corresponding reduction in Retained earnings of $100 million, net of tax. The adoption impact was primarily attributable to a $124 million increase in the allowance for credit losses on employee loans.

The following discussion highlights changes to the Firm’s accounting policies as a result of this adoption.

Instruments Measured at Amortized Cost and Certain Off-Balance Sheet Credit Exposures

Allowance for Credit Losses

The ACL for financial instruments measured at amortized cost and certain off-balance sheet exposures (e.g., HFI loans and lending commitments, HTM securities, customer and other receivables and certain guarantees) represents an estimate of expected credit losses over the entire life of the financial instrument.

Factors considered by management when determining the ACL include payment status, fair value of collateral, expected payments of principal and interest, as well as internal or external information relating to past events, current conditions and reasonable and supportable forecasts. The Firm’s three forecasts include assumptions about certain macroeconomic variables including, but not limited to, U.S. gross domestic product, equity market indices, unemployment rates, as well as commercial real estate and home price indices. At the conclusion of the Firm’s reasonable and supportable forecast period of 13 quarters, there is a gradual reversion back to historical averages.

The ACL is measured on a collective basis when similar risk characteristics exist for multiple instruments considering all available information relevant to assessing the collectability of cash flows. Generally, the Firm applies a probability of default/loss given default model for instruments that are collectively assessed, under which the ACL is calculated as the product of probability of default, loss given default and exposure at default. These parameters are forecast for each collective group of assets using a scenario-based statistical model and at the conclusion of the Firm’s reasonable and supportable forecast period, the parameters gradually revert back to historical averages.



September 2020 Form 10-Q	52



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

If the instrument does not share similar risk characteristics with other instruments, including when it is probable that the Firm will be unable to collect the full payment of principal and interest on the instrument when due, the ACL is measured on an individual basis. The Firm generally applies a discounted cash flow method for instruments that are individually assessed.

The Firm may also elect to use an approach that considers the fair value of the collateral when measuring the ACL if the loan is collateral dependent (i.e., repayment of the loan is expected to be provided substantially by the sale or operation of the underlying collateral and the borrower is experiencing financial difficulty).

Additionally, the Firm can elect to use an approach to measure the ACL using the fair value of collateral where the borrower is required to, and reasonably expected to, continually adjust and replenish the amount of collateral securing the instrument to reflect changes in the fair value of such collateral. The Firm has elected to use this approach for certain securities-based loans, customer receivables representing margin loans, Securities purchased under agreements to resell and Securities borrowed.

Credit quality indicators considered in developing the ACL include:

•

Corporate loans, Secured lending facilities, Commercial real estate loans and securities, and Other loans: Internal risk ratings developed by the Credit Risk Management Department which are refreshed at least annually, and more frequently as necessary. These ratings generally correspond to external ratings published by S&P. The Firm also considers transaction structure, including type of collateral, collateral terms, and position of the obligation within the capital structure. In addition, for Commercial real estate, the Firm considers property type and location, net operating income, LTV ratios, among others, as well as commercial real estate price and credit spread indices and capitalization rates.


•	Residential real estate loans: Loan origination Fair Isaac Corporation (“FICO”) credit scores as determined by independent credit agencies in the United States and loan-to-value (“LTV”) ratios.


•	Employee loans: Employment status, which includes those currently employed by the Firm and for which the Firm can deduct any unpaid amounts due to it through certain compensation arrangements; and those no longer employed by the Firm where such compensation arrangements are no longer applicable.

For Securities-based loans, the Firm generally measures the ACL based on the fair value of collateral.

Qualitative and environmental factors such as economic and business conditions, the nature and volume of the portfolio, and lending terms and the volume and severity of past due loans are also considered in the ACL calculations.

Presentation of ACL and Provision for Credit Losses



	ACL	Provision for credit losses
Instruments measured at amortized cost (e.g., HFI loans, HTM securities and customer and other receivables)	Contra asset	Other revenue
Employee loans	Contra asset	Compensation and benefits expense
Off-balance sheet instruments (e.g., HFI lending commitments and certain guarantees)	Other liabilities and accrued expenses	Other expense

Troubled Debt Restructurings (“TDRs”)

The Firm may modify the terms of certain loans for economic or legal reasons related to a borrower’s financial difficulties by granting one or more concessions that the Firm would not otherwise consider. Such modifications are accounted for and reported as a TDR, except for certain modifications related to the Coronavirus Disease (“COVID-19”) as noted in “Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19” herein. A loan that has been modified in a TDR is generally considered to be impaired and is evaluated individually. TDRs are also generally classified as nonaccrual and may be returned to accrual status only after the Firm expects repayment of the remaining contractual principal and interest and there is sustained repayment performance for a reasonable period.

Nonaccrual

The Firm places financial instruments on nonaccrual status if principal or interest is past due for a period of 90 days or more or payment of principal or interest is in doubt unless the obligation is well-secured and in the process of collection, or in certain cases when related to COVID-19 as noted in “Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19” herein. For any instrument placed on nonaccrual status, the Firm reverses any unpaid interest accrued with an offsetting reduction to Interest income. Principal and interest payments received on nonaccrual instruments are applied to principal if there is doubt regarding the ultimate collectability of principal. If collection of the principal is not in doubt, interest income is realized on a cash basis. If neither principal nor interest collection is in doubt and the instruments are brought current, instruments are generally placed on accrual status and interest income is recognized using the effective interest method.

Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19

In the first quarter of 2020, the Firm elected to apply the guidance issued by Congress in the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) as well as by the U.S. banking agencies stating that certain concessions granted to borrowers that are current on existing loans, either individually or as part of a program for creditworthy borrowers who are experiencing short-term financial or operational problems as a result of COVID-19, generally would not be considered TDRs.



	53	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

Additionally, these loans generally would not be considered nonaccrual status unless collectability concerns exist despite the modification provided. For loans remaining on accrual status, the Firm elected to continue recognizing interest income during the modification periods.

ACL Write-offs

The Firm writes-off a financial instrument in the period that it is deemed uncollectible and records a reduction in the ACL and the balance of the financial instrument in the balance sheet. However, for accrued interest receivable balances that are separately recorded from the related financial instruments, the Firm's nonaccrual policy requires that accrued interest receivable be written off against Interest income when the related financial instrument is placed in nonaccrual status. Accordingly, the Firm elected not to measure an ACL for accrued interest receivables. However, in the case of loans which are modified as a result of COVID-19 and remain on accrual status due to the relief noted in “Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19,” accrued interest receivable balances are assessed for any required ACL.

Available-for-Sale (“AFS”) Investment Securities

AFS securities are reported at fair value in the balance sheets. Interest income, including amortization of premiums and accretion of discounts, is included in Interest income in the Income statements. Unrealized gains are recorded in OCI and unrealized losses are recorded either in OCI or in Other revenues as described below.

AFS securities in an unrealized loss position are first evaluated to determine whether there is an intent to sell or it is more likely than not the Firm will be required to sell before recovery of the amortized cost basis. If so, the entire unrealized loss is recognized in Other revenues, as any previously established ACL is written off and the amortized cost basis is written down to the fair value of the security.

For all other AFS securities in an unrealized loss position, any portion of unrealized losses representing a credit loss is recognized in Other revenues and as an increase to the ACL for AFS securities, with the remainder of unrealized losses recognized in OCI. When considering whether a credit loss exists, relevant information as discussed in Note 2 of the 2019 Form 10-K is considered, except that with the adoption of Financial Instruments—Credit Losses in 2020, the length of time the fair value has been less than the amortized cost basis is no longer considered.

Presentation of ACL and Provision for Credit Losses



	ACL	Provision for credit losses
AFS securities	Contra Investment securities	Other revenue

Nonaccrual & ACL Write-Offs on AFS Securities

AFS securities follow the same nonaccrual and write-off guidance as discussed in “Instruments Measured at Amortized Cost and Certain Off-Balance Sheet Credit Exposures” herein, except as set forth in “Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19.”

Goodwill

The Firm completed its annual goodwill impairment testing as of July 1, 2020. The Firm’s impairment testing did not indicate any goodwill impairment, as each of the Firm’s reporting units with goodwill had a fair value that was in excess of its carrying value.

3. Acquisitions

Acquisition of E*TRADE

On October 2, 2020, the Firm completed the acquisition of 100% of E*TRADE Financial Corporation (“E*TRADE”) in a stock-for-stock transaction, which is expected to increase the scale and breadth of the Wealth Management business segment. Given the recency of the closing, the purchase accounting analysis is still preliminary, however, the transaction is expected to result in the addition of approximately $77 billion in assets, inclusive of approximately $5 billion of Goodwill and $3 billion of Intangible assets. Total consideration for the transaction was approximately $11.9 billion, which principally consists of the $11 billion fair value of 233 million common shares issued from Common stock held in treasury, at an exchange ratio of 1.0432 per E*TRADE common share. In addition, the Firm issued Series M and Series N preferred shares with a fair value of approximately $0.7 billion in exchange for E*TRADE’s existing preferred stock.

Planned Acquisition of Eaton Vance

On October 8, 2020, the Firm entered into a definitive agreement under which it will acquire Eaton Vance Corp. (“Eaton Vance”) in a cash and stock transaction valued, as of the announcement, at approximately $7 billion, based on the closing price of the Firm’s common stock and the number of Eaton Vance’s fully diluted shares outstanding on October 7, 2020. Under the terms of the agreement, Eaton Vance common stockholders will receive $28.25 in cash and 0.5833 Morgan Stanley common shares for each Eaton Vance common share. In addition, Eaton Vance common shareholders will receive a one-time special cash dividend of $4.25 per share to be paid pre-closing by Eaton Vance. The acquisition is subject to customary closing conditions, and is expected to close in the second quarter of 2021.



September 2020 Form 10-Q	54



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

4. Cash and Cash Equivalents

Cash and cash equivalents consist of Cash and due from banks and Interest bearing deposits with banks. Cash equivalents are highly liquid investments with remaining maturities of three months or less from the acquisition date that are readily convertible to cash and are not held for trading purposes.



$ in millions	At September 30, 2020		At December 31, 2019
Cash and due from banks	$	13,840	$	6,763
Interest bearing deposits with banks	80,932		75,408
Total Cash and cash equivalents	$	94,772	$	82,171
Restricted cash	$	37,186	$	32,512

Cash and cash equivalents also include Restricted cash such as cash segregated in compliance with federal or other regulations, including minimum reserve requirements set by the Federal Reserve Bank and other central banks, and the Firm's initial margin deposited with clearing organizations.

5. Fair Values

Recurring Fair Value Measurements

Assets and Liabilities Measured at Fair Value on a Recurring Basis



	At September 30, 2020
$ in millions	Level 1			Level 2			Level 3			Netting¹			Total
Assets at fair value
Trading assets:
U.S. Treasury and agency securities	$	41,488		$	27,033		$	122		$	—		$	68,643
Other sovereign government obligations	31,171			5,909			10			—			37,090
State and municipal securities	—			1,479			—			—			1,479
MABS	—			999			443			—			1,442
Loans and lending commitments²	—			3,982			4,351			—			8,333
Corporate and other debt	—			27,158			2,727			—			29,885
Corporate equities³	102,975			655			135			—			103,765
Derivative and other contracts:
Interest rate	2,784			239,900			1,114			—			243,798
Credit	—			9,138			768			—			9,906
Foreign exchange	16			67,016			152			—			67,184
Equity	1,244			65,115			1,127			—			67,486
Commodity and other	3,022			12,031			3,480			—			18,533
Netting¹	(5,913		)	(304,977		)	(1,060		)	(59,715		)	(371,665		)
Total derivative and other contracts	1,153			88,223			5,581			(59,715		)	35,242
Investments⁴	664			144			821			—			1,629
Physical commodities	—			2,615			—			—			2,615
Total trading assets⁴	177,451			158,197			14,190			(59,715		)	290,123
Investment securities—AFS	46,946			37,590			—			—			84,536
Securities purchased under agreements to resell	—			15			—			—			15
Total assets at fair value	$	224,397		$	195,802		$	14,190		$	(59,715	)	$	374,674



	At September 30, 2020
$ in millions	Level 1			Level 2			Level 3			Netting¹			Total
Liabilities at fair value
Deposits	$	—		$	3,574		$	105		$	—		$	3,679
Trading liabilities:
U.S. Treasury and agency securities	11,311			462			1			—			11,774
Other sovereign government obligations	25,589			1,513			—			—			27,102
Corporate and other debt	—			8,623			2			—			8,625
Corporate equities³	59,950			344			57			—			60,351
Derivative and other contracts:
Interest rate	2,942			226,788			478			—			230,208
Credit	—			9,602			652			—			10,254
Foreign exchange	17			65,390			53			—			65,460
Equity	1,219			75,900			3,272			—			80,391
Commodity and other	3,025			10,304			1,676			—			15,005
Netting¹	(5,913		)	(304,977		)	(1,060		)	(52,204		)	(364,154		)
Total derivative and other contracts	1,290			83,007			5,071			(52,204		)	37,164
Total trading liabilities	98,140			93,949			5,131			(52,204		)	145,016
Securities sold under agreements to repurchase	—			718			448			—			1,166
Other secured financings	—			9,876			309			—			10,185
Borrowings	—			65,063			4,081			—			69,144
Total liabilities at fair value	$	98,140		$	173,180		$	10,074		$	(52,204	)	$	229,190



	At December 31, 2019
$ in millions	Level 1			Level 2			Level 3			Netting¹			Total
Assets at fair value
Trading assets:
U.S. Treasury and agency securities	$	36,866		$	28,992		$	22		$	—		$	65,880
Other sovereign government obligations	23,402			4,347			5			—			27,754
State and municipal securities	—			2,790			1			—			2,791
MABS	—			1,690			438			—			2,128
Loans and lending commitments²	—			6,253			5,073			—			11,326
Corporate and other debt	—			22,124			1,396			—			23,520
Corporate equities³	123,942			652			97			—			124,691
Derivative and other contracts:
Interest rate	1,265			182,977			1,239			—			185,481
Credit	—			6,658			654			—			7,312
Foreign exchange	15			64,260			145			—			64,420
Equity	1,219			48,927			922			—			51,068
Commodity and other	1,079			7,255			2,924			—			11,258
Netting¹	(2,794		)	(235,947		)	(993		)	(47,804		)	(287,538		)
Total derivative and other contracts	784			74,130			4,891			(47,804		)	32,001
Investments⁴	481			252			858			—			1,591
Physical commodities	—			1,907			—			—			1,907
Total trading assets⁴	185,475			143,137			12,781			(47,804		)	293,589
Investment securities—AFS	32,902			29,321			—			—			62,223
Securities purchased under agreements to resell	—			4			—			—			4
Total assets at fair value	$	218,377		$	172,462		$	12,781		$	(47,804	)	$	355,816



September 2020 Form 10-Q	55



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)



	At December 31, 2019
$ in millions	Level 1			Level 2			Level 3			Netting¹			Total
Liabilities at fair value
Deposits	$	—		$	1,920		$	179		$	—		$	2,099
Trading liabilities:
U.S. Treasury and agency securities	11,191			34			—			—			11,225
Other sovereign government obligations	21,837			1,332			1			—			23,170
Corporate and other debt	—			7,410			—			—			7,410
Corporate equities³	63,002			79			36			—			63,117
Derivative and other contracts:
Interest rate	1,144			171,025			462			—			172,631
Credit	—			7,391			530			—			7,921
Foreign exchange	6			67,473			176			—			67,655
Equity	1,200			49,062			2,606			—			52,868
Commodity and other	1,194			7,118			1,312			—			9,624
Netting¹	(2,794		)	(235,947		)	(993		)	(42,531		)	(282,265		)
Total derivative and other contracts	750			66,122			4,093			(42,531		)	28,434
Total trading liabilities	96,780			74,977			4,130			(42,531		)	133,356
Securities sold under agreements to repurchase	—			733			—			—			733
Other secured financings	—			7,700			109			—			7,809
Borrowings	—			60,373			4,088			—			64,461
Total liabilities at fair value	$	96,780		$	145,703		$	8,506		$	(42,531	)	$	208,458

MABS—Mortgage- and asset-backed securities


1.	For positions with the same counterparty that cross over the levels of the fair value hierarchy, both counterparty netting and cash collateral netting are included in the column titled “Netting.” Positions classified within the same level that are with the same counterparty are netted within that level. For further information on derivative instruments and hedging activities, see Note 7.


2.	For a further breakdown by type, see the following Detail of Loans and Lending Commitments at Fair Value table.


3.	For trading purposes, the Firm holds or sells short equity securities issued by entities in diverse industries and of varying sizes.


4.	Amounts exclude certain investments that are measured based on NAV per share, which are not classified in the fair value hierarchy. For additional disclosure about such investments, see “Net Asset Value Measurements” herein.

Detail of Loans and Lending Commitments at Fair Value¹



$ in millions	At September 30, 2020		At December 31, 2019
Corporate	$	14	$	20
Secured lending facilities	445		951
Commercial Real Estate	769		2,098
Residential Real Estate	824		1,192
Securities-based lending and Other loans	6,281		7,065
Total	$	8,333	$	11,326


1.	Loans previously classified as corporate have been further disaggregated; prior period balances have been revised to conform with current period presentation.

Unsettled Fair Value of Futures Contracts¹


1.	These contracts are primarily Level 1, actively traded, valued based on quoted prices from the exchange and are excluded from the previous recurring fair value tables.

For a description of the valuation techniques applied to the Firm’s major categories of assets and liabilities measured at fair value on a recurring basis, see Note 3 to the financial statements in the 2019 Form 10-K. During the current quarter, there were no significant revisions made to the Firm’s valuation techniques.

Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions	2020			2019			2020			2019
U.S. Treasury and agency securities
Beginning balance	$	97		$	5		$	22		$	54
Realized and unrealized gains (losses)	(1		)	—			—			—
Purchases	109			11			133			18
Sales	(36		)	—			(42		)	(54		)
Net transfers	(47		)	2			9			—
Ending balance	$	122		$	18		$	122		$	18
Unrealized gains (losses)	$	(1	)	$	—		$	—		$	—
Other sovereign government obligations
Beginning balance	$	11		$	10		$	5		$	17
Realized and unrealized gains (losses)	(1		)	(3		)	—			(2		)
Purchases	1			2			8			13
Sales	(1		)	(2		)	(3		)	(6		)
Net transfers	—			5			—			(10		)
Ending balance	$	10		$	12		$	10		$	12
Unrealized gains (losses)	$	—		$	(3	)	$	—		$	(2	)
State and municipal securities
Beginning balance	$	—		$	16		$	1		$	148
Sales	—			(2		)	—			(43		)
Net transfers	—			(13		)	(1		)	(104		)
Ending balance	$	—		$	1		$	—		$	1
Unrealized gains (losses)	$	—		$	—		$	—		$	—
MABS
Beginning balance	$	379		$	480		$	438		$	354
Realized and unrealized gains (losses)	13			(10		)	(60		)	(9		)
Purchases	13			5			172			66
Sales	(54		)	(58		)	(162		)	(157		)
Settlements	—			—			—			(39		)
Net transfers	92			(16		)	55			186
Ending balance	$	443		$	401		$	443		$	401
Unrealized gains (losses)	$	8		$	(8	)	$	(35	)	$	(38	)
Loans and lending commitments
Beginning balance	$	4,068		$	5,604		$	5,073		$	6,870
Realized and unrealized gains (losses)	20			(51		)	(161		)	3
Purchases and originations	846			852			1,926			1,934
Sales	(725		)	(464		)	(1,139		)	(1,541		)
Settlements	(285		)	(811		)	(1,907		)	(2,130		)
Net transfers¹	427			(261		)	559			(267		)
Ending balance	$	4,351		$	4,869		$	4,351		$	4,869
Unrealized gains (losses)	$	27		$	(55	)	$	(137	)	$	283



September 2020 Form 10-Q	56



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions	2020			2019			2020			2019
Corporate and other debt
Beginning balance	$	2,686		$	1,364		$	1,396		$	1,076
Realized and unrealized gains (losses)	(107		)	157			(184		)	269
Purchases	451			341			2,217			632
Sales	(325		)	(474		)	(425		)	(587		)
Settlements	—			—			(311		)	(7		)
Net transfers	22			2			34			7
Ending balance	$	2,727		$	1,390		$	2,727		$	1,390
Unrealized gains (losses)	$	(96	)	$	114		$	(186	)	$	217
Corporate equities
Beginning balance	$	83		$	98		$	97		$	95
Realized and unrealized gains (losses)	32			1			—			(41		)
Purchases	32			5			42			44
Sales	(27		)	(16		)	(27		)	(268		)
Net transfers	15			15			23			273
Ending balance	$	135		$	103		$	135		$	103
Unrealized gains (losses)	$	39		$	7		$	14		$	(38	)
Investments
Beginning balance	$	759		$	785		$	858		$	757
Realized and unrealized gains (losses)	55			(15		)	(6		)	19
Purchases	7			7			37			28
Sales	(16		)	(7		)	(37		)	(43		)
Net transfers	16			15			(31		)	24
Ending balance	$	821		$	785		$	821		$	785
Unrealized gains (losses)	$	44		$	(12	)	$	(19	)	$	22
Net derivatives: Interest rate
Beginning balance	$	760		$	816		$	777		$	618
Realized and unrealized gains (losses)	(147		)	(40		)	(95		)	143
Purchases	36			69			153			132
Issuances	(15		)	(11		)	(41		)	(22		)
Settlements	(31		)	2			36			16
Net transfers	33			(48		)	(194		)	(99		)
Ending balance	$	636		$	788		$	636		$	788
Unrealized gains (losses)	$	(139	)	$	120		$	(37	)	$	214
Net derivatives: Credit
Beginning balance	$	131		$	(138	)	$	124		$	40
Realized and unrealized gains (losses)	(16		)	(183		)	11			36
Purchases	17			44			66			103
Issuances	(51		)	(19		)	(101		)	(162		)
Settlements	10			389			61			90
Net transfers	25			12			(45		)	(2		)
Ending balance	$	116		$	105		$	116		$	105
Unrealized gains (losses)	$	(16	)	$	20		$	2		$	41



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions	2020			2019			2020			2019
Net derivatives: Foreign exchange
Beginning balance	$	17		$	(29	)	$	(31	)	$	75
Realized and unrealized gains (losses)	86			67			202			(83		)
Purchases	—			—			3			—
Issuances	(4		)	—			(5		)	—
Settlements	(9		)	5			(27		)	—
Net transfers	9			9			(43		)	60
Ending balance	$	99		$	52		$	99		$	52
Unrealized gains (losses)	$	75		$	79		$	136		$	26
Net derivatives: Equity
Beginning balance	$	(1,884	)	$	(1,715	)	$	(1,684	)	$	(1,485	)
Realized and unrealized gains (losses)	3			(61		)	75			59
Purchases	19			36			192			75
Issuances	(181		)	(207		)	(706		)	(227		)
Settlements	(151		)	(56		)	(167		)	(173		)
Net transfers	49			622			145			370
Ending balance	$	(2,145	)	$	(1,381	)	$	(2,145	)	$	(1,381	)
Unrealized gains (losses)	$	32		$	(86	)	$	(143	)	$	81
Net derivatives: Commodity and other
Beginning balance	$	2,087		$	1,861		$	1,612		$	2,052
Realized and unrealized gains (losses)	(29		)	120			373			35
Purchases	1			126			26			145
Issuances	(40		)	(36		)	(65		)	(71		)
Settlements	(181		)	(107		)	(101		)	(307		)
Net transfers	(34		)	10			(41		)	120
Ending balance	$	1,804		$	1,974		$	1,804		$	1,974
Unrealized gains (losses)	$	(251	)	$	33		$	(6	)	$	(89	)
Deposits
Beginning balance	$	90		$	138		$	179		$	27
Realized and unrealized losses (gains)	4			5			8			16
Issuances	—			23			—			70
Settlements	(2		)	(8		)	(13		)	(12		)
Net transfers	13			(13		)	(69		)	44
Ending balance	$	105		$	145		$	105		$	145
Unrealized losses (gains)	$	4		$	5		$	8		$	16
Nonderivative trading liabilities
Beginning balance	$	74		$	36		$	37		$	16
Realized and unrealized losses (gains)	(6		)	(7		)	(21		)	(37		)
Purchases	(7		)	(13		)	(23		)	(31		)
Sales	5			6			23			36
Settlements	—			—			3			—
Net transfers	(6		)	18			41			56
Ending balance	$	60		$	40		$	60		$	40
Unrealized losses (gains)	$	(4	)	$	(7	)	$	(21	)	$	(37	)



	57	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions	2020			2019			2020			2019
Securities sold under agreements to repurchase
Beginning balance	$	440		$	—		$	—		$	—
Realized and unrealized losses (gains)	8			—			(22		)	—
Issuances	—			—			470			—
Ending balance	$	448		$	—		$	448		$	—
Unrealized losses (gains)	$	8		$	—		$	(22	)	$	—
Other secured financings
Beginning balance	$	300		$	154		$	109		$	208
Realized and unrealized losses (gains)	11			(1		)	(1		)	5
Issuances	3			—			10			—
Settlements	(5		)	—			(208		)	(8		)
Net transfers	—			(43		)	399			(95		)
Ending balance	$	309		$	110		$	309		$	110
Unrealized losses (gains)	$	11		$	(1	)	$	(1	)	$	5
Borrowings
Beginning balance	$	4,135		$	3,939		$	4,088		$	3,806
Realized and unrealized losses (gains)	(32		)	88			(284		)	498
Issuances	194			201			992			610
Settlements	(70		)	(260		)	(346		)	(438		)
Net transfers	(146		)	(430		)	(369		)	(938		)
Ending balance	$	4,081		$	3,538		$	4,081		$	3,538
Unrealized losses (gains)	$	(33	)	$	91		$	(282	)	$	459
Portion of Unrealized losses (gains) recorded in OCI—Change in net DVA	22			(23		)	(124		)	68

Net transfers in the current year period reflect the largely offsetting impacts of transfers in of $857 million of equity margin loans and transfers out of $707 million of equity margin loans. The loans were transferred into Level 3 in the first quarter as the significance of the margin loan rate input increased as a result of reduced liquidity, and transferred out of Level 3 in the second quarter as liquidity conditions improved reducing the significance of the input.

Level 3 instruments may be hedged with instruments classified in Level 1 and Level 2. The realized and unrealized gains or losses for assets and liabilities within the Level 3 category presented in the previous tables do not reflect the related realized and unrealized gains or losses on hedging instruments that have been classified by the Firm within the Level 1 and/or Level 2 categories.

The unrealized gains (losses) during the period for assets and liabilities within the Level 3 category may include changes in fair value during the period that were attributable to both observable and unobservable inputs. Total realized and unrealized gains (losses) are primarily included in Trading revenues in the income statements.

Additionally, in the previous tables, consolidations of VIEs are included in Purchases and deconsolidations of VIEs are included in Settlements.

Significant Unobservable Inputs Used in Recurring and Nonrecurring Level 3 Fair Value Measurements

Valuation Techniques and Unobservable Inputs



	Balance / Range (Average)¹
$ in millions, except inputs	At September 30, 2020			At December 31, 2019
Assets Measured at Fair Value on a Recurring Basis
U.S. Treasury and agency securities	$	122		$	22
Comparable pricing:
Bond price	102 to 108 points (104 points)			N/M
MABS	$	443		$	438
Comparable pricing:
Bond price	0 to 80 points (47 points)			0 to 96 points (47 points)
Loans and lending commitments	$	4,351		$	5,073
Margin loan model:
Discount rate	N/A			1% to 9% (2%)
Volatility skew	N/A			15% to 80% (28%)
Credit Spread	N/A			9 to 39 bps (19 bps)
Margin loan rate	1% to 5% (3%)			N/A
Comparable pricing:
Loan price	70 to 103 points (96 points)			69 to 100 points (93 points)
Corporate and other debt	$	2,727		$	1,396
Comparable pricing:
Bond price	10 to 103 points (94 points)			11 to 108 points (84 points)
Discounted cash flow:
Recovery rate	51% to 62% (53% / 51%)			35		%
Option model:
At the money volatility	21		%	21		%
Corporate equities	$	135		$	97
Comparable pricing:
Equity price	100		%	100		%
Investments	$	821		$	858
Discounted cash flow:
WACC	10% to 21% (15%)			8% to 17% (15%)
Exit multiple	7 to 17 times (11 times)			7 to 16 times (11 times)
Market approach:
EBITDA multiple	8 to 29 times (11 times)			7 to 24 times (11 times)
Comparable pricing:
Equity price	50% to 100% (98%)			75% to 100% (99%)
Net derivative and other contracts:
Interest rate	$	636		$	777
Option model:
IR volatility skew	0% to 162% (62% / 75%)			24% to 156% (63% / 59%)
IR curve correlation	59% to 97% (87% / 92%)			47% to 90% (72% / 72%)
Bond volatility	4% to 32% (13% / 8%)			4% to 15% (13% / 14%)
Inflation volatility	25% to 64% (44% / 42%)			24% to 63% (44% / 41%)
IR curve	1		%	1		%



September 2020 Form 10-Q	58



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)



	Balance / Range (Average)¹
$ in millions, except inputs	At September 30, 2020			At December 31, 2019
Credit	$	116		$	124
Credit default swap model:
Cash-synthetic basis	6 points			6 points
Bond price	0 to 95 points (52 points)			0 to 104 points (45 points)
Credit spread	20 to 435 bps (79 bps)			9 to 469 bps (81 bps)
Funding spread	71 to 138 bps (116 bps)			47 to 117 bps (84 bps)
Correlation model:
Credit correlation	29% to 56% (35%)			29% to 62% (36%)
Foreign exchange²	$	99		$	(31	)
Option model:
IR - FX correlation	13% to 59% (37% / 37%)			32% to 56% (46% / 46%)
IR volatility skew	0% to 162% (62% / 75%)			24% to 156% (63% / 59%)
IR curve	8% to 9% (8% / 8%)			10% to 11% (10% / 10%)
Foreign exchange volatility skew	-7% to -5% (-6% / -6%)			N/A
Contingency probability	95% (95%)			85% to 95% (94% / 95%)
Equity²	$	(2,145	)	$	(1,684	)
Option model:
At the money volatility	16% to 92% (42%)			9% to 90% (36%)
Volatility skew	-2% to 0% (-1%)			-2% to 0% (-1%)
Equity correlation	5% to 96% (70%)			5% to 98% (70%)
FX correlation	-60% to 60% (-17%)			-79% to 60% (-37%)
IR correlation	-7% to 44% (20% / 18%)			-11% to 44% (18% / 16%)
Commodity and other	$	1,804		$	1,612
Option model:
Forward power price	$-1 to $116 ($28) per MWh			$3 to $182 ($28) per MWh
Commodity volatility	8% to 95% (19%)			7% to 183% (18%)
Cross-commodity correlation	43% to 99% (92%)			43% to 99% (93%)
Liabilities Measured at Fair Value on a Recurring Basis
Deposits	$	105		$	179
Option Model:
Equity at the money volatility	7% to 23% (7%)			16% to 37% (20%)
Corporate equities	$	57		$	36
Comparable pricing:
Equity price	100% (100%)			N/M
Securities sold under agreements to repurchase	$	448		$	—
Discounted cash flow:
Funding spread	105 to 130 bps (114 bps)			N/A
Other secured financings	$	309		$	109
Discounted cash flow:
Funding spread	110 bps (110 bps)			111 to 124 bps (117 bps)
Comparable pricing:
Loan price	25 to 101 points (68 points)			N/A



	Balance / Range (Average)¹
$ in millions, except inputs	At September 30, 2020		At December 31, 2019
Borrowings	$	4,081	$	4,088
Option model:
At the money volatility	6% to 70% (23%)		5% to 44% (21%)
Volatility skew	-2% to 0% (0%)		-2% to 0% (0%)
Equity correlation	37% to 98% (81%)		38% to 94% (78%)
Equity - FX correlation	-72% to 13% (-28%)		-75% to 26% (-25%)
IR - FX Correlation	-28% to 6% (-6% / -6%)		-26% to 10% (-7% / -7%)
Nonrecurring Fair Value Measurement
Loans	$	2,088	$	1,500
Corporate loan model:
Credit spread	52 bps to 668 bps (380 bps)		69 to 446 bps (225 bps)
Warehouse model:
Credit spread	191 bps to 580 bps (379 bps)		287 to 318 bps (297 bps)

Points—Percentage of par

IR—Interest rate

FX—Foreign exchange


1.	A single amount is disclosed for range and average when there is no significant difference between the minimum, maximum and average. Amounts represent weighted averages except where simple averages and the median of the inputs are more relevant.


2.	Includes derivative contracts with multiple risks (i.e., hybrid products).

The previous tables provide information on the valuation techniques, significant unobservable inputs, and the ranges and averages for each major category of assets and liabilities measured at fair value on a recurring and nonrecurring basis with a significant Level 3 balance. The level of aggregation and breadth of products cause the range of inputs to be wide and not evenly distributed across the inventory of financial instruments. Further, the range of unobservable inputs may differ across firms in the financial services industry because of diversity in the types of products included in each firm’s inventory. Generally, there are no predictable relationships between multiple significant unobservable inputs attributable to a given valuation technique.

Other than as follows, during the current year period, there were no significant revisions made to the descriptions of the Firm’s significant unobservable inputs. For margin loans, the margin loan rate is the annualized rate that reflects the possibility of losses as a result of movements in the price of the underlying margin loan collateral. The rate is calibrated from the previously disclosed discount rate, credit spread and/or volatility measures. For a description of the Firm’s significant unobservable inputs and qualitative information about the effect of hypothetical changes in the values of those inputs, see Note 3 to the financial statements in the 2019 Form 10-K.



	59	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

Net Asset Value Measurements

Fund Interests



	At September 30, 2020				At December 31, 2019
$ in millions	Carrying Value		Commitment		Carrying Value		Commitment
Private equity	$	2,400	$	614	$	2,078	$	450
Real estate	1,383		140		1,349		150
Hedge¹	62		—		94		4
Total	$	3,845	$	754	$	3,521	$	604


1.	Investments in hedge funds may be subject to initial period lock-up or gate provisions, which restrict an investor from withdrawing from the fund during a certain initial period or restrict the redemption amount on any redemption date, respectively.

Amounts in the previous table represent the Firm’s carrying value of general and limited partnership interests in fund investments, as well as any related performance-based fees in the form of carried interest. The carrying amounts are measured based on the NAV of the fund taking into account the distribution terms applicable to the interest held. This same measurement applies whether the fund investments are accounted for under the equity method or fair value.

For a description of the Firm’s investments in private equity funds, real estate funds and hedge funds, which are measured based on NAV, see Note 3 to the financial statements in the 2019 Form 10-K.

See Note 14 for information regarding general partner guarantees, which include potential obligations to return performance fee distributions previously received. See Note 20 for information regarding unrealized carried interest at risk of reversal.

Nonredeemable Funds by Contractual Maturity



	Carrying Value at September 30, 2020
$ in millions	Private Equity		Real Estate
Less than 5 years	$	1,551	$	415
5-10 years	765		374
Over 10 years	84		594
Total	$	2,400	$	1,383

Nonrecurring Fair Value Measurements

Carrying and Fair Values



	At September 30, 2020
	Fair Value
$ in millions	Level 2		Level 3¹		Total
Assets
Loans	$	4,827	$	2,088	$	6,915
Other assets—Other investments	—		18		18
Total	$	4,827	$	2,106	$	6,933
Liabilities
Other liabilities and accrued expenses—Lending commitments	$	221	$	69	$	290
Total	$	221	$	69	$	290



	At December 31, 2019
	Fair Value
$ in millions	Level 2		Level 3¹		Total
Assets
Loans	$	1,543	$	1,500	$	3,043
Other assets—Other investments	—		113		113
Total	$	1,543	$	1,613	$	3,156
Liabilities
Other liabilities and accrued expenses—Lending commitments	$	132	$	69	$	201
Total	$	132	$	69	$	201


1.	For significant Level 3 balances, refer to “Significant Unobservable Inputs Used in Recurring and Nonrecurring Level 3 Fair Value Measurements” section herein for details of the significant unobservable inputs used for nonrecurring fair value measurement.

Gains (Losses) from Fair Value Remeasurements¹



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions	2020			2019			2020			2019
Assets
Loans²	$	(43	)	$	(27	)	$	(467	)	$	(12	)
Intangibles	(1		)	—			(1		)	—
Other assets—Other investments³	(2		)	(3		)	(54		)	(8		)
Other assets—Premises, equipment and software⁴	(29		)	(4		)	(35		)	(8		)
Total	$	(75	)	$	(34	)	$	(557	)	$	(28	)
Liabilities
Other liabilities and accrued expenses—Lending commitments²	$	25		$	(19	)	$	(54	)	$	82
Total	$	25		$	(19	)	$	(54	)	$	82


1.	Gains and losses for Loans and Other assets—Other investments are classified in Other revenues. For other items, gains and losses are recorded in Other revenues if the item is held for sale; otherwise, they are recorded in Other expenses.

Nonrecurring changes in the fair value of loans and lending commitments were calculated as follows: for the held-for-investment category, based on the value of the underlying collateral; and for the held-for-sale category, based on recently executed transactions, market price quotations, valuation models that incorporate market observable inputs where possible, such as comparable loan or debt prices and CDS spread levels adjusted for any basis difference between cash and derivative instruments, or default recovery analysis where such transactions and quotations are unobservable.


3.	Losses related to Other assets—Other investments were determined using techniques that included discounted cash flow models, methodologies that incorporate multiples of certain comparable companies and recently executed transactions.


4.	Losses related to Other assets—Premises, equipment and software generally include impairments as well as write-offs related to the disposal of certain assets.



September 2020 Form 10-Q	60



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

Financial Instruments Not Measured at Fair Value



	At September 30, 2020
	Carrying Value		Fair Value
$ in millions			Level 1		Level 2		Level 3		Total
Financial assets
Cash and cash equivalents	$	94,772	$	94,772	$	—	$	—	$	94,772
Investment securities—HTM	46,169		30,893		17,200		861		48,954
Securities purchased under agreements to resell	88,268		—		86,756		1,538		88,294
Securities borrowed	100,803		—		100,804		—		100,804
Customer and other receivables¹	68,541		—		65,624		2,903		68,527
Loans²	146,237		—		25,942		121,217		147,159
Other assets	466		—		466		—		466
Financial liabilities
Deposits	$	235,574	$	—	$	235,924	$	—	$	235,924
Securities sold under agreements to repurchase	40,210		—		39,876		375		40,251
Securities loaned	7,924		—		7,921		—		7,921
Other secured financings	3,672		—		3,672		—		3,672
Customer and other payables¹	189,754		—		189,754		—		189,754
Borrowings	134,300		—		138,925		5		138,930
	Commitment Amount
Lending commitments³	$	118,966	$	—	$	965	$	406	$	1,371



	At December 31, 2019
	Carrying Value		Fair Value
$ in millions			Level 1		Level 2		Level 3		Total
Financial assets
Cash and cash equivalents	$	82,171	$	82,171	$	—	$	—	$	82,171
Investment securities—HTM	43,502		30,661		12,683		789		44,133
Securities purchased under agreements to resell	88,220		—		86,794		1,442		88,236
Securities borrowed	106,549		—		106,551		—		106,551
Customer and other receivables¹	51,134		—		48,215		2,872		51,087
Loans²	130,637		—		22,293		108,059		130,352
Other assets	495		—		495		—		495
Financial liabilities
Deposits	$	188,257	$	—	$	188,639	$	—	$	188,639
Securities sold under agreements to repurchase	53,467		—		53,486		—		53,486
Securities loaned	8,506		—		8,506		—		8,506
Other secured financings	6,889		—		6,800		92		6,892
Customer and other payables¹	195,035		—		195,035		—		195,035
Borrowings	128,166		—		133,563		10		133,573
	Commitment Amount
Lending commitments³	$	119,004	$	—	$	748	$	338	$	1,086


1.	Accrued interest and dividend receivables and payables have been excluded. Carrying value approximates fair value for these receivables and payables.


2.	Amounts include loans measured at fair value on a nonrecurring basis.


3.	Represents Lending commitments accounted for as Held for Investment and Held for Sale. For a further discussion on lending commitments, see Note 14.

The previous tables exclude certain financial instruments such as equity method investments and all non-financial assets and liabilities such as the value of the long-term relationships with the Firm’s deposit customers.



	61	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

6. Fair Value Option

The Firm has elected the fair value option for certain eligible instruments that are risk managed on a fair value basis to mitigate income statement volatility caused by measurement basis differences between the elected instruments and their associated risk management transactions or to eliminate complexities of applying certain accounting models.

Borrowings Measured at Fair Value on a Recurring Basis



$ in millions	At September 30, 2020		At December 31, 2019
Business Unit Responsible for Risk Management
Equity	$	31,673	$	30,214
Interest rates	28,986		27,298
Commodities	5,097		4,501
Credit	1,257		1,246
Foreign exchange	2,131		1,202
Total	$	69,144	$	64,461

Net Revenues from Borrowings under the Fair Value Option



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions	2020			2019			2020			2019
Trading revenues	$	(1,455	)	$	(795	)	$	(1,447	)	$	(5,888	)
Interest expense	77			93			241			280
Net revenues¹	$	(1,532	)	$	(888	)	$	(1,688	)	$	(6,168	)


1.	Amounts do not reflect any gains or losses from related economic hedges.

Gains (losses) from changes in fair value are recorded in Trading revenues and are mainly attributable to movements in the reference price or index, interest rates or foreign exchange rates.

Gains (Losses) Due to Changes in Instrument-Specific Credit Risk



	Three Months Ended September 30,
	2020						2019
$ in millions	Trading Revenues			OCI			Trading Revenues			OCI
Loans and other debt¹	$	56		$	—		$	(3	)	$	—
Lending commitments	(3		)	—			—			—
Deposits	—			(19		)	—			1
Borrowings	(8		)	(720		)	(2		)	442



	Nine Months Ended September 30,
	2020						2019
$ in millions	Trading Revenues			OCI			Trading Revenues			OCI
Loans and other debt¹	$	(183	)	$	—		$	148		$	—
Lending commitments	(2		)	—			(2		)	—
Deposits	—			(10		)	—			(2		)
Borrowings	(14		)	991			(9		)	(702		)



$ in millions	At September 30, 2020			At December 31, 2019
Cumulative pre-tax DVA gain (loss) recognized in AOCI	$	(1,017	)	$	(1,998	)


1.	Loans and other debt instrument-specific credit gains (losses) were determined by excluding the non-credit components of gains and losses.

Difference Between Contractual Principal and Fair Value¹



$ in millions	At September 30, 2020			At December 31, 2019
Loans and other debt²	$	13,552		$	13,037
Nonaccrual loans²	11,411			10,849
Borrowings³	(2,103		)	(1,665		)


1.	Amounts indicate contractual principal greater than or (less than) fair value.


2.	The majority of the difference between principal and fair value amounts for loans and other debt relates to distressed debt positions purchased at amounts well below par.


3.	Excludes borrowings where the repayment of the initial principal amount fluctuates based on changes in a reference price or index.

The previous tables exclude non-recourse debt from consolidated VIEs, liabilities related to transfers of financial assets treated as collateralized financings, pledged commodities and other liabilities that have specified assets attributable to them.

Fair Value Loans on Nonaccrual Status



$ in millions	At September 30, 2020		At December 31, 2019
Nonaccrual loans	$	1,119	$	1,100
Nonaccrual loans 90 or more days past due	$	238	$	330



September 2020 Form 10-Q	62



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

7. Derivative Instruments and Hedging Activities

Fair Values of Derivative Contracts

At September 30, 2020



	Assets
$ in millions	Bilateral OTC			Cleared OTC			Exchange- Traded			Total
Designated as accounting hedges
Interest rate	$	1,109		$	4		$	—		$	1,113
Foreign exchange	63			9			—			72
Total	1,172			13			—			1,185
Not designated as accounting hedges
Interest rate	232,894			9,261			530			242,685
Credit	6,889			3,017			—			9,906
Foreign exchange	65,734			1,299			79			67,112
Equity	28,255			—			39,231			67,486
Commodity and other	13,378			—			5,155			18,533
Total	347,150			13,577			44,995			405,722
Total gross derivatives	$	348,322		$	13,590		$	44,995		$	406,907
Amounts offset
Counterparty netting	(263,488		)	(11,426		)	(42,320		)	(317,234		)
Cash collateral netting	(52,608		)	(1,823		)	—			(54,431		)
Total in Trading assets	$	32,226		$	341		$	2,675		$	35,242
Amounts not offset¹
Financial instruments collateral	(14,117		)	—			—			(14,117		)
Other cash collateral	(88		)	—			—			(88		)
Net amounts	$	18,021		$	341		$	2,675		$	21,037
Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable										$	2,848



	Liabilities
$ in millions	Bilateral OTC			Cleared OTC			Exchange- Traded			Total
Designated as accounting hedges
Interest rate	$	—		$	—		$	—		$	—
Foreign exchange	92			40			—			132
Total	92			40			—			132
Not designated as accounting hedges
Interest rate	222,102			7,258			848			230,208
Credit	6,638			3,616			—			10,254
Foreign exchange	63,885			1,405			38			65,328
Equity	38,518			—			41,873			80,391
Commodity and other	9,910			—			5,095			15,005
Total	341,053			12,279			47,854			401,186
Total gross derivatives	$	341,145		$	12,319		$	47,854		$	401,318
Amounts offset
Counterparty netting	(263,488		)	(11,426		)	(42,320		)	(317,234		)
Cash collateral netting	(46,148		)	(772		)	—			(46,920		)
Total in Trading liabilities	$	31,509		$	121		$	5,534		$	37,164
Amounts not offset¹
Financial instruments collateral	(9,085		)	—			(2,240		)	(11,325		)
Other cash collateral	(62		)	(3		)	—			(65		)
Net amounts	$	22,362		$	118		$	3,294		$	25,774
Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable										5,282

At December 31, 2019



	Assets
$ in millions	Bilateral OTC			Cleared OTC			Exchange- Traded			Total
Designated as accounting hedges
Interest rate	$	673		$	—		$	—		$	673
Foreign exchange	41			1			—			42
Total	714			1			—			715
Not designated as accounting hedges
Interest rate	179,450			4,839			519			184,808
Credit	4,895			2,417			—			7,312
Foreign exchange	62,957			1,399			22			64,378
Equity	27,621			—			23,447			51,068
Commodity and other	9,306			—			1,952			11,258
Total	284,229			8,655			25,940			318,824
Total gross derivatives	$	284,943		$	8,656		$	25,940		$	319,539
Amounts offset
Counterparty netting	(213,710		)	(7,294		)	(24,037		)	(245,041		)
Cash collateral netting	(41,222		)	(1,275		)	—			(42,497		)
Total in Trading assets	$	30,011		$	87		$	1,903		$	32,001
Amounts not offset¹
Financial instruments collateral	(15,596		)	—			—			(15,596		)
Other cash collateral	(46		)	—			—			(46		)
Net amounts	$	14,369		$	87		$	1,903		$	16,359
Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable										$	1,900



	Liabilities
$ in millions	Bilateral OTC			Cleared OTC			Exchange- Traded			Total
Designated as accounting hedges
Interest rate	$	1		$	—		$	—		$	1
Foreign exchange	121			38			—			159
Total	122			38			—			160
Not designated as accounting hedges
Interest rate	168,597			3,597			436			172,630
Credit	4,798			3,123			—			7,921
Foreign exchange	65,965			1,492			39			67,496
Equity	30,135			—			22,733			52,868
Commodity and other	7,713			—			1,911			9,624
Total	277,208			8,212			25,119			310,539
Total gross derivatives	$	277,330		$	8,250		$	25,119		$	310,699
Amounts offset
Counterparty netting	(213,710		)	(7,294		)	(24,037		)	(245,041		)
Cash collateral netting	(36,392		)	(832		)	—			(37,224		)
Total in Trading liabilities	$	27,228		$	124		$	1,082		$	28,434
Amounts not offset¹
Financial instruments collateral	(7,747		)	—			(287		)	(8,034		)
Other cash collateral	(14		)	—			—			(14		)
Net amounts	$	19,467		$	124		$	795		$	20,386
Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable										$	3,680


1.	Amounts relate to master netting agreements and collateral agreements that have been determined by the Firm to be legally enforceable in the event of default but where certain other criteria are not met in accordance with applicable offsetting accounting guidance.



	63	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

See Note 5 for information related to the unsettled fair value of futures contracts not designated as accounting hedges, which are excluded from the previous tables.

Notionals of Derivative Contracts

At September 30, 2020



	Assets
$ in billions	Bilateral OTC		Cleared OTC		Exchange- Traded		Total
Designated as accounting hedges
Interest rate	$	6	$	120	$	—	$	126
Foreign exchange	6		1		—		7
Total	12		121		—		133
Not designated as accounting hedges
Interest rate	4,234		6,726		409		11,369
Credit	136		124		—		260
Foreign exchange	2,941		102		10		3,053
Equity	466		—		416		882
Commodity and other	118		—		79		197
Total	7,895		6,952		914		15,761
Total gross derivatives	$	7,907	$	7,073	$	914	$	15,894



	Liabilities
$ in billions	Bilateral OTC		Cleared OTC		Exchange- Traded		Total
Designated as accounting hedges
Interest rate	$	—	$	64	$	—	$	64
Foreign exchange	6		2		—		8
Total	6		66		—		72
Not designated as accounting hedges
Interest rate	4,108		6,596		668		11,372
Credit	143		128		—		271
Foreign exchange	2,943		100		8		3,051
Equity	473		—		579		1,052
Commodity and other	91		—		76		167
Total	7,758		6,824		1,331		15,913
Total gross derivatives	$	7,764	$	6,890	$	1,331	$	15,985

At December 31, 2019



	Assets
$ in billions	Bilateral OTC		Cleared OTC		Exchange- Traded		Total
Designated as accounting hedges
Interest rate	$	14	$	94	$	—	$	108
Foreign exchange	2		—		—		2
Total	16		94		—		110
Not designated as accounting hedges
Interest rate	4,230		7,398		732		12,360
Credit	136		79		—		215
Foreign exchange	2,667		91		10		2,768
Equity	429		—		419		848
Commodity and other	99		—		61		160
Total	7,561		7,568		1,222		16,351
Total gross derivatives	$	7,577	$	7,662	$	1,222	$	16,461



	Liabilities
$ in billions	Bilateral OTC		Cleared OTC		Exchange- Traded		Total
Designated as accounting hedges
Interest rate	$	—	$	71	$	—	$	71
Foreign exchange	9		2		—		11
Total	9		73		—		82
Not designated as accounting hedges
Interest rate	4,185		6,866		666		11,717
Credit	153		84		—		237
Foreign exchange	2,841		91		14		2,946
Equity	455		—		515		970
Commodity and other	85		—		61		146
Total	7,719		7,041		1,256		16,016
Total gross derivatives	$	7,728	$	7,114	$	1,256	$	16,098

The Firm believes that the notional amounts of derivative contracts generally overstate its exposure. In most circumstances, notional amounts are used only as a reference point from which to calculate amounts owed between the parties to the contract. Furthermore, notional amounts do not reflect the benefit of legally enforceable netting arrangements or risk mitigating transactions.

For a discussion of the Firm's derivative instruments and hedging activities, see Note 5 to the financial statements in the 2019 Form 10-K.



September 2020 Form 10-Q	64



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

Gains (Losses) on Accounting Hedges



	Three Months Ended						Nine Months Ended
	September 30,						September 30,
$ in millions	2020			2019			2020			2019
Fair value hedges—Recognized in Interest income
Interest rate contracts	$	12		$	(7	)	$	(68	)	$	(26	)
Investment Securities—AFS	(11		)	8			78			27
Fair value hedges—Recognized in Interest expense
Interest rate contracts	$	(1,004	)	$	1,999		$	5,908		$	6,046
Deposits¹	62			—			(153		)	—
Borrowings	915			(1,996		)	(5,844		)	(6,111		)
Net investment hedges—Foreign exchange contracts
Recognized in OCI	$	(260	)	$	251		$	54		$	201
Forward points excluded from hedge effectiveness testing—Recognized in Interest income	(6		)	30			19			107

Fair Value Hedges—Hedged Items



$ in millions	At September 30, 2020			At December 31, 2019
Investment Securities—AFS
Amortized cost basis currently or previously hedged	$	2,146		$	917
Basis adjustments included in amortized cost²	$	74		$	14
Deposits¹
Carrying amountcurrently or previously hedged	$	18,241		$	5,435
Basis adjustments included in carrying amount²	$	146		$	(7	)
Borrowings
Carrying amount currently or previously hedged	$	107,653		$	102,456
Basis adjustments included in carrying amount—Outstanding hedges	$	7,697		$	2,593
Basis adjustments included in carrying amount—Terminated hedges	$	(762	)	$	—


1.	The Firm began designating interest rate swaps as fair value hedges of certain Deposits in the fourth quarter of 2019.


2.	Hedge accounting basis adjustments are primarily related to outstanding hedges.

Net Derivative Liabilities and Collateral Posted



$ in millions	At September 30, 2020		At December 31, 2019
Net derivative liabilities with credit risk-related contingent features	$	27,659	$	21,620
Collateral posted	23,426		17,392

The previous table presents the aggregate fair value of certain derivative contracts that contain credit risk-related contingent features that are in a net liability position for which the Firm has posted collateral in the normal course of business.

Incremental Collateral and Termination Payments upon Potential Future Ratings Downgrade



$ in millions	At September 30, 2020
One-notch downgrade	$	246
Two-notch downgrade	315
Bilateral downgrade agreements included in the amounts above¹	$	487


1.	Amount represents arrangements between the Firm and other parties where upon the downgrade of one party, the downgraded party must deliver collateral to the other party. These bilateral downgrade arrangements are used by the Firm to manage the risk of counterparty downgrades.

The additional collateral or termination payments that may be called in the event of a future credit rating downgrade vary by contract and can be based on ratings by either or both of Moody’s Investors Service, Inc. (“Moody’s”) and S&P Global Ratings. The previous table shows the future potential collateral amounts and termination payments that could be called or required by counterparties or exchange and clearing organizations in the event of one-notch or two-notch downgrade scenarios based on the relevant contractual downgrade triggers.

Maximum Potential Payout/Notional of Credit Protection Sold¹



	Years to Maturity at September 30, 2020
$ in billions	< 1		1-3		3-5		Over 5		Total
Single-name CDS
Investment grade	$	10	$	16	$	31	$	13	$	70
Non-investment grade	6		10		15		4		35
Total	$	16	$	26	$	46	$	17	$	105
Index and basket CDS
Investment grade	$	3	$	11	$	44	$	35	$	93
Non-investment grade	6		6		25		20		57
Total	$	9	$	17	$	69	$	55	$	150
Total CDS sold	$	25	$	43	$	115	$	72	$	255
Other credit contracts	—		—		—		—		—
Total credit protection sold	$	25	$	43	$	115	$	72	$	255
CDS protection sold with identical protection purchased									$	222



	Years to Maturity at December 31, 2019
$ in billions	< 1		1-3		3-5		Over 5		Total
Single-name CDS
Investment grade	$	16	$	17	$	33	$	9	$	75
Non-investment grade	9		9		16		1		35
Total	$	25	$	26	$	49	$	10	$	110
Index and basket CDS
Investment grade	$	4	$	7	$	46	$	11	$	68
Non-investment grade	7		4		17		10		38
Total	$	11	$	11	$	63	$	21	$	106
Total CDS sold	$	36	$	37	$	112	$	31	$	216
Other credit contracts	—		—		—		—		—
Total credit protection sold	$	36	$	37	$	112	$	31	$	216
CDS protection sold with identical protection purchased									$	187



	65	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

Fair Value Asset (Liability) of Credit Protection Sold¹



$ in millions	At September 30, 2020			At December 31, 2019
Single-name CDS
Investment grade	$	764		$	1,057
Non-investment grade	(969		)	(540		)
Total	$	(205	)	$	517
Index and basket CDS
Investment grade	$	994		$	1,052
Non-investment grade	(2,546		)	134
Total	$	(1,552	)	$	1,186
Total CDS sold	$	(1,757	)	$	1,703
Other credit contracts	(4		)	(17		)
Total credit protection sold	$	(1,761	)	$	1,686

Investment grade/non-investment grade determination is based on the internal credit rating of the reference obligation. Internal credit ratings serve as the Credit Risk Management Department’s assessment of credit risk and the basis for a comprehensive credit limits framework used to control credit risk. The Firm uses quantitative models and judgment to estimate the various risk parameters related to each obligor.

Protection Purchased with CDS



	Notional
$ in billions	At September 30, 2020		At December 31, 2019
Single name	$	115	$	118
Index and basket	143		103
Tranched index and basket	18		15
Total	$	276	$	236



	Fair Value Asset (Liability)
$ in millions	At September 30, 2020		At December 31, 2019
Single name	$	72	$	(723	)
Index and basket	1,276		(1,139		)
Tranched index and basket	61		(450		)
Total	$	1,409	$	(2,312	)

The Firm enters into credit derivatives, principally CDS, under which it receives or provides protection against the risk of default on a set of debt obligations issued by a specified reference entity or entities. A majority of the Firm’s counterparties for these derivatives are banks, broker-dealers, and insurance and other financial institutions.

The fair value amounts as shown in the previous tables are prior to cash collateral or counterparty netting. For further information on credit derivatives and other contracts, see Note 5 to the financial statements in the 2019 Form 10-K.

8. Investment Securities

AFS and HTM Securities



	At September 30, 2020
$ in millions	Amortized Cost¹		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
AFS securities
U.S. government and agency securities:
U.S. Treasury securities	$	45,796	$	1,150	$	—	$	46,946
U.S. agency securities²	26,887		769		6		27,650
Total U.S. government and agency securities	72,683		1,919		6		74,596
Corporate and other debt:
Agency CMBS	4,653		355		1		5,007
Corporate bonds	1,756		43		1		1,798
State and municipal securities	1,682		60		18		1,724
FFELP student loan ABS³	1,455		—		44		1,411
Total corporate and other debt	9,546		458		64		9,940
Total AFS securities	82,229		2,377		70		84,536
HTM securities
U.S. government and agency securities:
U.S. Treasury securities	28,754		2,138		—		30,892
U.S. agency securities²	16,598		610		7		17,201
Total U.S. government and agency securities	45,352		2,748		7		48,093
Corporate and other debt:
Non-agency CMBS	817		45		1		861
Total HTM securities	46,169		2,793		8		48,954
Total investment securities	$	128,398	$	5,170	$	78	$	133,490



September 2020 Form 10-Q	66



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)



	At December 31, 2019
$ in millions	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
AFS securities
U.S. government and agency securities:
U.S. Treasury securities	$	32,465	$	224	$	111	$	32,578
U.S. agency securities²	20,725		249		100		20,874
Total U.S. government and agency securities	53,190		473		211		53,452
Corporate and other debt:
Agency CMBS	4,810		55		57		4,808
Corporate bonds	1,891		17		1		1,907
State and municipal securities	481		22		—		503
FFELP student loan ABS³	1,580		1		28		1,553
Total corporate and other debt	8,762		95		86		8,771
Total AFS securities	61,952		568		297		62,223
HTM securities
U.S. government and agency securities:
U.S. Treasury securities	30,145		568		52		30,661
U.S. agency securities²	12,589		151		57		12,683
Total U.S. government and agency securities	42,734		719		109		43,344
Corporate and other debt:
Non-agency CMBS	768		22		1		789
Total HTM securities	43,502		741		110		44,133
Total investment securities	$	105,454	$	1,309	$	407	$	106,356


1.	Amounts are net of any ACL.


2.	U.S. agency securities consist mainly of agency-issued debt, agency mortgage pass-through pool securities and CMOs.


3.	Underlying loans are backed by a guarantee, ultimately from the U.S. Department of Education, of at least 95% of the principal balance and interest outstanding.

In the first quarter of 2020, the Firm transferred certain municipal securities from Trading assets into AFS securities as a result of a change in intent due to the severe deterioration in liquidity for these instruments. These securities had a fair value of $441 million at the end of the first quarter of 2020.

Investment Securities in an Unrealized Loss Position



	At September 30, 2020				At December 31, 2019
$ in millions	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
U.S. government and agency securities:
U.S. Treasury securities
Less than12 months	$	—	$	—	$	4,793	$	28
12 months or longer	—		—		7,904		83
Total	—		—		12,697		111
U.S. agency securities
Less than12 months	1,198		3		2,641		20
12 months or longer	1,294		3		7,697		80
Total	2,492		6		10,338		100
Total U.S. government and agency securities:
Less than12 months	1,198		3		7,434		48
12 months or longer	1,294		3		15,601		163
Total	2,492		6		23,035		211
Corporate and other debt:
Agency CMBS
Less than12 months	17		—		2,294		26
12 months or longer	189		1		681		31
Total	206		1		2,975		57
Corporate bonds
Less than12 months	127		—		194		1
12 months or longer	21		1		44		—
Total	148		1		238		1
State and municipal securities
Less than12 months	606		18		—		—
Total	606		18		—		—
FFELP student loan ABS
Less than12 months	322		1		91		—
12 months or longer	1,089		43		1,165		28
Total	1,411		44		1,256		28
Total Corporate and other debt:
Less than12 months	1,072		19		2,579		27
12 months or longer	1,299		45		1,890		59
Total	2,371		64		4,469		86
Total AFS securities in an unrealized loss position
Less than12 months	2,270		22		10,013		75
12 months or longer	2,593		48		17,491		222
Total	$	4,863	$	70	$	27,504	$	297

For AFS securities, the Firm believes there are no securities in an unrealized loss position that have credit losses after performing the analysis described in Note 2. Additionally, the Firm does not intend to sell the securities and is not likely to be required to sell the securities prior to recovery of the amortized cost basis. Furthermore, the securities have not experienced credit losses as they are predominantly investment grade and the Firm expects to recover the amortized cost basis.

As of September 30, 2020, the HTM securities net carrying amount reflects an ACL of $24 million related to Non-agency CMBS. See Note 2 for a description of the ACL methodology



	67	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

used beginning in 2020 following the Firm’s adoption of CECL and see Note 2 to the financial statements in the 2019 Form 10-K for prior period credit loss considerations. There were no HTM securities in an unrealized loss position as of December 31, 2019 that were other-than-temporarily impaired. As of September 30, 2020, and December 31, 2019, Non-Agency CMBS HTM securities were predominantly on accrual status and investment grade.

See Note 15 for additional information on securities issued by VIEs, including U.S. agency mortgage-backed securities, non-agency CMBS and FFELP student loan ABS.

Investment Securities by Contractual Maturity



	At September 30, 2020
$ in millions	Amortized Cost¹		Fair Value		Annualized Average Yield
AFS securities
U.S. government and agency securities:
U.S. Treasury securities:
Due within 1 year	$	15,671	$	15,741	0.9	%
After 1 year through 5 years	27,523		28,399		1.5	%
After 5 years through 10 years	2,602		2,806		1.7	%
Total	45,796		46,946
U.S. agency securities:
Due within 1 year	215		215		0.8	%
After 1 year through 5 years	70		71		1.6	%
After 5 years through 10 years	1,235		1,274		1.8	%
After 10 years	25,367		26,090		1.9	%
Total	26,887		27,650
Total U.S. government and agency securities	72,683		74,596		1.5	%
Corporate and other debt:
Agency CMBS:
Due within 1 year	44		45		2.5	%
After 1 year through 5 years	535		547		1.8	%
After 5 years through 10 years	3,399		3,728		2.5	%
After 10 years	675		687		1.8	%
Total	4,653		5,007
Corporate bonds:
Due within 1 year	210		213		2.5	%
After 1 year through 5 years	1,269		1,301		2.6	%
After 5 years through 10 years	266		273		2.7	%
After 10 years	11		11		1.7	%
Total	1,756		1,798
State and municipal securities:
Due within 1 year	3		3		1.8	%
After 1 year through 5 years	16		16		2.2	%
After 5 years through 10 years	103		109		2.6	%
After 10 Years	1,560		1,596		2.7	%
Total	1,682		1,724



	At September 30, 2020
$ in millions	Amortized Cost¹		Fair Value		Annualized Average Yield
FFELP student loan ABS:
After 1 year through 5 years	93		88		0.8	%
After 5 years through 10 years	257		241		0.8	%
After 10 years	1,105		1,082		1.2	%
Total	1,455		1,411
Total corporate and other debt	9,546		9,940		2.3	%
Total AFS securities	82,229		84,536		1.6	%

HTM securities
U.S. government and agency securities:
U.S. Treasury securities:
Due within 1 year	$	3,065	$	3,095	2.6	%
After 1 year through 5 years	16,991		17,880		2.0	%
After 5 years through 10 years	7,616		8,572		2.2	%
After 10 years	1,082		1,345		2.5	%
Total	28,754		30,892
U.S. agency securities:
After 5 years through 10 years	279		288		1.9	%
After 10 years	16,319		16,913		2.0	%
Total	16,598		17,201
Total U.S. government and agency securities	45,352		48,093		2.2	%
Corporate and other debt:
Non-agency CMBS:
Due within 1 year	110		109		4.6	%
After 1 year through 5 years	77		78		3.7	%
After 5 years through 10 years	576		616		3.8	%
After 10 years	54		58		3.8	%
Total corporate and other debt	817		861		3.9	%
Total HTM securities	46,169		48,954		2.2	%
Total investment securities	$	128,398	$	133,490	1.8	%


1.	Amounts are net of any ACL.

Gross Realized Gains (Losses) on Sales of AFS Securities



	Three Months Ended September 30,					Nine Months Ended September 30,
$ in millions	2020		2019			2020			2019
Gross realized gains	$	55	$	27		$	120		$	99
Gross realized (losses)	—		(1		)	(14		)	(10		)
Total¹	$	55	$	26		$	106		$	89


1.	Realized gains and losses are recognized in Other revenues in the income statements.



September 2020 Form 10-Q	68



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

9. Collateralized Transactions

Offsetting of Certain Collateralized Transactions



	At September 30, 2020
$ in millions	Gross Amounts		Amounts Offset			Net Amounts Presented		Amounts Not Offset¹			Net Amounts
Assets
Securities purchased under agreements to resell	$	199,725	$	(111,442	)	$	88,283	$	(86,057	)	$	2,226
Securities borrowed	104,642		(3,839		)	100,803		(97,169		)	3,634
Liabilities
Securities sold under agreements to repurchase	$	152,760	$	(111,384	)	$	41,376	$	(35,742	)	$	5,634
Securities loaned	11,821		(3,897		)	7,924		(7,725		)	199
Net amounts for which master netting agreements are not in place or may not be legally enforceable
Securities purchased under agreements to resell											$	2,117
Securities borrowed											601
Securities sold under agreements to repurchase											4,698
Securities loaned											149



	At December 31, 2019
$ in millions	Gross Amounts		Amounts Offset			Net Amounts Presented		Amounts Not Offset¹			Net Amounts
Assets
Securities purchased under agreements to resell	$	247,545	$	(159,321	)	$	88,224	$	(85,200	)	$	3,024
Securities borrowed	109,528		(2,979		)	106,549		(101,850		)	4,699
Liabilities
Securities sold under agreements to repurchase	$	213,519	$	(159,319	)	$	54,200	$	(44,549	)	$	9,651
Securities loaned	11,487		(2,981		)	8,506		(8,324		)	182
Net amounts for which master netting agreements are not in place or may not be legally enforceable
Securities purchased under agreements to resell											$	2,255
Securities borrowed											1,181
Securities sold under agreements to repurchase											8,033
Securities loaned											101


1.	Amounts relate to master netting agreements that have been determined by the Firm to be legally enforceable in the event of default but where certain other criteria are not met in accordance with applicable offsetting accounting guidance.

For further discussion of the Firm’s collateralized transactions, see Note 7 to the financial statements in the 2019 Form 10-K. For information related to offsetting of derivatives, see Note 7.

Gross Secured Financing Balances by Remaining Contractual Maturity



	At September 30, 2020
$ in millions	Overnight and Open		Less than 30 Days		30-90 Days		Over 90 Days		Total
Securities sold under agreements to repurchase	$	69,210	$	37,965	$	13,144	$	32,441	$	152,760
Securities loaned	5,752		278		1,169		4,622		11,821
Total included in the offsetting disclosure	$	74,962	$	38,243	$	14,313	$	37,063	$	164,581
Trading liabilities— Obligation to return securities received as collateral	21,753		—		—		—		21,753
Total	$	96,715	$	38,243	$	14,313	$	37,063	$	186,334



	At December 31, 2019
$ in millions	Overnight and Open		Less than 30 Days		30-90 Days		Over 90 Days		Total
Securities sold under agreements to repurchase	$	67,158	$	81,300	$	26,904	$	38,157	$	213,519
Securities loaned	2,378		3,286		516		5,307		11,487
Total included in the offsetting disclosure	$	69,536	$	84,586	$	27,420	$	43,464	$	225,006
Trading liabilities— Obligation to return securities received as collateral	23,877		—		—		—		23,877
Total	$	93,413	$	84,586	$	27,420	$	43,464	$	248,883

Gross Secured Financing Balances by Class of Collateral Pledged



$ in millions	At September 30, 2020		At December 31, 2019
Securities sold under agreements to repurchase
U.S. Treasury and agency securities	$	55,759	$	68,895
State and municipal securities	864		905
Other sovereign government obligations	70,281		109,414
ABS	1,945		2,218
Corporate and other debt	4,923		6,066
Corporate equities	18,256		25,563
Other	732		458
Total	$	152,760	$	213,519
Securities loaned
Other sovereign government obligations	$	4,254	$	3,026
Corporate equities	7,034		8,422
Other	533		39
Total	$	11,821	$	11,487
Total included in the offsetting disclosure	$	164,581	$	225,006
Trading liabilities—Obligation to return securities received as collateral
Corporate equities	$	21,724	$	23,873
Other	29		4
Total	$	21,753	$	23,877
Total	$	186,334	$	248,883



	69	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

Carrying Value of Assets Loaned or Pledged without Counterparty Right to Sell or Repledge



$ in millions	At September 30, 2020		At December 31, 2019
Trading assets	$	34,952	$	41,201
Loans, before ACL	—		750
Total	$	34,952	$	41,951

The Firm pledges certain of its trading assets and loans to collateralize securities sold under agreements to repurchase, securities loaned, other secured financings and derivatives and to cover customer short sales. Counterparties may or may not have the right to sell or repledge the collateral.

Pledged financial instruments that can be sold or repledged by the secured party are identified as Trading assets (pledged to various parties) in the balance sheets.

Fair Value of Collateral Received with Right to Sell or Repledge



$ in millions	At September 30, 2020		At December 31, 2019
Collateral received with right to sell or repledge	$	609,445	$	679,280
Collateral that was sold or repledged¹	455,883		539,412


1.	Does not include securities used to meet federal regulations for the Firm’s U.S. broker-dealers.

Securities Segregated for Regulatory Purposes


1.	Securities segregated under federal regulations for the Firm’s U.S. broker-dealers are sourced from Securities purchased under agreements to resell and Trading assets in the balance sheets.

The Firm receives collateral in the form of securities in connection with securities purchased under agreements to resell, securities borrowed, securities-for-securities transactions, derivative transactions, customer margin loans and securities-based lending. In many cases, the Firm is permitted to sell or repledge this collateral to secure securities sold under agreements to repurchase, to enter into securities lending and derivative transactions or for delivery to counterparties to cover short positions.

Customer Margin Lending

The Firm provides margin lending arrangements which allow customers to borrow against the value of qualifying securities. Receivables under margin lending arrangements are included within Customer and other receivables in the balance sheets.

Under these agreements and transactions, the Firm receives collateral, which includes U.S. government and agency securities, other sovereign government obligations, corporate and other debt, and corporate equities. Customer receivables generated from margin lending activities are collateralized by customer-owned securities held by the Firm. The Firm monitors required margin levels and established credit terms daily and, pursuant to such guidelines, requires customers to deposit additional collateral, or reduce positions, when necessary.

For a further discussion of the Firm’s margin lending activities, see Note 7 to the financial statements in the 2019 Form 10-K.

Other Secured Financings

The Firm has additional secured liabilities. For a further discussion of other secured financings, see Note 13.

10. Loans, Lending Commitments and Related Allowance for Credit Losses

As of September 30, 2020, the Firm’s loan portfolio consists of the following types of loans:


•	Corporate. Corporate includes revolving lines of credit, term loans and bridge loans made to corporate entities for a variety of purposes.


•	Secured lending facilities. Secured lending facilities include loans provided to clients, which are collateralized by various assets including residential and commercial real estate mortgage loans, corporate loans, and other assets.


•	Residential Real Estate. Residential real estate loans mainly include non-conforming loans and HELOC.


•	Commercial Real Estate. Commercial real estate loans include owner-occupied loans and income-producing loans.

•

Securities-based lending and Other. Securities-based lending includes loans which allow clients to borrow money against the value of qualifying securities for any suitable purpose other than purchasing, trading, or carrying securities or refinancing margin debt. The majority of these loans are structured as revolving lines of credit. Other primarily includes certain loans originated in the tailored lending business within the Wealth Management business segment.



September 2020 Form 10-Q	70



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

Loans by Type¹



	At September 30, 2020
$ in millions	Loans Held for Investment			Loans Held for Sale		Total Loans
Corporate	$	7,628		$	8,552	$	16,180
Secured lending facilities	26,496			3,521		30,017
Commercial real estate	7,265			891		8,156
Residential real estate	33,674			49		33,723
Securities-based lending and Other loans	59,006			68		59,074
Total loans	134,069			13,081		147,150
ACL	(913		)			(913		)
Total loans, net	$	133,156		$	13,081	$	146,237
Fixed rate loans, net						$	31,342
Floating or adjustable rate loans, net						114,895
Loans to non-U.S. borrowers, net						23,591



	At December 31, 2019
$ in millions	Loans Held for Investment			Loans Held for Sale		Total Loans
Corporate	$	5,426		$	6,192	$	11,618
Secured lending facilities	24,502			4,200		28,702
Commercial real estate	7,859			2,049		9,908
Residential real estate	30,184			13		30,197
Securities-based lending and Other loans	50,438			123		50,561
Total loans	118,409			12,577		130,986
ACL	(349		)			(349		)
Total loans, net	$	118,060		$	12,577	$	130,637
Fixed rate loans, net						$	22,716
Floating or adjustable rate loans, net						107,921
Loans to non-U.S. borrowers, net						21,617


1.	Loans previously classified as corporate have been further disaggregated; prior period balances have been revised to conform with current period presentation.

Loans Held for Investment before Allowance by Origination Year



	At September 30, 2020
	Corporate
$ in millions	Investment Grade		Non-Investment Grade		Total
Revolving Loans	$	1,556	$	4,264	$	5,820
2020	582		176		758
2019	279		159		438
2018	195		—		195
2017	—		64		64
2016	114		—		114
Prior	127		112		239
Total	$	2,853	$	4,775	$	7,628



	At September 30, 2020
	Secured lending facilities
$ in millions	Investment Grade		Non-Investment Grade		Total
Revolving Loans	$	4,457	$	14,832	$	19,289
2020	206		378		584
2019	297		2,000		2,297
2018	1,063		1,449		2,512
2017	245		570		815
2016	—		620		620
Prior	—		379		379
Total	$	6,268	$	20,228	$	26,496



	At September 30, 2020
	Commercial real estate
$ in millions	Investment Grade		Non-Investment Grade		Total
2020	$	17	$	744	761
2019	637		2,318		2,955
2018	601		1,053		1,654
2017	188		629		817
2016	235		451		686
Prior	—		392		392
Total	$	1,678	$	5,587	$	7,265



	At September 30, 2020
	Residential real estate
	by FICO Scores						by LTV Ratio				Total
$ in millions	≥ 740		680-739		≤ 679		≤ 80%		> 80%		Total
Revolving Loans	$	89	$	34	$	5	$	128	$	—	$	128
2020	6,438		1,337		138		7,487		426		7,913
2019	5,791		1,306		175		6,812		460		7,272
2018	2,442		685		83		2,952		258		3,210
2017	2,875		732		93		3,436		264		3,700
2016	3,524		953		134		4,305		306		4,611
Prior	4,814		1,716		310		6,094		746		6,840
Total	$	25,973	$	6,763	$	938	$	31,214	$	2,460	$	33,674



	At September 30, 2020
	Securities-based lending¹		Other²
$ in millions			Investment Grade		Non-Investment Grade		Total
Revolving Loans	$	47,251	$	4,238	$	684	$	52,173
2020	—		860		431		1,291
2019	18		1,106		674		1,798
2018	232		334		456		1,022
2017	—		663		116		779
2016	—		579		113		692
Prior	16		1,068		167		1,251
Total	$	47,517	$	8,848	$	2,641	$	59,006

1. Securities-based loans are subject to collateral maintenance provisions, and at September 30, 2020, these loans are predominantly over-collateralized. For more information on the ACL methodology related to securities-based loans, see Note 2.

2. Other loans primarily include certain loans originated in the tailored lending business within the Wealth Management business segment.



	71	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

Past Due Status of Loans Held for Investment before Allowance



	At September 30, 2020
$ in millions	Current		Past Due¹		Total
Corporate	$	7,628	$	—	$	7,628
Secured lending facilities	26,496		—		26,496
Commercial real estate	7,264		1		7,265
Residential real estate	33,476		198		33,674
Securities-based lending and Other loans	58,881		125		59,006
Total	$	133,745	$	324	$	134,069


1.	The majority of the amounts are past due for a period of 90 days or more.

Nonaccrual Loans Held for Investment before Allowance



$ in millions	At September 30, 2020		At December 31, 2019
Corporate	$	184	$	299
Commercial real estate	185		85
Residential real estate	92		94
Securities-based lending and Other loans	133		5
Total¹	$	594	$	483
Nonaccrual loans without an ACL	$	91	$	120


1.	Includes all HFI loans that are 90 days or more past due.

See Note 2 for a description of the ACL calculated under the CECL methodology, including credit quality indicators, used for HFI loans beginning in 2020.

Troubled Debt Restructurings

Troubled debt restructurings typically include modifications of interest rates, collateral requirements, other loan covenants and payment extensions. See Note 2 for further information on TDR guidance issued by Congress in the CARES Act as well as by the U.S. banking agencies.

For a discussion of the Firm’s ACL methodology under the prior incurred loss model, including credit quality indicators, used for HFI loans as of December 31, 2019, and a further discussion of the Firm’s loans, see Notes 2 and 8 in the 2019 Form 10-K.

Allowance for Credit Losses Rollforward—Loans



$ in millions	Corporate			Secured lending facilities			CRE			Residential real estate		SBL and Other			Total
December 31, 2019	$	115		$	101		$	75		$	25	$	33		$	349
Effect of CECL adoption	(2		)	(42		)	34			21		(2		)	9
Gross charge-offs	(33		)	—			(26		)	—		—			(59		)
Recoveries	3			—			—			—		2			5
Net (charge-offs) recoveries	(30		)	—			(26		)	—		2			(54		)
Provision (release)¹	281			131			173			12		4			601
Other	3			1			(34		)	—		38			8
September 30, 2020	$	367		$	191		$	222		$	58	$	75		$	913



$ in millions	Corporate			Secured lending facilities			CRE			Residential real estate			SBL and Other		Total
December 31, 2018	$	62		$	60		$	67		$	20		$	29	$	238
Gross charge-offs	—			—			—			(1		)	—		(1		)
Provision (release)¹	40			28			(6		)	5			1		68
Other	(6		)	(1		)	(1		)	—			—		(8		)
September 30, 2019	$	96		$	87		$	60		$	24		$	30	$	297


1.	The provision for loan losses was $63 million in the current quarter and $34 million in the prior year quarter.

Allowance for Credit Losses Rollforward—Lending Commitments



$ in millions	Corporate			Secured lending facilities			CRE			Residential real estate			SBL and Other			Total
December 31, 2019	$	201		$	27		$	7		$	—		$	6		$	241
Effect of CECL adoption	(41		)	(11		)	1			2			(1		)	(50		)
Provision (release)¹	119			24			7			(1		)	7			156
Other	—			—			(4		)	—			4			—
September 30, 2020	$	279		$	40		$	11		$	1		$	16		$	347



$ in millions	Corporate			Secured lending facilities		CRE		Residential real estate		SBL and Other			Total
December 31, 2018	$	178		$	16	$	3	$	—	$	6		$	203
Provision (release)¹	27			7		2		—		—			36
Other	(4		)	—		—		—		(1		)	(5		)
September 30, 2019	$	201		$	23	$	5	$	—	$	5		$	234

CRE—Commercial real estate

SBL—Securities-based lending


1.	The provision (release) for lending commitments was $48 million in the current quarter and $16 million in the prior year quarter.

The aggregate allowance for loans and lending commitments increased in the current year period, principally reflecting the



September 2020 Form 10-Q	72



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

provision for credit losses within the Institutional Securities business segment primarily resulting from the continued economic impact of COVID-19. This provision was the result of risks related to vulnerable sectors and higher downgrade sensitivity, changes in asset quality trends, as well as revisions to our forecasts reflecting expected future market and macroeconomic conditions. The base scenario used in our ACL models as of September 30, 2020 was generated using a combination of industry consensus economic forecasts, forward rates, and internally developed and validated models. Given the nature of our lending portfolio, the most sensitive model input is U.S. GDP. The base scenario, among other things, assumes a continued recovery in the last quarter of 2020 through 2021, supported by fiscal stimulus and monetary policy measures. For a further discussion of the Firm’s loans as well as the Firm’s allowance methodology prior to the adoption of CECL, refer to Notes 2 and 8 to the financial statements in the 2019 Form 10-K. See Note 5 for further information regarding Loans and lending commitments held at fair value. See Note 14 for details of current commitments to lend in the future.

Employee Loans



$ in millions	At September 30, 2020			At December 31, 2019
Currently employed by the Firm¹	$	2,940		N/A
No longer employed by the Firm²	142			N/A
Employee loans	$	3,082		$	2,980
ACL³	(165		)	(61		)
Employee loans, net of ACL	$	2,917		$	2,919
Remaining repayment term, weighted average in years	5.1			4.8


1.	These loans are predominantly current.


2.	These loans are predominantly past due for a period of 90 days or more.


3.	The change in ACL includes a $124 million increase due to the adoption of CECL in the first quarter of 2020.

Employee loans are granted in conjunction with a program established primarily to recruit certain Wealth Management representatives, are full recourse and generally require periodic repayments, and are due in full upon termination of employment with the Firm. These loans are recorded in Customer and other receivables in the balance sheets. The ACL as of September 30, 2020 was calculated under the CECL methodology, while the ACL at December 31, 2019 was calculated under the prior incurred loss model. The related provision is recorded in Compensation and benefits expense in the income statements. See Note 2 for a description of the CECL allowance methodology, including credit quality indicators, for employee loans.

11. Other Assets—Equity Method Investments

Equity Method Investments



	Three Months Ended September 30,					Nine Months Ended September 30,
$ in millions	2020		2019			2020			2019
Income (loss)¹	$	10	$	(13	)	$	(24	)	$	(39	)


1.	The current year period includes an impairment of the Investment Management business segment’s investment in a third-party asset manager.

Equity method investments, other than investments in certain fund interests, are summarized above and are included in Other assets in the balance sheets with related income or loss included in Other revenues in the income statements. See “Net Asset Value Measurements—Fund Interests” in Note 5 for the carrying value of certain of the Firm’s fund interests, which are comprised of general and limited partnership interests, as well as any related carried interest.

Japanese Securities Joint Venture



	Three Months Ended September 30,					Nine Months Ended September 30,
$ in millions	2020		2019			2020		2019
Income (loss) from investment in MUMSS	$	15	$	(4	)	$	46	$	5

For more information on Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. (“MUMSS”) and other relationships with Mitsubishi UFJ Financial Group, Inc., see Note 10 to the financial statements in the 2019 Form 10-K.

12. Deposits

Deposits



$ in millions	At September 30, 2020		At December 31, 2019
Savings and demand deposits	$	202,577	$	149,465
Time deposits	36,676		40,891
Total	$	239,253	$	190,356
Deposits subject to FDIC insurance	$	173,173	$	149,966
Time deposits that equal or exceed the FDIC insurance limit	$	20	$	12



	73	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

Time Deposit Maturities



$ in millions	At September 30, 2020
2020	$	5,457
2021	17,986
2022	4,984
2023	4,086
2024	2,784
Thereafter	1,379
Total	$	36,676

13. Borrowings and Other Secured Financings

Borrowings



$ in millions	At September 30, 2020		At December 31, 2019
Original maturities of one year or less	$	4,553	$	2,567
Original maturities greater than one year
Senior	$	187,717	$	179,519
Subordinated	11,174		10,541
Total	$	198,891	$	190,060
Total borrowings	$	203,444	$	192,627
Weighted average stated maturity, in years¹	7.4		6.9


1.	Only includes borrowings with original maturities greater than one year.

Other Secured Financings



$ in millions	At September 30, 2020		At December 31, 2019¹
Original maturities:
One year or less	$	9,141	$	7,103
Greater than one year	4,716		7,595
Total	$	13,857	$	14,698
Transfers of assets accounted for as secured financings	$	1,108	$	1,115


1.	Prior period balances have been conformed to the current presentation.

Other secured financings include the liabilities related to certain ELNs, transfers of financial assets that are accounted for as financings rather than sales, pledged commodities, consolidated VIEs where the Firm is deemed to be the primary beneficiary and other secured borrowings. These liabilities are generally payable from the cash flows of the related assets accounted for as Trading assets. See Note 15 for further information on other secured financings related to VIEs and securitization activities.

For transfers of assets that fail to meet accounting criteria for a sale, the Firm continues to record the assets and recognizes the associated liabilities in the balance sheets.

14. Commitments, Guarantees and Contingencies

Commitments



	Years to Maturity at September 30, 2020
$ in millions	Less than 1		1-3		3-5		Over 5		Total
Lending:
Corporate	$	14,707	$	36,048	$	37,002	$	4,888	$	92,645
Secured lending facilities	5,554		3,693		1,302		133		10,682
Commercial and Residential real estate	137		226		38		260		661
Securities-based lending and Other	12,421		2,934		369		386		16,110
Forward-starting secured financing receivables	81,340		—		—		—		81,340
Central counterparty¹	300		—		—		9,329		9,629
Underwriting	675		—		—		—		675
Investment activities	947		241		41		286		1,515
Letters of credit and other financial guarantees	172		1		—		3		176
Total	$	116,253	$	43,143	$	38,752	$	15,285	$	213,433
Lending commitments participated to third parties									$	8,647
Forward-starting secured financing receivables settled within three business days									$	72,771

Beginning in the first quarter of 2020, commitments to central counterparties are presented separately; these commitments were previously included in Corporate Lending commitments and Forward-starting secured financing receivables depending on the type of agreement. These commitments relate to the Firm’s membership in certain clearinghouses and are contingent upon the default of a clearinghouse member or other stress events.

Since commitments associated with these instruments may expire unused, the amounts shown do not necessarily reflect the actual future cash funding requirements.

For a further description of these commitments, refer to Note 13 to the financial statements in the 2019 Form 10-K.



September 2020 Form 10-Q	74



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

Guarantees

Maximum Potential Payout/Notional of Obligations under Guarantee Arrangements



	Years to Maturity at September 30, 2020
$ in millions	Less than 1		1-3		3-5		Over 5		Total
Credit derivatives	$	25,206	$	42,799	$	114,950	$	72,312	$	255,267
Other credit contracts	—		190		—		104		294
Non-credit derivatives	1,531,263		1,122,139		367,428		779,686		3,800,516
Standby letters of credit and other financial guarantees issued¹	1,082		1,475		758		3,967		7,282
Market value guarantees	92		28		—		—		120
Liquidity facilities	4,342		—		—		—		4,342
Whole loan sales guarantees	1		—		9		23,176		23,186
Securitization representations and warranties	—		—		—		67,024		67,024
General partner guarantees	59		161		12		115		347
Client clearing guarantees	92		—		—		—		92



$ in millions	Carrying Amount Asset (Liability)
Credit derivatives²	$	(1,757	)
Other credit contracts	(4		)
Non-credit derivatives²	(88,369		)
Standby letters of credit and other financial guarantees issued¹	113
Market value guarantees	—
Liquidity facilities	6
Whole loan sales guarantees	—
Securitization representations and warranties³	(42		)
General partner guarantees	(66		)
Client clearing guarantees	—


1.	These amounts include certain issued standby letters of credit participated to third parties, totaling $0.6 billion of notional and collateral/recourse, due to the nature of the Firm’s obligations under these arrangements. As of September 30, 2020, the carrying amount of standby letters of credit and other financial guarantees issued includes an allowance for credit losses of $86 million.


2.	The carrying amounts of derivative contracts that meet the accounting definition of a guarantee are shown on a gross basis. For further information on derivatives contracts, see Note 7.


3.	Primarily related to residential mortgage securitizations.

The Firm has obligations under certain guarantee arrangements, including contracts and indemnification agreements, that contingently require the Firm to make payments to the guaranteed party based on changes in an underlying measure (such as an interest or foreign exchange rate, security or commodity price, an index, or the occurrence or non-occurrence of a specified event) related to an asset, liability or equity security of a guaranteed party. Also included as guarantees are contracts that contingently require the Firm to make payments to the guaranteed party based on another entity’s failure to perform under an agreement, as well as indirect guarantees of the indebtedness of others.

Client Clearing Guarantees. In the first quarter of 2020, FICC’s sponsored clearing model was updated such that the Firm could be responsible for liquidation of a sponsored member’s account and guarantees any resulting loss to the FICC in the event the sponsored member fails to fully pay any net liquidation amount due from the sponsored member to the FICC. Accordingly, the Firm’s maximum potential payout amount as of September 30, 2020 reflects the total of the estimated net liquidation amounts for sponsored member accounts.

For more information on the nature of the obligations and related business activities for our guarantees, see Note 13 to the financial statements in the 2019 Form 10-K.

Other Guarantees and Indemnities

In the normal course of business, the Firm provides guarantees and indemnifications in a variety of transactions. These provisions generally are standard contractual terms. Certain of these guarantees and indemnifications related to indemnities, exchange and clearinghouse member guarantees and merger and acquisition guarantees are described in Note 13 to the financial statements in the 2019 Form 10-K.

In addition, in the ordinary course of business, the Firm guarantees the debt and/or certain trading obligations (including obligations associated with derivatives, foreign exchange contracts and the settlement of physical commodities) of certain subsidiaries. These guarantees generally are entity or product specific and are required by investors or trading counterparties. The activities of the Firm’s subsidiaries covered by these guarantees (including any related debt or trading obligations) are included in the financial statements.

Finance Subsidiary

The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary.

Contingencies

Legal

In addition to the matters described in the following paragraphs, in the normal course of business, the Firm has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with its activities as a global diversified financial services institution. Certain of the actual or threatened legal actions include claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages. In some cases, the entities that would otherwise be the primary defendants in such cases are bankrupt or are in financial distress. These actions have included, but are not limited to, residential mortgage and credit crisis-related matters.



	75	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

While the Firm has identified below any individual proceedings where the Firm believes a material loss to be reasonably possible and reasonably estimable, there can be no assurance that material losses will not be incurred from claims that have not yet been asserted or are not yet determined to be probable or possible and reasonably estimable losses.

The Firm contests liability and/or the amount of damages as appropriate in each pending matter. Where available information indicates that it is probable a liability had been incurred at the date of the financial statements and the Firm can reasonably estimate the amount of that loss, the Firm accrues the estimated loss by a charge to income.

In many proceedings and investigations, however, it is inherently difficult to determine whether any loss is probable or even possible or to estimate the amount of any loss. In addition, even where a loss is possible or an exposure to loss exists in excess of the liability already accrued with respect to a previously recognized loss contingency, it is not always possible to reasonably estimate the size of the possible loss or range of loss.

For certain legal proceedings and investigations, the Firm cannot reasonably estimate such losses, particularly for proceedings and investigations where the factual record is being developed or contested or where plaintiffs or government entities seek substantial or indeterminate damages, restitution, disgorgement or penalties. Numerous issues may need to be resolved, including through potentially lengthy discovery and determination of important factual matters, determination of issues related to class certification and the calculation of damages or other relief, and by addressing novel or unsettled legal questions relevant to the proceedings or investigations in question, before a loss or additional loss or range of loss or additional range of loss can be reasonably estimated for a proceeding or investigation.

For certain other legal proceedings and investigations, the Firm can estimate reasonably possible losses, additional losses, ranges of loss or ranges of additional loss in excess of amounts accrued but does not believe, based on current knowledge and after consultation with counsel, that such losses will have a material adverse effect on the Firm’s financial statements as a whole, other than the matters referred to in the following paragraphs.

On July 15, 2010, China Development Industrial Bank (“CDIB”) filed a complaint against the Firm, styled China Development Industrial Bank v. Morgan Stanley & Co. Incorporated et al., which is pending in the Supreme Court of the State of New York, New York County (“Supreme Court of NY”). The complaint relates to a $275 million CDS referencing the super senior portion of the STACK 2006-1 CDO. The complaint asserts claims for common law fraud, fraudulent inducement and fraudulent concealment and alleges that the Firm misrepresented the risks of the STACK 2006-1 CDO to

CDIB, and that the Firm knew that the assets backing the CDO were of poor quality when it entered into the CDS with CDIB. The complaint seeks compensatory damages related to the approximately $228 million that CDIB alleges it has already lost under the CDS, rescission of CDIB’s obligation to pay an additional $12 million, punitive damages, equitable relief, fees and costs. On February 28, 2011, the court denied the Firm’s motion to dismiss the complaint. On December 21, 2018, the court denied the Firm’s motion for summary judgment and granted in part the Firm’s motion for sanctions relating to spoliation of evidence. On January 24, 2019, CDIB filed a notice of appeal from the court’s December 21, 2018 order, and on January 25, 2019, the Firm filed a notice of appeal from the same order. On March 7, 2019, the court denied the relief that CDIB sought in a motion to clarify and resettle the portion of the court’s December 21, 2018 order granting spoliation sanctions. On May 21, 2020, the Appellate Division, First Department (“First Department”), modified the Supreme Court of NY’s order to deny the Firm’s motion for sanctions relating to spoliation of evidence and otherwise affirmed the denial of the Firm’s motion for summary judgment. On June 19, 2020, the Firm moved for leave to appeal the First Department’s decision to the New York Court of Appeals (“Court of Appeals”), which the First Department denied on July 24, 2020. Based on currently available information, the Firm believes it could incur a loss in this action of up to approximately $240 million plus pre- and post-judgment interest, fees and costs.

On September 23, 2014, Financial Guaranty Insurance Company (“FGIC”) filed a complaint against the Firm in the Supreme Court of NY styled Financial Guaranty Insurance Company v. Morgan Stanley ABS Capital I Inc. et al. relating to the Morgan Stanley ABS Capital I Inc. Trust 2007-NC4. The complaint asserts claims for breach of contract and fraudulent inducement and alleges, among other things, that the loans in the trust breached various representations and warranties and defendants made untrue statements and material omissions to induce FGIC to issue a financial guaranty policy on certain classes of certificates that had an original balance of approximately $876 million. The complaint seeks, among other relief, specific performance of the loan breach remedy procedures in the transaction documents, compensatory, consequential and punitive damages, attorneys’ fees and interest. On January 23, 2017, the court denied the Firm’s motion to dismiss the complaint. On September 13, 2018, the First Department affirmed in part and reversed in part the lower court’s order denying the Firm’s motion to dismiss. On December 20, 2018, the First Department denied plaintiff’s motion for leave to appeal its decision to the Court of Appeals or, in the alternative, for re-argument. Based on currently available information, the Firm believes that it could incur a loss in this action of up to approximately $277 million, the total original unpaid balance of the mortgage loans for which the Firm received repurchase demands from a certificate holder and FGIC that the Firm did not repurchase, plus pre- and post- judgment interest, fees and costs, as well as claim payments that FGIC has



September 2020 Form 10-Q	76



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

made and will make in the future. In addition, plaintiff is seeking to expand the number of loans at issue and the possible range of loss could increase.

On January 23, 2015, Deutsche Bank National Trust Company, in its capacity as trustee, filed a complaint against the Firm styled Deutsche Bank National Trust Company solely in its capacity as Trustee of the Morgan Stanley ABS Capital I Inc. Trust 2007-NC4 v. Morgan Stanley Mortgage Capital Holdings LLC as Successor-by-Merger to Morgan Stanley Mortgage Capital Inc., and Morgan Stanley ABS Capital I Inc., pending in the Supreme Court of NY. The complaint asserts claims for breach of contract and alleges, among other things, that the loans in the trust, which had an original principal balance of approximately $1.05 billion, breached various representations and warranties. The complaint seeks, among other relief, specific performance of the loan breach remedy procedures in the transaction documents, compensatory, consequential, rescissory, equitable and punitive damages, attorneys’ fees, costs and other related expenses, and interest. On December 11, 2015, the court granted in part and denied in part the Firm’s motion to dismiss the complaint. On October 19, 2018, the court granted the Firm’s motion for leave to amend its answer and to stay the case pending resolution of Deutsche Bank National Trust Company’s appeal to the Court of Appeals in another case, styled Deutsche Bank National Trust Company v. Barclays Bank PLC, regarding the applicable statute of limitations. On January 17, 2019, the First Department reversed the trial court’s order to the extent that it had granted in part the Firm’s motion to dismiss the complaint. On June 4, 2019, the First Department granted the Firm’s motion for leave to appeal to the Court of Appeals. On March 19, 2020, the Firm filed a motion for partial summary judgment. Based on currently available information, the Firm believes that it could incur a loss in this action of up to approximately $277 million, the total original unpaid balance of the mortgage loans for which the Firm received repurchase demands from a certificate holder and a monoline insurer that the Firm did not repurchase, plus pre- and post-judgment interest, fees and costs, but plaintiff is seeking to expand the number of loans at issue and the possible range of loss could increase.

Tax

In matters styled Case number 15/3637 and Case number 15/4353, the Dutch Tax Authority (“Dutch Authority”) is challenging in the Dutch courts, the prior set-off by the Firm of approximately €124 million (approximately $145 million) plus accrued interest of withholding tax credits against the Firm’s corporation tax liabilities for the tax years 2007 to 2013. The Dutch Authority alleges that the Firm was not entitled to receive the withholding tax credits on the basis, inter alia, that a Firm subsidiary did not hold legal title to certain securities subject to withholding tax on the relevant dates. The Dutch Authority has also alleged that the Firm failed to provide certain information to the Dutch Authority and keep adequate books and records. On April 26, 2018, the District Court in Amsterdam issued a decision dismissing the Dutch Authority’s claims with respect

to certain of the tax years in dispute. On May 12, 2020, the Court of Appeal in Amsterdam granted the Dutch Authority’s appeal in matters re-styled Case number 18/00318 and Case number 18/00319. On June 22, 2020, the Firm filed an appeal against the decision of the Court of Appeal in Amsterdam before the Dutch High Court.

15. Variable Interest Entities and Securitization Activities

Consolidated VIE Assets and Liabilities by Type of Activity



	At September 30, 2020				At December 31, 2019
$ in millions	VIE Assets		VIE Liabilities		VIE Assets		VIE Liabilities
OSF	$	672	$	429	$	696	$	391
MABS¹	447		108		265		4
Other²	942		42		987		66
Total	$	2,061	$	579	$	1,948	$	461

OSF—Other structured financings

Amounts include transactions backed by residential mortgage loans, commercial mortgage loans and other types of assets, including consumer or commercial assets and may be in loan or security form. The value of assets is determined based on the fair value of the liabilities and the interests owned by the Firm in such VIEs as the fair values for the liabilities and interests owned are more observable.


2.	Other primarily includes operating entities, investment funds and structured transactions.

Consolidated VIE Assets and Liabilities by Balance Sheet Caption



$ in millions	At September 30, 2020		At December 31, 2019
Assets
Cash and cash equivalents	$	284	$	488
Trading assets at fair value	1,376		943
Customer and other receivables	8		18
Intangible assets	101		111
Other assets	292		388
Total	$	2,061	$	1,948
Liabilities
Other secured financings	$	536	$	422
Other liabilities and accrued expenses	43		39
Total	$	579	$	461
Noncontrolling interests	$	275	$	192

Consolidated VIE assets and liabilities are presented in the previous tables after intercompany eliminations. Generally, most assets owned by consolidated VIEs cannot be removed unilaterally by the Firm and are not available to the Firm while the related liabilities issued by consolidated VIEs are non-recourse to the Firm. However, in certain consolidated VIEs, the Firm either has the unilateral right to remove assets or provides additional recourse through derivatives such as total return swaps, guarantees or other forms of involvement.

In general, the Firm’s exposure to loss in consolidated VIEs is limited to losses that would be absorbed on the VIE net assets recognized in its financial statements, net of amounts absorbed by third-party variable interest holders.



	77	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

Non-consolidated VIEs



	At September 30, 2020
$ in millions	MABS¹		CDO		MTOB		OSF		Other²
VIE assets (UPB)	$	136,362	$	3,744	$	6,404	$	2,190	$	50,040
Maximum exposure to loss³
Debt and equity interests	$	16,821	$	390	$	—	$	1,059	$	10,581
Derivative and other contracts	—		—		4,342		—		3,853
Commitments, guarantees and other	810		—		—		—		685
Total	$	17,631	$	390	$	4,342	$	1,059	$	15,119
Carrying value of variable interests—Assets
Debt and equity interests	$	16,821	$	390	$	—	$	1,059	$	10,581
Derivative and other contracts	—		—		6		—		621
Total	$	16,821	$	390	$	6	$	1,059	$	11,202
Additional VIE assets owned⁴									$	11,832
Carrying value of variable interests—Liabilities
Derivative and other contracts	$	—	$	—	$	1	$	—	$	114
Total	$	—	$	—	$	1	$	—	$	114



	At December 31, 2019
$ in millions	MABS¹		CDO		MTOB		OSF		Other²
VIE assets (UPB)	$	125,603	$	2,976	$	6,965	$	2,288	$	51,305
Maximum exposure to loss³
Debt and equity interests	$	16,314	$	240	$	—	$	1,009	$	11,977
Derivative and other contracts	—		—		4,599		—		2,995
Commitments, guarantees and other	631		—		—		—		266
Total	$	16,945	$	240	$	4,599	$	1,009	$	15,238
Carrying value of variable interests–Assets
Debt and equity interests	$	16,314	$	240	$	—	$	1,008	$	11,977
Derivative and other contracts	—		—		6		—		388
Total	$	16,314	$	240	$	6	$	1,008	$	12,365
Additional VIE assets owned⁴									$	11,453
Carrying value of variable interests—Liabilities
Derivative and other contracts	$	—	$	—	$	—	$	—	$	444

MTOB—Municipal tender option bonds


1.	Amounts include transactions backed by residential mortgage loans, commercial mortgage loans and other types of assets, including consumer or commercial assets. and may be in loan or security form.


2.	Other primarily includes exposures to commercial real estate property and investment funds.


3.	Where notional amounts are utilized in quantifying the maximum exposure related to derivatives, such amounts do not reflect changes in fair value recorded by the Firm.

Additional VIE assets owned represents the carrying value of total exposure to non-consolidated VIEs for which the maximum exposure to loss is less than specific thresholds, primarily interests issued by securitization SPEs. The Firm’s maximum exposure to loss generally equals the fair value of the assets owned. These assets are primarily included in Trading assets and Investment securities and are measured at fair value (see Note 5). The Firm does not provide additional support in these transactions through contractual facilities, guarantees or similar derivatives.

The majority of the VIEs included in the previous tables are sponsored by unrelated parties; examples of the Firm’s involvement with these VIEs include its secondary market-making activities and the securities held in its Investment securities portfolio (see Note 8).

The Firm’s maximum exposure to loss is dependent on the nature of the Firm’s variable interest in the VIE and is limited to the notional amounts of certain liquidity facilities and other credit support, total return swaps and written put options, as well as the fair value of certain other derivatives and investments the Firm has made in the VIE.

The Firm’s maximum exposure to loss in the previous tables does not include the offsetting benefit of hedges or any reductions associated with the amount of collateral held as part of a transaction with the VIE or any party to the VIE directly against a specific exposure to loss.

Liabilities issued by VIEs generally are non-recourse to the Firm.

Detail of Mortgage- and Asset-Backed Securitization Assets



	At September 30, 2020				At December 31, 2019
$ in millions	UPB		Debt and Equity Interests		UPB		Debt and Equity Interests
Residential mortgages	$	20,056	$	3,264	$	30,353	$	3,993
Commercial mortgages	59,111		3,940		53,892		3,881
U.S. agency collateralized mortgage obligations	52,335		8,021		36,366		6,365
Other consumer or commercial loans	4,860		1,596		4,992		2,075
Total	$	136,362	$	16,821	$	125,603	$	16,314

Transferred Assets with Continuing Involvement



	At September 30, 2020
$ in millions	RML		CML		U.S. Agency CMO		CLN and Other¹
SPE assets (UPB)²	$	7,225	$	81,900	$	22,951	$	12,223
Retained interests
Investment grade	$	47	$	794	$	745	$	—
Non-investment grade	16		221		—		89
Total	$	63	$	1,015	$	745	$	89
Interests purchased in the secondary market
Investment grade	$	1	$	129	$	26	$	—
Non-investment grade	24		60		—		—
Total	$	25	$	189	$	26	$	—
Derivative assets	$	—	$	—	$	—	$	500
Derivative liabilities	—		—		—		127



September 2020 Form 10-Q	78



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)



	At December 31, 2019
$ in millions	RML		CML		U.S. Agency CMO		CLN and Other¹
SPE assets (UPB)²	$	9,850	$	86,203	$	19,132	$	8,410
Retained interests
Investment grade	$	29	$	720	$	2,376	$	1
Non-investment grade	17		254		—		92
Total	$	46	$	974	$	2,376	$	93
Interests purchased in the secondary market
Investment grade	$	6	$	197	$	77	$	—
Non-investment grade	75		51		—		—
Total	$	81	$	248	$	77	$	—
Derivative assets	$	—	$	—	$	—	$	339
Derivative liabilities	—		—		—		145



	Fair Value At September 30, 2020
$ in millions	Level 2		Level 3		Total
Retained interests
Investment grade	$	771	$	22	$	793
Non-investment grade	5		72		77
Total	$	776	$	94	$	870
Interests purchased in the secondary market
Investment grade	$	154	$	2	$	156
Non-investment grade	66		18		84
Total	$	220	$	20	$	240
Derivative assets	$	495	$	5	$	500
Derivative liabilities	126		1		127



	Fair Value at December 31, 2019
$ in millions	Level 2		Level 3		Total
Retained interests
Investment grade	$	2,401	$	4	$	2,405
Non-investment grade	6		97		103
Total	$	2,407	$	101	$	2,508
Interests purchased in the secondary market
Investment grade	$	278	$	2	$	280
Non-investment grade	68		58		126
Total	$	346	$	60	$	406
Derivative assets	$	337	$	2	$	339
Derivative liabilities	144		1		145

RML—Residential mortgage loans

CML—Commercial mortgage loans


1.	Amounts include CLO transactions managed by unrelated third parties.


2.	Amounts include assets transferred by unrelated transferors.

The previous tables include transactions with SPEs in which the Firm, acting as principal, transferred financial assets with continuing involvement and received sales treatment. The transferred assets are carried at fair value prior to securitization, and any changes in fair value are recognized in the income statements. The Firm may act as underwriter of the beneficial interests issued by these securitization vehicles, for which Investment banking revenues are recognized. The Firm may retain interests in the securitized financial assets as one or more tranches of the securitization. These retained interests are generally carried at fair value in the balance sheets with changes in fair value recognized in the income statements. Fair value for these interests is measured using techniques that are consistent

with the valuation techniques applied to the Firm’s major categories of assets and liabilities as described in Note 2 in the 2019 Form 10-K and Note 5 herein. Further, as permitted by applicable guidance, certain transfers of assets where the Firm’s only continuing involvement is a derivative are only reported in the following Assets Sold with Retained Exposure table.

Proceeds from New Securitization Transactions and Sales of Loans



	Three Months Ended September 30,				Nine Months Ended September 30,
$ in millions	2020		2019		2020		2019
New transactions¹	$	12,969	$	8,651	$	30,629	$	20,897
Retained interests	1,991		902		7,215		4,424
Sales of corporate loans to CLO SPEs^{1, 2}	234		—		373		—


1.	Net gains on new transactions and sales of corporate loans to CLO entities at the time of the sale were not material for all periods presented.


2.	Sponsored by non-affiliates.

The Firm has provided, or otherwise agreed to be responsible for, representations and warranties regarding certain assets transferred in securitization transactions sponsored by the Firm (see Note 14).

Assets Sold with Retained Exposure



$ in millions	At September 30, 2020		At December 31, 2019
Gross cash proceeds from sale of assets¹	$	31,800	$	38,661
Fair value
Assets sold	$	32,006	$	39,137
Derivative assets recognized in the balance sheets	631		647
Derivative liabilities recognized in the balance sheets	423		152


1.	The carrying value of assets derecognized at the time of sale approximates gross cash proceeds.

The Firm enters into transactions in which it sells securities, primarily equities and contemporaneously enters into bilateral OTC derivatives with the purchasers of the securities, through which it retains exposure to the sold securities.

For a discussion of the Firm’s VIEs, the determination and structure of VIEs and securitization activities, see Note 14 to the financial statements in the 2019 Form 10-K.

16. Regulatory Requirements

Regulatory Capital Framework and Requirements

For a discussion of the Firm’s regulatory capital framework, see Note 15 to the financial statements in the 2019 Form 10-K.

The Firm is required to maintain minimum risk-based and leverage-based capital ratios under regulatory capital requirements. A summary of the calculations of regulatory capital and RWA follows.



	79	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

Minimum risk-based capital ratio requirements apply to Common Equity Tier 1 capital, Tier 1 capital and Total capital (which includes Tier 2 capital). Capital standards require certain adjustments to, and deductions from, capital for purposes of determining these ratios. At September 30, 2020 and December 31, 2019, the Firm’s ratios for determining regulatory compliance are based on the Advanced Approach and the Standardized Approach rules, respectively.

In the current year period, the U.S. banking agencies have adopted an interim final rule altering, for purposes of the regulatory capital rules, the required adoption time period for CECL. As of September 30, 2020, the risk-based and leverage-based capital amounts and ratios, as well as RWA, adjusted average assets and supplementary leverage exposure are calculated excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period in accordance with the interim final rule.

In addition to the minimum risk-based capital ratio requirements, the Firm is subject to the following Common Equity Tier 1 buffers:


•	A greater than 2.5% capital conservation buffer;


•	The G-SIB capital surcharge, currently at 3%; and


•	Up to a 2.5% CCyB, currently set by U.S. banking agencies at zero.

The Firm’s Regulatory Capital and Capital Ratios



	At September 30, 2020
$ in millions	Required Ratio¹		Amount		Ratio
Risk-based capital
Common Equity Tier 1 capital	10.0	%	$	71,157	16.9	%
Tier 1 capital	11.5	%	79,905		19.0	%
Total capital	13.5	%	89,763		21.4	%
Total RWA			420,081



$ in millions	Required Ratio¹		At September 30, 2020
Leverage-based capital
Adjusted average assets²			$	962,435
Tier 1 leverage ratio	4.0	%	8.3		%
Supplementary leverage exposure^3,4			$	1,084,348
SLR³	5.0	%	7.4		%



	At December 31, 2019
$ in millions	Required Ratio¹		Amount		Ratio
Risk-based capital
Common Equity Tier 1 capital	10.0	%	$	64,751	16.4	%
Tier 1 capital	11.5	%	73,443		18.6	%
Total capital	13.5	%	82,708		21.0	%
Total RWA			394,177



$ in millions	Required Ratio¹		At December 31, 2019
Leverage-based capital
Adjusted average assets²			$	889,195
Tier 1 leverage ratio	4.0	%	8.3		%
Supplementary leverage exposure^3,4			$	1,155,177
SLR³	5.0	%	6.4		%


1.	Required ratios are inclusive of any buffers applicable as of the date presented. Failure to maintain the buffers would result in restrictions on the Firm’s ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers.

Adjusted average assets represents the denominator of the Tier 1 leverage ratio and is composed of the average daily balance of consolidated on-balance sheet assets for the quarters ending on the respective balance sheet dates, reduced by disallowed goodwill, intangible assets, investments in covered funds, defined benefit pension plan assets, after-tax gain on sale from assets sold into securitizations, investments in the Firm’s own capital instruments, certain defined tax assets and other capital deductions.


3.	Based on a Federal Reserve interim final rule in effect until March 31, 2021, the Firm’s SLR and Supplementary leverage exposure as of September 30, 2020 reflect the exclusion of U.S. Treasury securities and deposits at Federal Reserve Banks.

U.S. Bank Subsidiaries’ Regulatory Capital and Capital Ratios

The OCC establishes capital requirements for the Firm’s U.S. bank subsidiaries, which as of September 30, 2020 include Morgan Stanley Bank, N.A. (“MSBNA”) and Morgan Stanley Private Bank, National Association (“MSPBNA”) (collectively, the “U.S. Bank Subsidiaries”), and evaluates their compliance with such capital requirements. Regulatory capital requirements for the U.S. Bank Subsidiaries are calculated in a similar manner to the Firm’s regulatory capital requirements, although G-SIB capital surcharge requirements do not apply to the U.S. Bank Subsidiaries.

The OCC’s regulatory capital framework includes Prompt Corrective Action (“PCA”) standards, including “well-capitalized” PCA standards that are based on specified regulatory capital ratio minimums. For the Firm to remain an FHC, the U.S. Bank Subsidiaries must remain well-capitalized



September 2020 Form 10-Q	80



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

in accordance with the OCC’s PCA standards. In addition, failure by the U.S. Bank Subsidiaries to meet minimum capital requirements may result in certain mandatory and discretionary actions by regulators that, if undertaken, could have a direct material effect on the U.S. Bank Subsidiaries’ and the Firm’s financial statements.

At September 30, 2020 and December 31, 2019, the U.S. Bank Subsidiaries’ risk-based capital ratios are based on the Standardized Approach rules. At September 30, 2020, the risk-based and leverage-based capital amounts and ratios are calculated excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period.

MSBNA’s Regulatory Capital



	At September 30, 2020
$ in millions	Well-Capitalized Requirement		Required Ratio¹		Amount		Ratio
Risk-based capital
Common Equity Tier 1 capital	6.5	%	7.0	%	$	17,764	19.7	%
Tier 1 capital	8.0	%	8.5	%	17,764		19.7	%
Total capital	10.0	%	10.5	%	18,442		20.4	%
Leverage-based capital
Tier 1 leverage	5.0	%	4.0	%	$	17,764	10.7	%
SLR	6.0	%	3.0	%	17,764		8.5	%



	At December 31, 2019
$ in millions	Well-Capitalized Requirement		Required Ratio¹		Amount		Ratio
Risk-based capital
Common Equity Tier 1 capital	6.5	%	7.0	%	$	15,919	18.5	%
Tier 1 capital	8.0	%	8.5	%	15,919		18.5	%
Total capital	10.0	%	10.5	%	16,282		18.9	%
Leverage-based capital
Tier 1 leverage	5.0	%	4.0	%	$	15,919	11.3	%
SLR	6.0	%	3.0	%	15,919		8.7	%

MSPBNA’s Regulatory Capital



	At September 30, 2020
$ in millions	Well-Capitalized Requirement		Required Ratio¹		Amount		Ratio
Risk-based capital
Common Equity Tier 1 capital	6.5	%	7.0	%	$	8,528	23.4	%
Tier 1 capital	8.0	%	8.5	%	8,528		23.4	%
Total capital	10.0	%	10.5	%	8,611		23.6	%
Leverage-based capital
Tier 1 leverage	5.0	%	4.0	%	$	8,528	8.2	%
SLR	6.0	%	3.0	%	8,528		7.8	%



	At December 31, 2019
$ in millions	Well-Capitalized Requirement		Required Ratio¹		Amount		Ratio
Risk-based capital
Common Equity Tier 1 capital	6.5	%	7.0	%	$	7,962	24.8	%
Tier 1 capital	8.0	%	8.5	%	7,962		24.8	%
Total capital	10.0	%	10.5	%	8,016		25.0	%
Leverage-based capital
Tier 1 leverage	5.0	%	4.0	%	$	7,962	9.9	%
SLR	6.0	%	3.0	%	7,962		9.4	%


1.	Required ratios are inclusive of any buffers applicable as of the date presented. Failure to maintain the buffers would result in restrictions on the U.S. Bank Subsidiaries' ability to make capital distributions, including the payment of dividends.

U.S. Broker-Dealer Regulatory Capital Requirements

MS&Co. Regulatory Capital



$ in millions	At September 30, 2020		At December 31, 2019
Net capital	$	14,183	$	13,708
Excess net capital	10,217		10,686

MS&Co. is a registered U.S. broker-dealer and registered futures commission merchant and, accordingly, is subject to the minimum net capital requirements of the SEC and the CFTC. MS&Co. has consistently operated with capital in excess of its regulatory capital requirements.

As an Alternative Net Capital broker-dealer, and in accordance with Securities Exchange Act of 1934 (“Exchange Act”) Rule 15c3-1, Appendix E, MS&Co. is subject to minimum net capital and tentative net capital requirements. In addition, MS&Co. must notify the SEC if its tentative net capital falls below certain levels. At September 30, 2020 and December 31, 2019, MS&Co. has exceeded its net capital requirement and has tentative net capital in excess of the minimum and notification requirements.

MSSB Regulatory Capital



$ in millions	At September 30, 2020		At December 31, 2019
Net capital	$	2,758	$	3,387
Excess net capital	2,581		3,238

MSSB is a registered U.S. broker-dealer and introducing broker for the futures business and, accordingly, is subject to the minimum net capital requirements of the SEC. MSSB has consistently operated with capital in excess of its regulatory capital requirements.

Other Regulated Subsidiaries

MSIP, a London-based broker-dealer subsidiary, is subject to the capital requirements of the PRA, and MSMS, a Tokyo-based broker-dealer subsidiary, is subject to the capital requirements



	81	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

of the Financial Services Agency. MSIP and MSMS have consistently operated with capital in excess of their respective regulatory capital requirements.

Certain other U.S. and non-U.S. subsidiaries of the Firm are subject to various securities, commodities and banking regulations, and capital adequacy requirements promulgated by the regulatory and exchange authorities of the countries in which they operate. These subsidiaries have consistently operated with capital in excess of their local capital adequacy requirements.

17. Total Equity

Preferred Stock



	Shares Outstanding			Carrying Value
$ in millions, except per share data	At September 30, 2020	Liquidation Preference per Share		At September 30, 2020		At December 31, 2019
Series
A	44,000	$	25,000	$	1,100	$	1,100
C¹	519,882	1,000		408		408
E	34,500	25,000		862		862
F	34,000	25,000		850		850
H	52,000	25,000		1,300		1,300
I	40,000	25,000		1,000		1,000
J	60,000	25,000		1,500		1,500
K	40,000	25,000		1,000		1,000
L	20,000	25,000		500		500
Total				$	8,520	$	8,520
Shares authorized				30,000,000


1.	Series C preferred stock is held by MUFG.

For a description of Series A through Series L preferred stock issuances, see Note 16 to the financial statements in the 2019 Form 10-K. The preferred stock has a preference over the common stock upon liquidation. The Firm’s preferred stock qualifies as and is included in Tier 1 capital in accordance with regulatory capital requirements (see Note 16).

Common Shares Outstanding for Basic and Diluted EPS



	Three Months Ended September 30,		Nine Months Ended September 30,
in millions	2020	2019	2020	2019
Weighted average common shares outstanding, basic	1,542	1,604	1,546	1,632
Effect of dilutive Stock options, RSUs and PSUs	24	23	19	21
Weighted average common shares outstanding and common stock equivalents, diluted	1,566	1,627	1,565	1,653
Weighted average antidilutive common stock equivalents (excluded from the computation of diluted EPS)	—	—	7	2

Share Repurchases



	Three Months Ended September 30,				Nine Months Ended September 30,
$ in millions	2020		2019		2020		2019
Repurchases of common stock under the Firm's Share Repurchase Program	$	—	$	1,500	$	1,347	$	3,860

On March 15, 2020, the Financial Services Forum announced that each of its eight member banks, including the Firm, had voluntarily suspended their share repurchase programs. On June 25, 2020, the Federal Reserve published summary results of CCAR and announced that large BHCs, including the Firm, generally would be restricted in making share repurchases during the current quarter, and on September 30, 2020, the restrictions were extended through the fourth quarter of 2020.

A portion of common stock repurchases was conducted under a sales plan with MUFG, whereby MUFG sold shares of the Firm’s common stock to the Firm, as part of the Firm’s Share Repurchase Program. The sales plan is only intended to maintain MUFG’s ownership percentage below 24.9% in order to comply with MUFG’s passivity commitments to the Board of Governors of the Federal Reserve System and has no impact on the strategic alliance between MUFG and the Firm, including the joint ventures in Japan.

Dividends



$ in millions, except per share data	Three Months Ended September 30, 2020				Three Months Ended September 30, 2019
	Per Share¹		Total		Per Share¹		Total
Preferred Stock Series
A	$	256	$	11	$	256	$	11
C	25		13		25		13
E	445		15		445		15
F	430		15		430		15
G²	—		—		414		8
H³	248		13		378		20
I	398		16		398		16
J⁴	261		16		—		—
K	366		15		366		15
L	305		6		—		—
Total Preferred stock			$	120			$	113
Common stock	0.35		$	551	$	0.35	$	577



September 2020 Form 10-Q	82



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)



$ in millions, except per share data	Nine Months Ended September 30, 2020				Nine Months Ended September 30, 2019
	Per Share¹		Total		Per Share¹		Total
Preferred Stock Series
A	$	761	$	33	$	758	$	33
C	75		39		75		39
E	1,336		45		1,336		45
F	1,289		44		1,289		45
G²	—		—		1,242		24
H³	897		47		1,059		55
I	1,195		48		1,195		48
J⁴	955		58		694		42
K	1,097		45		1,097		45
L	914		18		—		—
Total Preferred stock			$	377			$	376
Common stock	1.05		$	1,662	$	0.95	$	1,594


1.	Common and Preferred Stock dividends are payable quarterly, unless otherwise noted.


2.	Series G preferred stock was redeemed during the first quarter of 2020. For further information, see Note 16 to the financial statements in the 2019 Form 10-K.


3.	Series H was payable semiannually until July 15, 2019, and is now payable quarterly.


4.	Series J was payable semiannually until July 15, 2020, and is now payable quarterly.

Cumulative Adjustments to Beginning Retained Earnings Related to the Adoption of Accounting Updates



	Nine Months Ended
$ in millions	September 30, 2020
Financial Instruments—Credit Losses	$	(100	)



	Nine Months Ended
$ in millions	September 30, 2019
Leases	$	63

Accumulated Other Comprehensive Income (Loss)¹



$ in millions	CTA			AFS Securities			Pension, Postretirement and Other			DVA			Total
June 30, 2020	$	(1,017	)	$	1,827		$	(620	)	$	(189	)	$	1
OCI during the period	81			(62		)	5			(562		)	(538		)
September 30, 2020	$	(936	)	$	1,765		$	(615	)	$	(751	)	$	(537	)
June 30, 2019	$	(865	)	$	108		$	(574	)	$	(720	)	$	(2,051	)
OCI during the period	(96		)	214			3			332			453
September 30, 2019	$	(961	)	$	322		$	(571	)	$	(388	)	$	(1,598	)
December 31, 2019	$	(897	)	$	207		$	(644	)	$	(1,454	)	$	(2,788	)
OCI during the period	(39		)	1,558			29			703			2,251
September 30, 2020	$	(936	)	$	1,765		$	(615	)	$	(751	)	$	(537	)
December 31, 2018	$	(889	)	$	(930	)	$	(578	)	$	105		$	(2,292	)
OCI during the period	(72		)	1,252			7			(493		)	694
September 30, 2019	$	(961	)	$	322		$	(571	)	$	(388	)	$	(1,598	)

CTA—Cumulative foreign currency translation adjustments


1.	Amounts are net of tax and noncontrolling interests.

Components of Period Changes in OCI



	Three Months Ended September 30, 2020
$ in millions	Pre-tax Gain (Loss)			Income Tax Benefit (Provision)			After-tax Gain (Loss)			Non- controlling Interests			Net
CTA
OCI activity	$	34		$	76		$	110		$	29		$	81
Reclassified to earnings	—			—			—			—			—
Net OCI	$	34		$	76		$	110		$	29		$	81
Change in net unrealized gains (losses) on AFS securities
OCI activity	$	(26	)	$	6		$	(20	)	$	—		$	(20	)
Reclassified to earnings	(55		)	13			(42		)	—			(42		)
Net OCI	$	(81	)	$	19		$	(62	)	$	—		$	(62	)
Pension, postretirement and other
OCI activity	$	(1	)	$	1		$	—		$	—		$	—
Reclassified to earnings	6			(1		)	5			—			5
Net OCI	$	5		$	—		$	5		$	—		$	5
Change in net DVA
OCI activity	$	(747	)	$	178		$	(569	)	$	(1	)	$	(568	)
Reclassified to earnings	8			(2		)	6			—			6
Net OCI	$	(739	)	$	176		$	(563	)	$	(1	)	$	(562	)



	Three Months Ended September 30, 2019
$ in millions	Pre-tax Gain (Loss)			Income Tax Benefit (Provision)			After-tax Gain (Loss)			Non- controlling Interests			Net
CTA
OCI activity	$	(26	)	$	(73	)	$	(99	)	$	(3	)	$	(96	)
Reclassified to earnings	—			—			—			—			—
Net OCI	$	(26	)	$	(73	)	$	(99	)	$	(3	)	$	(96	)
Change in net unrealized gains (losses) on AFS securities
OCI activity	$	307		$	(73	)	$	234		$	—		$	234
Reclassified to earnings	(26		)	6			(20		)	—			(20		)
Net OCI	$	281		$	(67	)	$	214		$	—		$	214
Pension, postretirement and other
OCI activity	$	—		$	—		$	—		$	—		$	—
Reclassified to earnings	4			(1		)	3			—			3
Net OCI	$	4		$	(1	)	$	3		$	—		$	3
Change in net DVA
OCI activity	$	441		$	(106	)	$	335		$	5		$	330
Reclassified to earnings	2			—			2			—			2
Net OCI	$	443		$	(106	)	$	337		$	5		$	332



	83	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)



	Nine Months Ended September 30, 2020
$ in millions	Pre-tax Gain (Loss)			Income Tax Benefit (Provision)			After-tax Gain (Loss)			Non- controlling Interests		Net
CTA
OCI activity	$	19		$	(17	)	$	2		$	38	$	(36	)
Reclassified to earnings	(3		)	—			(3		)	—		(3		)
Net OCI	$	16		$	(17	)	$	(1	)	$	38	$	(39	)
Change in net unrealized gains (losses) on AFS securities
OCI activity	$	2,142		$	(503	)	$	1,639		$	—	$	1,639
Reclassified to earnings	(106		)	25			(81		)	—		(81		)
Net OCI	$	2,036		$	(478	)	$	1,558		$	—	$	1,558
Pension, postretirement and other
OCI activity	$	20		$	(4	)	$	16		$	—	$	16
Reclassified to earnings	16			(3		)	13			—		13
Net OCI	$	36		$	(7	)	$	29		$	—	$	29
Change in net DVA
OCI activity	$	967		$	(233	)	$	734		$	41	$	693
Reclassified to earnings	14			(4		)	10			—		10
Net OCI	$	981		$	(237	)	$	744		$	41	$	703



	Nine Months Ended September 30, 2019
$ in millions	Pre-tax Gain (Loss)			Income Tax Benefit (Provision)			After-tax Gain (Loss)			Non- controlling Interests			Net
CTA
OCI activity	$	2		$	(58	)	$	(56	)	$	16		$	(72	)
Reclassified to earnings	—			—			—			—			—
Net OCI	$	2		$	(58	)	$	(56	)	$	16		$	(72	)
Change in net unrealized gains (losses) on AFS securities
OCI activity	$	1,726		$	(406	)	$	1,320		$	—		$	1,320
Reclassified to earnings	(89		)	21			(68		)	—			(68		)
Net OCI	$	1,637		$	(385	)	$	1,252		$	—		$	1,252
Pension, postretirement and other
OCI activity	$	—		$	(1	)	$	(1	)	$	—		$	(1	)
Reclassified to earnings	10			(2		)	8			—			8
Net OCI	$	10		$	(3	)	$	7		$	—		$	7
Change in net DVA
OCI activity	$	(713	)	$	177		$	(536	)	$	(36	)	$	(500	)
Reclassified to earnings	9			(2		)	7			—			7
Net OCI	$	(704	)	$	175		$	(529	)	$	(36	)	$	(493	)

18. Interest Income and Interest Expense



	Three Months Ended September 30,					Nine Months Ended September 30,
$ in millions	2020			2019		2020			2019
Interest income
Investment securities	$	529		$	579	$	1,603		$	1,563
Loans	967			1,208		3,171			3,599
Securities purchased under agreements to resell and Securities borrowed¹	(187		)	871		70			2,865
Trading assets, net of Trading liabilities	537			728		1,902			2,188
Customer receivables and Other²	210			964		1,171			2,931
Total interest income	$	2,056		$	4,350	$	7,917		$	13,146

Interest expense
Deposits	$	178		$	505	$	804		$	1,460
Borrowings	714			1,219		2,534			3,941
Securities sold under agreements to repurchase and Securities loaned³	165			681		883			2,016
Customer payables and Other⁴	(487		)	727		(746		)	2,468
Total interest expense	$	570		$	3,132	$	3,475		$	9,885
Net interest	$	1,486		$	1,218	$	4,442		$	3,261


1.	Includes fees paid on Securities borrowed.


2.	Includes interest from Cash and cash equivalents.


3.	Includes fees received on Securities loaned.


4.	Includes fees received from prime brokerage customers for stock loan transactions entered into to cover customers’ short positions.

Interest income and Interest expense are classified in the income statements based on the nature of the instrument and related market conventions. When included as a component of the instrument’s fair value, interest is included within Trading revenues or Investments revenues. Otherwise, it is included within Interest income or Interest expense. k

Accrued Interest



$ in millions	At September 30, 2020		At December 31, 2019
Customer and other receivables	$	2,244	$	1,661
Customer and other payables	2,545		2,223

19. Income Taxes

The Firm is under continuous examination by the IRS and other tax authorities in certain countries, such as Japan and the U.K., and in states and localities in which it has significant business operations, such as New York.

The Firm believes that the resolution of these tax examinations will not have a material effect on the annual financial statements, although a resolution could have a material impact in the income statements and on the effective tax rate for any period in which such resolutions occur.



September 2020 Form 10-Q	84



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

The Firm has established a liability for unrecognized tax benefits, and associated interest, if applicable (“tax liabilities”), that it believes is adequate in relation to the potential for additional assessments. Once established, the Firm adjusts such tax liabilities only when new information is available or when an event occurs necessitating a change.

It is reasonably possible that significant changes in the balance of unrecognized tax benefits may occur within the next 12 months. At this time, however, it is not possible to reasonably estimate the expected change to the total amount of unrecognized tax benefits and the impact on the Firm’s effective tax rate over the next 12 months.

Net Discrete Tax Provisions (Benefits)



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions	2020			2019			2020			2019
Recurring¹	$	—		$	—		$	(94	)	$	(127	)
Intermittent	(113		)	(89		)	(10		)	(190		)

1. Recurring discrete tax items are related to conversion of employee share-based awards.

20. Segment, Geographic and Revenue Information

Selected Financial Information by Business Segment



	Three Months Ended September 30, 2020
$ in millions	IS		WM		IM			I/E			Total
Investment banking	$	1,707	$	135	$	—		$	(16	)	$	1,826
Trading	2,807		268		2			15			3,092
Investments	87		1		258			—			346
Commissions and fees¹	639		477		1			(80		)	1,037
Asset management¹	114		2,793		795			(38		)	3,664
Other	114		94		1			(3		)	206
Total non-interest revenues	5,468		3,768		1,057			(122		)	10,171
Interest income	1,086		1,065		7			(102		)	2,056
Interest expense	492		176		8			(106		)	570
Net interest	594		889		(1		)	4			1,486
Net revenues	$	6,062	$	4,657	$	1,056		$	(118	)	$	11,657
Income before provision for income taxes	$	2,048	$	1,120	$	315		$	4		$	3,487
Provision for income taxes	385		278		72			1			736
Net income	1,663		842		243			3			2,751
Net income applicable to noncontrolling interests	16		—		18			—			34
Net income applicable to Morgan Stanley	$	1,647	$	842	$	225		$	3		$	2,717



	Three Months Ended September 30, 2019
$ in millions	IS			WM		IM			I/E			Total
Investment banking	$	1,535		$	118	$	—		$	(18	)	$	1,635
Trading	2,533			61		2			12			2,608
Investments	(18		)	—		105			—			87
Commissions and fees¹	643			416		1			(70		)	990
Asset management¹	100			2,639		664			(40		)	3,363
Other	51			81		—			(1		)	131
Total non-interest revenues	4,844			3,315		772			(117		)	8,814
Interest income	3,112			1,378		4			(144		)	4,350
Interest expense	2,933			335		12			(148		)	3,132
Net interest	179			1,043		(8		)	4			1,218
Net revenues	$	5,023		$	4,358	$	764		$	(113	)	$	10,032
Income before provision for income taxes	$	1,307		$	1,238	$	165		$	—		$	2,710
Provision for income taxes	189			276		27			—			492
Net income	1,118			962		138			—			2,218
Net income applicable to noncontrolling interests	45			—		—			—			45
Net income applicable to Morgan Stanley	$	1,073		$	962	$	138		$	—		$	2,173



	85	September 2020 Form 10-Q



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)



	Nine Months Ended September 30, 2020
$ in millions	IS			WM		IM			I/E			Total
Investment banking	$	4,902		$	403	$	—		$	(66	)	$	5,239
Trading	10,375			413		(13		)	56			10,831
Investments	98			9		552			—			659
Commissions and fees¹	2,230			1,538		1			(270		)	3,499
Asset management¹	342			7,980		2,144			(120		)	10,346
Other	(628		)	216		(39		)	(7		)	(458		)
Total non-interest revenues	17,319			10,559		2,645			(407		)	30,116
Interest income	4,809			3,468		22			(382		)	7,917
Interest expense	3,184			653		33			(395		)	3,475
Net interest	1,625			2,815		(11		)	13			4,442
Net revenues	$	18,944		$	13,374	$	2,634		$	(394	)	$	34,558
Income before provision for income taxes	$	5,991		$	3,317	$	674		$	6		$	9,988
Provision for income taxes	1,326			758		136			1			2,221
Net income	4,665			2,559		538			5			7,767
Net income applicable to noncontrolling interests	75			—		81			—			156
Net income applicable to Morgan Stanley	$	4,590		$	2,559	$	457		$	5		$	7,611



	Nine Months Ended September 30, 2019
$ in millions	IS		WM		IM			I/E			Total
Investment banking	$	4,158	$	365	$	(1	)	$	(55	)	$	4,467
Trading	8,221		525		(2		)	37			8,781
Investments	257		1		543			—			801
Commissions and fees¹	1,889		1,250		1			(205		)	2,935
Asset management¹	310		7,544		1,893			(115		)	9,632
Other	416		281		(6		)	(6		)	685
Total non-interest revenues	15,251		9,966		2,428			(344		)	27,301
Interest income	9,457		4,139		14			(464		)	13,146
Interest expense	9,376		950		35			(476		)	9,885
Net interest	81		3,189		(21		)	12			3,261
Net revenues	$	15,332	$	13,155	$	2,407		$	(332	)	$	30,562
Income before provision for income taxes	$	4,365	$	3,669	$	538		$	(4	)	$	8,568
Provision for income taxes	703		830		104			(1		)	1,636
Net income	3,662		2,839		434			(3		)	6,932
Net income applicable to noncontrolling interests	97		—		32			—			129
Net income applicable to Morgan Stanley	$	3,565	$	2,839	$	402		$	(3	)	$	6,803

I/E–Intersegment Eliminations


1.	Substantially all revenues are from contracts with customers.

For a discussion about the Firm’s business segments, see Note 21 to the financial statements in the 2019 Form 10-K.

Detail of Investment Banking Revenues



	Three Months Ended September 30,						Nine Months Ended September 30,
$ in millions	2020			2019			2020			2019
Institutional Securities Advisory	$	357		$	550		$	1,181		$	1,462
Institutional Securities Underwriting	1,350			985			3,721			2,696
Firm Investment banking revenues from contracts with customers	95		%	85		%	92		%	90		%

Trading Revenues by Product Type



	Three Months Ended September 30,				Nine Months Ended September 30,
$ in millions	2020		2019		2020		2019
Interest rate	$	511	$	894	$	2,593	$	2,283
Foreign exchange	138		69		603		383
Equity security and index¹	1,478		1,076		4,494		4,005
Commodity and other	495		300		1,363		986
Credit	470		269		1,778		1,124
Total	$	3,092	$	2,608	$	10,831	$	8,781


1.	Dividend income is included within equity security and index contracts.

The previous table summarizes realized and unrealized gains and losses, from derivative and non-derivative financial instruments, included in Trading revenues in the income statements. The Firm generally utilizes financial instruments across a variety of product types in connection with its market-making and related risk management strategies. The trading revenues presented in the table are not representative of the manner in which the Firm manages its business activities and are prepared in a manner similar to the presentation of trading revenues for regulatory reporting purposes.

Investment Management Investments Revenues—Net Cumulative Unrealized Carried Interest

The Firm’s portion of net cumulative performance-based fees in the form of unrealized carried interest, for which the Firm is not obligated to pay compensation, are at risk of reversing when the return in certain funds fall below specified performance targets. See Note 14 for information regarding general partner guarantees, which include potential obligations to return performance fee distributions previously received.



September 2020 Form 10-Q	86



Table of Contents
Notes to Consolidated Financial Statements (Unaudited)

Investment Management Asset Management Revenues—Reduction of Fees Due to Fee Waivers



	Three Months Ended September 30,				Nine Months Ended September 30,
$ in millions	2020		2019		2020		2019
Fee waivers	$	37	$	11	$	70	$	32

The Firm waives a portion of its fees in the Investment Management business segment from certain registered money market funds that comply with the requirements of Rule 2a-7 of the Investment Company Act of 1940.

Certain Other Fee Waivers

Separately, the Firm’s employees, including its senior officers, may participate on the same terms and conditions as other investors in certain funds that the Firm sponsors primarily for client investment, and the Firm may waive or lower applicable fees and charges for its employees.

Net Revenues by Region



	Three Months Ended September 30,				Nine Months Ended September 30,
$ in millions	2020		2019		2020		2019
Americas	$	8,387	$	7,489	$	24,798	$	22,336
EMEA	1,473		1,409		4,670		4,687
Asia	1,797		1,134		5,090		3,539
Total	$	11,657	$	10,032	$	34,558	$	30,562

For a discussion about the Firm’s geographic net revenues, see Note 21 to the financial statements in the 2019 Form 10-K.

Revenue Recognized from Prior Services



	Three Months Ended September 30,				Nine Months Ended September 30,
$ in millions	2020		2019		2020		2019
Non-interest revenues	$	556	$	841	$	1,616	$	1,995

The previous table includes revenue from contracts with customers recognized where some or all services were performed in prior periods and is primarily composed of investment banking advisory fees and distribution fees.

Receivables from Contracts with Customers

Receivables from contracts with customers, which are included within Customer and other receivables in the balance sheets, arise when the Firm has both recorded revenues and has the right per the contract to bill the customer.

Assets by Business Segment



$ in millions	At September 30, 2020		At December 31, 2019
Institutional Securities	$	704,323	$	691,201
Wealth Management	244,425		197,682
Investment Management	7,192		6,546
Total¹	$	955,940	$	895,429

1. Parent assets have been fully allocated to the business segments.



	87	September 2020 Form 10-Q



Table of Contents
Financial Data Supplement (Unaudited)

Average Balances and Interest Rates and Net Interest Income



	Three Months Ended September 30,
	2020							2019
$ in millions	Average Daily Balance		Interest			Annualized Average Rate		Average Daily Balance		Interest		Annualized Average Rate
Interest earning assets
Investment securities¹	$	133,726	$	529		1.6	%	$	104,700	$	579	2.2	%
Loans¹	144,985		967			2.7		122,320		1,208		3.9
Securities purchased under agreements to resell and Securities borrowed²:
U.S.	123,614		(99		)	(0.3	)	146,578		835		2.3
Non-U.S.	58,567		(88		)	(0.6	)	76,871		36		0.2
Trading assets, net of Trading liabilities³:
U.S.	78,417		443			2.2		78,169		630		3.2
Non-U.S.	21,092		94			1.8		17,104		98		2.3
Customer receivables and Other⁴:
U.S.	81,908		171			0.8		62,113		703		4.5
Non-U.S.	63,657		39			0.2		60,073		261		1.7
Total	$	705,966	$	2,056		1.2	%	$	667,928	$	4,350	2.6	%
Interest bearing liabilities
Deposits¹	$	236,119	$	178		0.3	%	$	179,715	$	505	1.1	%
Borrowings^{1, 5}	205,166		714			1.4		196,777		1,219		2.5
Securities sold under agreements to repurchase and Securities loaned⁶:
U.S.	30,154		81			1.1		36,335		505		5.5
Non-U.S.	28,320		84			1.2		30,111		176		2.3
Customer payables and Other⁷:
U.S.	119,846		(399		)	(1.3	)	121,800		448		1.5
Non-U.S.	64,524		(88		)	(0.5	)	65,036		279		1.7
Total	$	684,129	$	570		0.3	%	$	629,774	$	3,132	2.0	%
Net interest income and net interest rate spread			$	1,486		0.9	%			$	1,218	0.6	%



	Nine Months Ended September 30,
	2020							2019
$ in millions	Average Daily Balance		Interest			Annualized Average Rate		Average Daily Balance		Interest		Annualized Average Rate
Interest earning assets
Investment securities¹	$	122,613	$	1,603		1.7	%	$	99,782	$	1,563	2.1	%
Loans¹	142,261		3,171			3.0		118,926		3,599		4.0
Securities purchased under agreements to resell and Securities borrowed²:
U.S.	127,868		194			0.2		144,686		2,774		2.6
Non-U.S.	59,831		(124		)	(0.3	)	76,814		91		0.2
Trading assets, net of Trading liabilities³:
U.S.	76,418		1,558			2.7		77,434		1,922		3.3
Non-U.S.	22,570		344			2.0		14,362		266		2.5
Customer receivables and Other⁴:
U.S.	78,705		892			1.5		61,479		2,110		4.6
Non-U.S.	61,699		279			0.6		59,033		821		1.9
Total	$	691,965	$	7,917		1.5	%	$	652,516	$	13,146	2.7	%
Interest bearing liabilities
Deposits¹	$	223,733	$	804		0.5	%	$	178,894	$	1,460	1.1	%
Borrowings^{1, 5}	199,855		2,534			1.7		192,854		3,941		2.7
Securities sold under agreements to repurchase and Securities loaned⁶:
U.S.	30,315		501			2.2		32,479		1,489		6.1
Non-U.S.	29,315		382			1.7		31,555		527		2.2
Customer payables and Other⁷:
U.S.	123,662		(693		)	(0.7	)	116,383		1,587		1.8
Non-U.S.	64,608		(53		)	(0.1	)	65,331		881		1.8
Total	$	671,488	$	3,475		0.7	%	$	617,496	$	9,885	2.1	%
Net interest income and net interest rate spread			$	4,442		0.8	%			$	3,261	0.6	%


1.	Amounts include primarily U.S. balances.


2.	Includes fees paid on Securities borrowed.


3.	Excludes non-interest earning assets and non-interest bearing liabilities, such as equity securities.


4.	Includes Cash and cash equivalents.


5.	Includes borrowings carried at fair value, whose interest expense is considered part of fair value and therefore is recorded within Trading revenues.


6.	Includes fees received on Securities loaned. The annualized average rate was calculated using (a) interest expense incurred on all securities sold under agreements to repurchase and securities loaned transactions, whether or not such transactions were reported in the balance sheets and (b) net average on-balance sheet balances, which exclude certain securities-for-securities transactions.


7.	Includes fees received from prime brokerage customers for stock loan transactions entered into to cover customers’ short positions.



September 2020 Form 10-Q	88



Table of Contents
Glossary of Common Terms and Acronyms



2019 Form 10-K	Annual report on Form 10-K for year ended December 31, 2019 filed with the SEC

ABS	Asset-backed securities

ACL	Allowance for credit losses

AFS	Available-for-sale

AML	Anti-money laundering

AOCI	Accumulated other comprehensive income (loss)

AUM	Assets under management or supervision

Balance sheets	Consolidated balance sheets

BEAT	Base erosion and anti-abuse tax

BHC	Bank holding company

bps	Basis points; one basis point equals 1/100th of 1%

Cash flow statements	Consolidated cash flow statements

CCAR	Comprehensive Capital Analysis and Review

CCyB	Countercyclical capital buffer

CDO	Collateralized debt obligation(s), including Collateralized loan obligation(s)

CDS	Credit default swaps

CECL	Current Expected Credit Losses, as calculated under the Financial Instruments—Credit Losses accounting update

CFTC	U.S. Commodity Futures Trading Commission

CLN	Credit-linked note(s)

CLO	Collateralized loan obligation(s)

CMBS	Commercial mortgage-backed securities

CMO	Collateralized mortgage obligation(s)

CVA	Credit valuation adjustment

DVA	Debt valuation adjustment

EBITDA	Earnings before interest, taxes, depreciation and amortization



ELN	Equity-linked note(s)

EMEA	Europe, Middle East and Africa

EPS	Earnings per common share

E.U.	European Union

FDIC	Federal Deposit Insurance Corporation

FFELP	Federal Family Education Loan Program

FFIEC	Federal Financial Institutions Examination Council

FHC	Financial Holding Company

FICC	Fixed Income Clearing Corporation

FICO	Fair Isaac Corporation

Financial statements	Consolidated financial statements

FVA	Funding valuation adjustment

GILTI	Global Intangible Low-Taxed Income

G-SIB	Global systemically important banks

HELOC	Home Equity Line of Credit

HQLA	High-quality liquid assets

HTM	Held-to-maturity

I/E	Intersegment eliminations

IHC	Intermediate holding company

IM	Investment Management

Income statements	Consolidated income statements

IRS	Internal Revenue Service

IS	Institutional Securities

LCR	Liquidity coverage ratio, as adopted by the U.S. banking agencies

LIBOR	London Interbank Offered Rate

M&A	Merger, acquisition and restructuring transaction

MSBNA	Morgan Stanley Bank, N.A.

MS&Co.	Morgan Stanley & Co. LLC



	89	September 2020 Form 10-Q



Table of Contents
Glossary of Common Terms and Acronyms



MSIP	Morgan Stanley & Co. International plc

MSMS	Morgan Stanley MUFG Securities Co., Ltd.

MSPBNA	Morgan Stanley Private Bank, National Association

MSSB	Morgan Stanley Smith Barney LLC

MUFG	Mitsubishi UFJ Financial Group, Inc.

MUMSS	Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.

MWh	Megawatt hour

N/A	Not Applicable

N/M	Not Meaningful

NAV	Net asset value

Non-GAAP	Non-generally accepted accounting principles

NSFR	Net stable funding ratio, as proposed by the U.S. banking agencies

OCC	Office of the Comptroller of the Currency

OCI	Other comprehensive income (loss)

OIS	Overnight index swap

OTC	Over-the-counter

OTTI	Other-than-temporary impairment

PRA	Prudential Regulation Authority

PSU	Performance-based stock unit

RMBS	Residential mortgage-backed securities



ROE	Return on average common equity

ROTCE	Return on average tangible common equity

ROU	Right-of-use

RSU	Restricted stock unit

RWA	Risk-weighted assets

SEC	U.S. Securities and Exchange Commission

SLR	Supplementary leverage ratio

SOFR	Secured Overnight Financing Rate

S&P	Standard & Poor’s

SPE	Special purpose entity

SPOE	Single point of entry

TDR	Troubled debt restructuring

TLAC	Total loss-absorbing capacity

U.K.	United Kingdom

UPB	Unpaid principal balance

U.S.	United States of America

U.S. GAAP	Accounting principles generally accepted in the United States of America

VaR	Value-at-Risk

VIE	Variable interest entity

WACC	Implied weighted average cost of capital

WM	Wealth Management



September 2020 Form 10-Q	90



Table of Contents

Other Information

None.

Legal Proceedings

The following developments have occurred since previously reporting certain matters in the Firm’s 2019 Form 10-K, the Firm’s Quarterly Reports on Form 10-Q for the quarterly period ended March 31, 2020 (the “First Quarter Form 10-Q”) and the quarterly period ended June 30, 2020 (the “Second Quarter Form 10-Q”). See also the disclosures set forth under “Legal Proceedings” in the 2019 Form 10-K, the First Quarter Form 10-Q, and the Second Quarter Form 10-Q.

Residential Mortgage and Credit Crisis Related Matter

On July 24, 2020, the First Department in China Development Industrial Bank v. Morgan Stanley & Co. Incorporated, et al. denied the Firm’s motion for leave to appeal to the First Department’s decision denying the Firm’s motion for sanctions relating to spoliation of evidence and otherwise affirming the order of the Supreme Court of NY denying the Firm’s motion for summary judgment.

On September 2, 2020, the parties in U.S. Bank National Association, solely in its capacity as Trustee of the Morgan Stanley Mortgage Loan Trust 2007-2AX (MSM 2007-2AX) v. Morgan Stanley Mortgage Capital Holdings LLC, Successor-by-Merger to Morgan Stanley Mortgage Capital Inc. and GreenPoint Mortgage Funding, Inc. entered into a settlement agreement, which was approved in a Trust Instructional Proceeding on October 20, 2020.

European Matter

The plaintiff and the Firm are due to file final submissions in the Court of Appeal of Milan in the matter styled Banco Popolare Societá Cooperativa v. Morgan Stanley & Co. International plc & others by November 23, 2020.

Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

Three Months Ended September 30, 2020



$ in millions, except per share data	Total Number of Shares Purchased¹	Average Price Paid Per Share		Total Shares Purchased as Part of Share Repurchase Program^2,3	Dollar Value of Remaining Authorized Repurchase
July	30,610	$	48.10	—	$	—
August	560,008	$	48.90	—	$	—
September	18,360	$	52.08	—	$	—
Total	608,978	$	48.96	—


1.	Refers to shares acquired by the Firm in satisfaction of the tax withholding obligations on stock-based awards granted under the Firm’s stock-based compensation plans during the three months ended September 30, 2020.

Share purchases under publicly announced programs are made pursuant to open-market purchases, Rule 10b5-1 plans or privately negotiated transactions (including with employee benefit plans) as market conditions warrant and at prices the Firm deems appropriate and may be suspended at any time. On April 18, 2018, the Firm entered into a sales plan with Mitsubishi UFJ Financial Group, Inc. (“MUFG”). See Note 17 to the financial statements for further information on the sales plan.

The Firm’s Board of Directors has authorized the repurchase of the Firm’s outstanding stock under a share repurchase program (the “Share Repurchase Program”) from time to time as conditions warrant and subject to regulatory non-objection. The Share Repurchase Program is a program for capital management purposes that considers, among other things, business segment capital needs, as well as equity-based compensation and benefit plan requirements. The Share Repurchase Program has no set expiration or termination date.

Share repurchases by the Firm are subject to regulatory non-objection. On June 27, 2019, the Federal Reserve published summary results of CCAR and the Firm received a non-objection to its 2019 Capital Plan. The Firm’s 2019 Capital Plan includes a share repurchase of up to $6.0 billion of its outstanding common stock during the period beginning July 1, 2019 through June 30, 2020. On March 15, 2020, the Financial Services Forum announced that each of its eight member banks, including the Firm, had voluntarily suspended their share repurchase programs. As a result, $1.7 billion of share repurchase authorization expired unused on June 30, 2020. On June 25, 2020, the Federal Reserve published summary results of CCAR and announced that large BHCs, including the Firm, generally would be restricted in making share repurchases during the current quarter, and on September 30, 2020, the restrictions were extended through the fourth quarter of 2020. For further information, see “Liquidity and Capital Resources—Regulatory Requirements—Capital Plans and Stress Tests.”



	91	September 2020 Form 10-Q



Table of Contents

Controls and Procedures

Under the supervision and with the participation of the Firm’s management, including the Chief Executive Officer and Chief Financial Officer, the Firm conducted an evaluation of the effectiveness of the Firm’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Firm’s disclosure controls and procedures were effective as of the end of the period covered by this report.

No change in the Firm’s internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) occurred during the period covered by this report that materially affected, or is reasonably likely to materially affect, the Firm’s internal control over financial reporting.

Exhibits

Exhibit Index



Exhibit No.	Description

3.1	Amended and Restated Certificate of Incorporation of Morgan Stanley, as amended to date.

10.1	Form of Aircraft Time-Sharing Agreement.

15	Letter of awareness from Deloitte & Touche LLP, dated November 3, 2020, concerning unaudited interim financial information.

31.1	Rule 13a-14(a) Certification of Chief Executive Officer.

31.2	Rule 13a-14(a) Certification of Chief Financial Officer.

32.1	Section 1350 Certification of Chief Executive Officer.

32.2	Section 1350 Certification of Chief Financial Officer.

101	Interactive Data Files pursuant to Rule 405 of Regulation S-T formatted in Inline eXtensible Business Reporting Language (“Inline XBRL”).

104	Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).



September 2020 Form 10-Q	92



Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



MORGAN STANLEY (Registrant)

By:	/s/ JONATHAN PRUZAN
	Jonathan Pruzan Executive Vice President and Chief Financial Officer

By:	/s/ RAJA J. AKRAM
	Raja J. Akram Deputy Chief Financial Officer, Chief Accounting Officer and Controller

Date: November 3, 2020

S-1

EXHIBIT 3.1

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

MORGAN STANLEY

The present name of the corporation is Morgan Stanley. The corporation was incorporated under the name “Sears Acquisition Corporation” by the filing of its original Certificate of Incorporation with the Secretary of State of the State of Delaware on October 1, 1981. This Amended and Restated Certificate of Incorporation of the corporation, which restates and integrates and also further amends the provisions of the corporation’s Certificate of Incorporation, was duly adopted in accordance with the provisions of the Certificate of Incorporation and Sections 242 and 245 of the General Corporation Law of the State of Delaware by the requisite vote of the holders of the outstanding stock of the corporation entitled to vote thereon at a meeting which was called and held upon notice in accordance with Section 222 of the General Corporation Law of the State of Delaware. The Certificate of Incorporation of the corporation is hereby amended, integrated and restated to read in its entirety as follows:

ARTICLE I

Name

The name of the Corporation (which is hereafter referred to as the “Corporation”) is Morgan Stanley.

ARTICLE II

Address

The address of the Corporation’s registered office in the State of Delaware is The Corporation Trust Center, 1209 Orange Street in the City of Wilmington, County of New Castle. The name of the Corporation’s registered agent at such address is The Corporation Trust Company.

ARTICLE III

Purpose

The purpose of the Corporation shall be to engage in any lawful act or activity for which corporations may be organized and incorporated under the General Corporation Law of the State of Delaware.

ARTICLE IV

Capitalization

The total number of shares of stock which the Corporation shall have the authority to issue is three billion five hundred thirty million (3,530,000,000), consisting of thirty million (30,000,000) shares of Preferred Stock, par value $0.01 per share (hereinafter referred to as “Preferred Stock”), and three billion five hundred million (3,500,000,000) shares of Common Stock, par value $0.01 per share (hereinafter referred to as “Common Stock”).

The Preferred Stock may be issued from time to time in one or more series. The Board of Directors is hereby authorized to provide for the issuance of shares of Preferred Stock in series and, by filing a certificate pursuant to the applicable law of the State of Delaware (hereinafter referred to as a “Preferred Stock Designation”), to establish from time to time the number of shares to be included in each such series, and to fix the designation, powers, preferences and rights of the shares of each such series and the qualifications, limitations and restrictions thereof. The authority of the Board of Directors with respect to each series shall include, but not be limited to, determination of the following:

(1) The designation of the series, which may be by distinguishing number, letter or title.

(2) The number of shares of the series, which number the Board of Directors may thereafter (except where otherwise provided in the Preferred Stock Designation) increase or decrease (but not below the number of shares thereof then outstanding).

(3) The amounts payable on, and the preferences, if any, of shares of the series in respect of dividends, and whether such dividends, if any, shall be cumulative or noncumulative.

(4) Dates at which dividends, if any, shall be payable.

(5) The redemption rights and price or prices, if any, for shares of the series.

(6) The terms and amount of any sinking fund provided for the purchase or redemption of shares of the series.

(7) The amounts payable on, and the preferences, if any, of shares of the series in the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation.

(8) Whether the shares of the series shall be convertible into or exchangeable for shares of any other class or series, or any other security, of the Corporation or any other corporation, and, if so, the specification of such other class or series of such other security, the conversion or exchange price or prices or rate or rates, any adjustments thereof, the date or dates at which such shares shall be convertible or exchangeable and all other terms and conditions upon which such conversion or exchange may be made.

(9) Restrictions on the issuance of shares of the same series or of any other class or series.

(10) The voting rights, if any, of the holders of shares of the series.

The Common Stock shall be subject to the express terms of the Preferred Stock and any series thereof. Except as may be provided in this Certificate of Incorporation or in a Preferred Stock Designation or by applicable law, the holders of shares of Common Stock shall be entitled to one vote for each such share upon all questions presented to the stockholders, the Common Stock shall have the exclusive right to vote for the election of directors and for all other

purposes, and holders of Preferred Stock shall not be entitled to receive notice of any meeting of stockholders at which they are not entitled to vote. The holders of the shares of Common Stock shall at all times, except as otherwise provided in this Certificate of Incorporation or as required by law, vote as one class, together with the holders of any other class or series of stock of the Corporation accorded such general voting rights.

The Corporation shall be entitled to treat the person in whose name any share of its stock is registered as the owner thereof for all purposes and shall not be bound to recognize any equitable or other claim to, or interest in, such share on the part of any other person, whether or not the Corporation shall have notice thereof, except as expressly provided by applicable law.

The voting powers, designations, preferences and relative, participating, optional or other special rights, and the qualifications, limitations or restrictions, of the Floating Rate Non-Cumulative Preferred Stock, Series A, are set forth in Exhibit A hereto and are incorporated herein by reference.

ARTICLE V

By-Laws

In furtherance of, and not in limitation of, the powers conferred by law, the Board of Directors is expressly authorized and empowered:

(1) to adopt, amend, or repeal the Bylaws of the Corporation; provided, however, that the Bylaws adopted by the Board of Directors under the powers hereby conferred may be amended or repealed by the Board of Directors or by the stockholders having voting power with respect thereto; and

(2) from time to time to determine whether and to what extent, and at what times and places, and under what conditions and regulations, the accounts and books of the Corporation, or any of them, shall be open to inspection of stockholders; and, except as so determined or as expressly provided in this Certificate of Incorporation or in any Preferred Stock Designation, no stockholder shall have any right to inspect any account, book or document of the Corporation other than such rights as may be conferred by applicable law.

The Corporation may in its Bylaws confer powers upon the Board of Directors in addition to the foregoing and in addition to the powers and authorities expressly conferred upon the Board of Directors by applicable law.

ARTICLE VI

Action of Stockholders

Subject to the rights of the holders of any series of Preferred Stock or any other series or class of stock as set forth in this Certificate of Incorporation, any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of stockholders of the Corporation and may not be effected by any consent in writing in lieu of a meeting of such stockholders.

ARTICLE VII

Board of Directors

Subject to the rights of the holders of any series of Preferred Stock, or any other series or class of stock as set forth in this Certificate of Incorporation, to elect additional directors under specified circumstances, the number of directors of the Corporation shall be fixed in such manner as prescribed in the Bylaws of the Corporation and may be increased or decreased from time to time in such manner as prescribed by the Bylaws.

Unless and except to the extent that the Bylaws of the Corporation shall so require, the election of directors of the Corporation need not be by written ballot.

The directors, other than those who may be elected by the holders of any series of Preferred Stock or any other series or class of stock as set forth in this Certificate of Incorporation, shall be elected annually at each annual meeting of stockholders of the Corporation to hold office for a term expiring at the next annual meeting of stockholders, with each director to hold office until his or her successor shall have been duly elected and qualified.

Subject to the rights of the holders of any series of Preferred Stock, or any other series or class of stock as set forth in this Certificate of Incorporation, to elect additional directors under specified circumstances, vacancies resulting from death, resignation, retirement, disqualification, removal from office or other cause, and newly created directorships resulting from any increase in the authorized number of directors, may be filled only by the affirmative vote of a majority of the remaining directors, though less than a quorum of the Board of Directors, and directors so chosen shall hold office for a term expiring at the next annual meeting of stockholders, and until such director’s successor shall have been duly elected and qualified. No decrease in the number of authorized directors constituting the Board of Directors shall shorten the term of any incumbent director.

Any director may be removed from office at any time, with or without cause.

ARTICLE VIII

Indemnification

Each person who is or was a director or officer of the Corporation shall be indemnified by the Corporation to the fullest extent permitted from time to time by the General Corporation Law of the State of Delaware as the same exists or may hereafter be amended (but, if permitted by applicable law, in the case of any such amendment, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than said law permitted the Corporation to provide prior to such amendment) or any other applicable laws as presently or hereafter in effect. The Corporation may, by action of the Board of Directors, provide indemnification to employees and agents (other than a director or officer) of the Corporation, to directors, officers, employees or agents of a subsidiary, and to each person serving as a director, officer, partner, member, employee or agent of another corporation, partnership, limited liability company, joint venture, trust or other enterprise, at the request of the Corporation, with the same scope and effect as the foregoing indemnification of directors and officers of the Corporation. The Corporation shall be required to indemnify any person seeking indemnification in connection with a proceeding (or part thereof) initiated by such person only if such proceeding (or part thereof) was authorized by the Board of Directors or is a proceeding to enforce such person’s claim to indemnification pursuant to the rights granted by this Certificate of Incorporation or otherwise by the Corporation. Without limiting the generality or the effect of the foregoing, the Corporation may enter into one or more agreements with any person which provide for indemnification greater or different than

that provided in this Article VIII. Any amendment or repeal of this Article VIII shall not adversely affect any right or protection existing hereunder in respect of any act or omission occurring prior to such amendment or repeal.

ARTICLE IX

Directors’ Liability

A director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (1) for any breach of the director’s duty of loyalty to the Corporation or its stockholders, (2) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (3) under Section 174 of the General Corporation Law of the State of Delaware, or (4) for any transaction from which the director derived an improper personal benefit. Any amendment or repeal of this Article IX shall not adversely affect any right or protection of a director of the Corporation existing hereunder in respect of any act or omission occurring prior to such amendment or repeal.

If the General Corporation Law of the State of Delaware shall be amended, to authorize corporate action further eliminating or limiting the liability of directors, then a director of the Corporation, in addition to the circumstances in which he is not liable immediately prior to such amendment, shall be free of liability to the fullest extent permitted by the General Corporation Law of the State of Delaware, as so amended.

ARTICLE X

Amendments

Except as may be expressly provided in this Certificate of Incorporation, the Corporation reserves the right at any time and from time to time to amend, alter, change or repeal any provision contained in this Certificate of Incorporation or a Preferred Stock Designation, and any other provisions authorized by the laws of the State of Delaware at the time in force may be added or inserted, in the manner now or hereafter prescribed herein or by applicable law, and all rights, preferences and privileges of whatsoever nature conferred upon stockholders, directors or any other persons whomsoever by and pursuant to this Certificate of Incorporation in its present form or as hereafter amended are granted subject to the right reserved in this Article X; provided, however, that any amendment or repeal of Article VIII or Article IX of this Certificate of Incorporation shall not adversely affect any right or protection existing thereunder in respect of any act or omission occurring prior to such amendment or repeal, and provided further that no Preferred Stock Designation shall be amended after the issuance of any shares of the series of Preferred Stock created thereby, except in accordance with the terms of such Preferred Stock Designation and the requirements of applicable law.

IN WITNESS WHEREOF, Morgan Stanley has caused this Amended and Restated Certificate of Incorporation to be executed by its duly authorized officer on this 9th day of April, 2008.




MORGAN STANLEY

By:	/s/ Martin M. Cohen
	Name:	Martin M. Cohen
	Office:	Vice President and Counsel and Assistant Secretary

Exhibit A

DESIGNATION OF PREFERENCES AND RIGHTS OF THE

FLOATING RATE NON-CUMULATIVE PREFERRED STOCK, SERIES A

(Liquidation Preference $25,000 per share)

The designation, preferences, privileges, voting rights, and other special rights and qualifications, limitations and restrictions of the Floating Rate Non-Cumulative Preferred Stock, Series A (“Series A”) are fixed as follows:

1. Designation. The distinctive serial designation of such series of preferred stock is “Floating Rate Non-Cumulative Preferred Stock, Series A.” Each share of Series A shall be identical in all respects to every other share of Series A, except as to the respective dates from which dividends thereon shall accrue, to the extent such dates may differ as permitted pursuant to Section 4(a) below.

2. Number of Shares. The authorized number of shares of Series A shall be 46,000. Shares of Series A that are redeemed, purchased or otherwise acquired by the Corporation, or converted into another series of Preferred Stock, shall be cancelled and shall revert to authorized but unissued shares of Preferred Stock; provided that this Section 2 shall not apply to any purchase or other acquisition of shares of Series A by any subsidiary of the Corporation.

3. Definitions. As used herein with respect to Series A:

(a) “Allowable Capital” has the meaning set forth in Section 7.

(b) “Board of Directors” means the board of directors of the Corporation.

(d) “Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a day on which banking institutions in New York City generally are authorized or obligated by law, regulation or executive order to close.

(e) “Calculation Agent” means, at any time, the person or entity appointed by the Corporation and serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a successor agent at any time and from time to time, provided that the Corporation shall use its best efforts to ensure that there is, at all relevant times when the Series A is outstanding, a person or entity appointed and serving as such agent. The Calculation Agent may be a person or entity affiliated with the Corporation.

(f) “Capital Units” means the outstanding Capital Units of the Corporation and of Morgan Stanley Finance plc. Each Capital Unit consists of a subordinated debenture issued by Morgan Stanley Finance plc and guaranteed by the Corporation on a subordinated basis, and a related purchase contract issued by the Corporation that requires the holder to purchase one depositary share representing ownership of multiple shares of the Corporation’s cumulative preferred stock.

(g) “Capital Units Cumulative Preferred Stock” means shares, if any, of the Corporation’s 8.03% Cumulative Preferred Stock, par value $0.01 per share, with a stated value $200 per share, which the Corporation may issue under the terms of the outstanding Capital Units.

(h) “Certificate of Designation” means this Certificate of Designation relating to the Series A, as it may be amended or supplemented from time to time.

(i) “Certification of Incorporation” shall mean the amended and restated certificate of incorporation of the Corporation, as it may be amended from time to time, and shall include this Certificate of Designation.

(j) “Common Stock” means the common stock, par value $0.01 per share, of the Corporation.

(k) “Dividend Determination Date” means, for each Dividend Period, the second London Business Day immediately preceding the first day of such Dividend Period.

(l) “Dividend Payment Date” means January 15, April 15, July 15, and October 15 of each year.

(m) “Dividend Period” has the meaning set forth in Section 4(a).

(n) “Dividend Record Date” has the meaning set forth in Section 4(a).

(o) “Junior Stock” means any class or series of capital stock of the Corporation that ranks junior to Series A as to the payment of dividends. Junior Stock includes the Common Stock.

(p) “LIBOR” has the meaning set forth in Section 4(a).

(q) “Liquidation Preference” has the meaning set forth in Section 5(b).

(r) “London Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is a day on which dealings in U.S. dollars are transacted in the London interbank market.

(s) “Nonpayment” has the meaning set forth in Section 8(b).

(t) “Parity Stock” means any other class or series of stock of the Corporation that ranks equally with the Series A in the payment of dividends.

(u) “Preferred Stock” means any and all series of preferred stock of the Corporation, including the Series A.

(v) “Preferred Stock Directors” has the meaning set forth in Section 8(b).

(w) “Regulations” has the meaning set forth in Section 7.

(x) “Required Unrestricted Capital Provisions” has the meaning set forth in Section 7.

(y) “Tier 1 Capital Equivalent” has the meaning set forth in Section 7.

(z) “Voting Preferred Stock” means any other class or series of Preferred Stock of the Corporation ranking equally with the Series A as to the distribution of assets upon liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and are exercisable. Voting Preferred Stock includes the Capital Units Cumulative Preferred Stock, if issued, and any class or series of cumulative Preferred Stock that the Corporation may issue in the future, to the extent their like voting rights are exercisable at such time. Whether a plurality, majority or other portion of the shares of Series A and any other Voting Preferred Stock have been voted in favor of any matter shall be determined by reference to the liquidation amounts of the shares voted.

4. Dividends.

(a) Rate. Holders of Series A will be entitled to receive, when, as and if declared by the Board of Directors or a duly authorized committee of the Board of Directors, out of funds legally available for the payment of dividends under Delaware law, non-cumulative cash dividends from the original issue date (in the case of the initial Dividend Period only) or the immediately preceding Dividend Payment Date, quarterly in arrears on each Dividend Payment Date, commencing on October 15, 2006. These dividends will accrue, with respect to each Dividend Period (as defined below), on the liquidation preference amount of $25,000 per share at a rate per annum equal to the greater of (1) three-month U.S. Dollar LIBOR (as defined below) on the related Dividend Determination Date plus .70% or (2) 4%. In the event that the Corporation issues additional shares of Series A after the original issue date, dividends on such shares may accrue from the original issue date or any other date specified by the Board of Directors or an authorized committee thereof at the time such additional shares are issued.

Dividends that are payable on Series A on any Dividend Payment Date will be payable to holders of record of Series A as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or a duly authorized committee of the Board of Directors that is not more than 60 nor less than 10 days prior to such Dividend Payment Date (each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend Record Date whether or not such day is a Business Day.

For any Dividend Period, LIBOR (the London interbank offered rate) shall be determined by the Calculation Agent on the Dividend Determination Date in the following manner:

(i) LIBOR will be the rate for deposits in U.S. dollars for a period of three months, commencing on the first day of such Dividend Period, that appears on Page 3750, or any successor page, on Moneyline Telerate Inc., or any successor service, at approximately 11:00 a.m., London time, on that Dividend Determination Date.

(ii) If no such rate appears, then the Calculation Agent will request the principal London offices of each of four major reference banks in the London interbank market, as selected by the Calculation Agent after consultation with the Corporation, to provide the Calculation Agent with its offered quotation for deposits in U.S. dollars for a period of three months, commencing on the first day of such Dividend Period, to prime banks in the London interbank market at approximately 11:00 a.m., London time, on that Dividend Determination Date and in a principal amount that is representative of a single transaction in U.S. dollars in that market at that time. If at least two quotations are provided, LIBOR determined on that Dividend Determination Date will be the arithmetic mean of those quotations. If fewer than two quotations are provided, LIBOR will be determined for the first day of such Dividend Period as the arithmetic mean of the rates quoted at approximately 11:00 a.m., New York time, on that Dividend Determination Date, by three major banks in New York City, as selected by the Calculation Agent after consultation with the Corporation, for loans in U.S. dollars to leading European banks, for a period of three months, commencing on the first day of such Dividend Period, and in a principal amount that is representative of a single transaction in U.S. dollars in that market at that time. If the banks so selected by the Calculation Agent are not quoting as set forth above, LIBOR for that Dividend Determination Date will be the same as LIBOR for the immediately preceding Dividend Period, or, if there was no Dividend Period, the dividend payable will be based on the initial dividend rate.

The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends for any Dividend Period, will be maintained on file at the Corporation’s principal offices, will be made available to any stockholder upon request and will be final and binding in the absence of manifest error.

Holders of Series A shall not be entitled to any dividends, whether payable in cash, securities or other property, other than dividends (if any) declared and payable on the Series A as specified in this Section 4 (subject to the other provisions of this Certificate of Designation).

Dividends on shares of the Series A will not be cumulative. Accordingly, if the Board of Directors (or a duly authorized committee thereof) does not declare a dividend on the Series A payable in respect of any Dividend Period before the related Dividend Payment Date, such dividend will not accrue and the Corporation will have no obligation to pay a dividend for that Dividend Period on the Dividend Payment Date or at any future time, whether or not dividends on the Series A are declared for any future Dividend Period.

(b) Priority of Dividends. The Series A will rank (i) senior to the Common Stock and any class or series of the Corporation’s capital stock expressly stated to be junior to the Series A, (ii) junior to any class or series of the Corporation’s capital stock expressly stated to be senior to the Series A (issued with the requisite consent of the holders of the Series A, if required) and (iii) except as described in the following sentence, at least equally with each other class or series of Preferred Stock the Corporation may issue with respect to the payment of dividends and the distribution of assets upon liquidation, dissolution or winding up of the Corporation. The Series A will rank junior as to payment of dividends, but on a parity as to amounts payable upon liquidation, dissolution or winding up of the Corporation, with any Capital Units Cumulative Preferred Stock, any other class or series of cumulative Preferred Stock that the Corporation may issue in the future and any other class or series of Preferred Stock that the Corporation may issue in the future that is expressly stated to be senior as to payment of dividends, but on a parity as to amounts payable upon our liquidation, dissolution or winding up, to the Series A.

So long as any share of Series A remains outstanding, no dividend or distribution shall be paid or declared on Junior Stock, and no Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by the Corporation, directly or indirectly, during a Dividend Period, unless the full dividend for the latest completed Dividend Period on all outstanding shares of Series A has been declared and paid (or declared and a sum sufficient for the payment thereof has been set aside). The foregoing limitation shall not apply to:


•	repurchases, redemptions or other acquisitions of shares of Junior Stock in connection with (1) any employment contract, benefit plan or other similar arrangement with or for the benefit of any one or more employees, officers, directors or consultants or (2) a dividend reinvestment or stockholder stock purchase plan;


•	an exchange, redemption, reclassification or conversion of any class or series of Junior Stock, or any junior stock of a subsidiary of the Corporation, for any class or series of Junior Stock;


•	the purchase of fractional interests in shares of Junior Stock under the conversion or exchange provisions of Junior Stock or the security being converted or exchanged;


•	any declaration of a dividend in connection with any stockholders’ rights plan, or the issuance of rights, stock or other property under any stockholders’ rights plan, or the redemption or repurchase of rights pursuant to the plan; or


•	any dividend in the form of stock, warrants, options or other rights where the dividend stock or the stock issuable upon exercise of such warrants, options or other rights is the same stock as that on which the dividend is being paid or ranks equal or junior to that stock.

In addition, the foregoing limitation shall not restrict the ability of Morgan Stanley & Co. Incorporated, or any other affiliate of the Corporation, to engage in any market-making transactions in Junior Stock in the ordinary course of business.

When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within a related Dividend Period) in full upon the Series A and any shares of Parity Stock, all dividends declared on the Series A and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of parity stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the related Dividend Period) shall be declared pro rata so that the respective amounts of such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series A and all Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the related Dividend Period) bear to each other.

Subject to the foregoing, dividends (payable in cash, securities or other property) may be determined by the Board of Directors or a duly authorized committee of the Board of Directors and may be declared and paid on the Common Stock and any other stock ranking, as to dividends, equally with or junior to the Series A, from time to time out of any funds legally available for such payment, and the Series A shall not be entitled to participate in any such dividends.

5. Liquidation Rights.

(a) Voluntary or Involuntary Liquidation. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation, holders of Series A shall be entitled to receive out of the assets of the Corporation or proceeds thereof available for distribution to stockholders of the Corporation, after satisfaction of all liabilities, if any, to creditors of the Corporation, and before any distribution of such assets or proceeds is made to or set aside for the holders of Common Stock and any other classes or series of capital stock of the Corporation ranking junior to the Series A as to such distribution, a liquidating distribution in an amount equal to $25,000 per share, together with an amount equal to all dividends, if any, that have been declared but not paid prior to the date of payment of such distribution (but without any accumulation in respect of dividends that have not been declared prior to such payment date). Holders of the Series A Preferred Stock will not be entitled to any other amounts from the Corporation after they have received their full liquidation preference.

(b) Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation or proceeds thereof are not sufficient to pay the Liquidation Preference (as defined below) in full to all holders of Series A and all holders of any stock of the Corporation ranking equally with the Series A as to such distribution, the amounts paid to the holders of Series A and to the holders of all such other stock shall be paid pro rata in accordance with the respective aggregate Liquidation Preference of the holders of Series A and the holders of all such other stock. In any such distribution, the “Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder in such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an amount equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series A and on which dividends accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as applicable).

(c) Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series A and any other shares of the Corporation’s stock ranking equally as to such liquidation distribution, the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds thereof) according to their respective rights and preferences.

(d) Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the merger or consolidation of the Corporation with or into any other corporation or other entity, including a merger or consolidation in which the holders of Series A receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash, securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation, dissolution or winding up of the Corporation.

6. Redemption.

(a) Optional Redemption. The Series A may not be redeemed by the Corporation prior to July 15, 2011. On or after July 15, 2011, subject to obtaining any then required regulatory approval, the Corporation, at its option, may redeem, in whole at any time or in part from time to time, the shares of Series A at the time outstanding, upon notice given as provided in Section 6(c) below, at a redemption price equal to $25,000 per share, together (except as otherwise provided herein below), for the purposes of the redemption price only, with an amount equal to dividends accrued but unpaid for the then current Dividend Period at the rate set forth in Section 4(a) to, but excluding, the date fixed for redemption (regardless of whether any dividends are actually declared for that Dividend Period). The redemption price for any shares of Series A shall be payable on the

redemption date to the holder of such shares against surrender of the certificate(s) evidencing such shares to the Corporation or its agent. Any accrued and unpaid dividend for the then current Dividend Period payable on a redemption date that occurs subsequent to the Dividend Record Date for a Dividend Period shall not be paid to the holder entitled to receive the redemption price on the redemption date, but rather shall be paid to the holder of record of the redeemed shares on such Dividend Record Date relating to the Dividend Payment Date as provided in Section 4 above.

(b) No Sinking Fund. The Series A will not be subject to any mandatory redemption, sinking fund or other similar provisions. Holders of Series A will have no right to require the redemption or repurchase of any shares of Series A.

(c) Notice of Redemption. Notice of every redemption of shares of Series A shall be given by first class mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice or in the mailing thereof, to any holder of shares of Series A designated for redemption shall not affect the validity of the proceedings for the redemption of any other shares of Series A. Notwithstanding the foregoing, if the depositary shares representing interests in the Series A are issued in book-entry form through The Depository Trust Company or any other similar facility, notice of redemption may be given to the holders of Series A at such time and in any manner permitted by such facility. Each such notice given to a holder shall state: (1) the redemption date; (2) the number of shares of Series A to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be redeemed from such holder; (3) the redemption price; and (4) the place or places where certificates for such shares are to be surrendered for payment of the redemption price.

(d) Partial Redemption. In case of any redemption of only part of the shares of Series A at the time outstanding, the shares to be redeemed shall be selected either pro rata or in such other manner as the Corporation may determine to be fair and equitable. Subject to the provisions hereof, the Corporation shall have full power and authority to prescribe the terms and conditions upon which shares of Series A shall be redeemed from time to time. If fewer than all the shares represented by any certificate are redeemed, a new certificate shall be issued representing the unredeemed shares without charge to the holder thereof.

(e) Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate and apart from its other funds, in trust for the pro rata benefit of the holders of any shares of Series A so called for redemption, so as to be and continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for redemption, all shares so called for redemption shall no longer be deemed outstanding and all rights with respect to such shares shall forthwith on such redemption date cease and terminate, except only the right of the holders thereof to receive the amount payable on such redemption, without interest. Any funds unclaimed at the end of two years from the redemption date shall, to the extent permitted by law, be released to the Corporation, after which time the holders of the shares so called for redemption shall look only to the Corporation for payment of the redemption price of such shares.

7. Conversion Upon Regulatory Changes. If both (i) and (ii) below occur:

(i) after June 26, 2006, the Corporation (by election or otherwise) becomes subject to any law, rule, regulation or guidance (together, “Regulations”) relating to its capital adequacy, which Regulation (x) modifies the existing requirements for treatment as Allowable Capital (as defined under the Securities and Exchange Commission rules relating to consolidated supervised entities as in effect from time to time), (y) provides for a type or level of capital characterized as “Tier 1” or its equivalent pursuant to Regulations of any governmental agency, authority or other body having regulatory jurisdiction over the Corporation (or any of its subsidiaries or consolidated affiliates) and implementing the capital standards published by the Basel Committee on Banking Supervision, the Securities and Exchange Commission, the Board of Governors of the Federal Reserve System or any other United States national governmental agency, authority or other body, or any other applicable regime based on capital standards published by the Basel Committee on Banking Supervision or its successor, or (z) provides for a type or level of capital that in the judgment of the Corporation (after consultation with legal counsel of recognized standing) is substantially equivalent to such “Tier 1” capital (such capital described in either (y) or (z) above is referred to below as “Tier 1 Capital Equivalent”), and

(ii) the Corporation affirmatively elects to qualify the Series A for treatment as Allowable Capital or Tier 1 Capital Equivalent without any sublimit or other quantitative restriction on the inclusion of the Series A in Allowable Capital or Tier 1 Capital Equivalent (other than any limitation the Corporation elects to accept and any limitation requiring that common equity or a specified form of common equity constitute the dominant form of Allowable Capital or Tier 1 Capital Equivalent) under such Regulations,

then, upon such affirmative election, the Series A shall be convertible at the Corporation’s option into a new series of Preferred Stock having terms and provisions substantially identical to those of the Series A, except that such new series may have such additional or modified rights, preferences, privileges and voting powers, and limitations and restrictions thereof, as are necessary in the judgment of the Board of Directors or a duly authorized committee of the Board of Directors (after consultation with legal counsel of recognized standing) to comply with the Required Unrestricted Capital Provisions (as defined below), provided that the Corporation shall not cause any such conversion unless the Board of Directors or a duly authorized committee of the Board of Directors determines that the rights, preferences, privileges and voting powers, and the qualifications, limitations and restrictions thereof, of such new series of Preferred Stock, taken as a whole, are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and the qualifications, limitations and restrictions thereof, of the Series A, taken as a whole.

As used above, the term “Required Unrestricted Capital Provisions” means such terms and provisions as are, in the judgment of the Board of Directors or a duly authorized committee of the Board of Directors (after consultation with counsel of recognized standing), required for preferred stock to be treated as Allowable Capital or Tier 1 Capital Equivalent, as applicable, without any sublimit or other quantitative restriction on the inclusion of such preferred stock in Allowable Capital or Tier 1 Capital Equivalent, as applicable (other than any limitation the Corporation elects to accept and any limitation requiring that common equity or a specified form of common equity constitute the dominant form of Allowable Capital or Tier 1 Capital Equivalent) pursuant to the applicable Regulations.

The Corporation shall provide notice to the holders of Series A of any election to qualify the Series A for Allowable Capital or Tier 1 Capital Equivalent treatment and of any determination to convert the Series A into a new series of Preferred Stock pursuant to the terms of this Section 7, promptly upon the effectiveness of any such election or determination. A copy of such notice and of the relevant Regulations shall be maintained on file at the principal offices of the Corporation and, upon request, will be made available to any stockholder of the Corporation. Any conversion of the Series A pursuant to this Section 7 shall be effected pursuant to such procedures as the Corporation may determine and publicly disclose.

Except as specified in this Section 7, holders of Series A shares shall have no right to exchange or convert such shares into any other securities.

8. Voting Rights.

(a) General. The holders of Series A shall not have any voting rights except as set forth below and as determined by the Board of Directors or an authorized committee thereof or as otherwise from to time required by law.

(b) Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any shares of the Series A, or any other Voting Preferred Stock, shall have not been declared and paid for the equivalent of six or more dividend payments, whether or not for consecutive dividend periods (a “Nonpayment”), the holders of such shares, voting together as a class with holders of any and all other series of Voting Preferred Stock then outstanding, will be entitled to vote for the election of a total of two additional members of the Board of Directors (the “Preferred Stock Directors”), provided that the election of any such directors shall not cause the Corporation to violate the corporate governance requirement of the New York Stock Exchange (or any other exchange on which the Corporation’s securities may be listed) that listed companies must have a majority of independent directors and provided further that the Board of Directors shall at no time include more than two Preferred Stock Directors. In that event, the number of directors on the Board of Directors shall automatically increase by two, and the new directors shall be elected at a special meeting called at the request of the holders of record of at least 20% of the Series A or of any other series of Voting Preferred Stock (unless such request is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held at such next annual or special meeting of stockholders), and at each subsequent annual meeting. Such request to call a special meeting for the initial election of the Preferred Stock Directors after a Nonpayment shall be made by written notice, signed by the requisite holders of Series A or other Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner as provided for in Section 10 below, or as may otherwise be required by law. The voting rights will continue until dividends on the shares of the Series A and any such series of Voting Preferred Stock shall have been fully paid (or declared and a sum sufficient for the payment of such dividends shall have been set aside for such payment) for at least four regular dividend periods following the Nonpayment.

If and when dividends for at least four regular dividend periods following a Nonpayment have been fully paid (or declared and a sum sufficient for such payment shall have been set aside) on the Series A and any other class or series of Voting Preferred Stock, the holders of the Series A and all other holders of Voting Preferred Stock shall be divested of the foregoing voting rights (subject to revesting in the event of each subsequent Nonpayment), the term of office of each Preferred Stock Director so elected shall terminate and the number of directors on the Board of Directors shall automatically decrease by two. In determining whether dividends have been paid for at least four regular dividend periods following a Nonpayment, the Corporation may take account of any dividend it elects to pay for any dividend period after the regular dividend date for that period has passed. Any Preferred Stock Director may be removed at any time without cause by the holders of record of a

majority of the outstanding shares of the Series A together with all series of Voting Preferred Stock then outstanding (voting together as a single class) to the extent such holders have the voting rights described above. So long as a Nonpayment shall continue, any vacancy in the office of a Preferred Stock Director (other than prior to the initial election after a Nonpayment) may be filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of the holders of record of a majority of the outstanding shares of Series A and all Voting Preferred Stock when they have the voting rights described above (voting together as a single class). The Preferred Stock Directors shall each be entitled to one vote per director on any matter.

(c) Other Voting Rights. So long as any shares of Series A are outstanding, in addition to any other vote or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at least two-thirds of the shares of Series A and any Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for the purpose, shall be necessary for effecting or validating:

(i) Authorization of Senior Stock. Any amendment or alteration of the provisions of the Certificate of Incorporation or this Certificate of Designation to authorize or create, or increase the authorized amount of, any shares of any class or series of stock of the Corporation ranking senior to the Series A with respect to the distribution of assets upon any liquidation, dissolution or winding up of the Corporation;

(ii) Amendment of Series A. Any amendment, alteration or repeal of any provision of the Certificate of Incorporation or this Certificate of Designation, whether by merger, consolidation or otherwise, so as to materially and adversely affect the special rights, preferences, privileges and voting powers of the Series A, taken as a whole; or

(iii) Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a binding share exchange or reclassification involving the Series A, or of a merger or consolidation of the Corporation with another entity, unless in each case (x) the shares of Series A remain outstanding or, in the case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights, preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers of the Series A, taken as a whole;

provided, however, that for all purposes of this Section 8(c), any increase in the amount of the authorized or issued Series A or the creation and issuance, or an increase in the authorized or issued amount, of any other class or series of Preferred Stock ranking equally with the Series A with respect to the distribution of assets upon liquidation, dissolution or winding up of the Corporation and ranking senior to or equally with the Series A with respect to the payment of dividends will not be deemed to adversely affect the rights, preferences, privileges or voting powers of, and will not require the affirmative vote or consent of, the holders of outstanding shares of Series A. In addition, any conversion of the Series A pursuant to Section 7 above shall not be deemed to adversely affect the rights, preferences, privileges and voting powers of the Series A.

If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in this Section 8(c) would adversely affect one or more but not all other series of Voting Preferred Stock (including the Series A for this purpose), then only such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the matter together as a class in lieu of all other series of Preferred Stock. If all series of a class of Preferred Stock are not equally affected by the proposed amendment, alteration, repeal, share exchange, reclassification, merger or consolidation described above, there shall be required a two-thirds approval of the class and a two-thirds approval of each series that will have a diminished status.

(d) Changes for Clarification. Without the consent of the holders of the Series A, so long as such action does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of the Series A, the Corporation may amend, alter, supplement or repeal any terms of the Series A:

(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of Designation that may be defective or inconsistent; or

(ii) to make any provision with respect to matters or questions arising with respect to the Series A that is not inconsistent with the provisions of this Certificate of Designation.

(e) Changes after Provision for Redemption. No vote or consent of the holders of Series A shall be required pursuant to Section 8(b), (c) or (d) above if, at or prior to the time when the act with respect to which any such vote or consent would otherwise be required pursuant to such Section, all outstanding shares of Series A shall have been redeemed, or shall have been called for redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to Section 6 above.

(f) Procedures for Voting and Consents. The rules and procedures for calling and conducting any meeting of the holders of Series A (including, without limitation, the fixing of a record date in connection therewith), the solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard to such a meeting or such consents shall be governed by any rules the Board of Directors or a duly authorized committee of the Board of Directors, in its discretion, may adopt from time to time, which rules and procedures shall conform to the requirements of the Certificate of Incorporation, the Bylaws, applicable law and any national securities exchange or other trading facility on which the Series A is listed or traded at the time. Whether the vote or consent of the holders of a plurality, majority or other portion of the shares of Series A and any Voting Preferred Stock has been cast or given on any matter on which the holders of shares of Series A are entitled to vote shall be determined by the Corporation by reference to the specified liquidation amounts of the shares voted or covered by the consent.

9. Record Holders. To the fullest extent permitted by applicable law, the Corporation and the transfer agent for the Series A may deem and treat the record holder of any share of Series A as the true and lawful owner thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.

10. Notices. All notices or communications in respect of Series A shall be sufficiently given if given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be permitted in this Certificate of Designation, in the Certificate of Incorporation or Bylaws or by applicable law.

11. No Preemptive Rights. No share of Series A shall have any rights of preemption whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto, regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.

12. Other Rights. The shares of Series A shall not have any voting powers, preferences or relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set forth herein or in the Certificate of Incorporation or as provided by applicable law.

CERTIFICATE OF DESIGNATIONS OF PREFERENCES AND RIGHTS

OF THE

10% SERIES B NON-CUMULATIVE NON-VOTING PERPETUAL

CONVERTIBLE PREFERRED STOCK

($1,000 LIQUIDATION PREFERENCE PER SHARE)

MORGAN STANLEY

Pursuant to Section 151 of the

General Corporation Law of the State of Delaware

MORGAN STANLEY, a Delaware corporation (the “Corporation”), DOES HEREBY CERTIFY that, pursuant to resolutions of the Preferred Stock Financing Committee of the Board of Directors of the Corporation adopted on September 28, 2008, the creation of Series B Non-Cumulative Non-Voting Perpetual Convertible Preferred Stock, par value $0.01 per share, liquidation preference $1,000 per share (“Series B”) of the Corporation was authorized and the designation, preferences, privileges, voting rights, and other special rights and qualifications, limitations and restrictions of the Series B, in addition to those set forth in the Certificate of Incorporation and Bylaws of the Corporation, are fixed as follows:

1. Designation. The distinctive serial designation of such series of preferred stock is “Series B Non-Cumulative Non-Voting Perpetual Convertible Preferred Stock.” Each share of Series B shall be identical in all respects to every other share of Series B, except as to the respective dates from which dividends thereon shall accrue, to the extent such dates may differ as permitted pursuant to Section 3 below.

2. Number of Shares. The authorized number of shares of Series B shall be 6,045,750. Shares of Series B that are purchased or otherwise acquired by the Corporation, or converted into Common Stock or another series of Preferred Stock, shall be cancelled and shall revert to authorized but unissued shares of Preferred Stock provided that this Section 2 shall not apply to any purchase or other acquisition of shares of Series B by any Subsidiary of the Corporation.

3. Dividends.

be payable shall not be a Business Day (as defined below), then the date of payment of dividends need not be made on such date, but such payment of dividends may be made on the next succeeding day that is a Business Day with the same force and effect as if made on the Dividend Payment Date, and no additional dividends shall be payable nor shall interest accrue on the amount payable from and after such Dividend Payment Date to the next succeeding Business Day. “Business Day” means any day that is not a Saturday or Sunday and that, in New York City, is not a day on which banking institutions generally are authorized or obligated by law or executive order to be closed.

Dividends on the Series B shall not be cumulative; Holders of Series B shall not be entitled to receive any dividends not declared by the Board of Directors or a duly authorized committee thereof and no interest, or sum of money in lieu of interest, shall be payable in respect of any dividend not so declared. Accordingly, if the Board of Directors (or a duly authorized committee thereof) does not declare a dividend on the Series B payable in respect of any Dividend Period before the related Dividend Payment Date, such dividend will not accrue and the Corporation will have no obligation to pay a dividend for that Dividend Period on that Dividend Payment Date or at any future time, whether or not dividends on the Series B are declared for any future Dividend Period. Declared and unpaid dividends shall not bear interest.

Dividends that are payable on the Series B on any Dividend Payment Date will be payable to holders of record of Series B as they appear on the stock register of the Corporation on the applicable Dividend Record Date, which shall be the 15th calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or a duly authorized committee of the Board of Directors that is not more than 60 nor less than 10 days prior to such Dividend Payment Date (each,

a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend Record Date whether or not such day is a Business Day.

The term “Dividend Period” means the period from and including each Dividend Payment Date to but excluding the next succeeding Dividend Payment Date (other than the initial Dividend Period, which shall commence on and include the date of initial issuance of the Series B and shall end on but exclude the next Dividend Payment Date). Dividends payable on the Series B shall be computed on the basis of a 360-day year consisting of twelve 30-day months.

(b) Priority of Dividends. The Series B will rank (i) senior to the Common Stock (as defined below) and any class or series of the Corporation’s capital stock expressly stated to be junior to the Series B, (ii) junior to any class or series of the Corporation’s capital stock expressly stated to be senior to the Series B (issued with the requisite consent of the Holders of the Series B, if required) and (iii) at least equally with each other class or series of Preferred Stock (as defined below) that the Corporation may issue with respect to the payment of dividends and the distribution of assets upon liquidation, dissolution or winding up of the Corporation. So long as any share of Series B remains outstanding, no dividend or distribution shall be paid or declared on Junior Stock, and no Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by the Corporation, directly or indirectly, during a Dividend Period, unless the full dividend for the latest completed Dividend Period on all outstanding shares of Series B has been declared and paid (or declared and a sum sufficient for the payment thereof has been set aside). The foregoing limitation shall not apply to (i) repurchases, redemptions or other acquisitions of shares of Junior Stock in connection with (1) any employment contract, benefit plan or other similar arrangement with or for the benefit of any one or more employees, officers, directors or consultants or (2) a dividend reinvestment or stockholder stock purchase plan; (ii) an exchange, redemption, reclassification or conversion of any class or series of Junior Stock, or any junior stock of a Subsidiary of the Corporation, for any class or series of Junior Stock; (iii) the purchase of fractional interests in shares of Junior Stock under the conversion or exchange provisions of Junior Stock or the security being converted or exchanged; (iv) any declaration of a dividend in connection with any stockholders’ rights plan, or the issuance of rights, stock or other property under any stockholders’ rights plan, or the redemption or repurchase of rights pursuant to the plan; or (v) any dividend in the form of stock, warrants, options or other rights where the dividend stock or the stock issuable upon exercise of such warrants, options or other rights is the same stock as that on which the dividend is being paid or ranks equal or junior to that stock. In addition, the foregoing limitation shall not restrict the ability of Morgan Stanley & Co. Incorporated, or any other affiliate of the Corporation, to engage in any market-making transactions in Junior Stock in the ordinary course of business.

When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within a related Dividend Period) in full upon the Series B and any shares of Parity Stock, all dividends declared on the Series B and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the related Dividend Period) shall be declared pro rata so that the respective amounts of such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series B and all Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the related Dividend Period) bear to each other.

Subject to the foregoing, dividends (payable in cash, securities or other property) may be determined by the Board of Directors or a duly authorized committee of the Board of Directors and may be declared and paid on the Common Stock and any other stock ranking, as to dividends, equally with or junior to the Series B, from time to time out of any funds legally available for such payment, and the Series B shall not be entitled to participate in any such dividends.

4. Liquidation Rights.

any, to creditors of the Corporation and subject to the rights of holders of any shares of capital stock of the Corporation then outstanding ranking senior to or pari passu with the Series B in respect of distributions upon liquidation, dissolution or winding up of the Corporation, and before any distribution of such assets or proceeds is made to or set aside for the holders of Common Stock and any other classes or series of capital stock of the Corporation ranking junior to the Series B as to such distribution, a liquidating distribution in an amount equal to $1,000 per share, together with an amount equal to all dividends, if any, that have been declared but not paid prior to the date of payment of such distribution (but without any accumulation in respect of dividends that have not been declared prior to such payment date). Holders of the Series B will not be entitled to any other amounts from the Corporation after they have received their full liquidation preference.

(b) Partial Payment. If in any distribution described in Section 4(a) above the assets of the Corporation or proceeds thereof are not sufficient to pay the Liquidation Preference (as defined below) in full to all Holders of Series B and all holders of any stock of the Corporation ranking equally with the Series B as to such distribution, the amounts paid to the Holders of Series B and to the holders of all such other stock shall be paid pro rata in accordance with the respective aggregate Liquidation Preference of the Holders of Series B and the holders of all such other stock. In any such distribution, the “Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder in such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an amount equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series B and on which dividends accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as applicable). Holders of the Series B will not be entitled to any other amounts from the Corporation after they have received the full amounts provided for in this Section 4 and will have no right or claim to any of the Corporation’s remaining assets.

(c) Residual Distributions. If the Liquidation Preference on the Series B and any other shares of the Corporation’s stock ranking equally as to such liquidation distribution has been paid in full, the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds thereof) according to their respective rights and preferences.

(d) Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 4, the merger or consolidation of the Corporation with or into any other corporation or other entity, including a merger or consolidation in which the Holders of Series B receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash, securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation, dissolution or winding up of the Corporation.

5. Voting Rights.

(a) General. The Holders of Series B shall not have any voting rights except as set forth below and as determined by the Board of Directors or an authorized committee thereof or as otherwise from time to time required by law.

(b) Right to Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any shares of the Series B, or any other Voting Preferred Stock, shall have not been declared and paid for the equivalent of six or more Dividend Periods, whether or not for consecutive Dividend Periods (a “Nonpayment”), the holders of such shares, voting together as a class with holders of any and all other series of Voting Preferred Stock then outstanding, will be entitled to vote for the election of a total of two additional members of the Board of Directors (the “Preferred Stock Directors”); provided that the election of any such directors shall not cause the Corporation to violate the corporate governance requirements of the New York Stock Exchange (or any other exchange on which the Corporation’s securities may be listed) that listed companies must have a majority of independent directors; and provided further that the Board of Directors shall at no time include more than two Preferred Stock Directors. In that event, the number of directors on the Board of Directors shall automatically increase by two, and the new directors shall be elected at a special meeting called at the request of the holders of record of at least 20% of the Series B or of any other series of Voting Preferred Stock (unless such request is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held at such next annual or special meeting of stockholders), and at each subsequent annual meeting. Such request to call a special meeting for the initial election of the Preferred Stock Directors after a Nonpayment shall be made by written notice, signed by the requisite holders of Series B or other Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner as provided for in Section 16 below, or as may otherwise be required by law. The voting rights will continue until dividends on the shares of the Series B and any such series of Voting Preferred Stock shall have been fully paid (or declared and a sum sufficient for the payment of such dividends shall have been set aside for such payment) for at least four regular dividend periods following the Nonpayment.

If and when dividends for at least four regular dividend periods following a Nonpayment have been fully paid (or declared and a sum sufficient for such payment shall have been set aside) on the Series B and any other class or series of Voting Preferred Stock, the holders of the Series B and all other holders of Voting Preferred Stock shall be divested of the foregoing voting rights (subject to revesting in the event of each subsequent Nonpayment), the term of office of each Preferred Stock Director so elected shall terminate and the number of directors on the Board of Directors shall automatically decrease by two. In determining whether dividends have been paid for at least four regular dividend periods following a Nonpayment, the Corporation may take account of any dividend it elects to pay for any dividend period after the regular dividend date for that period has passed.

vacancy in the office of a Preferred Stock Director (other than prior to the initial election after a Nonpayment) may be filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of the holders of record of a majority of the outstanding shares of Series B and all Voting Preferred Stock when they have the voting rights described above (voting together as a single class); provided that the filling of each vacancy shall not cause the Corporation to violate the corporate governance requirements of the New York Stock Exchange (or any other exchange on which the Corporation’s securities may be listed) that listed companies must have a majority of independent directors. Any such vote to remove, or to fill a vacancy in the office of, a Preferred Stock Director may be taken only at a special meeting called at the request of the holders of record of at least 20% of the Series B or of any other series of Voting Preferred Stock (unless such request is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held at such next annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to one vote per director on any matter.

The term “Voting Preferred Stock” means any other class or series of Preferred Stock of the Corporation ranking equally with the Series B as to payment of dividends and the distribution of assets upon liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and are exercisable. Voting Preferred Stock includes the Corporation’s Floating Rate Non-Cumulative Preferred Stock, Series A (the “Series A”), if outstanding, and any class or series of Preferred Stock, whether or not cumulative, that the Corporation may issue in the future, to the extent their like voting rights are exercisable at such time. Whether a plurality, majority or other portion of the shares of Series B and any other Voting Preferred Stock have been voted in favor of any matter shall be determined by reference to the relative liquidation preferences of the shares voted.

(c) Other Voting Rights. So long as any shares of Series B are outstanding, in addition to any other vote or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at least two-thirds of the shares of Series B and any Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for the purpose, shall be necessary for effecting or validating:

(i) Authorization of Senior Stock. Any amendment or alteration of the provisions of the Certificate of Incorporation or this Certificate of Designations to authorize or create, or increase the authorized amount of, any shares of any class or series of stock of the Corporation ranking senior to the Series B with respect to the payment of dividends or the distribution of assets upon any liquidation, dissolution or winding up of the Corporation;

(ii) Amendment of Series B. Any amendment, alteration or repeal of any provision of the Certificate of Incorporation or this Certificate of Designations, whether by merger, consolidation or otherwise, so as to materially and adversely affect the special rights, preferences, privileges and voting powers of the Series B, taken as a whole; or

(iii) Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a binding share exchange or reclassification involving the Series B, or of a merger or consolidation of the Corporation with another entity, unless in each case (x) the shares of Series B remain outstanding or are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate parent, and (y) such shares remaining outstanding as securities of the Corporation or such other entity as permitted by clause (x) or such preference securities, as the case may be, have such rights, preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers of the Series B, taken as a whole;

provided, however, that for all purposes of this Section 5(c), neither the issuance of any Series B in accordance with the terms of the Securities Purchase Agreement (as defined below) as in effect on the date hereof nor the creation and issuance, or an increase in the authorized or issued amount, of any other class or series of Preferred Stock ranking equally with the Series B with respect to the payment of dividends (whether such dividends are cumulative or non-cumulative) and the distribution of assets upon liquidation, dissolution or winding up of the Corporation will be deemed to adversely affect the rights, preferences, privileges or voting powers of, and neither will require the affirmative vote or consent of, the holders of outstanding shares of Series B. In addition, any conversion of the Series B pursuant hereto shall not be deemed to adversely affect the rights, preferences, privileges and voting powers of the Series B. For purposes of clarification, no Holder of Series B shall have any voting rights with respect to any binding share exchange, reclassification, merger or consolidation which complies with the provisions of clause (iii)(x) and (y) hereof.

Stock. If all series of a class of Preferred Stock that are otherwise entitled to vote on the matter are not equally affected by the proposed amendment, alteration, repeal, share exchange, reclassification, merger or consolidation described above, there shall be required a two-thirds approval of the class and a two-thirds approval of each series that will have a diminished status and that is otherwise entitled to vote thereon.

(d) Changes for Clarification. Without the consent of the holders of the Series B, so long as such action does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of the Series B, the Corporation may amend, alter, supplement or repeal any terms of the Series B:

(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of Designations that may be defective or inconsistent; or

(ii) to make any provision with respect to matters or questions arising with respect to the Series B that is not inconsistent with the provisions of this Certificate of Designations.

(e) Procedures for Voting and Consents. The rules and procedures for calling and conducting any meeting of the holders of Series B (including, without limitation, the fixing of a record date in connection therewith), the solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard to such a meeting or such consents shall be governed by any rules the Board of Directors or a duly authorized committee of the Board of Directors, in its discretion, may adopt from time to time, which rules and procedures shall conform to the requirements of the Certificate of Incorporation, the Bylaws, applicable law and any national securities exchange or other trading facility on which the Series B is listed or traded at the time. Whether the vote or consent of the holders of a plurality, majority or other portion of the shares of Series B and any Voting Preferred Stock has been cast or given on any matter on which the holders of shares of Series B are entitled to vote shall be determined by the Corporation by reference to the specified liquidation amounts of the shares voted or covered by the consent.

6. Redemption. The shares of Series B shall not be redeemable.

7. Rank. Any stock of any class or classes or series of the Corporation shall be deemed to rank:

(a) prior to shares of the Series B, either as to dividends or upon liquidation, dissolution or winding up, or both, if the holders of stock of such class or classes or series shall be entitled by the terms thereof to the receipt of dividends or of amounts distributable upon liquidation, dissolution or winding up, as the case may be, in preference or priority to the Holders of shares of the Series B;

(b) on a parity with shares of the Series B, either as to dividends or upon liquidation, dissolution or winding up, or both, whether or not the dividend rates, dividend payment dates, or redemption or liquidation prices per share thereof be different from those of the Series B, if the holders of stock of such class or classes or series shall be entitled by the terms thereof to the receipt of dividends or of amounts distributed upon liquidation, dissolution or winding up, as the case may be, in proportion to their respective dividend rates or liquidation prices, without preference or priority of one over the other as between the holders of such stock and the Holders of shares of Series B (the term “Parity Preferred Stock” being used to refer to any stock on a parity with the shares of Series B, either as to dividends or upon liquidation, dissolution or winding up, or both, as the content may require); and

(c) junior to shares of the Series B, either as to dividends or upon liquidation, dissolution or winding up, or both, if such class or classes or series shall be common stock or if the Holders of the Series B shall be entitled to the receipt of dividends or of amounts distributable upon liquidation, dissolution or winding up, as the case may be, in preference or priority to the holders of stock of such class or classes or series.

The Series B shall rank, as to dividends and upon liquidation, dissolution or winding up, on a parity with the Series A and any Parity Preferred Stock issued hereafter.

8. Additional Definitions. As used herein with respect to Series B:

“Capital Stock” of any Person means any and all shares, interests, rights to purchase, warrants, options, participations or other equivalents of or interests in (however designated) equity of such Person, including any preferred stock, excluding any debt securities convertible into such equity.

“Cash” means such coin or currency of the United States as at any time of payment is legal tender for the payment of public and private debts.

“Close of Business” means 5:00 p.m., New York City time.

“Closing Price” of the Common Stock or any securities distributed in a Spin-Off, as the case may be, means, as of any date of determination:

(a) the closing price on that date or, if no closing price is reported, the last reported sale price, of shares of the Common Stock or such other securities on the New York Stock Exchange on that date; or

(b) if the Common Stock or such other securities are not traded on the New York Stock Exchange, the closing price on that date as reported in composite transactions for the principal U.S. national or regional securities exchange on which the Common Stock or such other securities are so traded or, if no closing price is reported, the last reported sale price of shares of the Common Stock or such other securities on the principal U.S. national or regional securities exchange on which the Common Stock or such other securities are so traded on that date; or

(c) if the Common Stock or such other securities are not traded on a U.S. national or regional securities exchange, the last quoted bid price on that date for the Common Stock or such other securities in the over-the-counter market as reported by Pink Sheets LLC or a similar organization; or

(d) if the Common Stock or such other securities are not so quoted by Pink Sheets LLC or a similar organization, the market price of the Common Stock or such other securities on that date as determined by a nationally recognized independent investment banking not affiliated with the Corporation retained by the Corporation for this purpose.

For the purposes of this Certificate of Designations, all references herein to the closing price and the last reported sale price of the Common Stock on the New York Stock Exchange shall be such closing price and last reported sale price as reflected on the website of the New York Stock Exchange (www.nyse.com) and as reported by Bloomberg Professional Service; provided that in the event that there is a discrepancy between the closing price and the last reported sale price as reflected on the website of the New York Stock Exchange and as reported by Bloomberg Professional Service, the closing price and the last reported sale price on the website of the New York Stock Exchange shall govern.

“Common Stock” means the common stock, $0.01 par value, of the Corporation.

“Conversion Agent” shall mean BNY Mellon Shareowner Services, acting in its capacity as conversion agent for the Series B, and its successors and assigns or any other conversion agent appointed by the Corporation.

“Conversion Date” means each of a Mandatory Conversion Date and a Non-Mandatory Conversion Date.

“Conversion Price” at any time means for each share of Series B the price equal to $1,000 divided by the Conversion Rate in effect at such time (initially $31.25).

“Conversion Rate” means initially 32 shares of Common Stock per share of Series B, subject to adjustment in accordance with the provisions of this Certificate of Designations.

“Depositary” means DTC or its nominee or any successor depositary appointed by the Corporation.

“DTC” means The Depository Trust Company, together with its successors and assigns.

“Exchange Act” means the Securities Exchange Act of 1934, as amended.

“Ex-Dividend Date” means the first date on which the Common Stock trades, regular way, on the relevant exchange, or in the relevant market from which the Closing Price was obtained, without the right to receive such dividend or distribution.

“Fair Market Value” means the amount which a willing buyer would pay a willing seller in an arm’s-length transaction as determined by the Board of Directors.

“Full Mandatory Conversion Date” means the 3rd Trading Day immediately following the first date after the second anniversary of the Issue Date as of which, for 20 Trading Days within any period of 30 consecutive Trading Days beginning after such second anniversary and preceding such date, the Closing Price of the Common Stock has exceeded 150% of the then applicable Conversion Price.

“Fundamental Change” means the occurrence, prior to the Full Mandatory Conversion Date, of one of the following:

(i) a “person” or “group” within the meaning of Section 13( d) of the Exchange Act files a Schedule TO or any schedule, form or report under the Exchange Act disclosing that such person or group has become the direct or indirect ultimate “beneficial owner,” as defined in Rule 13d-3 under the Exchange Act, of common equity of the Corporation representing more than 50% of the voting power of the outstanding Common Stock;

(ii) consummation of any consolidation or merger of the Corporation or similar transaction or any sale, lease or other transfer in one transaction or a series of transactions of all or substantially all of the consolidated assets of the Corporation and its subsidiaries, taken as a whole, to any Person other than one of the Corporation’s subsidiaries, in each case pursuant to which the Common Stock will be converted into, or receive a distribution of the proceeds in, cash, securities or other property, other than pursuant to a transaction in which the Persons that “beneficially owned” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, voting shares of the Corporation immediately prior to such transaction beneficially own, directly or indirectly, voting shares representing a majority of the total voting power of all outstanding classes of voting shares of the continuing or surviving Person or the ultimate parent entity thereof immediately after the transaction; or

(iii) shares of the Common Stock or shares of any other stock into which the Series B is convertible are not listed for trading on any United States national securities exchange or cease to be traded in contemplation of a delisting (other than as a result of a transaction described in clause (ii) above);

provided, however, that a Fundamental Change with respect to clauses (i) and (ii) above will not be deemed to have occurred if at least 90% of the consideration received by holders of the Common Stock in the transaction or transactions consists of shares of common stock or American Depositary Receipts in respect of common stock that are traded on a U.S. national securities exchange or that will be so traded when issued or exchanged in connection with a Fundamental Change; and provided, further, that with respect to any shares of Series B that are beneficially owned by the Initial Holder or its affiliates, a Fundamental Change with respect to clauses (i) or (ii) above will not be deemed to have occurred if the Initial Holder or any of its affiliates is part of the person or group referred to in clause (i) above or is a counterparty to the Corporation in any of the transactions referred to in clause (ii) above.

“Holder” means the Person in whose name the shares of Series B are registered, which may be treated by the Corporation, Transfer Agent, Registrar, dividend disbursing agent and Conversion Agent as the absolute owner of the shares of Series B for the purpose of disbursing dividends and settling conversions and for all other purposes.

“Initial Holder” means Mitsubishi UFJ Financial Group, Inc.

“Issue Date” means the date of original issuance of any share of Series B.

“Junior Stock” means any class or series of capital stock of the Corporation that ranks junior to Series B as to the payment of dividends and rights in dissolution, liquidation and winding up of the Corporation. Junior Stock includes the Common Stock.

“Make-Whole Acquisition” means the occurrence, prior to the Full Mandatory Conversion Date, of one of the following:

(i) a “person” or “group” within the meaning of Section 13(d) of the Exchange Act files a Schedule TO or any schedule, form or report under the Exchange Act disclosing that such person or group has become the direct or indirect ultimate “beneficial owner,” as defined in Rule 13d-3 under the Exchange Act, of common equity of the Corporation representing more than 50% of the voting power of the outstanding Common Stock; or

(ii) consummation of any consolidation or merger of the Corporation or similar transaction or any sale, lease or other transfer in one transaction or a series of transactions of all or substantially all of the consolidated assets of the Corporation and its subsidiaries, taken as a whole, to any Person other than one of the Corporation’s subsidiaries, in each case pursuant to which the Common Stock will be converted into, or receive distributions of the proceeds in, cash, securities or other property, other than pursuant to a transaction in which the Persons that “beneficially owned” (as defined in Rule 13d-3 under the Exchange Act) directly or indirectly, voting shares of the Corporation immediately prior to such transaction beneficially own, directly or indirectly, voting shares representing a majority of the total voting power of all outstanding classes of voting shares of the continuing or surviving Person or the ultimate parent entity thereof immediately after the transaction;

of Series B that are beneficially owned by the Initial Holder or its affiliates, a Make-Whole Acquisition will not be deemed to have occurred if the Initial Holder or any of its affiliates is part of the person or group referred to in clause (i) above or is a counterparty to the Corporation in any of the transactions referred to in clause (ii) above.

“Make-Whole Acquisition Stock Price” means the consideration paid per share of Common Stock in a Make-Whole Acquisition. If such consideration consists only of cash, the Make-Whole Acquisition Stock Price shall equal the amount of cash paid per share of Common Stock. If such consideration consists of any property other than cash, the Make-Whole Acquisition Stock Price shall be the average of the Closing Price per share of Common Stock on each of the 10 consecutive Trading Days up to, but not including, the Make-Whole Acquisition Effective Date.

“Mandatory Conversion Date” means a Partial Mandatory Conversion Date or a Full Mandatory Conversion Date.

“Non-Mandatory Conversion Date” means an Early Conversion Date, a Make-Whole Acquisition Conversion Date or a Fundamental Change Conversion Date.

“Open of Business” means 9:00 a.m., New York City time.

“Ownership Limit” means a number of shares of Common Stock equal to 0.149 times the sum, without duplication, of (1) the total number of outstanding shares of Common Stock on such date of measurement and (2) the total number of shares of Common Stock to be converted on the Partial Mandatory Conversion Date.

“Parity Stock” means any other class or series of stock of the Corporation that ranks equally with the Series B in the payment of dividends and rights in dissolution, liquidation and winding up of the Corporation.

“Partial Mandatory Conversion Date” means the 3rd Trading Day immediately following the first date after the first anniversary of the Issue Date as of which, for 20 Trading Days within any period of 30 consecutive Trading Days beginning after such first anniversary and preceding such date, the Closing Price of the Common Stock has exceeded 150% of the then applicable Conversion Price.

“Person” means a legal person, including any individual, corporation, estate, partnership, joint venture, association, joint-stock company, limited liability company or trust.

“Preferred Stock” means any and all series of preferred stock of the Corporation, including the Series B.

“Reference Price” means the price per share of Common Stock in connection with a Fundamental Change. If the holders of shares of Common Stock receive only cash in connection with the Fundamental Change, the Reference Price shall be the cash amount paid per share. Otherwise the Reference Price shall be the average of the Closing Price per share of Common Stock on each of the 10 Trading Days up to, but not including, the effective date of the Fundamental Change.

“Registrar” shall mean BNY Mellon Shareowner Services, acting in its capacity as registrar for the Series B, and its successors and assigns or any other registrar appointed by the Corporation.

“Securities Purchase Agreement” means the Securities Purchase Agreement, dated as of December 19, 2007, between the Corporation and the Investor listed on the signature page thereto.

“Subsidiary” means with respect to any Person, any other Person more than fifty percent (50%) of the shares of the voting stock or other voting interests of which are owned or controlled, or the ability to select or elect more than fifty percent (50%) of the directors or similar managers is held, directly or indirectly, by such first Person or one or more of its Subsidiaries or by such first Person and one or more of its Subsidiaries.

“Trading Day” means a day on which the Common Stock (i) is not suspended from trading on any national or regional securities exchange or association or over-the-counter market at the Close of Business and (ii) has traded at least once on the national or regional securities exchange or association or over-the-counter market that is the primary market for the trading of the Common Stock.

“Transfer Agent” shall mean BNY Mellon Shareowner Services, acting in its capacity as transfer agent for the Series B, and its respective successors and assigns or any other transfer agent appointed by the Corporation.

9. Early Conversion at the Option of the Holder. Other than during a Make-Whole Acquisition Conversion Period, any Holder shall have the right to convert such Holder’s shares of Series B, in whole or in part (but in no event less than one share of Series B), at any time prior to the Full Mandatory Conversion Date (“Early Conversion”), into shares of Common Stock at the then applicable Conversion Rate, subject to satisfaction of the conversion procedures set forth in Section 10(b). The date of such Early Conversion is referred to herein as the “Early Conversion Date.”

10. Conversion.

(a) Mandatory Conversion on Mandatory Conversion Date.

(i) On the Partial Mandatory Conversion Date, one half of the outstanding shares of Series B held by each Holder thereof will mandatorily convert into shares of Common Stock at the then applicable Conversion Rate; provided that to the extent such conversion would result in the number of shares of Common Stock beneficially owned by the Initial Holder and its affiliates exceeding the Ownership Limit (such shares of Common Stock that would exceed the Ownership Limit, the “Excess Shares”) the number of shares of Series B of the Initial Holder so converted on the Partial Mandatory Conversion Date shall be limited to the number of shares of Series B such that after giving effect to such conversion, the shares of Common Stock beneficially owned by the Initial Holder and its affiliates equal the Ownership Limit; and provided further, that to the extent that there are Excess Shares and shares of Common Stock are issued upon settlement of the equity units sold pursuant to the Securities Purchase Agreement after the Partial Mandatory Conversion Date and prior to the Full Mandatory Conversion Date, outstanding shares of Series B held by the Initial Holder will mandatorily convert into shares of Common Stock (but not greater than the number of Excess Shares) at the then applicable Conversion Rate provided that the number of shares of Series B of the Initial Holder so converted shall be limited to the number of shares of Series B such that after giving effect to such conversion, the shares of Common Stock beneficially owned by the Initial Holder and its affiliates do not exceed the Ownership Limit. No action shall be required by the Holder thereof. The person or persons entitled to receive the shares of Common Stock issuable upon mandatory conversion of Series B will be treated as the record Holder(s) of such shares of Common Stock as of the Close of Business on the Partial Mandatory Conversion Date. Except as provided under Section 11(a)(xv), prior to the Close of Business on the Partial Mandatory Conversion Date, the shares of Common Stock issuable upon conversion of the Series B will not be deemed to be outstanding for any purpose and Holders shall have no rights with respect to such shares of Common Stock, including voting rights, rights to respond to tender offers and rights to receive any dividends or other distributions on the Common Stock, by virtue of holding the Series B.

(ii) On the Full Mandatory Conversion Date, all of the outstanding shares of Series B will mandatorily convert into shares of Common Stock at the then applicable Conversion Rate. No action shall be required by the Holder thereof. The person or persons entitled to receive the shares of Common Stock issuable upon mandatory conversion of Series B will be treated as the record holder(s) of such shares of Common Stock as of the Close of Business on the Full Mandatory Conversion Date. Except as provided under Section 11(a)(xv), prior to the Close of Business on the Full Mandatory Conversion Date, the shares of Common Stock issuable upon conversion of the Series B will not be deemed to be outstanding for any purpose and Holders shall have no rights with respect to such shares of Common Stock, including voting rights, rights to respond to tender offers and rights to receive any dividends or other distributions on the Common Stock, by virtue of holding the Series B.

(iii) In addition to the number of shares of Common Stock issuable pursuant to this Section 10(a), if applicable, the Holders on a Mandatory Conversion Date shall have the right to receive an amount equal to any declared and unpaid dividends on the Series B for the most recent Dividend Period ending on a Mandatory Conversion Date to the extent such Holders were the Holders of record as of the Dividend Record Date for such dividend.

(b) Conversion Procedures for a Non-Mandatory Conversion Date. To effect conversion on a Non-Mandatory Conversion Date, a Holder who:

(i) holds a beneficial interest in a global certificate representing the Series B must deliver to DTC the appropriate instruction form for conversion pursuant to DTC’s conversion program and, if required, pay funds equal to the dividend payable on the next Dividend Payment Date to which such Holder is not entitled by virtue of Section 10(e) and, if required, pay all transfer or similar taxes or duties, if any; or

(ii) holds shares of Series B in certificated form must:

(A) complete and manually sign the conversion notice on the back of the Series B certificate or a facsimile of the conversion notice;

(B) deliver the completed conversion notice and the certificated shares of Series B to be converted to the Conversion Agent;

(D) if required, pay funds equal to the dividend payable on the next Dividend Payment Date to which such Holder is not entitled by virtue of Section 10(e); and

(E) if required, pay all transfer or similar taxes or duties, if any.

The conversion will be effective on the date on which a Holder has satisfied all of the foregoing requirements, to the extent applicable, which shall be the applicable Non-Mandatory Conversion Date. A Holder will not be required to pay any transfer or similar taxes or duties relating to the issuance or delivery of Common Stock if such Holder exercises its conversion rights, but such Holder will be required to pay any transfer or similar tax or duty that may be payable relating to any transfer involved in the issuance or delivery of Common Stock in a name other than the name of such Holder. A certificate representing Common Stock will be issued and delivered only after all applicable taxes and duties, if any, payable by the Holder have been paid in full.

The person or persons entitled to receive the Common Stock issuable upon conversion shall be treated for all purposes as the record Holder(s) of such shares of Common Stock as of the Close of Business on the applicable Non-Mandatory Conversion Date. No allowance or adjustment, except as set forth in Section 11(a), shall be made in respect of dividends payable to Holders of Common Stock of record as of any date prior to such applicable Non-Mandatory Conversion Date. Prior to such applicable Non-Mandatory Conversion Date, shares of Common Stock issuable upon conversion of any shares of Series B shall not be deemed outstanding for any purpose, and Holders shall have no rights with respect to the Common Stock (including voting rights, rights to respond to tender offers for the Common Stock and rights to receive any dividends or other distributions on the Common Stock) by virtue of holding shares of Series B.

In the event that a conversion is effected with respect to shares of Series B representing fewer than all the shares of Series B held by a Holder, upon such conversion the Corporation shall execute and the Registrar shall countersign and deliver to the Holder thereof, at the expense of the Corporation, a certificate evidencing the shares of Series B as to which conversion was not effected.

The Corporation shall deliver the shares of Common Stock to which the Holder converting pursuant to Section 9(a) is entitled on or prior to the third Trading Day immediately following the applicable Non-Mandatory Conversion Date.

(i) In the event of a Make-Whole Acquisition, each Holder shall have the option to convert its shares of Series B (a “Make-Whole Acquisition Conversion”) at the then applicable Conversion Rate during the period (the “Make-Whole Acquisition Conversion Period”) beginning on the effective date of the Make-Whole Acquisition (the “Make-Whole Acquisition Effective Date”) and ending on the date that is 30 days after the Make-Whole Acquisition Effective Date and receive an additional number of shares of Common Stock in the form of Make-Whole Shares as set forth in this Section 10(c). The date of such Make-Whole Acquisition Conversion is referred to herein as the “Make-Whole Acquisition Conversion Date.”

(ii) The number of “Make-Whole Shares” shall be determined for the Series B by reference to the table below for the applicable Make-Whole Acquisition Effective Date and the applicable Make-Whole Acquisition Stock Price:



Effective Date	$25.25	$26.00	$27.50	$30.00	$32.50	$35.00	$37.50	$40.00
October 14, 2008	7.6040	7.1523	6.3231	5.1706	4.2577	3.5420	2.9855	2.5588
October 14, 2009	7.6040	7.0734	6.2025	4.9612	3.9362	3.0896	2.3903	1.8122
October 14, 2010 and thereafter	7.6040	7.0758	6.1992	4.9399	3.8789	2.9723	2.1872	1.4965
Effective Date	$45.00	$50.00	$55.00	$60.00	$70.00	$80.00	$90.00	$100.00
October 14, 2008	1.9853	1.6463	1.4313	1.2805	1.0698	0.9198	0.8044	0.7122
October 14, 2009	0.9388	0.6034	0.5113	0.4532	0.3777	0.3252	0.2847	0.2523
October 14, 2010 and thereafter	0.3474	—	—	—	—	—	—	—

(A) The exact Make-Whole Acquisition Stock Prices and Effective Dates may not be set forth in the table above, in which case:

higher and lower Make-Whole Acquisition Stock Price amounts and the two Make-Whole Acquisition Effective Dates, as applicable, based on a 365-day year;

(2) if the Make-Whole Acquisition Stock Price is in excess of $100.00 per share (subject to adjustment pursuant hereto), no Make-Whole Shares will be issued upon conversion of the Series B; and

(3) if the Make-Whole Acquisition Stock Price is less than $25.25 per share (subject to adjustment pursuant hereto), no Make-Whole Shares will be issued upon conversion of the Series B.

(B) The Make-Whole Acquisition Stock Prices set forth in the table above (and the corresponding prices set forth in clauses (2) and (3) above) are subject to adjustment pursuant hereto and shall be adjusted as of any date the Conversion Rate is adjusted. The adjusted Make-Whole Acquisition Stock Prices (and corresponding prices set forth in clauses (2) and (3) above) shall equal the Make-Whole Acquisition Stock Prices (and corresponding prices set forth in clauses (2) and (3) above), respectively, applicable immediately prior to such adjustment multiplied by a fraction, the numerator of which is the Conversion Rate immediately prior to the adjustment giving rise to the Make-Whole Acquisition Stock Price adjustments and the denominator of which is the Conversion Rate as so adjusted. The number of Make-Whole Shares in the table above shall also be subject to adjustment in the same manner as the Conversion Rate pursuant to Section II.

(iii) On or before the twentieth day prior to the date on which the Corporation anticipates consummating the Make-Whole Acquisition (or, if later, within two Business Days after the Corporation becomes aware of a Make-Whole Acquisition described in clause (i) of the definition of such term), a written notice shall be sent by or on behalf of the Corporation, by first-class mail, postage prepaid, to the Holders as they appear in the records of the Corporation. Such notice shall contain:

(A) the date on which the Make-Whole Acquisition is anticipated to be effected;

(B) the date, which shall be 30 days after the Make-Whole Acquisition Effective Date, by which the Make-Whole Acquisition conversion option must be exercised;

(C) the amount of cash, securities and other consideration payable per share of Common Stock or Series B, respectively; and

(D) the instructions a Holder must follow to exercise its conversion option in connection with such Make-Whole Acquisition.

(iv) To exercise a Make-Whole Acquisition Conversion option, a Holder must, no later than the Close of Business on the date by which the Make-Whole Acquisition Conversion option must be exercised as specified in the notice delivered under Section 10(c)(iii), comply with the procedures set forth in Section 10(b).

(v) If a Holder does not elect to exercise the Make-Whole Acquisition Conversion option pursuant to this Section 10(c), the shares of Series B or successor securities held by it shall remain outstanding but shall not be eligible to receive Make-Whole Shares.

(vi) Upon a Make-Whole Acquisition Conversion, the Conversion Agent shall, except as otherwise provided in the instructions provided by the Holder thereof in the written notice provided to the Corporation or its successor as set forth in Section 10(b), deliver to the Holder such cash, securities or other property as are issuable with respect to Make-Whole Shares in the Make-Whole Acquisition.

(vii) In the event that a Make-Whole Acquisition Conversion is effected with respect to shares of Series B or successor securities representing fewer than all the shares of Series B or successor securities held by a Holder, upon such Make-Whole Acquisition Conversion, the Corporation or its successor shall execute and the Conversion Agent shall, unless otherwise instructed in writing, countersign and deliver to the Holder thereof, at the expense of the Corporation or its successors, a certificate evidencing the shares of Series B or such successor securities held by the Holder as to which a Make-Whole Acquisition Conversion was not effected.

(viii) If a Holder elects to convert its shares of Series B in connection with a Make-Whole Acquisition, such Holder shall not be entitled to an adjusted conversion price pursuant to Section 10(g) to the extent such Make-Whole Acquisition also constitutes a Fundamental Change.

(d) Registration of Common Stock. In the event that a Holder shall not by written notice designate the name in which shares of Common Stock to be issued upon conversion of such Series B should be registered or the address to which the certificate or certificates representing such shares of Common Stock should be sent, the Corporation shall be entitled to register such shares, and make such payment, in the name of the Holder as shown on the records of the Corporation and to send the certificate or certificates representing such shares of Common Stock to the address of such Holder shown on the records of the Corporation.

(e) Dividends. If a Non-Mandatory Conversion Date on which a Holder elects to convert Series B is prior to the Close of Business on the Dividend Record Date relating to any declared dividend for the Dividend Period in which such Holder is electing to convert, such Holder will not have the right to receive any declared dividends for that Dividend Period. If a Non-Mandatory Conversion Date on which a Holder elects to convert Series B is after the Close of Business on the Dividend Record Date for any declared dividend and prior to the Dividend Payment Date, such Holder shall receive that dividend on the relevant Dividend Payment Date if such Holder was the Holder of record at the Close of Business on the Dividend Record Date for that dividend. Notwithstanding the preceding sentence, if the Non-Mandatory Conversion Date is after the Close of Business on the Dividend Record Date and prior to the Open of Business on the Dividend Payment Date, whether or not such Holder was the Holder of record at the Close of Business on the Dividend Record Date, the Holder must pay to the Conversion Agent upon conversion of the shares of Series B an amount in cash equal to the dividend payable on the Dividend Payment Date for the then-current Dividend Period on the shares of Series B being converted.

(f) Outstanding Shares of Series B. Shares of Series B shall cease to be outstanding on the applicable Conversion Date, subject to the right of Holders of such shares to receive shares of common Stock issuable upon conversion of such shares of Series B.

(g) Conversion Upon Fundamental Change.

(i) If the Reference Price in connection with a Fundamental Change is less than the then applicable Conversion Price, a Holder may convert each share of Series B during the period beginning on the effective date of the Fundamental Change and ending on the date that is 30 days after the effective date of such Fundamental Change at an adjusted conversion price equal to the greater of (1) the Reference Price and (2) $12.625, subject to adjustment as described herein (the “Base Price”). The date of such conversion upon a Fundamental Change is referred to herein as the “Fundamental Change Conversion Date.”

(ii) The Base Price shall be adjusted as of any date the Conversion Rate of the Series B is adjusted pursuant hereto. The adjusted Base Price shall equal the Base Price applicable immediately prior to such adjustment multiplied by a fraction, the numerator of which is the Conversion Rate immediately prior to the adjustment giving rise to the Base Price adjustment and the denominator of which is the Conversion Rate as so adjusted. If the Reference Price is less than the Base Price, Holders shall receive a maximum of 79.2079 shares of Common Stock per share of Series B (subject to adjustment in a manner inverse to the adjustments to the Base Price).

(iii) On or before the 20th day prior to the date on which the Corporation anticipates consummating the Fundamental Change (or, if later, within two Business Days after the Corporation becomes aware of a Fundamental Change described in clause (i) of the definition of such term), a written notice shall be sent by or on behalf of the Corporation, by first-class mail, postage prepaid, to the Holders as they appear in the records of the Corporation. Such notice shall contain:

(A) the date on which the Fundamental Change is anticipated to be effected; and

(B) the date, which shall be 30 days after the effective date of a Fundamental Change, by which the Fundamental Change conversion option must be exercised.

(iv) On the effective date of a Fundamental Change, another written notice shall be sent by or on behalf of the Corporation, by first-class mail, postage prepaid, to the Holders as they appear in the records of the Corporation. Such notice shall contain:

(A) the date that shall be 30 days after the effective date of the Fundamental Change;

(B) the adjusted conversion price following the Fundamental Change;

(C) the amount of cash, securities and other consideration payable per share of Common Stock or Series B, respectively; and

(D) the instructions a Holder must follow to exercise its conversion option in connection with such Fundamental Change.

(v) To exercise its conversion option upon a Fundamental Change, a Holder must, no later than the Close of Business on the date by which the conversion option upon the Fundamental Change must be exercised as specified in the notice delivered under Section 10(g)(iv), comply with the procedures set forth in Section 10(b).

(vi) If a Holder does not elect to exercise its conversion option upon a Fundamental Change pursuant to this Section 10(g), the shares of Series B or successor securities held by it will remain outstanding but shall not thereafter be entitled to convert in accordance with Section 10(g).

(vii) Upon a conversion upon a Fundamental Change, the Conversion Agent shall, except as otherwise provided in the instructions provided by the Holder thereof in the written notice provided to the Corporation or its successor as set forth in Section 10(b), deliver to the Holder such cash, securities or other property as are issuable with respect to the adjusted conversion price following the Fundamental Change.

(viii) In the event that a conversion upon a Fundamental Change is effected with respect to shares of Series B or successor securities representing fewer than all the shares of Series B or successor securities held by a Holder, upon such conversion the Corporation or its successor shall execute and the Conversion Agent shall, unless otherwise instructed in writing, countersign and deliver to the Holder thereof, at the expense of the Corporation, a certificate evidencing the shares of Series B or such successor securities held by the Holder as to which a conversion upon a Fundamental Change was not effected.

(ix) If a Holder elects to convert its shares of Series B in connection with a Fundamental Change, such Holder shall not be entitled to Make-Whole Shares pursuant to Section 10(c) to the extent such Fundamental Change also constitutes a Make-Whole Acquisition.

(h) A Holder cannot effect both a Make-Whole Acquisition Conversion and a Fundamental Change Conversion with respect to a share of Series B.

(i) Notwithstanding anything to the contrary in this Certificate of Designations, a Holder of shares of Series B shall not, for a period of 35 calendar days after any Conversion Date, sell any shares of Common Stock or other equity securities it receives upon conversion of the shares it converted on such Conversion Date.

11. Anti-Dilution Adjustments.

(a) The Conversion Rate shall be adjusted from time to time by the Corporation as follows:

(i) If the Corporation, at any time or from time to time while any of the Series B is outstanding, issues shares of Common Stock as a dividend or distribution on shares of Common Stock, or if the Corporation effects a share split or share combination in respect of the Common Stock, then the Conversion Rate shall be adjusted based on the following formula:




CR1	=	CR0	×	OS1
CR1	=	CR0	×	OS0

where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the Record Date for such dividend or distribution, or the Close of Business on the effective date of such share split or combination, as applicable;

CR1	=	the new Conversion Rate in effect immediately after the Close of Business on the Record Date for such dividend or distribution, or the Close of Business on the effective date of such share split or share combination, as applicable;

OS0	=	the number of shares of Common Stock outstanding immediately prior to the Close of Business on the Record Date for such dividend or distribution, or the Close of Business on the effective date of such share split or share combination, as applicable; and

OS1	=	the number of shares of Common Stock outstanding immediately after such dividend or distribution, or the Close of Business on the effective date of such share split or share combination, as applicable.

The Corporation will not pay any dividend or make any distribution on shares of Common Stock held in treasury by the Corporation.

(ii) Except as otherwise provided for by Section 11(a)(iv) below, if the Corporation, at any time or from time to time while any of the Series B is outstanding, distributes to all or substantially all holders of its outstanding shares of Common Stock any rights or warrants entitling them for a period of not more than 45 calendar days from the Record Date of such distribution to subscribe for or purchase shares of Common Stock at a price per share less than the Closing Price of the Common Stock on the Trading Day immediately preceding the Record Date of such distribution, the Conversion Rate shall be adjusted based on the following formula:




CR1	=	CR0	×	OS0 + X
CR1	=	CR0	×	OS0 + Y

where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the Record Date for such distribution;

CR1	=	the new Conversion Rate in effect immediately after the Close of Business on the Record Date for such distribution;

OS0	=	the number of shares of Common Stock outstanding immediately prior to the Close of Business on the Record Date for such distribution;

X	=	the total number of shares of Common Stock issuable pursuant to such rights or warrants; and

Y	=	the number of shares of common Stock equal to the aggregate price payable to exercise such rights or warrants divided by the average of the Closing Prices of the Common Stock over the ten consecutive Trading Day period ending on the Trading Day immediately preceding the Ex-Dividend Date for such distribution.

To the extent that shares of common Stock are not delivered pursuant to such rights or warrants upon the expiration or termination of such rights or warrants, the Conversion Rate shall be readjusted to the Conversion Rate which would then be in effect had the adjustments made upon the distribution of such rights or warrants been made on the basis of the delivery of only the number of shares of Common Stock actually delivered.

In determining the aggregate price payable to exercise such rights or warrants, there shall be taken into account any amount payable on exercise thereof, with the value of such consideration, if other than Cash, to be determined in good faith by the Corporation’s Board of Directors.

(iii) If the Corporation, at any time or from time to time while any of the Series B is outstanding, shall, by dividend or otherwise, distribute to all or substantially all holders of its Common Stock shares of any class of Capital Stock of the Corporation (other than Common Stock as covered by Section 11(a)(i) above), evidences of its indebtedness, assets, property or rights or warrants to acquire the Corporation’s Capital Stock or other securities, but excluding (i) dividends or distributions as to which an adjustment under Section 11(a)(i), Section 11(a)(ii) or Section 11(a)(iv) hereof shall apply, (ii) dividends or distributions paid exclusively in Cash and (iii) Spin-Offs to which the provision set forth below in this Section 11(a)(iii) shall apply (any of such shares of Capital Stock, indebtedness, assets, property or rights or warrants to acquire the Corporation’s Common Stock or other securities, hereinafter in this Section 11(a)(iii) called the “Distributed Property”), then, in each such case the Conversion Rate shall be adjusted based on the following formula:




CR1	=	CR0	×	SP0
CR1	=	CR0	×	SP0 – FMV

Where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the Record Date for such distribution;

CR1	=	the new Conversion Rate in effect immediately after the Close of Business on the Record Date for such distribution;

SP0	=	the average of the Closing Prices of the Common Stock over the ten consecutive Trading Day period ending on the Trading Day immediately preceding the Ex-Dividend Date for such distribution; and

FMV	=	the fair market value (as determined in good faith by the Corporation’s Board of Directors) of the portion of Distributed Property with respect to each outstanding share of Common Stock on the Record Date for such distribution.

Notwithstanding the foregoing, if the then fair market value (as so determined) of the portion of the Distributed Property so distributed applicable to one share of Common Stock is equal to or greater than SP0 as set forth above, in lieu of the foregoing adjustment, the Corporation shall distribute to each Holder on the date the Distributed Property is distributed to holders of Common Stock, but without requiring such Holder to convert its shares of Series B, the amount of Distributed Property such Holder would have received had such Holder owned a number of shares of Common Stock equal to the Conversion Rate on the record date fixed for determination for stockholders entitled to receive such distribution. If the Board of Directors determines the fair market value of any distribution for purposes of this Section 11(a)(iii) by reference to the actual or when issued trading market for any securities, it shall in doing so consider the prices in such market over the same period used in computing the average of the Closing Prices of the Common Stock for purposes of calculating SP0 in the formula in this Section 11(a)(iii).

With respect to an adjustment pursuant to this Section 11(a)(iii) where there has been a payment of a dividend or other distribution on the Common Stock consisting of shares of Capital Stock of any class or series, or similar equity interest, of or relating to a Subsidiary or other business unit of the Corporation (a “Spin-Off”), the Conversion Rate in effect immediately before the Close of Business on the tenth Trading Day immediately following, and including, the effective date of the Spin-Off shall be increased based on the following formula:




CR1	=	CR0	×	FMV + MP0
CR1	=	CR0	×	MP0

where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the 10th Trading Day immediately following, and including, the effective date of the Spin-Off;

CR1	=	the new Conversion Rate in effect from and after the Close of Business on the 10th Trading Day immediately following, and including, the effective date of the Spin Off;

FMV	=	the average of the Closing Prices of the Capital Stock or similar equity interest distributed to holders of common Stock applicable to one share of Common Stock over the 10 consecutive Trading Day period immediately following, and including, the effective date of the Spin-Off; and

MP0	=	the average of the Closing Prices of Common Stock over the 10 consecutive Trading Day period immediately following, and including, the effective date of the Spin-Off.

Such adjustment shall occur on the 10th Trading Day immediately following, and including, the effective date of the Spin-Off (it being agreed that notwithstanding Section 9(a), the Holder of the Series B shall not be entitled to convert the Series B pursuant to an Early Conversion prior to such 10th Trading Day).

For purposes of this Section 11(a)(iii), Section 11(a)(i) and Section 11(a)(ii) hereof, any dividend or distribution to which this Section 11(a)(iii) is applicable that also includes shares of common Stock, or rights or warrants to subscribe for or purchase shares of Common Stock to which Section 11(a)(i) or 11(a)(ii) hereof applies (or both), shall be deemed instead to be (1) a dividend or distribution of the evidences of indebtedness, assets or shares of Capital Stock other than such shares of Common Stock or rights or warrants to which Section 11(a)(i) or 11(a)(ii) hereof applies (and any Conversion Rate adjustment required by this Section 11(a)(iii) with respect to such dividend or distribution shall then be made) immediately followed by (2) a dividend or distribution of such shares of Common Stock or such rights or warrants to which Section 11(a)(i) or 11(a)(ii) hereof applies (and any further Conversion Rate adjustment required by Section 11(a)(i) and 11(a)(ii) hereof with respect to such dividend or distribution shall then be made), except (A) the Close of Business on the Record Date of such dividend or distribution shall be substituted for “the Close of Business on the Record Date,” “the Close of Business on the Record Date or the Close of Business on the effective date,” “after the Close of Business on the Record Date for such dividend or distribution or the Close of Business on the effective date of such share split or share combination” and “the Close of Business on the Record Date for such distribution” within the meaning of Section 11(a)(i) and Section 11(a)(ii) hereof and (B) any shares of Common Stock included in such dividend or distribution shall not be deemed “outstanding immediately prior to the Close of Business on the Record Date or the Close of Business on the effective date” within the meaning of Section 11(a)(i) hereof.

(iv) If the Corporation, at any time or from time to time while any of the Series B is outstanding, distributes rights or warrants to all holders of Common Stock entitling the holders thereof to subscribe for, purchase or convert into shares of the Corporation’s Capital Stock (either initially or under certain circumstances), which rights or warrants, until the occurrence of a specified event or events (“Trigger Event”): (x) are deemed to be transferred with such shares of Common Stock; (y) are not exercisable; and (z) are also issued in respect of future issuances of Common Stock, shall be deemed not to have been distributed for purposes of Section 11(a)(iii) above, (and no adjustment to the Conversion Rate under Section 11(a)(iii) above will be required) until the occurrence of the earliest Trigger Event and a distribution or deemed distribution under the terms of such rights or warrants at which time an appropriate adjustment (if any is required) to the Conversion Rate shall be made in the same manner as provided for under Section 11(a)(iii) above. If any such rights or warrants are subject to events, upon the occurrence of which such rights or warrants become exercisable to purchase different securities, evidences of indebtedness or other assets, then the date of the occurrence of any and each such event shall be deemed to be the date of distribution and Record Date with respect to new rights or warrants with such rights (and a termination or expiration of the existing rights or warrants without exercise by any of the holders thereof). In addition, in the event of any distribution (or deemed distribution) of rights or warrants (of the type described in the preceding sentence) with respect thereto that was counted for purposes of calculating a distribution amount for which an adjustment to the Conversion Rate under this Section 11(a)(iv) was made, (1) in the case of any such rights or warrants that shall all have been redeemed or repurchased without exercise by any holders thereof, the Conversion Rate shall be readjusted upon such final redemption or repurchase to give effect to such distribution or Trigger Event, as the case may be, as though it were a Cash distribution, equal to the per share redemption or repurchase price received by a holder or holders of Common Stock with respect to such rights or warrants (assuming such holder had retained such rights or warrants), made to all holders of Common Stock as of the date of such redemption or repurchase, and (2) in the case of such rights or warrants that shall have expired or been terminated without exercise by any holders thereof, the Conversion Rate shall be readjusted as if such rights or warrants had not been issued.

(v) (1) If the Corporation, at any time or from time to time while any of the Series B is outstanding, makes a regular, quarterly Cash dividend or distribution to all or substantially all holders of Common Stock during any quarterly fiscal period that exceeds $0.27 (the “Initial Dividend Threshold”), the Conversion Rate shall be adjusted based on the following formula:




CR1	=	CR0	×	SP0
CR1	=	CR0	×	SP0 – C

where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the Record Date for such dividend or distribution;

CR1	=	the new Conversion Rate in effect immediately after the Close of Business on the Record Date for such dividend or distribution;

SP0	=	the average Closing Price of the Common Stock over the ten consecutive Trading Days ending on the Trading Day immediately preceding the Ex-Dividend Date for such dividend or distribution;

C	=	the amount in Cash per share the Corporation distributes or dividends to holders of Common Stock in excess of the Initial Dividend Threshold.

The Initial Dividend Threshold shall be adjusted in a manner inversely proportional to adjustments to the Conversion Rate; provided that no adjustment shall be made to the Initial Dividend Threshold for any adjustment made to the Conversion Rate pursuant to clauses (1) or (2) of this Section 11(a)(v).

(2) If the Corporation pays any cash dividend or distribution that is not a regular, quarterly cash dividend or distribution to all or substantially all holders of Common Stock, the Conversion Rate shall be adjusted based on the following formula:




CR1	=	CR0	×	SP0
CR1	=	CR0	×	SP0 – C

where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the Record Date for such dividend or distribution;




CR1	=	the new Conversion Rate in effect immediately after the Close of Business on the Record Date for such dividend or distribution;

SP0	=	the average Closing Price of the Common Stock over the ten consecutive Trading Days ending on the Trading Day immediately preceding the Ex-Dividend Date for such dividend or distribution;

C	=	the amount in Cash per share the Corporation distributes or dividends to holders of common Stock

(3) Notwithstanding the foregoing, if the portion of the Cash so distributed applicable to one share of Common Stock is equal to or greater than SP0 as set forth above, in lieu of the foregoing adjustment, the Corporation shall distribute to each Holder on the date the Cash dividend or distribution is paid to holders of Common Stock, but without requiring such Holder to convert its shares of Series B, the amount of Cash such Holder would have received had such Holder owned a number of shares of Common Stock equal to the Conversion Rate on the Record Date for such dividend or distribution. If such dividend or distribution is not so paid or made, the Conversion Rate shall again be adjusted to be the Conversion Rate that would then be in effect if such dividend or distribution had not been declared.

(4) For the avoidance of doubt, for purposes of this Section 11(a)(v), in the event of any reclassification of the Common Stock, as a result of which the Series B becomes convertible into more than one class of Common Stock, if an adjustment to the Conversion Rate is required pursuant to this Section 11(a)(v), references in this Section to one share of Common Stock or Closing Price of one share of Common Stock shall be deemed to refer to a unit or to the price of a unit consisting of the number of shares of each class of Common Stock into which the Series B is then convertible equal to the numbers of shares of such

class issued in respect of one share of Common Stock in such reclassification. The above provisions of this paragraph shall similarly apply to successive reclassifications.

(vi) If the Corporation or any of its Subsidiaries makes a payment of Cash or other consideration in respect of a tender offer or exchange offer for all or any portion of the Common Stock, where such Cash and the value of any such other consideration included in the payment per share of Common Stock validly tendered or exchanged exceeds the Closing Price of the Common Stock on the Trading Day next succeeding the last date (the “expiration date”) on which tenders or exchanges may be made pursuant to such tender or exchange offer (as it may be amended), the Conversion Rate shall be increased based on the following formula:




CR1	=	CR0	×	AC + (SP1 × OS1)
CR1	=	CR0	×	OS0 × SP1

Where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the expiration date;

CR1	=	the new Conversion Rate in effect immediately after the Close of Business on the expiration date;

AC	=	the aggregate value of all Cash and any other consideration (as determined in good faith by the Corporation’s Board of Directors) paid or payable for shares purchased in such tender or exchange offer;

OS0	=	the number of shares of Common Stock outstanding immediately prior to the date such tender or exchange offer expires;

OS1	=	the number of shares of Common Stock outstanding immediately after the date such tender or exchange offer expires (after giving effect to such tender offer or exchange offer); and

SP1	=	the average Closing Price of Common Stock over the ten consecutive Trading Days ending on the Trading Day next succeeding the expiration date.

If the Corporation or a Subsidiary is obligated to purchase shares of Common Stock pursuant to any such tender or exchange offer, but the Corporation or such Subsidiary is permanently prevented by applicable law from effecting any such purchases or all or any portion of such purchases are rescinded, then the Conversion Rate shall again be adjusted to be the Conversion Rate that would then be in effect if such tender or exchange offer had not been made or had only been made in respect of the purchases that had been effected. Except as set forth in the preceding sentence, if an adjustment to the Conversion Rate pursuant to this Section 11(a)(vi) with respect to any tender offer or exchange offer would result in a decrease in the Conversion Rate, no adjustment shall be made for such tender offer or exchange offer under this Section 11(a)(vi).

(vii) For purposes of this Section 11(a) the term “Record Date” shall mean, with respect to any dividend, distribution or other transaction or event in which the holders of Common Stock have the right to receive any Cash, securities or other property or in which the Common Stock (or other applicable security) is exchanged for or converted into any combination of Cash, securities or other property, the date fixed for determination of shareholders entitled to receive such Cash, securities or other property (whether such date is fixed by the Board of Directors or by statute, contract or otherwise).

(viii) If application of the formulas provided in Sections 11(a)(i), 11(a)(ii), 11(a)(iii), 11(a)(iv), 11(a)(v) or 11(a)(vi) above would result in a decrease in the Conversion Rate, no adjustment (other than a readjustment as described in such sections) to the Conversion Rate shall be made except in the case of a share split or combination of the Common Stock.

(ix) If one or more events occur requiring an adjustment be made to the Conversion Rate for a particular period, adjustments to the Conversion Rate shall be determined by the Corporation’s Board of Directors to reflect the combined impact of such Conversion Rate adjustments, as set out in this Section 11(a), during such period.

(x) Notwithstanding any of the foregoing clauses in this Section II, no adjustment in the Conversion Rate shall be required unless the adjustment would result in a change in the Conversion Rate of at least 1.00%; provided, however, that any adjustment which by reason of this Section 11(a)(x) is not required to be made shall be carried forward and the Corporation shall make such adjustment, regardless of whether the aggregate adjustment is less than 1.00%, within one year of the first such adjustment carried forward or in connection with any conversion of Series B. All calculations under this Section 11 shall be made to the nearest one-ten thousandth (1/10,000) of a cent or to the nearest one-ten thousandth (1/10,000) of a share, as the case may be.

No adjustment in the Conversion Rate need be made (i) for issuances of Common Stock pursuant to any present or future plan for reinvestment of dividends or interest payable on the Corporation’s securities or the investment of additional optional amounts in shares of Common Stock under any plan, (ii) upon the issuance of any shares of Common Stock or options or rights to purchase shares pursuant to any present or future employee, director or consultant benefit plan or program of, or assumed by, the Corporation or any of its Subsidiaries, (iii) upon the issuance of any shares of Common Stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible security outstanding as of the date the Series B was first issued, (iv) for a change in the par value of the Common Stock, (v) for repurchases of shares of common Stock in open market transactions or privately negotiated transactions, or (vi) for accumulated and unpaid dividends, other than as expressly contemplated by Section 11(a)(i).

No adjustment to the Conversion Rate need be made pursuant to Section 11(a)(i) through (ix) above for a transaction if Holders are permitted to participate in the transaction without conversion, concurrently with the holders of Common Stock, on a basis and with notice that the Board of Directors of the Corporation determines in good faith to be fair and appropriate in light of the basis and notice to holders of Common Stock participating in the transaction.

Whenever a provision of this Certificate of Designations requires the calculation of an average of the Closing Price over a span of multiple days, the Corporation will make appropriate adjustments to account for any adjustment to the Conversion Rate that becomes effective, or any event requiring an adjustment to the Conversion Rate that becomes effective, or any event requiring an adjustment to the Conversion Rate where the Ex-Dividend Date of the event occurs, at any time during the period from which the average is to be calculated.

(xi) Upon conversion of the Series B, the Holders shall receive, in addition to any shares of Common Stock issuable upon such conversion, any associated rights issued under any shareholder rights agreement of the Corporation that provides that each share of Common Stock issued upon conversion of the Series B at any time prior to the distribution of separate certificates representing such rights will be entitled to receive such rights unless, prior to conversion, the rights have separated from the Common Stock, expired, terminated or been redeemed or exchanged in accordance with such rights plan, and no adjustment shall be made to the Conversion Rate pursuant to Section 11(a)(iv) hereof. If, prior to any conversion, the rights have separated from the Common Stock, the Conversion Rate shall be adjusted at the time of separation as if the Corporation distributed to all holders of Common Stock, shares of Capital Stock, evidences of indebtedness, assets, property or rights or warrants as described in Section 11(a)(iv) hereof, subject to readjustment in the event of the expiration, termination or redemption of such rights.

(xii) Subject to applicable stock exchange rules and listing standards, the Corporation shall be entitled to increase the Conversion Rate by any amount for a period of at least 20 Business Days if the Board of Directors determines that such increase would be in the best interests in the Corporation; provided the Corporation has given to the Conversion Agent and DTC at least 15 days’ prior notice of any such increase in the Conversion Rate and the period during which it will be in effect. Subject to applicable stock exchange rules and listing standards, the Corporation shall be entitled to increase the Conversion Rate, in addition to the events requiring an increase in the Conversion Rate pursuant to Section 11 hereof, as it in its discretion shall determine to be advisable in order to avoid or diminish any tax to shareholders in connection with any stock dividends, subdivisions of shares, distributions of rights to purchase stock or securities or distributions of securities convertible into or exchangeable for stock hereafter made by the Corporation to its shareholders or other events.

(xiii) Whenever the Conversion Rate is adjusted as herein provided, the Corporation will issue a notice to the Conversion Agent and DTC containing the relevant information and make this information available on the Corporation’s website. In addition, the Corporation shall provide upon the request of a Holder of Series B, to the extent not posted on the Corporation website, a brief statement setting forth in reasonable detail how the adjustment to the Conversion Rate was determined and setting forth the adjusted Conversion Rate.

(xiv) For purposes of this Section 11, the number of shares of common Stock at any time outstanding shall not include shares held in the treasury of the Corporation but shall include shares issuable in respect of scrip certificates issued in lieu of fractions of shares of Common Stock.

(xv) If the record date for a dividend or distribution on Common Stock occurs prior to a Mandatory Conversion Date and the payment date for a dividend or distribution on Common Stock occurs after a Mandatory Conversion Date, and such dividend or distribution would have resulted in an adjustment to the Conversion Rate if such dividend or distribution does not result in an adjustment to the Conversion Rate but were paid prior to such Mandatory Conversion Date, then without duplication the Corporation shall deem the Holders to be holders of record of Common Stock for purposes of that dividend or distribution. In that case, the Holders will receive the number of shares of Common Stock issuable upon the applicable Mandatory Conversion Date together with the dividend or distribution on such shares of Common Stock so converted.

12. Reorganization Events.

(a) In the event of:

(i) any consolidation or merger of the Corporation with or into another Person or of another Person with or into the Corporation;

(ii) any sale, transfer, lease or conveyance to another Person of the property of the Company as an entirety or substantially as an entirety;

(iii) any statutory share exchange of the Corporation with another Person (other than in connection with a merger or acquisition); or

(iv) any liquidation, dissolution or termination of the Corporation;

in each case in which holders of Common Stock would be entitled to receive cash, securities or other property for their shares of Common Stock (any such event specified in this Section 12(a), a “Reorganization Event”), each share of Series B outstanding immediately prior to such Reorganization Event shall, without the consent of Holders, become convertible into the kind of cash, securities and other property receivable in such Reorganization Event by a holder of one share of common Stock that was not the counterparty to the Reorganization Event or an affiliate of such other party (such cash, securities and other property, the “Exchange Property”).

(b) In the event that holders of the shares of the Common Stock have the opportunity to elect the form of consideration to be received in such transaction, the “Exchange Property” that Holders of the Series B will be entitled to receive shall be deemed to be the weighted average of the types and amounts of consideration received by the holders of Common Stock that affirmatively make an election (or of all such holders if none make an election). The number of units of Exchange Property for each share of Series B converted following the effective date of such Reorganization Event shall be determined based on the Conversion Rate then in effect on the applicable Conversion Date, determined as if the references to a “share of Common Stock” in this Certificate of Designations were to “unit of Exchange Property.”

(c) After a Reorganization Event, for purposes of determining whether a Mandatory Conversion Date has occurred, the term “Closing Price” shall be deemed to refer to the closing sale price, last quoted bid price or mid-point of the last bid and ask prices, as the case may be, of any publicly traded securities that comprise all or part of the Exchange Property. For purposes of this Section 12, references to Common Stock in the definition of “Trading Day” shall be replaced by references to any publicly traded securities that comprise all or part of the Exchange Property.

(d) The above provisions of this Section 12 shall similarly apply to successive Reorganization Events and the provisions of Section 11 shall apply to any shares of capital stock of the Corporation (or any successor) received by the holders of the Common Stock in any such Reorganization Event.

(e) The Corporation (or any successor) shall, within 20 days of the occurrence of any Reorganization Event, provide written notice to the Holders of such occurrence of such event and of the kind and amount of the cash, securities or other property that constitutes the Exchange Property. Failure to deliver such notice shall not affect the operation of this Section 12 or the validity of any Reorganization Event.

13. Fractional Shares.

(a) No fractional shares of Common Stock shall be issued as a result of any conversion of shares of Series B.

(b) In lieu of any fractional share of Common Stock otherwise issuable in respect of any mandatory conversion pursuant to Section 10(a) or a conversion at the option of the Holder pursuant to Section 9(a), Section 10(c) or Section 10(g), the Corporation shall pay an amount in cash (computed to the nearest cent) equal to the same fraction of:

(i) in the case of a mandatory conversion pursuant to Section 10(a), a Make Whole Acquisition conversion pursuant to Section 10(c) or a Conversion Upon Fundamental Change pursuant to Section 10(g), the average of the Closing Prices over the five consecutive Trading Day period preceding the Trading Day immediately preceding the applicable Conversion Date; or

(ii) in the case of an Early Conversion pursuant to Section 9(a), the Closing Price of the Common Stock on the second Trading Day immediately preceding the Early Conversion Date.

(c) If more than one share of the Series B is surrendered for conversion at one time by or for the same Holder, the number of full shares of common Stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of the Series B so surrendered.

14. Reservation of common Stock.

(a) The Corporation shall at all times reserve and keep available out of its authorized and unissued Common Stock or shares held in the treasury by the Corporation, solely for issuance upon the conversion of shares of Series B as provided in this Certificate of Designations, free from any preemptive or other similar rights, such number of shares of Common Stock as shall from time to time be issuable upon the conversion of all the shares of Series B then outstanding. For purposes of this Section 14(a), the number of shares of common Stock that shall be deliverable upon the conversion of all outstanding shares of Series B shall be computed as if at the time of computation all such outstanding shares were held by a single Holder.

(b) Notwithstanding the foregoing, the Corporation shall be entitled to deliver upon conversion of shares of Series B, as herein provided, shares of Common Stock acquired by the Corporation (in lieu of the issuance of authorized and unissued shares of Common Stock), so long as any such acquired shares are free and clear of all liens, charges, security interests or encumbrances (other than liens, charges, security interests and other encumbrances created by the Holders).

(c) All shares of Common Stock delivered upon conversion of the Series B shall be duly authorized, validly issued, fully paid and non-assessable, free and clear of all liens, claims, security interests and other encumbrances (other than liens, charges, security interests and other encumbrances created by the Holders).

(d) Prior to the delivery of any securities that the Corporation shall be obligated to deliver upon conversion of the Series B, the Corporation shall use its reasonable best efforts to comply with all federal and state laws and regulations thereunder requiring the registration of such securities with, or any approval of or consent to the delivery thereof by, any governmental authority.

(e) The Corporation hereby covenants and agrees that, if at any time the Common Stock shall be listed on the New York Stock Exchange or any other national securities exchange or automated quotation system, the Corporation will, if permitted by the rules of such exchange or automated quotation system, list and keep listed, so long as the Common Stock shall be so listed on such exchange or automated quotation system, all the Common Stock issuable upon conversion of the Series B; provided, however, that if the rules of such exchange or automated quotation system permit the Corporation to defer the listing of such Common Stock until the first conversion of Series B into Common Stock in accordance with the provisions hereof, the Corporation covenants to list such Common Stock issuable upon conversion of the Series B in accordance with the requirements of such exchange or automated quotation system at such time.

15. Record Holders. To the fullest extent permitted by applicable law, the Corporation and the transfer agent for the Series B may deem and treat the record holder of any share of Series B as the true and lawful owner thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.

16. Notices. All notices or communications in respect of Series B shall be sufficiently given if given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be permitted in this Certificate of Designations, in the Certificate of Incorporation or Bylaws or by applicable law.

17. Preemptive or Subscription Rights. Except as expressly provided in any agreement between a Holder and the Corporation, no share of Series B shall have any rights of preemption whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto, regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.

18. Repurchase. Subject to the limitations imposed herein, the Corporation may purchase and sell shares of Series B from time to time to such extent, in such manner, and upon such terms as the Board or any duly authorized committee of the Board may determine; provided, however, that the Corporation shall not use any of its funds for any such purchase when there are reasonable grounds to believe that the Corporation is, or by such purchase would be, rendered insolvent.

19. Other Rights. The shares of Series B shall not have any voting powers, preferences or relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set forth herein or in the Certificate of Incorporation of the Corporation or as provided by applicable law.

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

IN WITNESS WHEREOF, the undersigned, being duly authorized thereto, does hereby affirm that this certificate is the act and deed of the Corporation and that the facts herein stated are true, and accordingly has hereunto set his hand this 10th day of October, 2008.




MORGAN STANLEY

By:		/s/ Daniel B. Park
		Name: Daniel B. Park
		Title: Assistant Treasurer

AMENDED

CERTIFICATE OF DESIGNATIONS OF PREFERENCES AND RIGHTS

OF THE

10% SERIES B NON-CUMULATIVE NON-VOTING PERPETUAL

CONVERTIBLE PREFERRED STOCK

($1,000 LIQUIDATION PREFERENCE PER SHARE)

MORGAN STANLEY

Pursuant to Section 151 of the

General Corporation Law of the State of Delaware

MORGAN STANLEY, a Delaware corporation (the “Corporation”), DOES HEREBY CERTIFY:

A. That, pursuant to resolutions of the Preferred Stock Financing Committee of the Board of Directors of the Corporation adopted on September 28, 2008, and by a Certificate of Designations filed in the office of the Secretary of State of the State of Delaware on October 10, 2008, the Corporation authorized the issuance of 6,045,750 shares of 10% Series B Non-Cumulative Non-Voting Perpetual Convertible Preferred Stock, par value $0.01 per share, liquidation preference $1,000 per share (“Series B”), of the Corporation and established the designation, preferences, privileges, voting rights, and other special rights and qualifications, limitations and restrictions of the Series B;

B. That no shares of Series B have been issued;

C. That, pursuant to resolutions of the Preferred Stock Financing Committee of the Board of Directors of the Corporation adopted on October 12, 2008, the Corporation adopted the following resolution amending the Certificate of Designations of the Series B and increasing the number of shares designated as Series B:

“RESOLVED, that, pursuant to Section 151(g) of the Delaware General Corporation Law, the Certificate of Designations of Rights and Preferences of the 10% Series B Non-Cumulative Non-Voting Perpetual Convertible Preferred Stock of the Corporation be and hereby is amended to read in its entirety as follows, and the number of shares designated as Series B Non-Cumulative Non-Voting Perpetual Convertible Preferred Stock of the Corporation be increased from 6,045,750 to 7,839,209:”

2. Number of Shares. The authorized number of shares of Series B shall be 7,839,209. Shares of Series B that are purchased or otherwise acquired by the Corporation, or converted into Common Stock or another series of Preferred Stock, shall be cancelled and shall revert to authorized but unissued shares of Preferred Stock provided that this Section 2 shall not apply to any purchase or other acquisition of shares of Series B by any Subsidiary of the Corporation.

3. Dividends.

(a) Rate. Holders of shares of Series B shall be entitled to receive, only when, as and if declared by the Board of Directors or a duly authorized committee thereof out of funds of the Corporation legally available for payment, non-cumulative cash dividends on the liquidation preference of $1,000 per share at a rate per annum equal to 10%; provided, that, if Stockholder Approval has not been received by February 17, 2009, if such Stockholder Approval is then required for the conversion of all of the Series B without a Violation, the per annum rate shall be increased to 13% per annum on and including February 17, 2009 and shall remain in effect until the date upon which Stockholder Approval is received or no longer required. Declared dividends on the Series B shall be payable from and including the date of initial issuance (in the case of the initial Dividend Period) or the immediately preceding Dividend Payment Date (in the case of Dividend Periods other than the initial Dividend Period), and shall be payable quarterly, in arrears, on each January 15, April 15, July 15 and October 15, commencing on January 15, 2009 (each such date a “Dividend Payment Date”). If any date on which dividends would otherwise be payable shall not be a Business Day (as defined below), then the date of payment of dividends need not be made on such date, but such payment of dividends may be made on the next succeeding day that is a Business Day with the same force and effect as if made on the Dividend Payment Date, and no additional dividends shall be payable nor shall interest accrue on the amount payable from and after such Dividend Payment Date to the next succeeding Business Day. “Business Day” means any day that is not a Saturday or Sunday and that, in New York City, is not a day on which banking institutions generally are authorized or obligated by law or executive order to be closed.

authorized committee of the Board of Directors that is not more than 60 nor less than 10 days prior to such Dividend Payment Date (each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend Record Date whether or not such day is a Business Day.

dividends declared on the Series B and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the related Dividend Period) shall be declared pro rata so that the respective amounts of such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series B and all Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the related Dividend Period) bear to each other.

Subject to the foregoing, dividends (payable in cash, securities or other property) may be determined by the Board of Directors or a duly authorized committee of the Board of Directors and may be declared and paid on the Common Stock and any other stock ranking, as to dividends, equally with or junior to the Series B, from time to time out of any funds legally available for such payment, and the Series B shall not be entitled to participate in any such dividends.

4. Liquidation Rights.

(a) Voluntary or Involuntary Liquidation. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation, Holders of Series B shall be entitled to receive out of the assets of the Corporation or proceeds thereof available for distribution to stockholders of the Corporation, after satisfaction of all liabilities, if any, to creditors of the Corporation and subject to the rights of holders of any shares of capital stock of the Corporation then outstanding ranking senior to or pari passu with the Series B in respect of distributions upon liquidation, dissolution or winding up of the Corporation, and before any distribution of such assets or proceeds is made to or set aside for the holders of Common Stock and any other classes or series of capital stock of the Corporation ranking junior to the Series B as to such distribution, a liquidating distribution in an amount equal to $1,000 per share, together with an amount equal to all dividends, if any, that have been declared but not paid prior to the date of payment of such distribution (but without any accumulation in respect of dividends that have not been declared prior to such payment date). Holders of the Series B will not be entitled to any other amounts from the Corporation after they have received their full liquidation preference.

5. Voting Rights.

dividends on the shares of the Series B and any such series of Voting Preferred Stock shall have been fully paid (or declared and a sum sufficient for the payment of such dividends shall have been set aside for such payment) for at least four regular dividend periods following the Nonpayment.

If and when dividends for at least four regular dividend periods following a Nonpayment have been fully paid (or declared and a sum sufficient for such payment shall have been set aside) on the Series B and any other class or series of Voting Preferred Stock, the holders of the Series B and all other holders of Voting Preferred Stock shall be divested of the foregoing voting rights (subject to revesting in the event of each subsequent Nonpayment), the term of office of each Preferred Stock Director so elected shall terminate and the number of directors on the Board of Directors shall automatically decrease by two. In determining whether dividends have been paid for at least four regular dividend periods following a Nonpayment, the Corporation may take account of any dividend it elects to pay for any dividend period after the regular dividend date for that period has passed.

Any Preferred Stock Director may be removed at any time without cause by the holders of record of a majority of the outstanding shares of the Series B together with all series of Voting Preferred Stock then outstanding (voting together as a single class) to the extent such holders have the voting rights described above. So long as a Nonpayment shall continue, any vacancy in the office of a Preferred Stock Director (other than prior to the initial election after a Nonpayment) may be filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of the holders of record of a majority of the outstanding shares of Series B and all Voting Preferred Stock when they have the voting rights described above (voting together as a single class); provided that the filling of each vacancy shall not cause the Corporation to violate the corporate governance requirements of the New York Stock Exchange (or any other exchange on which the Corporation’s securities may be listed) that listed companies must have a majority of independent directors. Any such vote to remove, or to fill a vacancy in the office of, a Preferred Stock Director may be taken only at a special meeting called at the request of the holders of record of at least 20% of the Series B or of any other series of Voting Preferred Stock (unless such request is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held at such next annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to one vote per director on any matter.

The term “Voting Preferred Stock” means any other class or series of Preferred Stock of the Corporation ranking equally with the Series B as to payment of dividends and the distribution of assets upon liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and are exercisable. Voting Preferred Stock includes the Corporation’s Floating Rate Non-Cumulative Preferred Stock, Series A (the “Series A”), and the Corporation’s 10% Series C Non-Cumulative Non-Voting Perpetual Preferred Stock (the “Series C”), in each case, if outstanding, and any class or series of Preferred Stock, whether or not cumulative, that the Corporation may issue in the future, to the extent their like voting rights are exercisable at such time. Whether a plurality, majority or other portion of the shares of Series B and any other Voting Preferred Stock have been voted in favor of any matter shall be determined by reference to the relative liquidation preferences of the shares voted.

with respect to the payment of dividends (whether such dividends are cumulative or non-cumulative) and the distribution of assets upon liquidation, dissolution or winding up of the Corporation will be deemed to adversely affect

the rights, preferences, privileges or voting powers of, and neither will require the affirmative vote or consent of, the holders of outstanding shares of Series B. In addition, any conversion of the Series B pursuant hereto shall not be deemed to adversely affect the rights, preferences, privileges and voting powers of the Series B. For purposes of clarification, no Holder of Series B shall have any voting rights with respect to any binding share exchange, reclassification, merger or consolidation which complies with the provisions of clause (iii)(x) and (y) hereof.

If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in this Section 5(c) for which a vote is otherwise required would adversely affect one or more but not all other series of Voting Preferred Stock (including the Series B for this purpose), then only such series of Preferred Stock as are adversely affected by and otherwise entitled to vote on the matter shall vote on the matter together as a class in lieu of all other series of Preferred Stock. If all series of a class of Preferred Stock that are otherwise entitled to vote on the matter are not equally affected by the proposed amendment, alteration, repeal, share exchange, reclassification, merger or consolidation described above, there shall be required a two-thirds approval of the class and a two-thirds approval of each series that will have a diminished status and that is otherwise entitled to vote thereon.

(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of Designations that may be defective or inconsistent; or

(ii) to make any provision with respect to matters or questions arising with respect to the Series B that is not inconsistent with the provisions of this Certificate of Designations.

(f) Authorization of Certain Parity Stock. Until October 13, 2013, if the Initial Holder or an Affiliate thereof beneficially owns shares of Series B representing at least 15% of the shares of Series B initially issued to the Initial Holder, in addition to any other vote or consent of stockholders required by law or by the Certificate of Incorporation, the consent of the Initial Holder shall be necessary for effecting or validating any amendment or alteration of the provisions of the Certificate of Incorporation or this Certificate of Designations to authorize or create, or increase the authorized amount of, any shares of any class or series of stock of the Corporation ranking pari passu with the Series B with respect to the payment of dividends or the distribution of assets upon any liquidation, dissolution or winding up of the Corporation if such class or series of stock:

(i) is issued for consideration with a fair market value that is less than the liquidation preference thereof;

(ii) has a dividend rate that is (x) higher than the dividend rate applicable to the Series B and (y) substantially higher than the dividend rate that would then be carried by a substantially equivalent publicly traded security then issued by a similar issuer with a long-term unsecured debt credit rating substantially equivalent to that of the Corporation; or

(iii) is convertible or exchangeable into Common Stock at a per share conversion or exchange price that is less than the closing price of the Common Stock on the day prior to the date of issuance thereof or the date that a binding agreement for the purchase and sale of such shares is entered into, if different from the date of issuance;

provided, however, that this paragraph (f) shall not apply (and no vote or consent of the Initial Holder or any other Holder of any Series B shall be required) in connection with any of the following: (A) any authorization, creation or issuance of any preferred stock in connection with any merger, business combination or share exchange involving an unaffiliated third party for the purpose of replacing or substituting the outstanding series or class of preferred stock of such third party; (B) any broadly

distributed underwritten offering of securities registered under the Securities Act of 1933, as amended; or (C) any broadly distributed placement of securities in a transaction exempt from registration under Rule 144A promulgated under the Securities Act of 1933.

6. Redemption. The shares of Series B shall not be redeemable.

7. Rank. Any stock of any class or classes or series of the Corporation shall be deemed to rank:

thereof to the receipt of dividends or of amounts distributed upon liquidation, dissolution or winding up, as the case may be, in proportion to their respective dividend rates or liquidation prices, without preference or priority of one over the other as between the holders of such stock and the Holders of shares of Series B (the term “Parity Preferred Stock” being used to refer to any stock on a parity with the shares of Series B, either as to dividends or upon liquidation, dissolution or winding up, or both, as the content may require); and

The Series B shall rank, as to dividends and upon liquidation, dissolution or winding up, on a parity with the Series A, the Series C and any Parity Preferred Stock issued hereafter.

8. Additional Definitions. As used herein with respect to Series B:

“Cash” means such coin or currency of the United States as at any time of payment is legal tender for the payment of public and private debts.

“Close of Business” means 5:00 p.m., New York City time.

“Closing Price” of the Common Stock or any securities distributed in a Spin-Off, as the case may be, means, as of any date of determination:

“Common Stock” means the common stock, $0.01 par value, of the Corporation.

“Conversion Date” means each of a Mandatory Conversion Date and a Non-Mandatory Conversion Date.

“Conversion Price” at any time means for each share of Series B the price equal to $1,000 divided by the Conversion Rate in effect at such time (initially $25.25).

“Conversion Rate” means initially 39.604 shares of Common Stock per share of Series B, subject to adjustment in accordance with the provisions of this Certificate of Designations.

“Depositary” means DTC or its nominee or any successor depositary appointed by the Corporation.

“DTC” means The Depository Trust Company, together with its successors and assigns.

“Exchange Act” means the Securities Exchange Act of 1934, as amended.

“Fair Market Value” means the amount which a willing buyer would pay a willing seller in an arm’s-length transaction as determined by the Board of Directors.

“Full Mandatory Conversion Date” means the 3rd Trading Day immediately following the later of (i) the first date after the second anniversary of the Issue Date as of which, for 20 Trading Days within any period of 30 consecutive Trading Days beginning after such second anniversary and preceding such date, the Closing Price of the Common Stock has exceeded 150% of the then applicable Conversion Price and (ii) the date Stockholder Approval shall have been received or is no longer required to permit conversion of all shares of Series B.

“Fundamental Change” means the occurrence, prior to the Full Mandatory Conversion Date, of one of the following:

(i) a “person” or “group” within the meaning of Section 13(d) of the Exchange Act files a Schedule TO or any schedule, form or report under the Exchange Act disclosing that such person or group has become the direct or indirect ultimate “beneficial owner,” as defined in Rule 13d-3 under the Exchange Act, of common equity of the Corporation representing more than 50% of the voting power of the outstanding Common Stock;

of common stock or American Depositary Receipts in respect of common stock that are traded on a U.S. national securities exchange or that will be so traded when issued or exchanged in connection with a Fundamental Change; and provided, further, that with respect to any shares of Series B that are beneficially owned by the Initial Holder or its affiliates, a Fundamental Change with respect to clauses (i) or (ii) above will not be deemed to have occurred if the Initial Holder or any of its affiliates is part of the person or group referred to in clause (i) above or is a counterparty to the Corporation in any of the transactions referred to in clause (ii) above.

“Initial Holder” means Mitsubishi UFJ Financial Group, Inc.

“Issue Date” means October 13, 2008.

“Make-Whole Acquisition” means the occurrence, prior to the Full Mandatory Conversion Date, of one of the following:

(i) a “person” or “group” within the meaning of Section 13(d) of the Exchange Act files a Schedule TO or any schedule, form or report under the Exchange Act disclosing that such person or group has become the direct or indirect ultimate “beneficial owner,” as defined in Rule 13d-3 under the Exchange Act, of common equity of the Corporation representing more than 50% of the voting power of the outstanding Common Stock; or

(ii) consummation of any consolidation or merger of the Corporation or similar transaction or any sale, lease or other transfer in one transaction or a series of transactions of all or substantially all of the consolidated assets of the Corporation and its subsidiaries, taken as a whole, to any Person other than one of the Corporation’s subsidiaries, in each case pursuant to which the Common Stock will be converted into, or receive distributions of the proceeds in, cash, securities or other property, other than pursuant to a transaction in which the Persons that “beneficially owned” (as defined in Rule 13d-3 under the Exchange Act) directly or indirectly, voting shares of the Corporation immediately prior to such transaction beneficially own, directly or indirectly, voting shares representing a majority of the total voting power of all outstanding classes of voting shares of the continuing or surviving Person or the ultimate parent entity thereof immediately after the transaction;

provided, however, that a Make-Whole Acquisition will not be deemed to have occurred if at least 90% of the consideration received by holders of the Common Stock in the transaction or transactions consists of shares of common stock or American Depositary Receipts in respect of common stock that are traded on a U.S. national securities exchange or that will be so traded when issued or exchanged in connection with a Make-Whole Acquisition; and provided, further, that with respect to any shares of Series B that are beneficially owned by the Initial Holder or its affiliates, a Make-Whole Acquisition will not be deemed to have occurred if the Initial Holder or any of its affiliates is part of the person or group referred to in clause (i) above or is a counterparty to the Corporation in any of the transactions referred to in clause (ii) above.

“Mandatory Conversion Date” means a Partial Mandatory Conversion Date or a Full Mandatory Conversion Date.

“Non-Mandatory Conversion Date” means an Early Conversion Date, a Make-Whole Acquisition Conversion Date or a Fundamental Change Conversion Date.

“Open of Business” means 9:00 a.m., New York City time.

“Partial Mandatory Conversion Date” means the 3rd Trading Day immediately following the later of (i) the first date after the first anniversary of the Issue Date as of which, for 20 Trading Days within any period of 30 consecutive Trading Days beginning after such first anniversary and preceding such date, the Closing Price of the Common Stock has exceeded 150% of the then applicable Conversion Price and (ii) the date Stockholder Approval shall have been received or is no longer required to permit conversion of all shares of Series B.

“Person” means a legal person, including any individual, corporation, estate, partnership, joint venture, association, joint-stock company, limited liability company or trust.

“Preferred Stock” means any and all series of preferred stock of the Corporation, including the Series B.

“Registrar” shall mean BNY Mellon Shareowner Services, acting in its capacity as registrar for the Series B, and its successors and assigns or any other registrar appointed by the Corporation.

“Securities Purchase Agreement” means the Securities Purchase Agreement, dated as of December 19, 2007, between the Corporation and the Investor listed on the signature page thereto.

“Stockholder Approval” means approval of stockholders of the Corporation necessary to approve the conversion of all of the Series B into Common Stock for purposes of Section 312.03 of the NYSE Listed Company Manual or the time at which such provisions shall for any reason become inapplicable or not required so as to permit the conversion of all shares of Series B.

“Violation” means a violation of the stockholder approval requirements of Section 312.03 of the NYSE Listed Company Manual to the extent then applicable.

9. Early Conversion at the Option of the Holder. Other than during a Make-Whole Acquisition Conversion Period, any Holder shall have the right to convert such Holder’s shares of Series B, in whole or in part (but in no event less than one share of Series B), at any time prior to the Mandatory Conversion Date (“Early Conversion”), into shares of Common Stock at the then applicable Conversion Rate, subject to satisfaction of the conversion procedures set forth in Section 10(b); provided that, prior to the receipt of Stockholder Approval, Early Conversion shall be limited to conversion into such number of shares of Common Stock the conversion into which would not result in a Violation. The date of such Early Conversion is referred to herein as the “Early Conversion Date.”

10. Conversion.

(a) Mandatory Conversion on Mandatory Conversion Date.

(b) Conversion Procedures for a Non-Mandatory Conversion Date. To effect conversion on a Non-Mandatory Conversion Date, a Holder who:

(ii) holds shares of Series B in certificated form must:

(A) complete and manually sign the conversion notice on the back of the Series B certificate or a facsimile of the conversion notice;

(B) deliver the completed conversion notice and the certificated shares of Series B to be converted to the Conversion Agent;

(D) if required, pay funds equal to the dividend payable on the next Dividend Payment Date to which such Holder is not entitled by virtue of Section 10(e); and

(E) if required, pay all transfer or similar taxes or duties, if any.

may be payable relating to any transfer involved in the issuance or delivery of Common Stock in a name other than the name of such Holder. A certificate representing Common Stock will be issued and delivered only after all applicable taxes and duties, if any, payable by the Holder have been paid in full.

The Corporation shall deliver the shares of Common Stock to which the Holder converting pursuant to Section 9 is entitled on or prior to the third Trading Day immediately following the applicable Non-Mandatory Conversion Date.

(i) In the event of a Make-Whole Acquisition, each Holder shall have the option to convert its shares of Series B (a “Make-Whole Acquisition Conversion”) at the then applicable Conversion Rate during the period (the “Make-Whole Acquisition Conversion Period”) beginning on the effective date of the Make-Whole Acquisition (the “Make-Whole Acquisition Effective Date”) and ending on the date that is 30 days after the Make-Whole Acquisition Effective Date and receive an additional number of shares of Common Stock in the form of Make-Whole Shares as set forth in this Section 10(c); provided that, prior to the receipt of Stockholder Approval, notwithstanding anything herein to the contrary, any conversion in connection with a Make-Whole Acquisition shall be limited to conversion into such number of shares of Common Stock so that such conversion would not result in a Violation. The date of such Make-Whole Acquisition Conversion is referred to herein as the “Make-Whole Acquisition Conversion Date.”



Effective Date	$21.375	$22.50	$25.00	$27.50	$30.00	$32.50	$35.00	$40.00
October 13, 2008	10.7854	9.8381	8.1076	6.7711	5.7228	4.8863	4.2143	3.2166
October 13, 2009	9.7691	8.7338	6.8121	5.2906	4.0621	3.0530	2.2300	1.3069
October 13, 2010 and thereafter	9.3474	8.2446	6.1634	4.4726	3.0670	1.8785	0.8903	—
Effective Date	$45.00	$50.00	$55.00	$60.00	$70.00	$80.00	$90.00	$100.00
October 13, 2008	2.5277	2.0384	1.6809	1.4108	1.0417	0.8038	0.6426	0.5256
October 13, 2009	0.9877	0.7694	0.6160	0.5044	0.3599	0.2723	0.2160	0.1763
October 13, 2010 and thereafter	—	—	—	—	—	—	—	—

(A) The exact Make-Whole Acquisition Stock Prices and Effective Dates may not be set forth in the table above, in which case:

(1) if the Make-Whole Acquisition Stock Price is between two Make-Whole Acquisition Stock Price amounts in the table or the Make-Whole Acquisition Effective Date is between two dates in the table, the number of Make-Whole Shares will be determined by straight-line interpolation between the number of Make-Whole Shares set forth for the higher and lower Make-Whole Acquisition Stock Price amounts and the two Make-Whole Acquisition Effective Dates, as applicable, based on a 365-day year;

(2) if the Make-Whole Acquisition Stock Price is in excess of $100.00 per share (subject to adjustment pursuant hereto), no Make-Whole Shares will be issued upon conversion of the Series B; and

(3) if the Make-Whole Acquisition Stock Price is less than $21.375 per share (subject to adjustment pursuant hereto), no Make-Whole Shares will be issued upon conversion of the Series B.

(A) the date on which the Make-Whole Acquisition is anticipated to be effected;

(B) the date, which shall be 30 days after the Make-Whole Acquisition Effective Date, by which the Make-Whole Acquisition conversion option must be exercised;

(C) the amount of cash, securities and other consideration payable per share of Common Stock or Series B, respectively; and

(D) the instructions a Holder must follow to exercise its conversion option in connection with such Make-Whole Acquisition.

Dividend Payment Date if such Holder was the Holder of record at the Close of Business on the Dividend Record Date for that dividend. Notwithstanding the preceding sentence, if the Non-Mandatory Conversion Date is after the Close of Business on the Dividend Record Date and prior to the Open of Business on the Dividend Payment Date, whether or not such Holder was the Holder of record at the Close of Business on the Dividend Record Date, the Holder must pay to the Conversion Agent upon conversion of the shares of Series B an amount in cash equal to the dividend payable on the Dividend Payment Date for the then-current Dividend Period on the shares of Series B being converted.

(f) Outstanding Shares of Series B. Shares of Series B shall cease to be outstanding on the applicable Conversion Date, subject to the right of Holders of such shares to receive shares of Common Stock issuable upon conversion of such shares of Series B.

(g) Conversion Upon Fundamental Change.

subject to adjustment as described herein (the “Base Price”), provided that, notwithstanding anything herein to the contrary, prior to the receipt of Stockholder Approval, any conversion in connection with a Fundamental Change shall be limited to conversion into such number of shares of Common Stock so that such conversion would not result in a Violation. The date of such conversion upon a Fundamental Change is referred to herein as the “Fundamental Change Conversion Date.”

(A) the date on which the Fundamental Change is anticipated to be effected; and

(B) the date, which shall be 30 days after the effective date of a Fundamental Change, by which the Fundamental Change conversion option must be exercised.

(A) the date that shall be 30 days after the effective date of the Fundamental Change;

(B) the adjusted conversion price following the Fundamental Change;

(C) the amount of cash, securities and other consideration payable per share of Common Stock or Series B, respectively; and

(D) the instructions a Holder must follow to exercise its conversion option in connection with such Fundamental Change.

(h) A Holder cannot effect both a Make-Whole Acquisition Conversion and a Fundamental Change Conversion with respect to a share of Series B.

11. Anti-Dilution Adjustments.

(a) The Conversion Rate shall be adjusted from time to time by the Corporation as follows:




CR1	=	CR0	×	OS1
CR1	=	CR0	×	OS0

where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the Record Date for such dividend or distribution, or the Close of Business on the effective date of such share split or combination, as applicable;

CR1	=	the new Conversion Rate in effect immediately after the Close of Business on the Record Date for such dividend or distribution, or the Close of Business on the effective date of such share split or share combination, as applicable;

OS0	=	the number of shares of Common Stock outstanding immediately prior to the Close of Business on the Record Date for such dividend or distribution, or the Close of Business on the effective date of such share split or share combination, as applicable; and

OS1	=	the number of shares of Common Stock outstanding immediately after such dividend or distribution, or the Close of Business on the effective date of such share split or share combination, as applicable.

The Corporation will not pay any dividend or make any distribution on shares of Common Stock held in treasury by the Corporation.




CR1	=	CR0	×	OS0 + X
CR1	=	CR0	×	OS0 + Y

where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the Record Date for such distribution;

CR1	=	the new Conversion Rate in effect immediately after the Close of Business on the Record Date for such distribution;

OS0	=	the number of shares of Common Stock outstanding immediately prior to the Close of Business on the Record Date for such distribution;

X	=	the total number of shares of Common Stock issuable pursuant to such rights or warrants; and

Y	=	the number of shares of Common Stock equal to the aggregate price payable to exercise such rights or warrants divided by the average of the Closing Prices of the Common Stock over the ten consecutive Trading Day period ending on the Trading Day immediately preceding the Ex-Dividend Date for such distribution.

To the extent that shares of Common Stock are not delivered pursuant to such rights or warrants upon the expiration or termination of such rights or warrants, the Conversion Rate shall be readjusted to the Conversion Rate which would then be in effect had the adjustments made upon the distribution of such rights or warrants been made on the basis of the delivery of only the number of shares of Common Stock actually delivered.

(iii) If the Corporation, at any time or from time to time while any of the Series B is outstanding, shall, by dividend or otherwise, distribute to all or substantially all holders of its Common Stock shares of any class of Capital Stock of the Corporation (other than Common Stock as covered by Section 11(a)(i) above), evidences of its indebtedness, assets, property or rights or warrants to acquire the Corporation’s Capital Stock or other securities, but excluding (1) dividends or distributions as to which an adjustment under Section 11(a)(i), Section 11(a)(ii) or Section 11(a)(iv) hereof shall apply, (2) dividends or distributions paid exclusively in Cash and (3) Spin-Offs to which the provision set forth below in this Section 11(a)(iii) shall apply (any of such shares of Capital Stock, indebtedness, assets, property or rights or warrants to acquire the Corporation’s Common Stock or other securities, hereinafter in this Section 11(a)(iii) called the “Distributed Property”), then, in each such case the Conversion Rate shall be adjusted based on the following formula:

where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the Record Date for such distribution;

CR1	=	the new Conversion Rate in effect immediately after the Close of Business on the Record Date for such distribution;

SP0	=	the average of the Closing Prices of the Common Stock over the ten consecutive Trading Day period ending on the Trading Day immediately preceding the Ex-Dividend Date for such distribution; and

FMV	=	the fair market value (as determined in good faith by the Corporation’s Board of Directors) of the portion of Distributed Property with respect to each outstanding share of Common Stock on the Record Date for such distribution.

where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the 10th Trading Day immediately following, and including, the effective date of the Spin-Off;

CR1	=	the new Conversion Rate in effect from and after the Close of Business on the 10th Trading Day immediately following, and including, the effective date of the Spin-Off;

FMV	=	the average of the Closing Prices of the Capital Stock or similar equity interest distributed to holders of Common Stock applicable to one share of Common Stock over the 10 consecutive Trading Day period immediately following, and including, the effective date of the Spin-Off; and

MP0	=	the average of the Closing Prices of Common Stock over the 10 consecutive Trading Day period immediately following, and including, the effective date of the Spin-Off.

Such adjustment shall occur on the 10th Trading Day immediately following, and including, the effective date of the Spin-Off (it being agreed that notwithstanding Section 10(a), the Holder of the Series B shall not be entitled to convert the Series B pursuant to an Early Conversion prior to such 10th Trading Day).

For purposes of this Section 11(a)(iii), Section 11(a)(i) and Section 11(a)(ii) hereof, any dividend or distribution to which this Section 11(a)(iii) is applicable that also includes shares of Common Stock, or rights or warrants to subscribe for or purchase shares of Common Stock to which Section 11(a)(i) or 11(a)(ii) hereof applies (or both), shall be deemed instead to be (1) a dividend or distribution of the evidences of indebtedness, assets or shares of Capital Stock other than such shares of Common Stock or rights or warrants to which Section 11(a)(i) or 11(a)(ii) hereof applies (and any Conversion Rate adjustment required by this Section 11(a)(iii) with respect to such dividend or distribution shall then be made) immediately followed by (2) a dividend or distribution of such shares of Common Stock or such rights or warrants to which Section 11(a)(i) or 11(a)(ii) hereof applies (and any further Conversion Rate adjustment required by Section 11(a)(i) and 11(a)(ii) hereof with respect to such dividend or distribution shall then be made), except (A) the Close of Business on the Record Date of such dividend or distribution shall be substituted for “the Close of Business on the Record Date,” “the Close of Business on the Record Date or the Close of Business on the effective date,” “after the Close of Business on the Record Date for such dividend or distribution or the Close of Business on the effective date of such share split or share combination” and “the Close of Business on the Record Date for such distribution” within the meaning of Section 11(a)(i) and Section 11(a)(ii) hereof and (B) any shares of Common Stock included in such dividend or distribution shall not be deemed “outstanding immediately prior to the Close of Business on the Record Date or the Close of Business on the effective date” within the meaning of Section 11(a)(i) hereof.

case of such rights or warrants that shall have expired or been terminated without exercise by any holders thereof, the Conversion Rate shall be readjusted as if such rights or warrants had not been issued.

where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the Record Date for such dividend or distribution;

CR1	=	the new Conversion Rate in effect immediately after the Close of Business on the Record Date for such dividend or distribution;

SP0	=	the average Closing Price of the Common Stock over the ten consecutive Trading Days ending on the Trading Day immediately preceding the Ex-Dividend Date for such dividend or distribution;

C	=	the amount in Cash per share the Corporation distributes or dividends to holders of Common Stock in excess of the Initial Dividend Threshold.

where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the Record Date for such dividend or distribution;





CR1	=	the new Conversion Rate in effect immediately after the Close of Business on the Record Date for such dividend or distribution;

SP0	=	the average Closing Price of the Common Stock over the ten consecutive Trading Days ending on the Trading Day immediately preceding the Ex-Dividend Date for such dividend or distribution;

C	=	the amount in Cash per share the Corporation distributes or dividends to holders of Common Stock

where




CR0	=	the Conversion Rate in effect immediately prior to the Close of Business on the expiration date;

CR1	=	the new Conversion Rate in effect immediately after the Close of Business on the expiration date;

AC	=	the aggregate value of all Cash and any other consideration (as determined in good faith by the Corporation’s Board of Directors) paid or payable for shares purchased in such tender or exchange offer;

OS0	=	the number of shares of Common Stock outstanding immediately prior to the date such tender or exchange offer expires;

OS1	=	the number of shares of Common Stock outstanding immediately after the date such tender or exchange offer expires (after giving effect to such tender offer or exchange offer); and

SP1	=	the average Closing Price of Common Stock over the ten consecutive Trading Days ending on the Trading Day next succeeding the expiration date.

(x) Notwithstanding any of the foregoing clauses in this Section 11, no adjustment in the Conversion Rate shall be required unless the adjustment would result in a change in the Conversion Rate of at least 1.00%; provided, however, that any adjustment which by reason of this Section 11(a)(x) is not required to be made shall be carried forward and the Corporation shall make such adjustment, regardless of whether the aggregate adjustment is less than 1.00%, within one year of the first such adjustment carried forward or in connection with any conversion of Series B. All calculations under this Section 11 shall be made to the nearest one-ten thousandth (1/10,000) of a cent or to the nearest one-ten thousandth (1/10,000) of a share, as the case may be.

(iv) for a change in the par value of the Common Stock, (v) for repurchases of shares of Common Stock in open market transactions or privately negotiated transactions, or (vi) for accumulated and unpaid dividends, other than as expressly contemplated by Section 11(a)(i).

(xiv) For purposes of this Section 11, the number of shares of Common Stock at any time outstanding shall not include shares held in the treasury of the Corporation but shall include shares issuable in respect of scrip certificates issued in lieu of fractions of shares of Common Stock.

of record of Common Stock for purposes of that dividend or distribution. In that case, the Holders will receive the number of shares of Common Stock issuable upon the applicable Mandatory Conversion Date together with the dividend or distribution on such shares of Common Stock so converted.

12. Reorganization Events.

(a) In the event of:

(i) any consolidation or merger of the Corporation with or into another Person or of another Person with or into the Corporation;

(ii) any sale, transfer, lease or conveyance to another Person of the property of the Company as an entirety or substantially as an entirety;

(iii) any statutory share exchange of the Corporation with another Person (other than in connection with a merger or acquisition); or

(iv) any liquidation, dissolution or termination of the Corporation;

in each case in which holders of Common Stock would be entitled to receive cash, securities or other property for their shares of Common Stock (any such event specified in this Section 12(a), a “Reorganization Event”), each share of Series B outstanding immediately prior to such Reorganization Event shall, without the consent of Holders, become convertible into the kind of cash, securities and other property receivable in such Reorganization Event by a holder of one share of Common Stock that was not the counterparty to the Reorganization Event or an affiliate of such other party (such cash, securities and other property, the “Exchange Property”).

13. Fractional Shares.

(a) No fractional shares of Common Stock shall be issued as a result of any conversion of shares of Series B.

(b) In lieu of any fractional share of Common Stock otherwise issuable in respect of any mandatory conversion pursuant to Section 10(a) or a conversion at the option of the Holder pursuant to Section 9, Section 10(c) or Section 10(g), the Corporation shall pay an amount in cash (computed to the nearest cent) equal to the same fraction of:

(ii) in the case of an Early Conversion pursuant to Section 9, the Closing Price of the Common Stock on the second Trading Day immediately preceding the Early Conversion Date.

(c) If more than one share of the Series B is surrendered for conversion at one time by or for the same Holder, the number of full shares of Common Stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of the Series B so surrendered.

14. Reservation of Common Stock.

(a) The Corporation shall at all times reserve and keep available out of its authorized and unissued Common Stock or shares held in the treasury by the Corporation, solely for issuance upon the conversion of shares of Series B as provided in this Certificate of Designations, free from any preemptive or other similar rights, such number of shares of Common Stock as shall from time to time be issuable upon the conversion of all the shares of Series B then outstanding. For purposes of this Section 14(a), the number of shares of Common Stock that shall be deliverable upon the conversion of all outstanding shares of Series B shall be computed as if at the time of computation all such outstanding shares were held by a single Holder.

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]




MORGAN STANLEY

By:	/s/ Walid A. Chammah
	Name:	Walid A. Chammah
	Title:	Co-President

CERTIFICATE OF DESIGNATIONS OF PREFERENCES AND RIGHTS

OF THE

10% SERIES C NON-CUMULATIVE NON-VOTING PERPETUAL

PREFERRED STOCK

($1,000 LIQUIDATION PREFERENCE PER SHARE)

MORGAN STANLEY

Pursuant to Section 151 of the

General Corporation Law of the State of Delaware

MORGAN STANLEY, a Delaware corporation (the “Corporation”), DOES HEREBY CERTIFY that, pursuant to resolutions of the Preferred Stock Financing Committee of the Board of Directors of the Corporation adopted on October 12, 2008, the creation of 10% Series C Non-Cumulative Non-Voting Perpetual Preferred Stock, par value $0.01 per share, liquidation preference $1,000 per share (“Series C”), of the Corporation was authorized and the designation, preferences, privileges, voting rights, and other special rights and qualifications, limitations and restrictions of the Series C, in addition to those set forth in the Certificate of Incorporation and Bylaws of the Corporation, are fixed as follows:

1. Designation. The distinctive serial designation of such series of preferred stock is “10% Series C Non-Cumulative Non-Voting Perpetual Preferred Stock.” Each share of Series C shall be identical in all respects to every other share of Series C, except as to the respective dates from which dividends thereon shall accrue, to the extent such dates may differ as permitted pursuant to Section 3 below.

2. Number of Shares. The authorized number of shares of Series C shall be 1,160,791. Shares of Series C that are purchased, redeemed or otherwise acquired by the Corporation shall be cancelled and shall revert to authorized but unissued shares of Preferred Stock provided that this Section 2 shall not apply to any purchase or other acquisition of shares of Series C by any Subsidiary of the Corporation.

3. Dividends.

(a) Rate. Holders of shares of Series C shall be entitled to receive, only when, as and if declared by the Board of Directors or a duly authorized committee thereof out of funds of the Corporation legally available for payment, non-cumulative cash dividends on the liquidation preference of $1,000 per share at a rate per annum equal to 10%. Declared dividends on the Series C shall be payable from and including the date of initial issuance (in the case of the initial Dividend Period) or the immediately preceding Dividend Payment Date (in the case of Dividend Periods other than the initial Dividend Period), and shall be payable quarterly, in arrears, on each January 15, April 15, July 15 and October 15, commencing on January 15, 2009 (each such date a “Dividend Payment Date”). If any date on which dividends would otherwise be payable shall not be a Business Day (as defined below), then the date of payment of dividends

need not be made on such date, but such payment of dividends may be made on the next succeeding day that is a Business Day with the same force and effect as if made on the Dividend Payment Date, and no additional dividends shall be payable nor shall interest accrue on the amount payable from and after such Dividend Payment Date to the next succeeding Business Day. “Business Day” means any day that is not a Saturday or Sunday and that, in New York City, is not a day on which banking institutions generally are authorized or obligated by law or executive order to be closed.

Dividends on the Series C shall not be cumulative; Holders of Series C shall not be entitled to receive any dividends not declared by the Board of Directors or a duly authorized committee thereof and no interest, or sum of money in lieu of interest, shall be payable in respect of any dividend not so declared. Accordingly, if the Board of Directors (or a duly authorized committee thereof) does not declare a dividend on the Series C payable in respect of any Dividend Period before the related Dividend Payment Date, such dividend will not accrue and the Corporation will have no obligation to pay a dividend for that Dividend Period on that Dividend Payment Date or at any future time, whether or not dividends on the Series C are declared for any future Dividend Period. Declared and unpaid dividends shall not bear interest.

Dividends that are payable on the Series C on any Dividend Payment Date will be payable to holders of record of Series C as they appear on the stock register of the Corporation on the applicable Dividend Record Date, which shall be the 15th calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or a duly authorized committee of the Board of Directors that is not more than 60 nor less than 10 days prior to such Dividend Payment Date (each,

a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend Record Date whether or not such day is a Business Day.

The term “Dividend Period” means the period from and including each Dividend Payment Date to but excluding the next succeeding Dividend Payment Date or any earlier redemption date (other than the initial Dividend Period, which shall commence on and include the date of initial issuance of the Series C and shall end on but exclude the next Dividend Payment Date). Dividends payable on the Series C shall be computed on the basis of a 360-day year consisting of twelve 30-day months.

(b) Priority of Dividends. The Series C will rank (i) senior to the Common Stock (as defined below) and any class or series of the Corporation’s capital stock expressly stated to be junior to the Series C, (ii) junior to any class or series of the Corporation’s capital stock expressly stated to be senior to the Series C (issued with the requisite consent of the Holders of the Series C, if required) and (iii) at least equally with each other class or series of Preferred Stock (as defined below) that the Corporation may issue with respect to the payment of dividends and the distribution of assets upon liquidation, dissolution or winding up of the Corporation. So long as any share of Series C remains outstanding, no dividend or distribution shall be paid or declared on Junior Stock, and no Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by the Corporation, directly or indirectly, during a Dividend Period, unless the full dividend for the latest completed Dividend Period on all outstanding shares of Series C has been declared and paid (or declared and a sum sufficient for the payment thereof has been set aside). The foregoing limitation shall not apply to (i) repurchases, redemptions or other acquisitions of shares of Junior Stock in connection with (1) any employment contract, benefit plan or other similar arrangement with or for the benefit of any one or more employees, officers, directors or consultants or (2) a dividend reinvestment or stockholder stock purchase plan; (ii) an exchange, redemption, reclassification or conversion of any class or series of Junior Stock, or any junior stock of a Subsidiary of the Corporation, for any class or series of Junior Stock; (iii) the purchase of fractional interests in shares of Junior Stock under the conversion or exchange provisions of Junior Stock or the security being converted or exchanged; (iv) any declaration of a dividend in connection with any stockholders’ rights plan, or the issuance of rights, stock or other property under any stockholders’ rights plan, or the redemption or repurchase of rights pursuant to the plan; or (v) any dividend in the form of stock, warrants, options or other rights where the dividend stock or the stock issuable upon exercise of such warrants, options or other rights is the same stock as that on which the dividend is being paid or ranks equal or junior to that stock. In addition, the foregoing limitation shall not restrict the ability of Morgan Stanley & Co. Incorporated, or any other affiliate of the Corporation, to engage in any market-making transactions in Junior Stock in the ordinary course of business.

When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within a related Dividend Period) in full upon the Series C and any shares of Parity Stock, all dividends declared on the Series C and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the related Dividend Period) shall be declared pro rata so that the respective amounts of such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series C and all Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the related Dividend Period) bear to each other.

Subject to the foregoing, dividends (payable in cash, securities or other property) may be determined by the Board of Directors or a duly authorized committee of the Board of Directors and may be declared and paid on the Common Stock and any other stock ranking, as to dividends, equally with or junior to the Series C, from time to time out of any funds legally available for such payment, and the Series C shall not be entitled to participate in any such dividends.

4. Liquidation Rights.

stock of the Corporation then outstanding ranking senior to or pari passu with the Series C in respect of distributions upon liquidation, dissolution or winding up of the Corporation, and before any distribution of such assets or proceeds is made to or set aside for the holders of Common Stock and any other classes or series of capital stock of the Corporation ranking junior to the Series C as to such distribution, a liquidating distribution in an amount equal to $1,000 per share, together with an amount equal to all dividends, if any, that have been declared but not paid prior to the date of payment of such distribution (but without any accumulation in respect of dividends that have not been declared prior to such payment date). Holders of the Series C will not be entitled to any other amounts from the Corporation after they have received their full liquidation preference.

(b) Partial Payment. If in any distribution described in Section 4(a) above the assets of the Corporation or proceeds thereof are not sufficient to pay the Liquidation Preference (as defined below) in full to all Holders of Series C and all holders of any stock of the Corporation ranking equally with the Series C as to such distribution, the amounts paid to the Holders of Series C and to the holders of all such other stock shall be paid pro rata in accordance with the respective aggregate Liquidation Preference of the Holders of Series C and the holders of all such other stock. In any such distribution, the “Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder in such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an amount equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series C and on which dividends accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as applicable). Holders of the Series C will not be entitled to any other amounts from the Corporation after they have received the full amounts provided for in this Section 4 and will have no right or claim to any of the Corporation’s remaining assets.

(c) Residual Distributions. If the Liquidation Preference on the Series C and any other shares of the Corporation’s stock ranking equally as to such liquidation distribution has been paid in full, the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds thereof) according to their respective rights and preferences.

(d) Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 4, the merger or consolidation of the Corporation with or into any other corporation or other entity, including a merger or consolidation in which the Holders of Series C receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash, securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation, dissolution or winding up of the Corporation.

5. Voting Rights.

(a) General. The Holders of Series C shall not have any voting rights except as set forth below and as determined by the Board of Directors or an authorized committee thereof or as otherwise from time to time required by law.

(b) Right to Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any shares of the Series C, or any other Voting Preferred Stock, shall have not been declared and paid for the equivalent of six or more Dividend Periods, whether or not for consecutive Dividend Periods (a “Nonpayment”), the holders of such shares, voting together as a class with holders of any and all other series of Voting Preferred Stock then outstanding, will be entitled to vote for the election of a total of two additional members of the Board of Directors (the “Preferred Stock Directors”); provided that the election of any such directors shall not cause the Corporation to violate the corporate governance requirements of the New York Stock Exchange (or any other exchange on which the Corporation’s securities may be listed) that listed companies must have a majority of independent directors; and provided further that the Board of Directors shall at no time include more than two Preferred Stock Directors. In that event, the number of directors on the Board of Directors shall automatically increase by two, and the new directors shall be elected at a special meeting called at the request of the holders of record of at least 20% of the Series C or of any other series of Voting Preferred Stock (unless such request is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held at such next annual or special meeting of stockholders), and at each subsequent annual meeting. Such request to call a special meeting for the initial election of the Preferred Stock Directors after a Nonpayment shall be made by written notice, signed by the requisite holders of Series C or other Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner as provided for in Section 10 below, or as may otherwise be required by law. The voting rights will continue until dividends on the shares of the Series C and any such series of Voting Preferred Stock shall have been fully paid (or declared and a sum sufficient for the payment of such dividends shall have been set aside for such payment) for at least four regular dividend periods following the Nonpayment.

If and when dividends for at least four regular dividend periods following a Nonpayment have been fully paid (or declared and a sum sufficient for such payment shall have been set aside) on the Series C and any other class or series of Voting Preferred Stock, the holders of the Series C and all other holders of Voting Preferred Stock shall be divested of the foregoing voting rights (subject to revesting in the event of each subsequent Nonpayment), the term of office of each Preferred Stock Director so elected shall terminate and the number of directors on the Board of Directors shall automatically decrease by two. In determining whether dividends have been paid for at least four regular dividend periods following a Nonpayment, the Corporation may take account of any dividend it elects to pay for any dividend period after the regular dividend date for that period has passed.

Any Preferred Stock Director may be removed at any time without cause by the holders of record of a majority of the outstanding shares of the Series C together with all series of Voting Preferred Stock then outstanding (voting together as a single class) to the extent such holders have the voting rights described above. So long as a Nonpayment shall continue, any

described above (voting together as a single class); provided that the filling of each vacancy shall not cause the Corporation to violate the corporate governance requirements of the New York Stock Exchange (or any other exchange on which the Corporation’s securities may be listed) that listed companies must have a majority of independent directors. Any such vote to remove, or to fill a vacancy in the office of, a Preferred Stock Director may be taken only at a special meeting called at the request of the holders of record of at least 20% of the Series C or of any other series of Voting Preferred Stock (unless such request is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held at such next annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to one vote per director on any matter.

The term “Voting Preferred Stock” means any other class or series of Preferred Stock of the Corporation ranking equally with the Series C as to payment of dividends and the distribution of assets upon liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and are exercisable. Voting Preferred Stock includes the Corporation’s Floating Rate Non-Cumulative Preferred Stock, Series A (the “Series A”) and the Series B Non-Cumulative Non-Voting Perpetual Convertible Preferred Stock (the “Series B”), in each case, if outstanding, and any class or series of Preferred Stock, whether or not cumulative, that the Corporation may issue in the future, to the extent their like voting rights are exercisable at such time. Whether a plurality, majority or other portion of the shares of Series C and any other Voting Preferred Stock have been voted in favor of any matter shall be determined by reference to the relative liquidation preferences of the shares voted.

(c) Other Voting Rights. So long as any shares of Series C are outstanding, in addition to any other vote or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at least two-thirds of the shares of Series C and any Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for the purpose, shall be necessary for effecting or validating:

(i) Authorization of Senior Stock. Any amendment or alteration of the provisions of the Certificate of Incorporation or this Certificate of Designations to authorize or create, or increase the authorized amount of, any shares of any class or series of stock of the Corporation ranking senior to the Series C with respect to the payment of dividends or the distribution of assets upon any liquidation, dissolution or winding up of the Corporation;

(ii) Amendment of Series C. Any amendment, alteration or repeal of any provision of the Certificate of Incorporation or this Certificate of Designations, whether by merger, consolidation or otherwise, so as to materially and adversely affect the special rights, preferences, privileges and voting powers of the Series C, taken as a whole; or

(iii) Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a binding share exchange or reclassification involving the Series C, or of a merger or consolidation of the Corporation with another entity, unless in each case (x) the shares of Series C remain outstanding or are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate parent, and (y) such shares remaining outstanding as securities of the Corporation or such other entity as permitted by clause (x) or such preference securities, as the case may be, have such rights, preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers of the Series C, taken as a whole;

provided, however, that for all purposes of this Section 5(c), the creation and issuance, or an increase in the authorized or issued amount, of any other class or series of Preferred Stock ranking equally with the Series C with respect to the payment of dividends (whether such dividends are cumulative or non-cumulative) and the distribution of assets upon liquidation, dissolution or winding up of the Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers of, and shall not require the affirmative vote or consent of, the holders of outstanding shares of Series C. For purposes of clarification, no Holder of Series C shall have any voting rights with respect to any binding share exchange, reclassification, merger or consolidation which complies with the provisions of clause (iii)(x) and (y) hereof.

If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in this Section 5(c) for which a vote is otherwise required would adversely affect one or more but not all other series of Voting Preferred Stock (including the Series C for this purpose), then only such series of Preferred Stock as are adversely affected by and otherwise entitled to vote on the matter shall vote on the matter together as a class in lieu of all other series of Preferred Stock. If all series of a class of Preferred Stock that are otherwise entitled to vote on the matter are not equally affected by the proposed amendment, alteration, repeal, share exchange, reclassification, merger or consolidation described above, there shall

be required a two-thirds approval of the class and a two-thirds approval of each series that will have a diminished status and that is otherwise entitled to vote thereon.

(d) Changes for Clarification. Without the consent of the holders of the Series C, so long as such action does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of the Series C, the Corporation may amend, alter, supplement or repeal any terms of the Series C:

(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of Designations that may be defective or inconsistent; or

(ii) to make any provision with respect to matters or questions arising with respect to the Series C that is not inconsistent with the provisions of this Certificate of Designations.

(e) Changes after Provision for Redemption. No vote or consent of the holders of Series C shall be required pursuant to this Section 5 or otherwise if, at or prior to the time when the act with respect to which any such vote or consent would otherwise be required pursuant to such Section, all outstanding shares of Series C shall have been redeemed, or shall have been called for redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to Section 6.

(f) Procedures for Voting and Consents. The rules and procedures for calling and conducting any meeting of the holders of Series C (including, without limitation, the fixing of a record date in connection therewith), the solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard to such a meeting or such consents shall be governed by any rules the Board of Directors or a duly authorized committee of the Board of Directors, in its discretion, may adopt from time to time, which rules and procedures shall conform to the requirements of the Certificate of Incorporation, the Bylaws, applicable law and any national securities exchange or other trading facility on which the Series C is listed or traded at the time. Whether the vote or consent of the holders of a plurality, majority or other portion of the shares of Series C and any Voting Preferred Stock has been cast or given on any matter on which the holders of shares of Series C are entitled to vote shall be determined by the Corporation by reference to the specified liquidation amounts of the shares voted or covered by the consent.

6. Redemption.

(a) Optional Redemption. The Series C may not be redeemed by the Corporation prior to October 15, 2011. On or after October 15, 2011, subject to obtaining any then required regulatory approval, the Corporation, at its option, may redeem, in whole at any time or in part from time to time, the shares of Series C at the time outstanding, upon notice given as provided in Section 6(c) below, at a redemption price equal to $1,100 per share, together (except as otherwise provided herein below), for the purposes of the redemption price only, with an amount equal to dividends accumulated but unpaid for the then current Dividend Period at the rate set forth in Section 3 to, but excluding, the date fixed for redemption (regardless of whether any dividends are actually declared for that Dividend Period). The redemption price for any shares of Series C shall be payable on the redemption date to the Holder of such shares against surrender of the certificate(s) evidencing such shares to the Corporation or its agent. Any accrued and unpaid dividend for the then current Dividend Period payable on a redemption date that occurs subsequent to the Dividend Record Date for a Dividend Period shall not be paid to the Holder entitled to receive the redemption price on the redemption date, but rather shall be paid to the Holder of record of the redeemed shares of Series C on such Dividend Record Date relating to the Dividend Payment Date as provided in Section 3 above.

(b) No Sinking Fund. The Series C will not be subject to any mandatory redemption, sinking fund or other similar provisions. Holders of Series C will have no right to require the redemption or repurchase of any shares of Series C.

(c) Notice of Redemption. Notice of every redemption of shares of Series C shall be given by first class mail, postage prepaid, addressed to the Holders of record of the shares of Series C to be redeemed at their respective last addresses appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly given, whether or not the Holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice or in the mailing thereof, to any Holder of shares of Series C designated for redemption shall not affect the validity of the proceedings for the redemption of any other shares of Series C. Notwithstanding the foregoing, if depositary shares representing interests in the Series C are issued in book-entry form through The Depository Trust Company or any other similar facility, notice of redemption may be given to the Holders of Series C at such time and in any manner permitted by such facility. Each such notice given to a Holder shall state: (1) the redemption date; (2) the number of shares of Series C to be redeemed and, if less than all the shares held by such Holder are to be redeemed, the number of such shares to be redeemed from such Holder; (3) the

redemption price; and (4) the place or places where certificates for such shares are to be surrendered for payment of the redemption price.

(d) Partial Redemption. In case of any redemption of only part of the shares of Series C at the time outstanding, the shares to be redeemed shall be selected either pro rata or in such other manner as the Corporation may determine to be fair and equitable. Subject to the provisions hereof, the Corporation shall have full power and authority to prescribe the terms and conditions upon which shares of Series C shall be redeemed from time to time. If fewer than all the shares of Series C represented by any certificate are redeemed, a new certificate shall be issued representing the unredeemed shares without charge to the holder thereof.

(e) Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate and apart from its other funds, in trust for the pro rata benefit of the Holders of any shares of Series C so called for redemption, so as to be and continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for redemption, all shares of Series C so called for redemption shall no longer be deemed outstanding and all rights with respect to such shares shall forthwith on such redemption date cease and terminate, except only the right of the Holders thereof to receive the amount payable on such redemption, without interest. Any funds unclaimed at the end of two years from the redemption date shall, to the extent permitted by law, be released to the Corporation, after which time the Holders of the shares of Series C so called for redemption shall look only to the Corporation for payment of the redemption price of such shares.

(f) Regulatory. Redemption of the Series C by the Corporation is subject to its receipt of any required prior approvals from the Federal Reserve. The Corporation hereby confirms that it is the Corporation’s intention that, at the time of any redemption of the Series C, the Corporation will repay the liquidation preference of any shares of Series C redeemed in

accordance with this Section 6 only out of the net proceeds received by the Corporation or its Subsidiaries from the issuance or sale of securities which will qualify as non-restricted core capital (as such term is defined in 12 C.F.R. 225 (Appendix A)) at the time of such issuance or sale.

7. Rank. Any stock of any class or classes or series of the Corporation shall be deemed to rank:

(a) prior to shares of the Series C, either as to dividends or upon liquidation, dissolution or winding up, or both, if the holders of stock of such class or classes or series shall be entitled by the terms thereof to the receipt of dividends or of amounts distributable upon liquidation, dissolution or winding up, as the case may be, in preference or priority to the Holders of shares of the Series C;

(b) on a parity with shares of the Series C, either as to dividends or upon liquidation, dissolution or winding up, or both, whether or not the dividend rates, dividend payment dates, or redemption or liquidation prices per share thereof be different from those of the Series C, if the holders of stock of such class or classes or series shall be entitled by the terms thereof to the receipt of dividends or of amounts distributed upon liquidation, dissolution or winding up, as the case may be, in proportion to their respective dividend rates or liquidation prices, without preference or priority of one over the other as between the holders of such stock and the Holders of shares of Series C (the term “Parity Preferred Stock” being used to refer to any stock on a parity with the shares of Series C, either as to dividends or upon liquidation, dissolution or winding up, or both, as the content may require); and

(c) junior to shares of the Series C, either as to dividends or upon liquidation, dissolution or winding up, or both, if such class or classes or series shall be common stock or if the Holders of the Series C shall be entitled to the receipt of dividends or of amounts distributable upon liquidation, dissolution or winding up, as the case may be, in preference or priority to the holders of stock of such class or classes or series.

The Series C shall rank, as to dividends and upon liquidation, dissolution or winding up, on a parity with the Series A, the Series B and any Parity Preferred Stock issued hereafter.

8. Additional Definitions. As used herein with respect to Series C:

“Common Stock” means the common stock, $0.01 par value, of the Corporation.

“Holder” means the Person in whose name the shares of Series C are registered, which may be treated by the Corporation, Transfer Agent, Registrar and dividend disbursing agent as the absolute owner of the shares of Series C for the purpose of disbursing dividends and for all other purposes.

“Junior Stock” means any class or series of capital stock of the Corporation that ranks junior to Series C as to the payment of dividends and rights in dissolution, liquidation and winding up of the Corporation. Junior Stock includes the Common Stock.

“Parity Stock” means any other class or series of stock of the Corporation that ranks equally with the Series C in the payment of dividends and rights in dissolution, liquidation and winding up of the Corporation.

“Person” means a legal person, including any individual, corporation, estate, partnership, joint venture, association, joint-stock company, limited liability company or trust.

“Preferred Stock” means any and all series of preferred stock of the Corporation, including the Series C.

“Registrar” shall mean BNY Mellon Shareowner Services, acting in its capacity as registrar for the Series C, and its successors and assigns or any other registrar appointed by the Corporation.

“Transfer Agent” shall mean BNY Mellon Shareowner Services, acting in its capacity as transfer agent for the Series C, and its respective successors and assigns or any other transfer agent appointed by the Corporation.

9. Record Holders. To the fullest extent permitted by applicable law, the Corporation and the transfer agent for the Series C may deem and treat the record holder of any share of Series C as the true and lawful owner thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.

10. Notices. All notices or communications in respect of Series C shall be sufficiently given if given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be permitted in this Certificate of Designations, in the Certificate of Incorporation or Bylaws or by applicable law.

11. Preemptive or Subscription Rights. Except as expressly provided in any agreement between a Holder and the Corporation, no share of Series C shall have any rights of preemption whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto, regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.

12. Repurchase. Subject to the limitations imposed herein, the Corporation may purchase and sell shares of Series C from time to time to such extent, in such manner, and

upon such terms as the Board or any duly authorized committee of the Board may determine; provided, however, that the Corporation shall not use any of its funds for any such purchase when there are reasonable grounds to believe that the Corporation is, or by such purchase would be, rendered insolvent.

13. Other Rights. The shares of Series C shall not have any voting powers, preferences or relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set forth herein or in the Certificate of Incorporation of the Corporation or as provided by applicable law. Holders of Series C shall have no right to exchange or convert such shares into any other security.

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]




MORGAN STANLEY

By:		/s/ Walid A. Chammah
		Name: Walid A. Chammah
		Title: Co-President

CERTIFICATE OF DESIGNATIONS

FIXED RATE CUMULATIVE PERPETUAL PREFERRED STOCK, SERIES D

MORGAN STANLEY

Morgan Stanley, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), in accordance with the provisions of Section 151 of the General Corporation Law of the State of Delaware, does hereby certify:

The board of directors of the Corporation (the “Board of Directors”) or an applicable committee of the Board of Directors, in accordance with the certificate of incorporation and bylaws of the Corporation and applicable law, adopted the following resolution on October 26, 2008 creating a series of 10,000,000 shares of Preferred Stock of the Corporation designated as “Fixed Rate Cumulative Perpetual Preferred Stock, Series D”.

RESOLVED, that pursuant to the provisions of the certificate of incorporation and the bylaws of the Corporation and applicable law, a series of Preferred Stock, par value $0.01 per share, of the Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and other powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions thereof, of the shares of such series, are as follows:

Part 1. Designation and Number of Shares. There is hereby created out of the authorized and unissued shares of preferred stock of the Corporation a series of preferred stock designated as the “Fixed Rate Cumulative Perpetual Preferred Stock, Series D” (the “Designated Preferred Stock”). The authorized number of shares of Designated Preferred Stock shall be 10,000,000.

Part 2. Standard Provisions. The Standard Provisions contained in Annex A attached hereto are incorporated herein by reference in their entirety and shall be deemed to be a part of this Certificate of Designations to the same extent as if such provisions had been set forth in full herein.

Part. 3. Definitions. The following terms are used in this Certificate of Designations (including the Standard Provisions in Annex A hereto) as defined below:

(a) “Common Stock” means the common stock, par value $0.01 per share, of the Corporation.

(b) “Dividend Payment Date” means January 15, April 15, July 15 and October 15 of each year.

(c) “Junior Stock” means the Common Stock and any other class or series of stock of the Corporation the terms of which expressly provide that it ranks junior to Designated Preferred Stock as to dividend rights and/or as to rights on liquidation, dissolution or winding up of the Corporation.

(d) “Liquidation Amount” means $1,000 per share of Designated Preferred Stock.

(e) “Minimum Amount” means $2,500,000,000.

(f) “Parity Stock” means any class or series of stock of the Corporation (other than Designated Preferred Stock) the terms of which do not expressly provide that such class or series will rank senior or junior to Designated Preferred Stock as to dividend rights and/or as to rights on liquidation, dissolution or winding up of the Corporation (in each case without regard to whether dividends accrue cumulatively or non-cumulatively). Without limiting the foregoing, Parity Stock shall include the Corporation’s (i) Series A Floating Rate Non-Cumulative Preferred Stock; (ii) Series B Non-Cumulative Non-Voting Perpetual Convertible Preferred Stock; and (iii) Series C Non-Cumulative Non-Voting Perpetual Preferred Stock.

(g) “Signing Date” means October 26, 2008.

Part. 4. Certain Voting Matters. Whether the vote or consent of the holders of a plurality, majority or other portion of the shares of Designated Preferred Stock and any Voting Parity Stock has been cast or given on any matter on which the holders of shares of Designated Preferred Stock are entitled to vote shall be determined by the Corporation by reference to the specified liquidation amount of the shares voted or covered by the consent as if the Corporation were liquidated on the record date for such vote or consent, if any, or, in the absence of a record date, on the date for such vote or consent. For purposes of determining the voting rights of the holders of Designated Preferred Stock under Section 7 of the Standard Provisions forming

part of this Certificate of Designations, each holder will be entitled to one vote for each $1,000 of liquidation preference to which such holder’s shares are entitled.

[Remainder of Page Intentionally Left Blank]

IN WITNESS WHEREOF, Morgan Stanley has caused this Certificate of Designations to be signed by Colm Kelleher, its Executive Vice President and Chief Financial Officer, this 28th day of October, 2008.




MORGAN STANLEY

By:		/s/ Colm Kelleher
Name:		Colm Kelleher
Title:		Executive Vice President and Chief Financial Officer

ANNEX A

STANDARD PROVISIONS

Section 1. General Matters. Each share of Designated Preferred Stock shall be identical in all respects to every other share of Designated Preferred Stock. The Designated Preferred Stock shall be perpetual, subject to the provisions of Section 5 of these Standard Provisions that form a part of the Certificate of Designations. The Designated Preferred Stock shall rank equally with Parity Stock and shall rank senior to Junior Stock with respect to the payment of dividends and the distribution of assets in the event of any dissolution, liquidation or winding up of the Corporation.

Section 2. Standard Definitions. As used herein with respect to Designated Preferred Stock:

(a) “Applicable Dividend Rate” means (i) during the period from the Original Issue Date to, but excluding, the first day of the first Dividend Period commencing on or after the fifth anniversary of the Original Issue Date, 5% per annum and (ii) from and after the first day of the first Dividend Period commencing on or after the fifth anniversary of the Original Issue Date, 9% per annum.

(b) “Appropriate Federal Banking Agency” means the “appropriate Federal banking agency” with respect to the Corporation as defined in Section 3(q) of the Federal Deposit Insurance Act (12 U.S.C. Section 1813(q)), or any successor provision.

(c) “Business Combination” means a merger, consolidation, statutory share exchange or similar transaction that requires the approval of the Corporation’s stockholders.

(d) “Business Day” means any day except Saturday, Sunday and any day on which banking institutions in the State of New York generally are authorized or required by law or other governmental actions to close.

(e) “Bylaws” means the bylaws of the Corporation, as they may be amended from time to time.

(f) “Certificate of Designations” means the Certificate of Designations or comparable instrument relating to the Designated Preferred Stock, of which these Standard Provisions form a part, as it may be amended from time to time.

(g) “Charter” means the Corporation’s certificate or articles of incorporation, articles of association, or similar organizational document.

(h) “Dividend Period” has the meaning set forth in Section 3(a).

(i) “Dividend Record Date” has the meaning set forth in Section 3(a).

(j) “Liquidation Preference” has the meaning set forth in Section 4(a).

(k) “Original Issue Date” means the date on which shares of Designated Preferred Stock are first issued.

(l) “Preferred Director” has the meaning set forth in Section 7(b).

(m) “Preferred Stock” means any and all series of preferred stock of the Corporation, including the Designated Preferred Stock.

(n) “Qualified Equity Offering” means the sale and issuance for cash by the Corporation to persons other than the Corporation or any of its subsidiaries after the Original Issue Date of shares of perpetual Preferred Stock, Common Stock or any combination of such stock, that, in each case, qualify as and may be included in Tier 1 capital of the Corporation at the time of issuance under the applicable risk-based capital guidelines of the Corporation’s Appropriate Federal Banking Agency (other than any such sales and issuances made pursuant to agreements or arrangements entered into, or pursuant to financing plans which were publicly announced, on or prior to October 13, 2008).

(o) “Share Dilution Amount” has the meaning set forth in Section 3(b).

(p) “Standard Provisions” mean these Standard Provisions that form a part of the Certificate of Designations relating to the Designated Preferred Stock.

(q) “Successor Preferred Stock” has the meaning set forth in Section 5(a).

(r) “Voting Parity Stock” means, with regard to any matter as to which the holders of Designated Preferred Stock are entitled to vote as specified in Sections 7(a) and 7(b) of these Standard Provisions that form a part of the Certificate of Designations, any and all series of Parity Stock upon which like voting rights have been conferred and are exercisable with respect to such matter.

Section 3. Dividends.

(a) Rate. Holders of Designated Preferred Stock shall be entitled to receive, on each share of Designated Preferred Stock if, as and when declared by the Board of Directors or any duly authorized committee of the Board of Directors, but only out of assets legally available therefor, cumulative cash dividends with respect to each Dividend Period (as defined below) at a rate per annum equal to the Applicable Dividend Rate on (i) the Liquidation Amount per share of Designated Preferred Stock and (ii) the amount of accrued and unpaid dividends for any prior Dividend Period on such share of Designated Preferred Stock, if any. Such dividends shall begin to accrue and be cumulative from the Original Issue Date, shall compound on each subsequent Dividend Payment Date (i.e., no dividends shall accrue on other dividends unless and until the first Dividend Payment Date for such other dividends has passed without such other dividends having been paid on such date) and shall be payable quarterly in arrears on each Dividend Payment Date, commencing with the first such Dividend Payment Date to occur at least 20 calendar days after the Original Issue Date. In the event that any Dividend Payment Date would otherwise fall on a day that is not a Business Day, the dividend payment due on that date will be postponed to the next day that is a Business Day and no additional dividends will accrue as a result of that postponement. The period from and including any Dividend Payment Date to, but

excluding, the next Dividend Payment Date is a “Dividend Period”, provided that the initial Dividend Period shall be the period from and including the Original Issue Date to, but excluding, the next Dividend Payment Date.

Dividends that are payable on Designated Preferred Stock in respect of any Dividend Period shall be computed on the basis of a 360-day year consisting of twelve 30-day months. The amount of dividends payable on Designated Preferred Stock on any date prior to the end of a Dividend Period, and for the initial Dividend Period, shall be computed on the basis of a 360-day year consisting of twelve 30-day months, and actual days elapsed over a 30-day month.

Dividends that are payable on Designated Preferred Stock on any Dividend Payment Date will be payable to holders of record of Designated Preferred Stock as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th calendar day immediately preceding such Dividend Payment Date or such other record date fixed by the Board of Directors or any duly authorized committee of the Board of Directors that is not more than 60 nor less than 10 days prior to such Dividend Payment Date (each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend Record Date whether or not such day is a Business Day.

Holders of Designated Preferred Stock shall not be entitled to any dividends, whether payable in cash, securities or other property, other than dividends (if any) declared and payable on Designated Preferred Stock as specified in this Section 3 (subject to the other provisions of the Certificate of Designations).

(b) Priority of Dividends. So long as any share of Designated Preferred Stock remains outstanding, no dividend or distribution shall be declared or paid on the Common Stock or any other shares of Junior Stock (other than dividends payable solely in shares of Common Stock) or Parity Stock, subject to the immediately following paragraph in the case of Parity Stock, and no Common Stock, Junior Stock or Parity Stock shall be, directly or indirectly, purchased, redeemed or otherwise acquired for consideration by the Corporation or any of its subsidiaries unless all accrued and unpaid dividends for all past Dividend Periods, including the latest completed Dividend Period (including, if applicable as provided in Section 3(a) above, dividends on such amount), on all outstanding shares of Designated Preferred Stock have been or are contemporaneously declared and paid in full (or have been declared and a sum sufficient for the payment thereof has been set aside for the benefit of the holders of shares of Designated Preferred Stock on the applicable record date). The foregoing limitation shall not apply to (i) redemptions, purchases or other acquisitions of shares of Common Stock or other Junior Stock in connection with the administration of any employee benefit plan in the ordinary course of business (including purchases to offset the Share Dilution Amount (as defined below) pursuant to a publicly announced repurchase plan) and consistent with past practice, provided that any purchases to offset the Share Dilution Amount shall in no event exceed the Share Dilution Amount; (ii) purchases or other acquisitions by a broker-dealer subsidiary of the Corporation solely for the purpose of market-making, stabilization or customer facilitation transactions in Junior Stock or Parity Stock in the ordinary course of its business; (iii) purchases by a broker-dealer subsidiary of the Corporation of capital stock of the Corporation for resale pursuant to an offering by the Corporation of such capital stock underwritten by such broker-dealer subsidiary; (iv) any dividends or distributions of rights or Junior Stock in connection with a stockholders’ rights plan or any redemption or repurchase of rights pursuant to any stockholders’ rights plan; (v) the acquisition by the Corporation or any of its subsidiaries of record ownership in Junior Stock or Parity Stock for the

beneficial ownership of any other persons (other than the Corporation or any of its subsidiaries), including as trustees or custodians; and (vi) the exchange or conversion of Junior Stock for or into other Junior Stock or of Parity Stock for or into other Parity Stock (with the same or lesser aggregate liquidation amount) or Junior Stock, in each case, solely to the extent required pursuant to binding contractual agreements entered into prior to the Signing Date or any subsequent agreement for the accelerated exercise, settlement or exchange thereof for Common Stock. “Share Dilution Amount” means the increase in the number of diluted shares outstanding (determined in accordance with generally accepted accounting principles in the United States, and as measured from the date of the Corporation’s consolidated financial statements most recently filed with the Securities and Exchange Commission prior to the Original Issue Date) resulting from the grant, vesting or exercise of equity-based compensation to employees and equitably adjusted for any stock split, stock dividend, reverse stock split, reclassification or similar transaction.

When dividends are not paid (or declared and a sum sufficient for payment thereof set aside for the benefit of the holders thereof on the applicable record date) on any Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within a Dividend Period related to such Dividend Payment Date) in full upon Designated Preferred Stock and any shares of Parity Stock, all dividends declared on Designated Preferred Stock and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts of such dividends declared shall bear the same ratio to each other as all accrued and unpaid dividends per share on the shares of Designated Preferred Stock (including, if applicable as provided in Section 3(a) above, dividends on such amount) and all Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend Payment Date) (subject to their having been declared by the Board of Directors or a duly authorized committee of the Board of Directors out of legally available funds and including, in the case of Parity Stock that bears cumulative dividends, all accrued but unpaid dividends) bear to each other. If the Board of Directors or a duly authorized committee of the Board of Directors determines not to pay any dividend or a full dividend on a Dividend Payment Date, the Corporation will provide written notice to the holders of Designated Preferred Stock prior to such Dividend Payment Date.

Subject to the foregoing, and not otherwise, such dividends (payable in cash, securities or other property) as may be determined by the Board of Directors or any duly authorized committee of the Board of Directors may be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds legally available for such payment, and holders of Designated Preferred Stock shall not be entitled to participate in any such dividends.

Section 4. Liquidation Rights.

(a) Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary, holders of Designated Preferred Stock shall be entitled to receive for each share of Designated Preferred Stock, out of the assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the Corporation, subject to the rights of any creditors of the Corporation, before any distribution of such assets or proceeds is made to or set aside for the holders of Common Stock and any other stock of the Corporation ranking junior to Designated Preferred Stock as to such distribution, payment in full in an amount equal to the sum of (i) the Liquidation Amount per share and (ii) the amount of any accrued and unpaid dividends (including, if applicable as provided in Section 3(a) above, dividends on such amount), whether or not declared, to the date of payment (such amounts collectively, the “Liquidation Preference”).

(b) Partial Payment. If in any distribution described in Section 4(a) above the assets of the Corporation or proceeds thereof are not sufficient to pay in full the amounts payable with respect to all outstanding shares of Designated Preferred Stock and the corresponding amounts payable with respect of any other stock of the Corporation ranking equally with Designated Preferred Stock as to such distribution, holders of Designated Preferred Stock and the holders of such other stock shall share ratably in any such distribution in proportion to the full respective distributions to which they are entitled.

(c) Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Designated Preferred Stock and the corresponding amounts payable with respect of any other stock of the Corporation ranking equally with Designated Preferred Stock as to such distribution has been paid in full, the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds thereof) according to their respective rights and preferences.

(d) Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 4, the merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in which the holders of Designated Preferred Stock receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,

securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation, dissolution or winding up of the Corporation.

Section 5. Redemption.

(a) Optional Redemption. Except as provided below, the Designated Preferred Stock may not be redeemed prior to the first Dividend Payment Date falling on or after the third anniversary of the Original Issue Date. On or after the first Dividend Payment Date falling on or after the third anniversary of the Original Issue Date, the Corporation, at its option, subject to the approval of the Appropriate Federal Banking Agency, may redeem, in whole or in part, at any time and from time to time, out of funds legally available therefor, the shares of Designated Preferred Stock at the time outstanding, upon notice given as provided in Section 5(c) below, at a redemption price equal to the sum of (i) the Liquidation Amount per share and (ii) except as otherwise provided below, any accrued and unpaid dividends (including, if applicable as provided in Section 3(a) above, dividends on such amount) (regardless of whether any dividends are actually declared) to, but excluding, the date fixed for redemption.

Notwithstanding the foregoing, prior to the first Dividend Payment Date falling on or after the third anniversary of the Original Issue Date, the Corporation, at its option, subject to the approval of the Appropriate Federal Banking Agency, may redeem, in whole or in part, at any time and from time to time, the shares of Designated Preferred Stock at the time outstanding, upon notice given as provided in Section 5(c) below, at a redemption price equal to the sum of (i) the Liquidation Amount per share and (ii) except as otherwise provided below, any accrued and unpaid dividends (including, if applicable as provided in Section 3(a) above, dividends on such amount) (regardless of whether any dividends are actually declared) to, but excluding, the date fixed for redemption; providedthat (x) the Corporation (or any successor by Business Combination) has received aggregate gross proceeds of not less than the Minimum Amount (plus the “Minimum Amount” as defined in the relevant certificate of designations for each other outstanding series of preferred stock of such successor that was originally issued to the United States Department of the Treasury (the “Successor Preferred Stock”) in connection with the Troubled Asset Relief Program Capital Purchase Program) from one or more Qualified Equity Offerings (including Qualified Equity Offerings of such successor), and (y) the aggregate redemption price of the Designated Preferred Stock (and any Successor Preferred Stock) redeemed pursuant to this paragraph may not exceed the aggregate net cash proceeds received by the Corporation (or any successor by Business Combination) from such Qualified Equity Offerings (including Qualified Equity Offerings of such successor).

The redemption price for any shares of Designated Preferred Stock shall be payable on the redemption date to the holder of such shares against surrender of the certificate(s) evidencing such shares to the Corporation or its agent. Any declared but unpaid dividends payable on a redemption date that occurs subsequent to the Dividend Record Date for a Dividend Period shall not be paid to the holder entitled to receive the redemption price on the redemption date, but rather shall be paid to the holder of record of the redeemed shares on such Dividend Record Date relating to the Dividend Payment Date as provided in Section 3 above.

(b) No Sinking Fund. The Designated Preferred Stock will not be subject to any mandatory redemption, sinking fund or other similar provisions. Holders of Designated Preferred Stock will have no right to require redemption or repurchase of any shares of Designated Preferred Stock.

(c) Notice of Redemption. Notice of every redemption of shares of Designated Preferred Stock shall be given by first class mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice or in the mailing thereof, to any holder of shares of Designated Preferred Stock designated for redemption shall not affect the validity of the proceedings for the redemption of any other shares of Designated Preferred Stock. Notwithstanding the foregoing, if shares of Designated Preferred Stock are issued in book-entry form through The Depository Trust Corporation or any other similar facility, notice of redemption may be given to the holders of Designated Preferred Stock at such time and in any manner permitted by such facility. Each notice of redemption given to a holder shall state: (1) the redemption date; (2) the number of shares of Designated Preferred Stock to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be redeemed from such holder; (3) the redemption price; and (4) the place or places where certificates for such shares are to be surrendered for payment of the redemption price.

(d) Partial Redemption. In case of any redemption of part of the shares of Designated Preferred Stock at the time outstanding, the shares to be redeemed shall be selected either pro rata or in such other manner as the Board of Directors or a duly authorized committee thereof may determine to be fair and equitable. Subject to the provisions hereof, the Board of

Directors or a duly authorized committee thereof shall have full power and authority to prescribe the terms and conditions upon which shares of Designated Preferred Stock shall be redeemed from time to time. If fewer than all the shares represented by any certificate are redeemed, a new certificate shall be issued representing the unredeemed shares without charge to the holder thereof.

(e) Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the redemption date specified in the notice all funds necessary for the redemption have been deposited by the Corporation, in trust for the pro rata benefit of the holders of the shares called for redemption, with a bank or trust company doing business in the Borough of Manhattan, The City of New York, and having a capital and surplus of at least $500 million and selected by the Board of Directors, so as to be and continue to be available solely therefor, then, notwithstanding that any certificate for any share so called for redemption has not been surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for redemption, all shares so called for redemption shall no longer be deemed outstanding and all rights with respect to such shares shall forthwith on such redemption date cease and terminate, except only the right of the holders thereof to receive the amount payable on such redemption from such bank or trust company, without interest. Any funds unclaimed at the end of three years from the redemption date shall, to the extent permitted by law, be released to the Corporation, after which time the holders of the shares so called for redemption shall look only to the Corporation for payment of the redemption price of such shares.

(f) Status of Redeemed Shares. Shares of Designated Preferred Stock that are redeemed, repurchased or otherwise acquired by the Corporation shall revert to authorized but unissued shares of Preferred Stock (provided that any such cancelled shares of Designated Preferred Stock may be reissued only as shares of any series of Preferred Stock other than Designated Preferred Stock).

Section 6. Conversion. Holders of Designated Preferred Stock shares shall have no right to exchange or convert such shares into any other securities.

Section 7. Voting Rights.

(a) General. The holders of Designated Preferred Stock shall not have any voting rights except as set forth below or as otherwise from time to time required by law.

(b) Preferred Stock Directors. Whenever, at any time or times, dividends payable on the shares of Designated Preferred Stock have not been paid for an aggregate of six quarterly Dividend Periods or more, whether or not consecutive, the authorized number of directors of the Corporation shall automatically be increased by two and the holders of the Designated Preferred Stock shall have the right, with holders of shares of any one or more other classes or series of Voting Parity Stock outstanding at the time, voting together as a class, to elect two directors (hereinafter the “Preferred Directors” and each a “Preferred Director”) to fill such newly created directorships at the Corporation’s next annual meeting of stockholders (or at a special meeting called for that purpose prior to such next annual meeting) and at each subsequent annual meeting of stockholders until all accrued and unpaid dividends for all past Dividend Periods, including the latest completed Dividend Period (including, if applicable as provided in Section 3(a) above, dividends on such amount), on all outstanding shares of Designated Preferred Stock have been declared and paid in full at which time such right shall terminate with respect to the Designated Preferred Stock, except as herein or by law expressly provided, subject to revesting in the event of each and every subsequent default of the character above mentioned; provided that it shall be a qualification for election for any Preferred Director that the election of such Preferred Director shall not cause the Corporation to violate any corporate governance requirements of any securities exchange or other trading facility on which securities of the Corporation may then be listed or traded that listed or traded companies must have a majority of independent directors. Upon any termination of the right of the holders of shares of Designated Preferred Stock and Voting Parity Stock as a class to vote for directors as provided above, the Preferred Directors shall cease to be qualified as directors, the term of office of all Preferred Directors then in office shall terminate immediately and the authorized number of directors shall be reduced by the number of Preferred Directors elected pursuant hereto. Any Preferred Director may be removed at any time, with or without cause, and any vacancy created thereby may be filled, only by the affirmative vote of the holders a majority of the shares of Designated Preferred Stock at the time outstanding voting separately as a class together with the holders of shares of Voting Parity Stock, to the extent the voting rights of such holders described above are then exercisable. If the office of any Preferred Director becomes vacant for any reason other than removal from office as aforesaid, the remaining Preferred Director may choose a successor who shall hold office for the unexpired term in respect of which such vacancy occurred.

(c) Class Voting Rights as to Particular Matters. So long as any shares of Designated Preferred Stock are outstanding, in addition to any other vote or consent of stockholders required by law or by the Charter, the vote or consent of the holders of at least 66 2/3% of the shares of Designated Preferred Stock at the time outstanding, voting as a separate class, given in person or

by proxy, either in writing without a meeting or by vote at any meeting called for the purpose, shall be necessary for effecting or validating:

(i) Authorization of Senior Stock. Any amendment or alteration of the Certificate of Designations for the Designated Preferred Stock or the Charter to authorize or create or increase the authorized amount of, or any issuance of, any shares of, or any securities convertible into or exchangeable or exercisable for shares of, any class or series of capital stock of the Corporation ranking senior to Designated Preferred Stock with respect to either or both the payment of dividends and/or the distribution of assets on any liquidation, dissolution or winding up of the Corporation;

(ii) Amendment of Designated Preferred Stock. Any amendment, alteration or repeal of any provision of the Certificate of Designations for the Designated Preferred Stock or the Charter (including, unless no vote on such merger or consolidation is required by Section 7(c)(iii) below, any amendment, alteration or repeal by means of a merger, consolidation or otherwise) so as to adversely affect the rights, preferences, privileges or voting powers of the Designated Preferred Stock; or

(iii) Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a binding share exchange or reclassification involving the Designated Preferred Stock, or of a merger or consolidation of the Corporation with another corporation or other entity, unless in each case (x) the shares of Designated Preferred Stock remain outstanding or, in the case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights, preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of Designated Preferred Stock immediately prior to such consummation, taken as a whole;

provided, however, that for all purposes of this Section 7(c), any increase in the amount of the authorized Preferred Stock, including any increase in the authorized amount of Designated Preferred Stock necessary to satisfy preemptive or similar rights granted by the Corporation to other persons prior to the Signing Date, or the creation and issuance, or an increase in the authorized or issued amount, whether pursuant to preemptive or similar rights or otherwise, of any other series of Preferred Stock, or any securities convertible into or exchangeable or exercisable for any other series of Preferred Stock, ranking equally with and/or junior to Designated Preferred Stock with respect to the payment of dividends (whether such dividends are cumulative or non-cumulative) and the distribution of assets upon liquidation, dissolution or winding up of the Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers, and shall not require the affirmative vote or consent of, the holders of outstanding shares of the Designated Preferred Stock.

(d) Changes after Provision for Redemption. No vote or consent of the holders of Designated Preferred Stock shall be required pursuant to Section 7(c) above if, at or prior to the time when any such vote or consent would otherwise be required pursuant to such Section, all outstanding shares of the Designated Preferred Stock shall have been redeemed, or shall have been called for redemption upon proper notice and sufficient funds shall have been deposited in trust for such redemption, in each case pursuant to Section 5 above.

(e) Procedures for Voting and Consents. The rules and procedures for calling and conducting any meeting of the holders of Designated Preferred Stock (including, without limitation, the fixing of a record date in connection therewith), the solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard to such a meeting or such consents shall be governed by any rules of the Board of Directors or any duly authorized committee of the Board of Directors, in its discretion, may adopt from time to

time, which rules and procedures shall conform to the requirements of the Charter, the Bylaws, and applicable law and the rules of any national securities exchange or other trading facility on which Designated Preferred Stock is listed or traded at the time.

Section 8. Record Holders. To the fullest extent permitted by applicable law, the Corporation and the transfer agent for Designated Preferred Stock may deem and treat the record holder of any share of Designated Preferred Stock as the true and lawful owner thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.

Section 9. Notices. All notices or communications in respect of Designated Preferred Stock shall be sufficiently given if given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be permitted in this Certificate of Designations, in the Charter or Bylaws or by applicable law. Notwithstanding the foregoing, if shares of Designated Preferred Stock are issued in book-entry form through The Depository Trust Corporation or any similar facility, such notices may be given to the holders of Designated Preferred Stock in any manner permitted by such facility.

Section 10. No Preemptive Rights. No share of Designated Preferred Stock shall have any rights of preemption whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto, regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.

Section 11. Replacement Certificates. The Corporation shall replace any mutilated certificate at the holder’s expense upon surrender of that certificate to the Corporation. The Corporation shall replace certificates that become destroyed, stolen or lost at the holder’s expense upon delivery to the Corporation of reasonably satisfactory evidence that the certificate has been destroyed, stolen or lost, together with any indemnity that may be reasonably required by the Corporation.

Section 12. Other Rights. The shares of Designated Preferred Stock shall not have any rights, preferences, privileges or voting powers or relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set forth herein or in the Charter or as provided by applicable law.

CERTIFICATE OF ELIMINATION OF

THE FIXED RATE CUMULATIVE PERPETUAL PREFERRED STOCK, SERIES D,

MORGAN STANLEY

Pursuant to Section 151(g)

of the General Corporation Law

of the State of Delaware

Morgan Stanley, a corporation organized and existing under the laws of the State of Delaware (the “Company”), in accordance with the provisions of Section 151(g) of the General Corporation Law of the State of Delaware, hereby certifies as follows:

1. That, pursuant to Section 151 of the General Corporation Law of the State of Delaware and authority granted in the Certificate of Incorporation of the Company, as theretofore amended, the Board of Directors of the Company, by resolution duly adopted, authorized the issuance of a series of 10,000,000 (ten million) shares of Fixed Rate Cumulative Perpetual Preferred Stock, Series D, par value $0.01 per share (the “Preferred Stock”), and established the voting powers, designations, preferences and relative, participating and other rights, and the qualifications, limitations or restrictions thereof, and, on October 28, 2008, filed a Certificate of Designation with respect to such Preferred Stock in the office of the Secretary of State of the State of Delaware.

2. That the Board of Directors of the Company has adopted resolutions approving the repurchase of said Preferred Stock, including resolutions authorizing each officer of the Company to execute and deliver such further documentation, and to take all such actions as any officer shall deem necessary or desirable, in furtherance of the repurchase of such Preferred Stock, which includes the execution and filing of this Certificate, and said Preferred Stock has been repurchased by the Company.

3. That no shares of said Preferred Stock are outstanding and no shares thereof will be issued subject to said Certificate of Designation.

4. That, accordingly, all matters set forth in the Certificate of Designation with respect to the Preferred Stock be, and hereby are, eliminated from the Certificate of Incorporation, as heretofore amended, of the Company.

IN WITNESS WHEREOF, the Company has caused this Certificate to be executed by its duly authorized officer this 23rd day of June, 2009.




MORGAN STANLEY

By:		/s/ Martin M. Cohen
		Name: Martin M. Cohen
		Office: Assistant Secretary and Counsel

CERTIFICATE OF ELIMINATION OF

THE 10% SERIES B NON-CUMULATIVE NON-VOTING PERPETUAL CONVERTIBLE

PREFERRED STOCK ($1,000 LIQUIDATION PREFERENCE PER SHARE)

MORGAN STANLEY

Pursuant to Section 151(g)

of the General Corporation Law

of the State of Delaware

1. That, pursuant to Section 151 of the General Corporation Law of the State of Delaware and authority granted in the Certificate of Incorporation of the Company, as theretofore amended, the Board of Directors of the Company, by resolution duly adopted, authorized the issuance of a series of 7,839,209 (seven million eight hundred thirty-nine thousand two hundred nine) shares of Series B Non-Cumulative Non-Voting Perpetual Convertible Preferred Stock, par value $0.01 per share, liquidation preference $1,000 per share (the “Preferred Stock”), and established the voting powers, designations, preferences and relative, participating and other rights, and the qualifications, limitations or restrictions thereof, and, on October 10, 2008, filed a Certificate of Designation with respect to such Preferred Stock, and, on October 13, 2008, amended such Certificate of Designation with respect to such Preferred Stock, in the office of the Secretary of State of the State of Delaware.

2. That the Board of Directors of the Company has adopted resolutions approving the conversion of said Preferred Stock into common stock of the Company, par value $0.01 per share (the “Common Stock”), including resolutions authorizing each officer of the Company to execute and deliver such further documentation, and to take all such actions as any officer shall deem necessary or desirable, in furtherance of the conversion of such Preferred Stock, which includes the execution and filing of this Certificate, and said Preferred Stock has been converted into Common Stock.

3. That no shares of said Preferred Stock are outstanding and no shares thereof will be issued subject to said Certificate of Designation.

[Remainder of Page Intentionally Blank]

IN WITNESS WHEREOF, the Company has caused this Certificate to be executed by its duly authorized officer this 20th day of July, 2011.




MORGAN STANLEY

By:		/s/ Martin M. Cohen
Name: Martin M. Cohen
Title: Corporate Secretary

[Signature Page to Series B Certificate of Elimination]

STATE OF DELAWARE

CERTIFICATE OF MERGER OF

DOMESTIC CORPORATIONS

Pursuant to Title 8, Section 251(c) of the Delaware General Corporation Law, the undersigned corporation executed the following Certificate of Merger:

FIRST: The name of the surviving corporation is Morgan Stanley , and the name of the corporation being merged into this surviving corporation is MSDW Credit Products Inc. .

SECOND: The Agreement of Merger has been approved, adopted, certified, executed and acknowledged by each of the constituent corporations.

THIRD: The name of the surviving corporation is Morgan Stanley a Delaware Corporation.

FOURTH: The Certificate of Incorporation of the surviving corporation shall be its Certificate of Incorporation.

FIFTH: The merger is to become effective on December 29, 2011 .

SIXTH: The Agreement of Merger is on file at c/o Morgan Stanley, 1585 Broadway, New York, New York , the place of business of the surviving corporation.

SEVENTH: A copy of the Agreement of Merger will be furnished by the surviving corporation on request, without cost, to any stockholder of the constituent corporations.

IN WITNESS WHEREOF, said surviving Corporation has caused this certificate to be signed by an authorized officer, the 29th day of December, A.D., 2011.




By:		/s/ Aaron Guth
		Authorized Officer

Name:		Aaron Guth
		Print or Type

Title:		Assistant Secretary

CERTIFICATE OF DESIGNATION OF PREFERENCES AND RIGHTS OF THE

FIXED-TO-FLOATING RATE NON-CUMULATIVE PREFERRED STOCK, SERIES E

(Liquidation Preference $25,000 per share)

MORGAN STANLEY

Pursuant to Section 151 of the

General Corporation Law of the State of Delaware

Morgan Stanley, a Delaware corporation (hereinafter called the “Corporation”), DOES HEREBY CERTIFY that, pursuant to resolutions of the Preferred Stock Financing Committee (the “Committee”) of the Board of Directors of the Corporation adopted on September 24, 2013, the creation of Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E, par value $0.01 per share, liquidation preference $25,000 per share (“Series E”), of the Corporation was authorized and the designation, preferences, privileges, voting rights, and other special rights and qualifications, limitations and restrictions of the Series E, in addition to those set forth in the Certificate of Incorporation and Bylaws of the Corporation, are fixed as follows:

1. Designation. The distinctive serial designation of such series of preferred stock is “Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E.” Each share of Series E shall be identical in all respects to every other share of Series E, except as to the respective dates from which dividends thereon shall accrue, to the extent such dates may differ as permitted pursuant to Section 4(a) below.

2. Number of Shares. The authorized number of shares of Series E shall be 34,500. Shares of Series E that are redeemed, purchased or otherwise acquired by the Corporation, or converted into another series of Preferred Stock, shall be cancelled and shall revert to authorized but unissued shares of Preferred Stock; provided that this Section 2 shall not apply to any purchase or other acquisition of shares of Series E by any subsidiary of the Corporation.

3. Definitions. As used herein with respect to Series E:

(a) “Board of Directors” means the board of directors of the Corporation.

(b) “Bylaws” means the amended and restated bylaws of the Corporation, as they may be amended from time to time.

(c) “Business Day” means any day, other than a Saturday or Sunday, that is neither a legal holiday nor a day on which banking institutions are authorized or required by law or regulation to close in The City of New York.

that there is, at all relevant times when the Series E is outstanding, a person or entity appointed and serving as such agent. The Calculation Agent may be a person or entity affiliated with the Corporation.

(e) “Certificate of Designation” means this Certificate of Designation relating to the Series E, as it may be amended or supplemented from time to time.

(f) “Certification of Incorporation” shall mean the amended and restated certificate of incorporation of the Corporation, as it may be amended from time to time, and shall include this Certificate of Designation.

(g) “Common Stock” means the common stock, par value $0.01 per share, of the Corporation.

(h) “Dividend Determination Date” means, for each Dividend Period during the Floating Rate Period, the second London Business Day immediately preceding the first day of such Dividend Period.

(i) “Dividend Payment Date” means January 15, April 15, July 15, and October 15 of each year, subject to adjustment as described in Section 4(a).

(j) “Dividend Period” has the meaning set forth in Section 4(a).

(k) “Dividend Record Date” has the meaning set forth in Section 4(a).

(l) “Federal Reserve Board” means the Board of Governors of the Federal Reserve System.

(m) “Fixed Rate Period” has the meaning set forth in Section 4(a).

(n) “Floating Rate Period” has the meaning set forth in Section 4(a).

(o) “Junior Stock” means any class or series of capital stock of the Corporation that ranks junior to Series E as to the payment of dividends and the distribution of assets upon liquidation, dissolution or winding up of the Corporation. Junior Stock includes the Common Stock.

(p) “LIBOR” has the meaning set forth in Section 4(a).

(q) “Liquidation Preference” has the meaning set forth in Section 5(b).

(r) “London Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is a day on which dealings in U.S. dollars are transacted in the London interbank market.

(s) “Nonpayment” has the meaning set forth in Section 7(b).

(t) “Original Issue Date” means September 30, 2013.

(u) “Parity Stock” means any other class or series of stock of the Corporation that ranks equally with the Series E in the payment of dividends, whether cumulative or non-cumulative, and the distribution of assets upon liquidation, dissolution or winding up of the Corporation. Parity stock includes the Corporation’s previously issued Floating Rate Non-Cumulative Preferred Stock, Series A, liquidation preference $25,000 per share (“Series A”) and the Corporation’s previously issued 10% Series C Non-Cumulative Non-Voting Perpetual Preferred Stock, liquidation preference $1,000 per share (“Series C”).

(v) “Preferred Stock” means any and all series of preferred stock of the Corporation, including the Series E.

(w) “Preferred Stock Directors” has the meaning set forth in Section 7(b).

(x) “Regulatory Capital Treatment Event” has the meaning set forth in Section 6(a).

(y) “Voting Preferred Stock” means any other class or series of Preferred Stock of the Corporation ranking equally with the Series E as to dividends (whether cumulative or non-cumulative) and the distribution of assets upon liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and are exercisable. Voting Preferred Stock includes the Series A and the Series C. Whether a plurality, majority or other portion of the shares of Series E and any other Voting Preferred Stock have been voted in favor of any matter shall be determined by reference to the liquidation amounts of the shares voted.

4. Dividends.

(a) Rate. Holders of Series E will be entitled to receive, when, as and if declared by the Board of Directors or a duly authorized committee of the Board of Directors, out of funds legally available for the payment of dividends under Delaware law, non-cumulative cash dividends from the Original Issue Date (in the case of the initial Dividend Period only) or the immediately preceding Dividend Payment Date, quarterly in arrears on each Dividend Payment Date, commencing on January 15, 2014. These dividends will accrue on the liquidation preference amount of $25,000 per share at a rate per annum equal to 7.125% with respect to each Dividend Period from and including the Original Issue Date to, but excluding, October 15, 2023 (the “Fixed Rate Period”) and at a rate per annum equal to the three-month U.S. dollar LIBOR on the related Dividend Determination Date plus 4.32% with respect to each Dividend Period from and including October 15, 2023 (the “Floating Rate Period”). In the event that the Corporation issues additional shares of Series E after the Original Issue Date, dividends on such shares may accrue from the Original Issue Date or any other date specified by the Board of Directors or an authorized committee thereof at the time such additional shares are issued.

Dividends that are payable on Series E on any Dividend Payment Date will be payable to holders of record of Series E as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or a duly authorized committee of the Board of Directors that is not more than 60 nor less than 10 days prior to such Dividend Payment Date (each, a “Dividend Record Date”).

exclude the January 15, 2014 Dividend Payment Date, and (ii) for any share of Series E issued after the Original Issue Date, the initial Dividend Period for such shares may commence on and include the Original Issue Date or such other date as the Board of Directors or a duly authorized committee of the Board of Directors shall determine and publicly disclose and shall end on and exclude the next Dividend Payment Date. Dividends payable on the Series E for any Dividend Period during the Fixed Rate Period will be computed on the basis of a 360-day year consisting of twelve 30-day months. Dividends payable on the Series E for any Dividend Period during the Floating Rate Period will be computed on the basis of a 360-day year and the actual number of days elapsed in the Dividend Period. Dividends for the initial Dividend Period for shares of Series E issued on the Original Issue Date will be calculated from the Original Issue Date. If any scheduled Dividend Payment Date up to and including the October 15, 2023 scheduled Dividend Payment Date is not a Business Day, then the payment will be made on the next succeeding Business Day and no additional dividends will accrue as a result of that postponement. If any scheduled Dividend Payment Date thereafter is not a Business Day, then the Dividend Payment Date will be postponed to the next succeeding Business Day unless such day falls in the next calendar month, in which case the Dividend Payment Date will be brought forward to the immediately preceding day that is a Business Day, and, in either case, dividends will accrue to, but excluding, the date dividends are paid.

For any Dividend Period during the Floating Rate Period, LIBOR (the London interbank offered rate) shall be determined by the Calculation Agent on the Dividend Determination Date in the following manner:

(i) LIBOR will be the rate for deposits in U.S. dollars for a period of three months, commencing on the first day of such Dividend Period, that appears on Reuters screen page “LIBOR01”, or any successor page, at approximately 11:00 a.m., London time, on that Dividend Determination Date.

(ii) If no such rate appears, then the Calculation Agent will request the principal London offices of each of four major reference banks in the London interbank market, selected by the Calculation Agent as directed by the Corporation, to provide the Calculation Agent with its offered quotation for deposits in U.S. dollars for a period of three months, commencing on the first day of such Dividend Period, to prime banks in the London interbank market at approximately 11:00 a.m., London time, on that Dividend Determination Date and in a principal amount that is representative of a single transaction in U.S. dollars in that market at that time. If at least two quotations are provided, LIBOR determined on that Dividend Determination Date will be the arithmetic mean of those quotations. If fewer than two quotations are provided, LIBOR will be determined for the first day of such Dividend Period as the arithmetic mean of the rates quoted at approximately 11:00 a.m., New York time, on that Dividend Determination Date, by three major banks in New York City, selected by the Calculation Agent as directed by the Corporation, for loans in U.S. dollars to leading European banks, for a period of three months, commencing on the first day of such Dividend Period, and in a principal amount that is representative of a single transaction in U.S. dollars in that market at that time. If the banks so selected by the Calculation Agent are not quoting as set forth above, LIBOR for that Dividend Determination Date will be the same as LIBOR for the immediately preceding Dividend Period, or, if there was no such Dividend Period, the dividend payable will be based on the initial dividend rate.

The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends for any Dividend Period, will be on file at the Corporation’s principal offices, will be made available to any stockholder upon request and will be final and binding in the absence of manifest error.

“Reuters” means Reuters 3000 Xtra Service or any successor service.

Holders of Series E shall not be entitled to any dividends, whether payable in cash, securities or other property, other than dividends (if any) declared and payable on the Series E as specified in this Section 4 (subject to the other provisions of this Certificate of Designation).

Dividends on shares of the Series E will not be cumulative. Accordingly, if the Board of Directors (or a duly authorized committee thereof) does not declare a dividend on the Series E payable in respect of any Dividend Period before the related Dividend Payment Date, such dividend will not accrue and the Corporation will have no obligation to pay a dividend for that Dividend Period on the Dividend Payment Date or at any future time, whether or not dividends on the Series E are declared for any future Dividend Period.

(b) Priority of Dividends. The Series E will rank (i) senior to the Common Stock and any class or series of the Corporation’s capital stock expressly stated to be junior to the Series E, (ii) junior to any class or series of the Corporation’s capital stock expressly stated to be senior to the Series E (issued with the requisite consent of the holders of the Series E, if required) and (iii) equally with the Series A, the Series C and each other class or series of Preferred Stock the Corporation may issue that is not expressly stated to be senior or junior to the Series E, with respect to the payment of dividends and the distribution of assets upon liquidation, dissolution or winding up of the Corporation.

So long as any share of Series E remains outstanding, no dividend or distribution shall be paid or declared on Junior Stock, and no Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by the Corporation, directly or indirectly, during a Dividend Period, unless the full dividend for the latest completed Dividend Period on all

outstanding shares of Series E has been declared and paid (or declared and a sum sufficient for the payment thereof has been set aside). The foregoing limitation shall not apply to:


•	repurchases, redemptions or other acquisitions of shares of Junior Stock in connection with (1) any employment contract, benefit plan or other similar arrangement with or for the benefit of any one or more employees, officers, directors or consultants or (2) a dividend reinvestment or stockholder stock purchase plan;


•	an exchange, redemption, reclassification or conversion of any class or series of Junior Stock, or any junior stock of a subsidiary of the Corporation, for any class or series of Junior Stock;


•	the purchase of fractional interests in shares of Junior Stock under the conversion or exchange provisions of Junior Stock or the security being converted or exchanged;


•	any declaration of a dividend in connection with any stockholders’ rights plan, or the issuance of rights, stock or other property under any stockholders’ rights plan, or the redemption or repurchase of rights pursuant to the plan; or


•	any dividend in the form of stock, warrants, options or other rights where the dividend stock or the stock issuable upon exercise of such warrants, options or other rights is the same stock as that on which the dividend is being paid or ranks equal or junior to that stock.

In addition, the foregoing limitation shall not restrict the ability of Morgan Stanley & Co. LLC, or any other affiliate of the Corporation, to engage in any market-making transactions in Junior Stock in the ordinary course of business.

When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within a related Dividend Period) in full upon the Series E and any shares of Parity Stock, all dividends declared on the Series E and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the related Dividend Period) shall be declared pro rata so that the respective amounts of such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series E and all Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the related Dividend Period) bear to each other.

Subject to the foregoing, dividends (payable in cash, securities or other property) may be determined by the Board of Directors or a duly authorized committee of the Board of Directors and may be declared and paid on the Common Stock and any stock ranking, as to dividends, equally with or junior to the Series E, from time to time out of any funds legally available for such payment, and the Series E shall not be entitled to participate in any such dividends.

(c) Restrictions on the Payment of Dividends. Dividends on the Series E will not be declared, paid or set aside for payment if the Corporation fails to comply, or if and to the extent such act would cause the Corporation to fail to comply, with applicable laws and regulations, including the capital adequacy guidelines of the Federal Reserve Board (or, as and if applicable, the capital adequacy guidelines or regulations of any successor appropriate federal banking agency) applicable to the Corporation.

5. Liquidation Rights.

(a) Voluntary or Involuntary Liquidation. Upon any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, holders of Series E shall be entitled to receive out of the assets of the Corporation or proceeds thereof available for distribution to stockholders of the Corporation, after satisfaction of all liabilities to creditors, if any, of the Corporation and subject to the rights of holders of any shares of capital stock of the Corporation then outstanding ranking senior to or pari passu with the Series E in respect of distributions upon liquidation, dissolution or winding up of the Corporation, and before any distribution of such assets or proceeds is made to or set aside for the holders of Common Stock and any other classes or series of capital stock of the Corporation ranking junior to the Series E as to such distribution, a liquidating distribution in an amount equal to $25,000 per share, together with an amount equal to all dividends, if any, that have been declared but not paid prior to the date of payment of such distribution (but without any accumulation in respect of dividends that have not been declared prior to such payment date). Holders of the Series E will not be entitled to any other amounts from the Corporation after they have received their full liquidation preference.

equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series E and on which dividends accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as applicable). Holders of the Series E will not be entitled to any other amounts from the Corporation after they have received the full amounts provided for in this Section 5 and will have no right or claim to any of the Corporation’s remaining assets.

(c) Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series E and any other shares of the Corporation’s stock ranking equally as to the Liquidation Preference, the holders of other stock of the Corporation ranking junior as to the Liquidation Preference shall be entitled to receive all remaining assets of the Corporation (or proceeds thereof) according to their respective rights and preferences.

(d) Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the merger or consolidation of the Corporation with or into any other corporation or other entity, including a merger or consolidation in which the holders of Series E receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash, securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation, dissolution or winding up of the Corporation.

6. Redemption.

(a) Optional Redemption. The Corporation may, at its option, redeem the Series E (i) in whole or in part, from time to time, on any Dividend Payment Date on or after October 15, 2023 or (ii) in whole but not in part at any time within 90 days following a Regulatory Capital Treatment Event (as defined below), in each case upon notice given as provided in Section 6(c) below, at a redemption price equal to $25,000 per share, together with (except as otherwise provided herein below) any declared and unpaid dividends to, but excluding, the date fixed for redemption, without accumulation of any undeclared dividends. The redemption price for any shares of Series E shall be payable on the redemption date to the holder of such shares against surrender of the certificate(s) evidencing such shares to the Corporation or its agent. Any declared and unpaid dividend for the then current Dividend Period payable on a redemption date that occurs subsequent to the Dividend Record Date for a Dividend Period shall not be paid to the holder entitled to receive the redemption price on the redemption date, but rather shall be paid to the holder of record of the redeemed shares on such Dividend Record Date relating to the Dividend Payment Date as provided in Section 4 above.

A “Regulatory Capital Treatment Event” means the good faith determination by the Corporation that, as a result of (i) any amendment to, or change in, the laws or regulations of the United States or any political subdivision of or in the United States that is enacted or becomes effective after September 24, 2013, (ii) any proposed change in those laws or regulations that is announced or becomes effective after September 24, 2013, or (iii) any official administrative decision or judicial decision or administrative action or other official pronouncement interpreting or applying those laws or regulations that is announced after September 24, 2013, there is more than an insubstantial risk that the Corporation will not be entitled to treat the full liquidation preference amount of $25,000 per share of Series E then outstanding as “Additional Tier 1” capital (or its equivalent) for purposes of the capital adequacy guidelines of the Federal Reserve Board (or, as and if applicable, the capital adequacy guidelines or regulations of any successor appropriate federal banking agency) as then in effect and applicable, for so long as any share of Series E is outstanding. “Appropriate federal banking agency” means the “appropriate federal banking agency” with respect to the Corporation as that term is defined in Section 3(q) of the Federal Deposit Insurance Act or any successor provision.

(b) No Sinking Fund. The Series E will not be subject to any mandatory redemption, sinking fund or other similar provisions. Holders of Series E will have no right to require the redemption or repurchase of any shares of Series E.

(c) Notice of Redemption. Notice of every redemption of shares of Series E shall be given by first class mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice or in the mailing thereof, to any holder of shares of Series E designated for redemption shall not affect the validity of the proceedings for the redemption of any other shares of Series E. Notwithstanding the foregoing, if the depositary shares representing interests in the Series E are issued in book-entry form through The Depository Trust Company or any other similar facility, notice of redemption may be given to the holders of Series E at such time and in any manner permitted by such facility. Each such notice given to a holder shall state: (1) the redemption date; (2) the number of shares of Series E to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be redeemed from such holder; (3) the redemption price; and (4) the place or places where certificates for such shares are to be surrendered for payment of the redemption price.

(d) Partial Redemption. In case of any redemption of only part of the shares of Series E at the time outstanding, the shares to be redeemed shall be selected either pro rata or by lot. Subject to the provisions hereof, the Corporation shall have

full power and authority to prescribe the terms and conditions upon which shares of Series E shall be redeemed from time to time. If fewer than all the shares represented by any certificate are redeemed, a new certificate shall be issued representing the unredeemed shares without charge to the holder thereof.

(e) Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate and apart from its other funds, in trust for the pro rata benefit of the holders of any shares of Series E so called for redemption, so as to be and continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for redemption, all shares so called for redemption shall no longer be deemed outstanding and all rights with respect to such shares shall forthwith on such redemption date cease and terminate, except only the right of the holders thereof to receive the amount payable on such redemption, without interest. Any funds unclaimed at the end of two years from the redemption date shall, to the extent permitted by law, be released to the Corporation, after which time the holders of the shares so called for redemption shall look only to the Corporation for payment of the redemption price of such shares.

7. Voting Rights.

(a) General. The holders of Series E shall not have any voting rights except as set forth below and as determined by the Board of Directors or an authorized committee thereof or as otherwise from time to time required by law.

(b) Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any shares of the Series E, or any other Voting Preferred Stock, shall have not been declared and paid for the equivalent of six or more dividend payments, whether or not for consecutive dividend periods (a “Nonpayment”), the holders of such shares, voting together as a class with holders of any and all other series of Voting Preferred Stock then outstanding, will be entitled to vote for the election of a total of two additional members of the Board of Directors (the “Preferred Stock Directors”), provided that the election of any such directors shall not cause the Corporation to violate the corporate governance requirement of the New York Stock Exchange (or any other exchange on which the Corporation’s securities may be listed) that listed companies must have a majority of independent directors and provided further that the Board of Directors shall at no time include more than two Preferred Stock Directors. In that event, the number of directors on the Board of Directors shall automatically increase by two, and the new directors shall be elected at a special meeting called at the request of the holders of record of at least 20% of the Series E or of any other series of Voting Preferred Stock (unless such request is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held at such next annual or special meeting of stockholders), and at each subsequent annual meeting. Such request to call a special meeting for the initial election of the Preferred Stock Directors after a Nonpayment shall be made by written notice, signed by the requisite holders of Series E or other Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner as provided for in Section 9 below, or as may otherwise be required by law. The voting rights will continue until dividends on the shares of the Series E and any such series of Voting Preferred Stock shall have been fully paid (or declared and a sum sufficient for the payment of such dividends shall have been set aside for such payment) for at least four consecutive regular dividend periods following the Nonpayment.

If and when dividends for at least four consecutive regular dividend periods following a Nonpayment have been fully paid (or declared and a sum sufficient for such payment shall have been set aside) on the Series E and any other class or series of Voting Preferred Stock, the holders of the Series E and all other holders of Voting Preferred Stock shall be divested of the foregoing voting rights (subject to revesting in the event of each subsequent Nonpayment), the term of office of each Preferred Stock Director so elected shall terminate and the number of directors on the Board of Directors shall automatically decrease by two. In determining whether dividends have been paid for at least four consecutive regular dividend periods following a Nonpayment, the Corporation may take account of any dividend it elects to pay for any dividend period after the regular dividend date for that period has passed. Any Preferred Stock Director may be removed at any time without cause by the holders of record of a majority of the outstanding shares of the Series E together with all series of Voting Preferred Stock then outstanding (voting together as a single class) to the extent such holders have the voting rights described above. So long as a Nonpayment shall continue, any vacancy in the office of a Preferred Stock Director (other than prior to the initial election after a Nonpayment) may be filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of the holders of record of a majority of the outstanding shares of Series E and all Voting Preferred Stock when they have the voting rights described above (voting together as a single class); provided that the filling of each vacancy shall not cause the Corporation to violate the corporate governance requirements of the New York Stock Exchange (or any other exchange on which the Corporation’s securities may be listed) that listed companies must have a majority of independent directors. Any such vote to remove, or to fill a vacancy in the office of, a Preferred Stock Director may be taken only at a special meeting called at the request of the holders of record of at least 20% of the Series E or of any other series of Voting Preferred Stock (unless such request is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held at such next annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to one vote per director on any matter.

(c) Other Voting Rights. So long as any shares of Series E are outstanding, in addition to any other vote or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at least two-thirds of the shares of Series E and any Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for the purpose, shall be necessary for effecting or validating:

(i) Authorization of Senior Stock. Any amendment or alteration of the provisions of the Certificate of Incorporation or this Certificate of Designation to authorize or create, or increase the authorized amount of, any shares of any class or series of stock of the Corporation ranking senior to the Series E with respect to the payment of dividends or the distribution of assets upon any liquidation, dissolution or winding up of the Corporation;

(ii) Amendment of Series E. Any amendment, alteration or repeal of any provision of the Certificate of Incorporation or this Certificate of Designation, whether by merger, consolidation or otherwise, so as to materially and adversely affect the special rights, preferences, privileges and voting powers of the Series E, taken as a whole; or

(iii) Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a binding share exchange or reclassification involving the Series E, or of a merger or consolidation of the Corporation with another entity, unless in each case (x) the shares of Series E remain outstanding or, in the case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights, preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers of the Series E, taken as a whole;

provided, however, that for all purposes of this Section 7(c), any increase in the amount of the authorized or issued Series E, Series A or Series C, or the creation and issuance, or an increase in the authorized or issued amount, of any other class or series of Preferred Stock ranking equally with the Series E with respect to the payment of dividends (whether such dividends are cumulative or non-cumulative) and the distribution of assets upon liquidation, dissolution or winding up of the Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers of, and will not require the affirmative vote or consent of, the holders of outstanding shares of Series E.

If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in this Section 7(c) would adversely affect one or more but not all other series of Voting Preferred Stock (including the Series E for this purpose), then only such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the matter together as a class in lieu of all other series of Preferred Stock. If all series of a class of Preferred Stock are not equally affected by the proposed amendment, alteration, repeal, share exchange, reclassification, merger or consolidation described above, there shall be required a two-thirds approval of the class and a two-thirds approval of each series that will have a diminished status.

(d) Changes for Clarification. Without the consent of the holders of the Series E, so long as such action does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of the Series E, the Corporation may amend, alter, supplement or repeal any terms of the Series E:

(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of Designation that may be defective or inconsistent; or

(ii) to make any provision with respect to matters or questions arising with respect to the Series E that is not inconsistent with the provisions of this Certificate of Designation.

(e) Changes after Provision for Redemption. No vote or consent of the holders of Series E shall be required pursuant to Section 7(b), (c) or (d) above if, at or prior to the time when the act with respect to which any such vote or consent would otherwise be required pursuant to such Section, all outstanding shares of Series E shall have been redeemed, or shall have been called for redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to Section 6 above.

(f) Procedures for Voting and Consents. The rules and procedures for calling and conducting any meeting of the holders of Series E (including, without limitation, the fixing of a record date in connection therewith), the solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard to such a meeting or such consents shall be governed by any rules the Board of Directors or a duly authorized committee of the Board of Directors, in its discretion, may adopt from time to time, which rules and procedures shall conform to the requirements of the Certificate of Incorporation, the Bylaws, applicable law and any national securities exchange or other trading facility on which the Series E is listed or traded at the time. Whether the vote or consent of the holders of a plurality, majority or other portion of the shares of Series E and any Voting Preferred Stock has been cast or given on any matter on which the holders of shares of Series E are

entitled to vote shall be determined by the Corporation by reference to the specified liquidation amounts of the shares voted or covered by the consent.

8. Record Holders. To the fullest extent permitted by applicable law, the Corporation and the transfer agent for the Series E may deem and treat the record holder of any share of Series E as the true and lawful owner thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.

9. Notices. All notices or communications in respect of Series E shall be sufficiently given if given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be permitted in this Certificate of Designation, in the Certificate of Incorporation or Bylaws or by applicable law.

10. No Preemptive Rights. No share of Series E shall have any rights of preemption whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto, regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.

11. Other Rights. The shares of Series E shall not have any voting powers, preferences or relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set forth herein or in the Certificate of Incorporation or as provided by applicable law.

IN WITNESS WHEREOF, Morgan Stanley has caused this certificate to be signed by Kevin Sheehan, its Assistant Treasurer, this 27th day of September, 2013.




MORGAN STANLEY

By		/s/ Kevin Sheehan
		Name: Kevin Sheehan
		Title: Assistant Treasurer

CERTIFICATE OF DESIGNATION OF PREFERENCES AND RIGHTS OF THE

FIXED-TO-FLOATING RATE NON-CUMULATIVE PREFERRED STOCK, SERIES F

(Liquidation Preference $25,000 per share)

MORGAN STANLEY

Pursuant to Section 151 of the

General Corporation Law of the State of Delaware

Morgan Stanley, a Delaware corporation (hereinafter called the “Corporation”), DOES HEREBY CERTIFY that, pursuant to resolutions of the Preferred Stock Financing Committee (the “Committee”) of the Board of Directors of the Corporation adopted on December 5, 2013, the creation of Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series F, par value $0.01 per share, liquidation preference $25,000 per share (“Series F”), of the Corporation was authorized and the designation, preferences, privileges, voting rights, and other special rights and qualifications, limitations and restrictions of the Series F, in addition to those set forth in the Certificate of Incorporation and Bylaws of the Corporation, are fixed as follows:

1. Designation. The distinctive serial designation of such series of preferred stock is “Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series F.” Each share of Series F shall be identical in all respects to every other share of Series F, except as to the respective dates from which dividends thereon shall accrue, to the extent such dates may differ as permitted pursuant to Section 4(a) below.

2. Number of Shares. The authorized number of shares of Series F shall be 39,100. Shares of Series F that are redeemed, purchased or otherwise acquired by the Corporation, or converted into another series of Preferred Stock, shall be cancelled and shall revert to authorized but unissued shares of Preferred Stock; provided that this Section 2 shall not apply to any purchase or other acquisition of shares of Series F by any subsidiary of the Corporation.

3. Definitions. As used herein with respect to Series F:

(a) “Board of Directors” means the board of directors of the Corporation.

(b) “Bylaws” means the amended and restated bylaws of the Corporation, as they may be amended from time to time.

that there is, at all relevant times when the Series F is outstanding, a person or entity appointed and serving as such agent. The Calculation Agent may be a person or entity affiliated with the Corporation.

(e) “Certificate of Designation” means this Certificate of Designation relating to the Series F, as it may be amended or supplemented from time to time.